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Abstract
Linear carbon-carbon chains with alternating hydroxyl and methyl substituents
are a common motif in various natural products. Many of these so-called
polypropionates (i.e. 4) show biological activity and are useful in the fields of medicine
and agriculture. The stereoselective synthesis of polypropionates has been extensively
investigated and numerous strategies and tactics have been developed.
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The sequential aldol reactions of thiopYran derivatives 122 and 125 followed by
desulfurization of aldol adducts is a strategy to rapidly construct hexapropionate
synthons (e.g. 165). The present work concerns the control of the stereoselectivity in the
two key aldol coupling steps inherent in this strategy.
In Section 2.2, the influence of reaction conditions and the relative configuration
of the p-alkoxy group of aldehydes cis-125b and trans-125c on the diastereoselectivity
of the 1st aldol coupling are discussed. The results were rationalized according to Evan's
merged 1,2- and 1,3-stereoinduction model (nonchelation), with the exception of the'
MgBr2eOE12 promoted reactions of 137b (M = TMS) with 125a, 125b and 125c, which
were accommodated by assuming chelation control. Under appropriate conditions, three
(126a-128a) of the four possible diastereomers could be obtained stereoselectively. The
fourth diastereomer (129a) was readily available by isomerization (vide infra).
In Section 2.3, the diastereoselectivities of the aldol reactions of (±)-125a with
(±)-126a and (±)-127a (previous work) and reactions of (±)-125a with (±)-128a and
(±)-129a (this work) are presented. These reactions occurred with high mutual kinetic
enantioselection (MKE) and were highly diastereoselective for the formation of one out
of eight possible diastereomers. The diastereoselectivity of aldol reactions of (±)-125a
with related p-alkoxy ketones (±)-166 and (±)-168 (previous work) and reactions with
111
(±)-172 and (±)-174 (this work) were also investigated. Contrary to the aldol reactions
of ~-hydroxyketones (126a-129a), reactions of ~-alkoxy ketones (166, 168, 172, 174)
proceeded without significant MKE. These reactions were also highly diastereoselective
giving two products, one each from the like and unlike reactions.
In Section 2.4, the use of imidazole as an effective catalyst for synlanti
isomerization of aldols via keto-enol tautomerism is described. A large variety of aldol
(e.g. 126) and bisaldol (e.g. 165) adducts were shown to undergo efficient isomerization
with minimal retroaldol and elimination reactions. The rate constants for this process
were determined for several substrates. It was found that thiopYfanone derived aldols
isomerize much faster than related cyclohexanone aldols and the ~-hydroxy ketones
(e.g. 128a) isomerize faster than ~-alkoxy derivatives (e.g. 172).
In section 2.5, the relative configuration of aldol adducts was rigorously
determined using chemical correlations and NMR methods.
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1. INTRODUCTION
1.1. POLVPROPIONATES
Linear carbon-carbon chains with alternating oxygen (hydroxyl or oxo) and
methyl substituents are a common structural motif in various natural products. These
structures 4 have been defined as polypropionates and their biosynthesis involves the
reaction between coenzyme A activated propionate monomers 2 and 3* catalyzed by
the polyketide sYnthase system (PKS) (Figure 1).1-4 Natural products that incorporate
polypropionates have attracted a lot of attention during the past 50 years with progress
in areas such as isolation, characterization, biosYnthesis, and improved methods in their
total sYnthesis. I-3,5-8 Many of these natural products that show biological activity have
been successfully applied in medicine and agriculture. 8 For example, the
heptapropionates 5a (6-deoxyerythronolide B), 5c (erythronolide B) and the related
erythromycin A (5b glycosylated at the C-2 and C-5 positions) (Figure 2) have
antifungal and antimicrobial activity. Erythromycin A is widely used in the treatment of
many infectious diseases by oral administration.8 The mode of action of erythromycin A
involves the inhibition of the peptidyl transferase center of the bacterial ribosome,
thereby inhibiting protein sYnthesis. 8 Antibiotic resistance to these natural products is a
growing concern. It would be desirable to SYnthesise novel libraries of erythromycin
analogues to probe the structure activity relationships (SAR) responsible for their
biological activity and discover new analogues with increased potency against resistant
microbes. Such an approach will require improved SYnthetic methodologies to allow the
facile sythesis of these stereochemically complext polypropionates.
Numerous synthetic methodologies have been used for stereoselective synthesis
of polypropionate fragments including Claisen rearrangements,9,10 iodocarbonylations,11
allenylmetal additions,12-15 crotyl metal additions,16-19 Diels_Alder,6,20-24 and aldol
• Monomer 3 is synthetically equivalent to a polypropionate monomer since a-C02H substituent is
removed upon chain elongation in the PKS catalyzed biosynthesis.
t Each carbon center on the polypropionate backbone that contains an hydroxyl or methyl substituent is a
potential stereogenic center.
1
1
propionate
x=O
or
X= OH, H
polyketide synthetase
system (PKS)
..
x x o
OH
2 (n+1) x 3 n
n =0, 1, 2, .. integer
4
polypropionate
Figure 1. Biosynthesis of polypropionates from reaction from 2 and 3.
o
6 Heptapropionate
5a-c
5a 6-Deoxyerythronolide B, R1 =R2 =H
5b Erythronolide A, R1 =R2 =OH
5c Erythronolide B, R1 =H, R2 =OH
5d Oleandolide
Figure 2. Heptapropionate natural products 5a-d.
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Figure 3. Polypropionate natural products 7a-c.
reactions6,25-44. The aldol reaction is highly suitable for the synthesis of polypropionates
because it gives carbon chains with oxygen functionalities in the 1,3-positions. Highly
3
stereoselective aldol reactions have contributed immensely to the efficiency of the
synthesis of polypropionate containing natural products. Examples are the
stereoselective synthesis of the heptapropionate 5d (oleandolide) 16,45,46 (structurally
related to the erythromycins 5a-c, Figure 2), the hexapropionates 7a (muamvatin)47,48
and 7b (denticulatin A)49-51 and the decapropionate 7c (siphonarin B)52 (Figure 3). The
origin of stereoselective aldol reactions is the natural result of understanding· the
underlying stereochemical control elements present in the aldol reaction and these will
be discussed in section 1.2.
1.2. ALDOL STEREOSELECTION
The aldol addition reaction is a C-C bond forming reaction that involves the
addition of an enol equivalent to an aldehyde (or ketone) resulting in the formation of a
p-hydroxy carbonyl product.53 Traditionally, aldol addition reactions were carried out
under protic conditions where the enol or enolate was generated reversibly in the
presence of the electrophilic carbonyl compound. Under these conditions, the reaction is
reversible and product formation is under thermodynamic control. There are many
limitations when the aldol reaction is conducted under equilibrating reaction conditions.
For example, when the two carbonyl components to be coupled are not identical and
both possess a hydrogen at an a-position to the carbonyl it is possible that an enol(ate)
could be generated from either carbonyl component and the subsequent addition of
these enol(ate)s to either of the carbonyl components results in the formation of
complex mixtures. This shortcoming was overcome by generating the enol- or enolate-
component quantitatively prior to the addition of the electrophilic carbonyl
component.53 This so called 'directed' aldol reaction generally gives products under
kinetic control. An aldol reaction leads to C-C bond formation with the potential of
generating two new stereogenic centers (Figure 4).54
The discovery and implementation of methodologies that allow the generation of
the newly formed stereogenic centers in a highly stereoselective manner has made the
aldol reaction a powerful tool for organic synthesis.55 The principles governing the
stereoselectivity of this versatile coupling reaction are presented in the following
sections.
4
•9 10 11
R2 =H, alkyl, alkoxy, NR2' SR
M =metal counterion such as Li, S, Mg, Sn, Ti
L = appropriate ligand such as halide alkyl, aryl, alkoxy, ester
Figure 4. Generalized aldol reaction
1.2.1. Relative Topicity with Achiral Substrates
The aldol reaction between achiral reaction partners leads to the formation of up
to two stereogenic centers and up to four possible stereoisomeric products.54 The
absolute and relative configuration of these newly generated centers is dependant on the
relative orientation of the 1t-faces of the enol(ate) and aldehyde in the transition state for
formation of the aldol adduct (Figure 5). The two enantiotopic faces of the aldehyde and
of the enolate are distinguished as Re/Si nomenclature according to IUPAC rules
(Figure 5). The relative configuration of the products can be defined using syn/anti
nomenclature. The SYn (same side) and the anti (opposite side) stereochemical
descriptors for aldols 13 and 14 refer to the relative disposition of the designated pairs
of non-hydrogen substituents with respect to the plane defined by the carbon chain
(C-l )-(C-2)-(C-3)-(C-4) in an extended (zigzag) conformation.
There are four ways in which the faces of the aldehyde and enol(ate) can be
orientated relative to each other in the the transition state.54 For example, the Si face of
aldehyde 9 can approach the Re face of enol(ate) 12 to give 2,3-sYn 13 (Si-Re' adduct)
or it can approach the Si face of enol(ate) 12 to give 2,3-anti 14 (Si-Si' adduct).
Following the same logic, the Re face of aldehyde 9 can approach the Si face of enolate
12 to give 2,3-sYn ent-13 (Re-Si' adduct), and approach of the Re aldehyde face of
aldehyde 9 to the Re face of enolate 12 gives the 2,3-anti ent-14 (Re-Re' adduct) (Figure
5). The two stereoisomers that have 2,3-syn relative configuration are enantiomers (i.e.
13 and ent-13) as are the two stereoisomers with 2,3-anti relative configuration (i.e. 14
and ent-14).
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Figure 5. Aldol reaction of an achiral aldehyde with an achiral enolate.
In an achiral environment, enantiomers will be produced in equal amounts;
however, the syn and anti diastereomers will generally be produced in different
amounts. The relative topicity of an aldol reaction describes the relative orientation of
the reacting faces of the aldehyde and enol(ate). Under kinetic control, one relative
topicity will be preferred reflecting a particular preference for a particular relative
orientation of the aldehyde and enol(ate) faces in the transition state (i.e. lk [Re-Re' or
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Si-Si'] vs. ul [Re-Si' or Si-Re']. The relative topicity in the transition state is directly
related to the relative configuration of the product and, for convenience, is denoted
according to product stereochemistry. For example, the relative topicity of an aldol
reaction where the Si face of aldehyde 9 adds to the Re face of enolate 12 to give adduct
13 with 2,3-syn relative configuration will be described as syn (Figure 2). The preferred
Relative Topicity can be determined from the product distribution, where:
Relative Topicity = syn/anti = [13 + ent-13] / [14 + ent-14]
Much effort has been invested to discover the factors influencing the preferred
relative topicity of the aldol reaction. It was found early on that the enolate geometry (E
or Z) can strongly influence the preferred relative topicity. Generally Z-enolates
produce syn aldol adducts selectively, whereas E-enolates give predominantly anti aldol
adducts (Scheme 1).56 Furthermore it was found that with increasing steric bulk of the
R2 moiety (H<C2H5<i-C3H7<t-C4H9) the syn diastereoselectivity of the Z-enolate
increased.57 A similar but less pronounced trend was found for the E-enolate, which
increasingly favoured anti diastereoselectivity as steric bulk of R2 moiety increased.57
These observations were rationalized with the model originally proposed by
Zimmerman and Traxler (Figure 6).58
The Zimmerman-Traxler model assumes a closed six-membered chairlike
transition state that involves coordination of the oxygen atoms of both the aldehyde and
enolate to a metal (e.g. lithium or boron) center as illustrated in Figure 6. As a result of
the six-membered closed-transition state the greatest steric interaction will occur when
both groups Rl and R2 occupy the axial orientations leading to a sterically unfavourable
1,3 diaxial interaction. Therefore as the steric demands of R2 increase, transition state B
from the Z-enolate will be relatively less favoured due to the increasingly unfavourable
Rl'~-~R2 steric interaction. Thus the Z-enolate selectively leads to the syn adduct due to
the absence of unfavourable steric interactions in TS A. The relative topicity of the
aldol reaction with the E-enolate is anti selective due to the absence of these
unfavourable R1BR2 steric interactions in TS C.
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Z-19
TSA
TSB
OH 0R1YRz
R3
(±)-20 syn
(±)-21 anti
E-19
TSC
TSD
•
OH 0
R1VR2
R3
(±)-21 anti
OH 0
R1Y R2
R3
(±)-20 syn
Figure 6. The Zimmerman-Traxler model
To take advantage of these relationships, the stereoselective preparation of
enolates is necessary. Studies of the addition of various lithium enolates of ketones 15
to benzaldehyde revealed that enolates generated with LHMDS usually give more Z-
enolate (Z-16) compared to enolates generated from LDA, while enolates generated
from LTMP usually give more E-enolate (E-16) (Scheme 1).57 In general, the formation
of boron enolates using reagents with sterically demanding ligands (eg. c-hex) and a
poor leaving group on boron (eg. CI) in the presence of a small amine base (eg. EhN)
provide the E-enolate (Scheme 1).59 The Z-enolate is preferentially obtained when
8
reagents with small ligands (eg. n-Bu), a good leaving group (eg. OTt) and a hindered
amine (eg. i-Pr2EtN) is used.6o A·theoretical model has been proposed to explain these
t ds 61,62ren .
Mukaiyama found that certain Lewis acids were able to promote the reaction of
enolsilanes with aldehydes to give aldol products.63 Unlike the aldol reactions of boron-
and lithium enolates, the Mukaiyama reaction does not involve the formation of metal-
enolates. This reaction is facilitated by the increased electrophilicity of the aldehyde
component due to coordination of the Lewis acid.64 From the examples of Lewis acid
promoted aldol reactions given in Table 1, it is apparent that the preferred relative
topicity of the Mukaiyama reaction is unaffected by the EIZ geometry of the
enolsilanes. Clearly a Zimmerman-Traxler model cannot explain the observed
stereoselectivities.
conditions i. and ii. favour Z-16
cond i.'LOA
or LHMOS
•
cond ii. BU2BOTf
ipr2NEt
PhCHO
Z-16 syn-17 anti-18
15 conditions iii. and iv. favour E-16
cond i. 17:18 3.3-50: 1
cond ii. 17:18 3-32: 1
cond iii. 17:18 1 : 1.2-11.5
cond iv. 17:18 1: 3.8-32
cond iii. LOA
[ OM ]or LTMP R2~ PhCHO• •
cond iv. ChX2BCI
E-16Et3N
syn-17 + anti-18
R2 = C2HS, i-C3H7 , i-C4Hg, t-C4Hg
Scheme 1. Effect of Z/E-enolate geometry on aldol relative topicity56,57
Open transition state models place the trigonal carbons of the enolsilane and
aldehyde components in a staggered orientation (Figure 7).65 There are six possible
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staggered orientations. Product formation is thought to be favoured from those
orientations that minimize dipolar repulsion between the oxygens of the aldehyde and
enolsilane and avoid unfavourable steric interactions between the substituents.
Table 1. Lewis acid promoted aldol reactions66
R2 OH a OH a
RJOTMS
Lewis Acid R1~R3 R1Y R3R1-CHO .. +
R2 R2
9 22 anti-23 syn-24
entry R1 R2 R3 Enolsilane Lewis acid 23: 24 yieldZ:E (anti:syn) 0/0
1 ipr Me OEt 15 : 85 TiCl4 93 : 7 75
2 ipr Me tBu 100: a BF3-0Et2 95 : 5 84
3 Ph Me OEt 25: 75 TiCI4-PPh3 91 : 9 27
4 Ph Me tBu 100: a BF3-OEh 95 : 5 95
5 Ph tBu OEt 76: 24 TiCl4 8: 92 a
6 Ph tBu OEt 5: 95 TiCl4 8: 92 a
a Not reported.
"LA
favoured
a R2~t H OH aR2§eH R~~H R1~R3R1 H ---- ---- ~--- H a-LA --- LA-a R1 R2TMsa R3 TMsa R3 TMsa R3
A B C anti-23
"LA
a R H OH a
H§2R2 H~2 H~R2 R1YR3R1 H ~ H a-LA ---- ~
--- LA-a R1R3 aTMs R3 aTMs R3 aTMs
R2
0 E F syn-24
Figure 7. Open transition state model for Mukaiyama aldol reaction.
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Notice that for entries 2 and 4 (Table 1) the Z-enol ilane selectively leads to the
formation of anti-23 whereas the Zimmennan-Traxler mo el would have predicted the
formation of syn-24 from a Z-enolate. An Open Transition State model accounts for the
observed selectivity. The transition state A, which leads to anti-23, is favoured because
it avoids dipolar repulsion and minimizes steric interactio s. Transitions states B, C, D
and F are disfavoured due to the steric interactions betwe n R3~Rl and R3~LA, and
transition C and E are also further disfavoured due to dipo ar repulsion arising from the
orientation of the two oxygens present in the aldehyde and enolsilane components.
Following the same reasoning as above, the preferred re ative topicities of the aldol
reactions in Table I can be rationalized.
1.2.2. Enantioselectivity with Achiral Substrates
There are up to four stereoisomers possible in an a dol reaction between achiral
substrates (Figure 5). Racemic syn or anti adducts can be iastereoselectivelyobtained
from aldol reactions that have good control of the relative opicity. A means to effect an
enantioselective synthesis would require a reaction wit a highly preferred relative
topicity under conditions where addition to one of th enantiotopic faces of the
aldehyde or of the enolate is preferred. Two approaches ave frequently been used. In
one, chiral ligands are coordinated to the metal enolat rendering the faces of the
enolate diastereotopic and of different reactivity.67-7o In the second approach, chiral
ligands are coordinated to the Lewis acidic metal used to promote a Mukaiyama aldol
reaction; coordination of the aldehyde to this chiral Lew·s acid renders the aldehyde
faces diastereotopic and of different reactivity.
An example of the first approach is the use of chiral (-)-diisopinocampheyl
ligands attached to boron enolate. There are four possible stereoisomers from the aldol
reaction of Z-26 with 27 (Scheme 2). For this aldol react"on Paterson et al. obtained a
single stereoisomer 28 with high selectivity67. As expect d, the reaction of the boron
enolate with Z geometry (Z-26) occurred with high prefer nee in the relative topicity to
give mostly syn adducts71 ( i.e. d.r. = syn : anti = 95 : 5), and isomer 28 was obtained
selectively due to the difference in the rates of addition 0 27 to the two diastereotopic
faces of enolate Z-26.
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25
(-)lpc2BOTf
ipr2EtN
~
OB(-)lpC2
R1~
Z-26
major product
HYy frY
27
--...~ 28 ent-28
total combined yield 75%
d.r. =[28 + ent-28] : [29 + ent-29] =95 : 5
e.r. =28 : ent-28 =20 : 1
29 ent-29
Scheme 2. The application of chiral boron enolates for enantioselective aldol reaction67
~MS
E-30 5 mol% 32
o OH
~C02Me
33
34
major product
o OH
(rC02Me
ent-33
ent-34
32 =
o
\ .
Ti(O'Pr)2
/
o
total combined yield 54%
d.r. = (33 + ent-33) : (34 + ent-34) = 98 : 2
e.r. =33 : ent-33 =1 : 200
Scheme 3. The application of chiral Lewis acids for enantioselective aldol reaction.
An example of the second approach is the Mukaiyama aldol reaction of
enolsilane E-30 with 31 catalyzed by the chiral Lewis acid 32 (i.e. (R)-BINOL-Ti(IV)
complex) (Scheme 3).72 Under the same reaction conditions the aldol reaction of Z-30
with 31 gave ent-33 with similar selectivity observed for reaction with E-30; this is
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another example where E/Z-enolate geometry has little influence on the relative topicity
of Mukaiyama aldol reactions.
1.2.3. Diastereoface Selectivity: Reaction of a Chiral Enol(ate) with an
Achiral Aldehyde
The two n-faces of a chiral enolate are diastereotopic. As a consequence, an
aldehyde would add to the two diastereotopic faces of the enolate at different rates and
with different diastereoselectivity. Chiral enolates are encountered in various contexts
and it is useful to differentiate those enolates where chirality is temporarily introduced
as part of a synthetic strategy to control diastereoselectivity from enolates where the
chirality is an integral part of the target structure. For example, the chirality can be
solely due to ligands attached to the coordinating metal of the enolate (see Scheme 2).
Alternatively, an otherwise achiral enolate of a carboxylic acid derivative can be made
chiral by using an ester of a chiral alcohol, or by using an amide or imide of a chiral
amine. This so-called chiral auxilIary approach is a very powerful method for the
stereoselective construction of polypropionate fragments (Scheme 4). An example
originally developed by Evans,73,74 is the stereoselective aldol reactions of the boron
enolates (e.g. 36) generated from the chiral imide 35. Evans et al. stereoselectively
obtained aldol adduct 38a from the aldol reaction of 36 with 37. As expected, the
reaction of the boron enolate with Z geometry (36) occurred with high preference in the
relative topicity to give syn adduct 38a. Evans demonstrated that base hydrolysis
(KOH) of 38a gives 39 with negligible isomerization.73 Heathcock et al. demonstrated
that the presence of Lewis acids (SnCI4, TiCl4 and EhAICI) can extend the scope of of
the Evans imides for stereoselective synthesis.74,75 For example, the reaction of 36 with
37 in presence of 2 equivalents of SnCl4 stereoselectively gave 38b, and in the presence
of 0.5 equivalents of SnCl4 stereoselectively gave 38c. Conceptually, the remaining
stereoisomer ent-38c can be stereoselectively obtained from the reaction of the
enantiomer of ent-36 with 37. If desired, the base hydrolysis of these adducts can give
the four stereoisomers 39, ent-39, 40 and ent-40.
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BU2BOTf
i-Pr2EtN, CH2CI2, O°C
•
36
'1H
37
o 0 OHA+0Y=o N 1 - 3Y. ~
'Pr
38a
KOH (aq)
• HOJfr
39
38a 78% yield
dr. 2,3-syn : 2,3-anti =>99 : 1
er. 497 : 1
36
37
SnCI4 2 equiv.
CH2CI2, -78°C
o 0 OH
A ~2A/
o N 1 r 3 TY.
'Pr
38b
KOH (aq)
• HOVY
ent-39
38b 60% yield
dr. 2,3-syn : 2,3-anti = 83 : 17
er. >100: 1
38c 51 % yield
dr. 2,3-syn : 2,3-anti =5 : 95
er. >100: 1
36
ent-36
37
SnCI4 0.5 equiv.
CH2CI2, -78°C
37
o 0 OH
A ~2~/
o N 1 I 3 TY.
IPr
38c
o 0 OHA*o N 1 - 3'L_{ ~
"ipr
ent-38c
KOH (aq)
•
KOH (aq)
•
HOJ&
40
HOJlr
ent-40
Scheme 4. Use of Evan's chiral auxillary.
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The synthesis of polypropionates often involves aldol reaction of chiral ketone
fragments with aldehydes. To illustrate the stereochemical outcome of an aldol reaction
of chiral enolate with achiral aldehyde the reaction between 41 (where the stereogenic
center is part of the enolate carbon skeleton) with 9 is discussed (Figure 8).
(a) (b)
............... ,.....-.....-..
OH 0 OH 0
~ Rl~R2R2Re Re' R1 3 1
n H" n,OLi 42 43
H>:=O "_,, H
•
2,3-syn-1',2-syn 2, 3-syn-1' ,2-anti
Rl U H3C~U "CH (Si-Re? (Re-Si?R2 3
OH 0 OH 0
Si Si' R1~R2 Rl~R2
9 (R)-41
44 45
2,3-anti-1',2-anti 2,3-anti-1',2-syn
(Si-Si) (Re-Re?
OH 0 OH 0
~R2 Rl~R2Re Re' R1 = =
- -
n H, il ,OLi ent-42 ent-43
H" 0 / " H 2,3-syn-1',2-syn 2,3-syn-1',2-antiR~ H3C~'R •
1 U U CH3 3 (Re-Si? (Si-Re?
Si OH 0
OH 0
~ R1~R2Si' - RR1 ~ 29 (8)-41 - -
ent-44 ent-45
2,3-anti-1',2-anti 2,3-anti-1',2-syn
(Re-Re? (Si-Si?
(a) relative topicity of aldol: 2,3-syn or 2,3-anti
(b) enolate diastereoface selectivity: l' ,2-syn or l' ,2-anti
Figure 8. Aldol reaction between chiral enolate 41 with achiral aldehyde 9.
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The reaction of an enantiopure enolate such as (R)-41 with an achiral aldehyde 9
can potentially lead to the formation of four diastereoisomers (i.e. 42-45, Figure 8). The
four diastereomers are produced from the four possible relative orientations for the
faces of the enolate and aldehyde in the bond forming step of the aldol reaction (Figure
8).54 For example, addition of the Re-face of enolate (R)-41 to Si-face of aldehyde 9
gives adduct 42 (Figure 8).
The reaction of an enantiopure enolate (8)-41 (the enantiomer of (R)-41) with
achiral 9 can also lead to the formation of four diastereomers (ent-42 - ent-45). These
four diastereomers are the enantiomers of the four diastereomers produced from (R)-41
and 9 (Figure 8). The reaction of racemic chiral enolate (±)-41 with achiral aldehyde 9
will lead to the formation of eight stereoisomers consisting of 4 enantiomeric pairs
(42 - 45 and ent-42 - ent-45) (Figure 8). In the absence of an external chiral influence,
all products will be racemic. In general, the ratio of diastereomers produced from the
reaction of achiral 9 with (R)-41, (8)-41, or (±)-41 will be identical under identical
reaction conditions.
There are two stereocontrol elements that need to be considered when an achiral
aldehyde adds to the diastereotopic faces of a chiral enolate. The relative topicity of the
aldol determines the 2,3-syn/anti relative configuration, just as the case for the reaction
between achiral reaction partners (compare Figure 5 and label (a) in Figure 8). The
second stereochemical control element is the diastereoface selectivity for addition to the
chiral enolate which determines the l' ,2-syn/anti relative configuration in the aldol
adducts (see label (b) in Figure 8). For convenience, the reacting enolate diastereoface
is defined according to the relative configuration present in the product. For example,
the aldol reaction where the aldehyde 9 adds to the Re-face of enolate (R)-41 gives
products 42 and 45 with l' ,2-syn relative configuration (Figure 8), will be described as
a syn addition. The diastereoface selectivity for the reaction is determined from the
product distribution. For example, the l' ,2-syn / l' ,2-anti selectivity for the reaction of
(R)-41 with 9 is ([42] + [45]) + ([43] + [44]).
The application of chiral ethyl ketones 46 to polypropionate synthesis by
Paterson et a1. 76-79 is presented to illustrate diastereoselective aldol reactions of chiral
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enolates
(5)-46
(5)-46
(5)-46
(-)(lpchBOTf,
Et3N
•
47a
47c
to
JJL2JBn
1 5 ~ 3 I 1
48a
2.4-cis-4,5-syn
d.r. 4a:rem = 93:7
combined yield 92%
48b
2,4-trans-4,5-anti
d.r. 4b:rem = 94:6
combined yield 740/0
~J:4JL2JBn
1 5 I 3 I 1
48c
2,4-trans-4,5-syn
d.r. 4c:rem = 93:7
combined yield 62%
JJLJBn
1 5 ~ 3 ~ 1
48d
2.4-cis-4,5-anti
Scheme 5. Diastereoselective aldol reactions of chiral enolates 47a-c with 27.
achiral aldehydes (Scheme 5). The use of Sn(OTf)2 and Et3N was optimal for the
formation of Z-enolate 47a from (S)-4677 (Scheme 5). The aldol reaction of 47a with 27
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was selective for the formation of 48a which results from preferential 4,5-syn aldol
relative topicity and 2,4-syn enolate diastereoface addition (Scheme 5).77,80 Reaction of
the E-boron enolate 47b with 27 gave 48b with excellent stereoselectivity. 79 The
observed selectivity is accounted for by the expected 4,5-anti relative topicity for an E-
boron enolate and 2,4-anti addition of the aldehyde to the chiral enolate. The
diastereoselective synthesis of 48c required a reaction with preferential 4,5-syn aldol
relative topicity and 2,4-anti enolate diastereoface selectivity. Paterson et al.78 achieved
the diastereoselective synthesis of 48c by using a Z-boron enolate with chiral ligands
attached to boron. The Z-boron enolate gave a preferential 4,5-syn relative topicity and
the chiral ligands on boron overpowered the innate enolate diastereofaceselectivity (cf.
48a from (8)-47a) to give 2,4-anti selectivity predominantly. The direct synthesis of
48d using similar methodology was not achieved.
1.2.4. Diastereoface Selectivity: Reaction of a Chiral Aldehyde with an
Achiral Enol(ate)
The reaction of an enantiopure aldehyde such as (8)-49 with an achiral enolate
12 can potentially lead to the formation of four diastereoisomers (i.e. aldol adducts 50-
53, Figure 9). The four diastereomers are produced from the four possible relative
orientations the faces of the aldehyde and enolate adopt in the bond forming step of the
aldol reaction (Figure 9).54 For example, addition of the Si-face of aldehyde (S)-49 to
Re-face of enolate 12 gives adduct 50 (Figure 9).
The reaction of an enantiopure aldehyde (R)-49 (the enantiomer of (S)-49) with
achiral 12 can also lead to the formation of four diasteromers (ent-50 - ent-53). These
four diastereomers are the enantiomers of the four diastereomers produced from (S)-49
and 12 (Figure 9). The reaction of racemic chiral aldehyde (±)-49 with achiral enolate
12 will lead to the formation of eight stereoisomers consisting of 4 enantiomeric pairs
(50-53 and ent-50 - ent-53) (Figure 9). In the absence of an external chiral influence,
all products will be racemic. In general, the ratio of diastereomers produced from the
reaction of achiral 12 with (8)-49, (R)-49, or (±)-49 will be identical under identical
reaction conditions.
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There are two stereochemical control elements that need to be considered when
an achiral enolate adds to the diastereotopic faces of a chiral aldehyde. The relative
(b) (a)
r---'---. r---'---.
OH 0 OH 0
Re Re'
R1ffR2 R1rrR2
n II 2 50 51
HH/ 0 H'li ",R 2, 3-syn-3, 4-syn 2, 3-syn-3, 4-antiR1"~ H3C~OLi • (Si-Re? (Re-Si?
CH3U U OH 0 OH 0R1rrR2 R1rrR2Si Si'
(5)-49 12 52 53
2, 3-anti-3, 4-syn 2, 3-anti-3, 4-anti
(Si-Si? (Re-Re?
OH 0 OH 0
Re'
R1~R2 R1rrR2
Re
n n ant-50 ant-51
H H" 0 H/, ",R
2 2, 3-syn-3, 4-syn 2, 3-syn-3, 4-anti
CH311~ H3C~OLi • (Re-Si? (Si-Re?
R1 U
U OH 0 OH 0
Si Si' R1rrR2 R1~R2
(R)-49 12 ent-52 ant-53
2, 3-anti-3, 4-syn 2, 3-anti-3, 4-anti
(Re-Re? (Si-Si?
(a) relative topicity of aldol: 2,3-syn or 2,3-anti
(b) aldehyde diastereoface selectivity: 3,4-syn or 3,4-anti
Figure 9. Aldol reaction between a chiral aldehyde and an achiral enol(ate).
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topicity of the aldol reaction determines the 2,3-syn/anti relative configuration, just as in
the case of the reaction between achiral reaction partners (compare Figure 5 and label
(a) in Figure 9) and in the case of the reaction between chiral enolate and achiral
aldehyde (compare labels (a) in Figures 8 and 9). The second stereochemical control
element is the diastereoface selectivity for addition to the chiral aldehyde which
determines the 3,4-syn/anti relative configuration in the aldol adducts (see label (b) in
Figure 9). For convenience, the reacting aldehyde diastereoface is defined according to
the relative configuration present in the product. For example, the aldol reaction where
the enolate 12 adds to the Si-face of the aldehyde (8)-49 gives products 50 and 52 with
3,4-syn relative configuration (Figure 9), will be described as a syn-selective addition.
The diastereoface selectivity for the reaction is determined from the product
distribution. For example, the 3,4-sYn / 3,4-anti selectivity for the reaction of (8)-49
with 12 is ([50]) + [52]) + ([51] + [53]).
Under kinetically controlled conditions, an achiral enolate will preferentially add
to the diastereotopic aldehyde face that gives the more stable transition state. Various
models that have been postulated to predict and account for the observed aldehyde
diastereoface selectivities are discussed below.
1.2.4.1. 1,2-Stereoinduction models
The presence of a stereogenic center at the a-position of an aldehyde can
strongly influence the diastereoface selectivity for addition of an enolate. For example,
a Re-facial preference has been found for the addition of lithium-enolates to (R)-54
(Table 2).81
The empirical model originally proposed by Cram for Grignard additions to
aldehydes successfully predicted the aldehyde diastereofacial preference of addition of
lithium-enolates to a-methyl substituted aldehydes.82 Cram's model for aldehydes
where the stereogenic center is at the a-position considers the conformation that orients
the largest group L of the three a-substituents anti to the c-o bond of the aldehyde.
Nucleophilic attack is predicted to occur preferentially on the face of the aldehyde
coincident with the smallest group 8 (Figure 10). It must be noted that the Cram model
is an empirical model which was derived by correlating the structures of the preferred
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products with those of the ·starting aldehydes. No attempt was made to use transition
state theory to predict the diastereofacial preference for addition to the aldehyde.
Table 2. Aldehyde diastereoface selectivities of addition of lithium enolates 55 to 5481
(R)-54
Re-face
+
Si-face
R
===<OLi
55
Re-attack
•
Si-attack
Ph~R
OH 0
syn-56
anti-57
entry R 56: 57
1 Me 3 : 1
2 tBu 4: 1
3 MeO 3:1
4 tBuO 4 : 1
5 Me2N 3 : 1
yield (0/0)
89
80
91
70
67
anti-57
anti-Cram adduct
Small = H
Medium = Me
Large = Ph
Nu =
a attack to less hindered I ~M~S¢= Nu Re-fa:e Ph/YirR
L OH 0
syn-56
Cram-adduct
R
===<OLi
Figure 10. The Cram model predicts Re-face attack
A more recent explanation to account for the observed Re-diastereofacial
selectivity presented in Table 2, was proposed by Felkin, Anh and Eisenstein.66,83-85 The
so-called Felkin-Anh model uses arguments based on torsional strain to propose a
21
reacting conformer. Felkin postulated that torsional strain present in partially formed
bonds represents a substantial fraction of the strain in fully formed bonds. This
hypothesis led to the assumption of a preferred transition state based on an aldehyde
conformation in which the bulkiest of the ligands a to the carbonyl (L) is oriented
perpendicular to the plane of the carbonyl group and to further minimize torsional strain
the next most demanding substituent (M) is oriented gauche to the carbonyl (e.g. TS B
depicted in Figure 11). A nuc1eophile will preferentially approach the carbonyl anti to
the bulky moiety L as depicted in TS B (Figure 11). A further evaluation of Felkin's
proposed model using ab initio calculations by Anh and Eisenstein found that the
conformer B is energetically the most favoured, not only for occasions where all a-
substituents are alkyl groups, but also where one of the a-substituents is an heteroatom.
In these cases, the heteroatom takes the place of the large ligand L, thereby minimizing
Coulombic repulsion between the electronegative hetereroatom and the incoming
nucleophile.
Molecular modelling studies determined that the favoured approach of a
nucleophile occured at a 109° angle to the plane of the aldehyde face, the so-called
Burgi-Dunitz trajectory.86-90 A Burgi-Dunitz trajectory for the incoming nucleophile
makes the assumption that the medium sized group should be gauche to the carbonyl
oxygen unnecessary. Both TS A and B (Figure 11) have the group L perpendicular to
the plane of the carbonyl group and have the nuc1eophile approaching the carbonyl anti
to the L group. If the angle of attack is 109° then TS B has less steric hindrance to the
nuc1eophile than TS A.
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syn-56
Felkin product
•
B
favoured Burgi-Dunitz approach
avoiding steric hindrance from M
Nu-
~ 0s~
L
109° Nu-
ll/
S:;rR
L
A
anti-57
Ph~R
OH 0
anti-Felkin product
Small = H
Medium =Me
Large = Ph
Nu =
R
===<OLi
Figure 11. Predicting aldehyde diastereoface selectivity with the Felkin-Anh model
Both the Cram and Felkin-Anh models predict the same stereochemical
outcome; the difference between these two stereochemical models is that Cram's model
identifies the sense of the relationship between starting material and product by an
empirical correlation. Whereas, the Felkin-Anh model attempts to give a mechanism-
based rationale for this relationship.
The presence of a heteroatom substituent such as oxygen at the a-position of an
aldehyde can strongly influence the diastereoface selectivity for addition of a
nucleophile. In 1959, Cram proposed a chelation model to account for the observed
stereoselectivity of addition of the Grignard reagent CH3MgI to a-oxygen substituted
ketones.91 In this model, it is assumed that the Lewis acidic Mg (II) coordinates to both
oxygens, and addition occurs preferentially from the least hindered face of the chelated
intermediate (Figure 12).
Table 3 presents the results of addition of enolates 59 to the a-alkoxy aldehyde
58 under several conditions.92 The aldehyde diastereoface selectivities in entries 1, 2
and 3 are in accordance to the predictions of the Felkin-Anh model. However, the
diastereoface selectivities obtained in entries 4-7 are contrary to the predictions of the
Felkin-Anh model. The so-called anti-Felkin products are rationalized by a chelation
control model (first proposed by Cram).91 That is the Lewis acids TiCl4 and SnCI4,
which have two vacant coordination sites, are assumed to be coordinated by both
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oxygens of the a-alkoxy aldehyde to form a reactive chelated intermediate.93 Under
these chelation controlled conditions, addition of a nuc1eophile to the less sterically
hindered diastereotopic face of the aldehyde leads to the anti-Pelkin aldol adduct (see
P· 12) 91,9319ure .
Felkin-Anh model Cram-Chelation control model
OH
BnO~N
- u
Felkin-adduct
o MeBno-¢
Pi H~
Nu
M
Bn6~b
~ Me
~ H Pi
Nu
anti-Felkin-
adduct
Figure 12. Pelkin-Anh and the Cram-chelation control model to rationalise the 1,2-
stereoinduction of an a-alkoxy aldehyde.
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Table 3. Diastereoface selectivity for addition of 59 to 5892
anti-Felkin adducts
(3,4-anti)
OH 0
Bno,4A2~I 3 T 1 OR
Felkin adducts
(3,4-syn)
OH 0
BnO~OR
58
+
Me OM\-==<
OR
59
Lewis Acid
60a
OH 0
BnO~OR
60c
60b
OH 0
snOrrOR
60d
Z-59 : Lewis 3,4-syn: 2,3-syn:
entry R M
E-59 acid 3,4-anti
a 2,3-antib
1 Me Li 5 : 95 20: 80 69 : 31
2 Me Li 95 : 5 26: 74 84: 16
3 tBu Li >99: 1 21 : 79 66: 34
4 Me TMS 17 : 83 TiCl4 >99: 1 23 : 77
5 Me TMS 17:83 SnCl4 >99: 1 20: 80
6 tBu TMS >99: 1 TiCl4 89 : 11 65 : 35
7 tBu TMS >99: 1 SnCl4 88 : 11 66:34
a The aldehyde diasteroface selectvity i.e. Felkin : anti-Felkin. b The relative topicity.
1.2.4.2. 1,3-Stereoinduction models
The influence of an heteroatom substituent at the aldehyde ~-position* on
diastereoface selectivity has been investigated and both chelation control- and 'open'
transition statet models have been proposed to explain the observed stereoselectivity for
additions of nucleophiles. 3-Benzyloxybutanal (61) has been used as a model substrate
* P-Position is also known as position 3 where the aldehyde carbon is designated position I, hence the
term 1,3-stereoinduction.
t Also known as non-chelation control models.
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to study 1,3-stereoinduction in the Lewis acid promoted Mukaiyama aldol reactions
with enolsilanes (Scheme 6).94,95
OTMS
==<Ph
62
•
BnO OH 0
~Ph
BnO OH 0
~Ph
BnO 0
~H
61
,,=<OTMS
Ph
63
64a (1 ,3-anti) 64b (1 ,3-syn)
92 : 8 (95% yield)
~Ph ~Ph
65a (1 ,3-anti) 65rem
92 : 8 (95% yield)
Scheme 6. The diastereoselectivity of Lewis acid promoted coupling·of 61 with
enolsilanes 62 and 63.
Reactions of 61 with 62 and 63 occur with high aldehyde diastereoface
selectivity to give 1,3-anti adducts. To account for the observed diastereofacial
preference it was proposed that the addition of the nucleophilic enolsilane occurred
from the least hindered face of a Ti-aldehyde chelate (Figure 13). Evidence for the
presence of a chelate was obtained by Keck in a study of the effect of stoichiometry and
temperature on the IH NMR spectra of solutions of TiCl4 and 61. It was concluded that
a conformationally rigid 1:1 TiCl4 :aldehyde complex was formed. The conformation of
the chelate aldehyde was derived from an analysis of· vicinal coupling constants
observed in the IH NMR spectrum. To account for the relatively small vicinal coupling
constants between H2C-2 and HC-3 (4.7 and 4.7 Hz), it was proposed that the 1:1
complex was a chelate with a conformation where proton HC-3 was in a pseudo-
equatorial orientation and the methyl substituent in a pseudo-axial orientation. The
observed diastereofacial selectivity can then be rationalized by addition of the
nucleophile to the least sterically hindered face of the aldehyde in the chelate as
depicted in Figure 13.
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BnO 0
~ +
3 1 H
61
"...
least hindered
approach
Nu
~ H Bn~3 rf2 ":,TiCI4H -,'
1 I 0
CH3
BnO OH
~NU
66
1,3-anti-adduct
Figure 13. Addition to the least hindered face of the chelated ~-substituted aldehyde 61.
Studies of the effect of various Lewis acids on the diastereoface selective
additions of allyl stannane and allyl trimethylsilane to the aldehyde 61 were performed
(Table 4).96,97 The 1,3-anti adduct was formed preferentially in all cases. The
diastereoselective formation of 69a in the presence of Lewis acids TiCI4, MgBr2 and
SnCl4 known to have two vacant coordination sites can be explained using the
previously discussed bidentate chelate model (Figure 13). However, because BF3-OEh
has only one vacant coordination site, BF3-0Eh cannot coordinate to both heteroatoms
simultaneously to give a bidentate chelate, an alternative model is required to
rationalize the observed stereoselectivity.
Table 4. Lewis acid promoted allyl-stannane 67 and allyl-silane 68 addition to ~­
substituted aldehyde 61.96,97
BnO 0
~H+LA
(PhbSn~
67
or
BnO OH BnQ OH
~~
61 69a (1,3-anti) 69b (1 ,3-syn)
69a (1,3-anti) : 69b (1,3-syn)
entry
1
2
Allyl reagent TiCI4
67 32 : 1
68 95 : 5
8.1 :1
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3.4 : 1
95 : 5
3.9: 1
85 : 15
To account for the observed aldehyde diastereoface selectivity Reetz proposed
that the coordination of the oxygen of the aldehyde to BF3.OEh resulted in a complex
which assumed an extended linear conformation so as to minimize electrostatic
repulsions (Figure 14).97 The nucleophile approaches from the least sterically hindered
aldehyde face (anti to the methyl group depicted in Figure 14) to afford the 1,3-anti
product.
61
........
,...
8- ®
B0 8+ 0 8
n~ " BF3
H Me ~ ~
Nu
..
BnO OH
~NU
66 (1,3-anti)
Figure 14. Reetz's polar 1,3 stereoinduction mode1.97
Though Reetz's proposed polar 1,3-stereoinduction model successfully accounts
for the aldehyde diastereofacial preference, it did not take into account the electrostatic
interactions within the. aldehyde substrate that affect the torsion angles along the carbon
backbone of the aldehyde. Evans proposed a revised polar 1,3 stereoinduction model
based on electrostatic interactions within the aldehyde which also included the effect of
a-substituents according to the Felkin-Anh model for 1,2-stereoinduction.98 In Evans'
model two assumptions common to the Felkin-Anh model were made. The first
assumption was that the preferred conformer sets the aldehyde in a staggered
relationship between the forming bond and the aldehyde a-substituents such that the
largest group at the a-position would be orthogonal to the aldehyde face (see Al in
Figure 15). The second assumption was that the Nu would approach the carbonyl from
the Burgi-Dunitz angle. The nucleophile preferentially attacks the least hindered
aldehyde face and thus the forming bond would be orientated anti instead of gauche to
the p stereogenic center. The approach of the Nu as depicted in diagrams Al and A2
(Figure 15) correctly predicts that additions will be selective for the 1,3-anti
diastereomer.
The factors that favour conformer A as depicted in Figure 15 can be identified
from a consideration of the steric and electronic interactions present in the aldehyde
conformers A-F (Figure 16). Conformers A and D are favoured since the p-substituent
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IS orientated anti to the Ca-C=O bond to minimize steric interactions (Figure 16).
70 71
o OH X
R1V0R2
72a (1, 3-anti)
Nu-
I
Ha~::~::Hb
F
3
BO.±. H
H : X
R
A1 A2
Figure 15. Evans revised polar 1,3-stereoinduction model.
Favoured
R X Ha~ftbHa~Hb Ha~ltb OH XH . X R H ~ R • NU~R
0:1" H ~r H ~:I" HII BF3 IBF3 BF3 72a (1,3 anti)
A B C
R X Ha~HbHa~Hb Ha~Hb OH X
H ~ X R X • =R H NU~RH"'~ ~ "0 H'>~
I I I
BF3 BF3 BF3 72b (1,3 syn)
D E F
Figure 16. Steric and electronic interactions present in the conformers of the BF3
coordinated aldehyde.
Conformers Band F are destabilized by the sterically unfavourable gauche interaction
present between the ~-substituent and c=o group. Conformers C and E are also
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expected to become unfavourable as the size of the p-substituent increases. In
conformers C and D, there is an added presence of a destabilising dipolar interaction
between the C-X bond (where X = heteroatom substituent) and the c=o bond. From a
process of elimination the conformer A is correctly identified to be the favoured
conformer which reacts with the Nu to deliver the 1,3 anti aldol adduct.
1.2.4.3. Merged 1,2- and 1,3-stereoinduction model
To account for the presence of a-substituents on the degree of 1,3-
stereoinduction, Evans has elegantly proposed a merged 1,2- and 1,3-stereoinduction
model to rationalize the observed selectivities in substrates which have substituents at
both the a- and p-positions to the aldehyde. The origin of this model was a natural
progression from an integration of both the Felkin-Anh model (which accounted for the
observed 1,2-stereoinduction) and Evan's revised polar 1,3-stereoinduction model (see
section 1.2.4.1 and 1.2.4.2).
)l2XMB
H 1 I 3 ipr
73a
OTMS
ipr~
74
Nu-
I
Me~Hb
F3B-O .Y.H
H -: OPIPr
G
75a
o OH OPMB
)l~2~ipr ~ 1 T 3 ipr
75b
75a (Felkin) : 75b (anti-Felkin)
98:2 (91 % yield)
Figure 17. Evans' merged 1,2- and 1,3-stereoinduction model for substrates with a 2,3-
anti relationship.
In essence, this merged model simply replaced either of the Ha or Hb hydrogens
depicted in the favoured conformer A (Figure 15) with an alkyl substituent. The
approach of the Nu is then predicted to occur from the least hindered face. A 2,3-anti
relationship between the a-methyl and p-alkoxy substituents will mutually reinforce the
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preferential approach of the Nu from the same aldehyde face as depicted in Figure 17.
This mutual reinforcement leads to a prediction of enhanced diastereoface selectivity
for nucleophilic addition to aldehydes of this type. This prediction is borne out by the
excellent 98:2 selectivity observed for the Felkin adduct of 75a from reaction of 73a
with 74 (Figure 17).
Unfavourable
stereoelectronic
interactions
in conformer L
o OPMB
H¥ipr
73b
Sterically
hindered
approach
OTMS
R~
toluene
Nu-
I
Ha~Me
F3B-O .±_.H
H ": OP
'Pr
H
\
Ha~Me
H .±.O-BF3
H ": OP
'Pr
o OH OPMB
R~ipr
76a
(anti-Felkin)
o OH OPMB
- .......~ R~ipr
76b
Felkin
Figure 18. Evans' merged 1,2- and 1,3-stereoinduction model for substrates with a 2,3-
sYll relationship.
Alternatively, if Hb in A (Figure 15) is replaced with an alkyl substituent
resulting in a SYn relationship between the a-alkyl and p-alkoxy substituents the
preferred aldehyde face for addition predicted by the Felkin-Anh model (Figure 11) will
be contrary to that predicted by the 1,3-stereoinduction model (Figure 15). Thus a SYll
relationship between the substituents at the a- and p-positions is said to be
nonreinforcing. For example, the 1,3-polar stereoinduction model suggests preferential
approach of the Nu as depicted in H in Figure 18; however, the Felkin-Anh model
suggests preferential approach of the Nu as depicted in conformer I in Figure 18. From
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this analysis, it becomes apparent that the diastereofacial selectivity of addition of a Nu
to the aldehyde is likely to be modest and cannot be reliably predicted if the relative
contributions towards stereocontrol from both a- and p-stereogenic centers are not
known.
1.2.5. Double Stereodifferentiation, Kinetic Resolution, and Mutual Kinetic
Enantioselection: Reaction of a Chiral Aldehyde with a Chiral
Enol(ate).
1.2.5.1. Double stereodifferentiation and the rule ofmultiplicativity
In the aldol reaction between a chiral aldehyde and chiral enolate there are three
identifiable stereochemical control elements that influence the reaction
diastereoselectivity (Figure 19). These are the aldehyde- and enolate-diastereoface
selectivities and the relative topicity of the aldol reaction. These selectivities are
influenced by the absolute configurations of the stereogenic centers present in both the
chiral aldehyde and chiral enolate. In an aldol reaction between an enantiopure aldehyde
and an enantiopure enolate, there are up to four possible diastereomeric products
resulting from the four possible relative orientations of the aldehyde and enolate faces
in the bond forming step. For example, adduct 77 is derived from bond formation step
where the Si-face of aldehyde (8)-49 is orientated towards the Re face of the enolate
(R)-41 (Figure 19). Conversely, the relative configuration about the positions
C-3/C-4, C-2/C-3 and C-1 '/C-2 can be used to define the stereoselectivity with respect
to the three stereochemical control elements (Figure 19). For example, the formation of
aldol adduct 77 is the result of a 3,4-syn aldehyde diastereoface addition, aI' ,2-syn
enolate diastereoface addition and 2,3-syn relative topicity.*
* For convenience the aldehyde and enolate diastereoface selectivity and the relative topicity are defined
according to the resultant relative configurations present in the product. For example, addition to the Si
face of aldehyde (S)-49 is equivalent to a 3,4-syn aldehyde diastereoface addition; Addition to the Re face
of enolate (R)-41 is equivalent to aI' ,2-syn enolate diastereoface addition; addition to the Si-face of (S)-
49 and to the Re-face of (R)-41 is equivalent to 2,3-syn relative topicity.
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unlike reaction
(a) (b) (c)
,.....-......-. ,.....-......-.,.---'--.,
OH 0 OH 0
R1~R2 R1~R23 1
Re Re'
n n
77 78
3,4-syn-2,3-syn-1 ',2-syn 3,4-anti-2,3-syn-1' ,2-anti
H H" 0
H, ,OM kSR' " H (Si-Re~H3C"~ H3C~ ., (Re~Si~
R1 U U R2 'CH3 OH 0 OH 0R1~R2 R1r0R2Si Si'
(5)-49 (R)-41 79 80
3,4-syn-2,3-anti-1 ',2-anti 3,4-anti-2,3-anti-1',2-syn
(Si-Si~ (Re-Re~
like reaction
Re Re'
n H, n,OM
H H" 0 ~ " HH3C'~ H3C~'R
R1 n n CH3 3
Si Si'
(5)-49 (5)-41
OH 0
R1~R2
81
3,4-anti-2,3-syn-1',2-synkss
__...~ (Re-Si~
OH 0
R1~R2
83
3,4-anti-2,3-anti-1' ,2-anti
(Re-Re~
OH 0
R1~R2
82
3,4-syn-2,3-syn-1' ,2-anti
(Si-Re~
OH 0
R1~R2
84
3,4-syn-2,3-anti-1',2-syn
(Si-Si~
(a) aldehyde diastereoface selectivity: 3,4-syn or 3,4-anti
(b) aldol relative topicity : 2,3-syn or 2,3-anti
(c) enolate diastereoface selectivity: 1',2-syn or 1',2-anti
Figure 19. Aldol reactions of (8)-49 with (R)-41 and with (8)-41.
The aldol reaction of (8)-49 with (R)-41 can give four diastereomeric adducts
77-80 and the reaction between aldehyde (8)-49 and enolate (8)-41 (the enantiomer of
(R)-41) can give four diastereomeric aldol adducts 81-84 (Figure 19). These two
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reactions depicted in Figure 19 are stereochemically related and can be defined as the
like and unlike reactions, where like refers to the reaction where the absolute
configurations of the fiducial stereogenic centers in 49 and 41 are identical (i.e. (8)-49
and (8)-41 as depicted in Figure 19), and the unlike reaction is where the absolute
configuration of the fiducial stereogenic centers in 49 and 41 are different (i.e. (8)-49
and (R)-41 as depicted in Figure 19). The terms 'like' and 'unlike', that describe
reactions where both reactants are chiral, was defined by Seebach and Prelog.99
The transition states for the unlike reaction of (8)-49 with (R)-41 are
diastereotopic with those for the like reaction of (8)-49 with (8)-41 and give
diastereomeric products. The rates of product formation for the like and unlike reactions
will be different as will the product distributions (i.e. diastereoselectivities). The
reaction with the higher diastereoselectivity is labeled the matched reaction, and the
other reaction with relatively lower diastereoselectivity is labeled the mismatched
reaction.
The phenomenon responsible for the differences in the diastereoselectivity
between the like and unlike reactions is often termed 'double stereodifferentiation'.
Double Stereodifferentiation which is present in any reaction between chiral reactants
has been described by the terms 'double asymmetric induction,100 and 'double
asymmetric synthesis' .101 Generally, the term 'asymmetry' has been freely used to
describe many stereoselective processes, the description 'double stereodifferentiation' is
however a more precise description of the phenomenon and is preferred. 102 The origin
of the differences in diastereoselectivity of the like and unlike reactions can be
understood from a consideration of the selectivities of the three stereochemical control
elements. For illustrative purposes the directions of the selectivities of the three
stereochemical control elements will be arbitrarily assigned and the consequences of
these selectivities on the diastereoselectivities of the like and unlike reactions will be
discussed. Table 5 presents the directions for each of the three stereocontrol elements
required for the formation of the eight aldol adducts from the reaction of (8)-49 with
(R)-41 and (8)-41. It is arbitrarily assumed that for aldol reaction of 49 and 41, the
preferential selectivities for the aldehyde diastereoface addition is 3,4-syn selective, the
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enolate diastereoface addition is l',2-syn selective and the relative topicity of the aldol
reaction is 2,3-syn selective.
Table 5. Relative configurations present in the unlike (77-80) and like (81-84) adducts.a
Entry Aldol Aldehyde d.s. Enolate d.s. Relative topicity
adduct
1 77
2 78
3 79
4 80
5 81
6 82
7 83 3,4-anti l' ,2-anti 2,3-anti
8 84 2,3-anti
a Text in grey cells are the favoured relative configurations which, for the sake of
illustration, were arbitrarily assigned as 3,4-syn, I '2-syn and 2,3-syn for the aldehyde d.s. ,
enolate d.s. and relative topicity, respectively
The unlike reaction of (8)-49 with (R)-41 can give adduct 77 (Table 5, entry 1)
which results from the favoured selectivities of all three stereochemical control
elements; the other three possible adducts (78, 79 and 80) each results from a
combination where only one of the stereochemical control elements is in the favoured
direction (Table 5, entries 2-4). It can be expected that this unlike reaction will be
highly diastereoselective for adduct 77.
Of the four possible adducts from the like reaction of (8)-49 with (8)-41, three
(81, 82 and 84) result from combination where two stereochemical control elements are
in the favoured direction, and one adduct (83) is disfavoured by all three stereocontrol
elements. It can be expected that this like reaction will have low diastereoselectivity
since three adducts 81, 82 and 84 are expected in comparable amounts. From an
examination of the preferences of the stereocontrol elements the double
stereodifferentiation of the like and unlike reactions can be rationalized. For this
particular example (Figure 19 and Table 5), the unlike reaction should be the matched
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reaction (high diastereoselectivity) and the like reaction should be the mismatched
reaction (low diastereoselectivity).
Masamune has discussed double stereodifferentiation in terms of the inherent
diastereoface selectivities of each substrate in aldol reactions that proceed with highly
selective relative topicity.101 For example, consider the aldol reaction of 85 and 87
(Figure 20).101 The inherent diastereoface selectivies of the chiral substrates 85 and 87
were determined from the diastereoselectivities of their respective reactions with
appropriate achiral reaction partners (Figure 20).
Reaction of (8)-85 with achiral 86 gave a 2.7: 1 mixture of 88a and 88b,
respectively. Both products result from an aldol reaction with 2,3-sYn relative topicity
as expected from a lithium Z-enolate according to the Zimmerman-Traxler model. The
products differ by which diastereotopic face of (8)-85 that the enolate adds to; 88a
results from 3,4-anti addition (anti-Felkin) and 88b results from 3,4-sYn addition
(Felkin). Thus, aldehyde (8)-85 is seen to exhibit a 2.7: 1 preference for addition of
enolates (like 86) to the Re face giving 3,4-anti adducts. Similarly, the reaction of (8)-
87 with benzaldehyde gave a 3.5:1 mixture of89a and 89b, respectively. Both products
result from an aldol reaction with 2,3-sYn relative topicity but differ by which
diastereoface of (8)-87 addition of benzaldehyde occurred; 89a results from a l',2-syn
addition and 89b from l' ,2-anti addition. Thus enolate (8)-87 has a 3.5:1 preference for
addition to the Si face to give l' ,2-syn products.
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OLi OLi ~~:,M~'" ~'PhMe3SiO Me3SiO Ph
86 (5)-87 (R)-87
3,4-anti 3,4-syn
anti-Felkin product Felkin product
~
-()to 86 OSiMe3
•
(8)-85 88a 2.7: 1 88b
1',2-syn 1',2-anti
0 ~ r-----.d'H (8)-87 ~h NhPh ' Ph = "• 2 l' OSiMe3 :: OSiMe3
OH 0 OH 0
89a 3.5 : 1 89b
~O (8)-87
V H like~
(matched rxn)
(8)-85 90a 8: 1 90b
~O (R)-87
V H unlike~n
(mismatched rxn)
= = = Ph
OSiMe3 ~OSiMe3
(8)-85 91a 1 : 1.5 91b
Note: The highly selective relative topicity for all
reactions results in only 2,3-syn adducts
Figure 20. Determining the inherent diastereoface selectivities of chiral aldehyde 85
and chiral enolate 87.
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The reaction of (8)-85 and (8)-87 (like reaction) gives a 8:1 mixture of 90a and
90b, respectively (Figure 20). Adduct 90a results from the preferred 3,4-anti aldehyde
diastereoface addition and the preferred l' ,2-syn enolate diastereoface addition. By
contrast, adduct 90b results from the disfavoured 3,4-syn aldehyde diastereoface
addition and disfavoured l' ,2-anti enolate diastereoface addition. It stands to reason that
the diastereoselective formation of adduct 90a is expected on the basis of the innate
diastereoface selectivities of (8)-85 and (8)-87. The related reaction of (8)-85 and (R)-
87 (unlike reaction) gives a 1:1.5 mixture of 91a and 91b, respectively (figure 20).
Adduct 91a results from the preferred 3,4-anti aldehyde diastereoface addition and the
disfavoured l' ,2-anti enolate diastereoface addition. Adduct 91b results from the
disfavoured 3,4-syn aldehyde diastereoface addition and the preferred l' ,2-syn enolate
diastereoface addition. Thus, the formation of both 91a and 91b results from the innate
diastereoface selectivity of one reactant but not the other. Consequently, lower
diastereoselectivity is anticipated and found for the unlike reaction (i.e. mismatched)
compared to the like reaction (i.e. matched).
It is possible to evaluate the magnitude of the diastereoselectivites for the like
and unlike aldol reactions in terms of the individual aldehyde- and enolate-diastereoface
selectivities. Masamune proposed that the diastereoselectivity of the matched pair can
be predicted from the product of the aldehyde and enolate diastereoface selectivities
provided that the relative topicity of the reaction was strongly biased (see Figure 21).
Furthermore, the diastereoselectivity of the mismatched pair can be predicted from the
ratio of the aldehyde and enolate diastereoface selectivities. This observation was
coined by Masamune as the 'Rule of Multiplicativity'. For reactions which are under
kinetic control the Rule of Multiplicativity has been derived using transition state
theory.I03 The Rule of Multiplicativity does not apply quantitatively to every aldol
reaction of chiral reaction partners. However, the rule is valid in a qualitative sense
since the resultant diastereoselectivity of a matched reaction will always be higher than
the individual diastereoface selectivities, and the diastereoselectivity for the mismatched
pair will always be lower than the individual diastereoface selectivities.
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Enolate d.s. of 87 = 2.7
(Figure 20)
Aldehyde d.s. of 85 = 3.5
(Figure 20)
Rule of Multiplicativity
Diastereoselectivity of matched rxn:
90a : 90b = 8: 1
Diastereoselectivity of mismatched rxn:
91a: 91b= 1: 1.5
Predicted Diastereoselectivity
of matched rxn:
Aldehyde d.s. x Enolate d.s
3.5 x 2.7 =9.5
Predicted Diastereoselectivitv
of mismatched rxn:
Aldehyde d.s. / Enolate d.s
3.5/2.7 =1.3
Figure 21. Application of the Rule of Multiplicativity
1.5.2.2. Kinetic resolution and mutual kinetic enantioselection
Another possible scenario for reactions of chiral substrates is when one reactant
is enantiopure and the other is racemic. For example the reaction of enantiopure
aldehyde (8)-49 with racemic enolate 41. This reaction would involve the two parallel
reactions of (8)-49 with (8)-41 and of (8)-49 with (R)-41 and can give a total of eight
diastereomeric products (77-84, Figure 19). Because the like and unlike reactions occur
at different rates (i.e. kSR *" kss), it follows that the enantiopure (8)-49 will preferentially
react with one of the enantiomers of enolate 41. It is expected that the matched reaction
will be the faster process. This kinetic preference for reaction of one enantiomer of the
racemate results in 'kinetic resolution' .104-106
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(8)-41
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(Si-Si~
OH 0
R1~R2
OH 0
R1~R2
ent-78
3,4-anti-2,3-syn-1',2-trans
(Re-Si~
OH 0
R1~R2
- - -
- - -
- - -
- - -
- - -
ent-80
3,4-anti-2,3-anti-1',2-cis
(Re-Re?
OH 0
R1~R2
Re Re'
n H, n,OM
H H" 0 ' " HR111~ H3C~==rr'l<'CHCHJ} R2 3
Si Si'
(R)-49 (R)-41
kss
•
ent-81
3,4-anti-2, 3-syn-1',2-cis
(Re-Si?
OH 0
R1~R2
ent-83
ent-82
3,4-syn-2,3-syn-1 ',2-trans
(Si-Re~
OH 0
R1~R2
ent-84
3,4-anti-2,3-anti-1 ',2-trans
(Re-Re~
3,4-syn-2,3-anti-1' ,2-cis
(Si-Si~
Figure 22. Aldol reaction of (R)-49 with (8)-41 and with (R)-41.
Another scenario to consider is for reactions of chiral substrates where both
reactants are racemic. An example would be the aldol reaction of racemic 49 with
racemic 41. This reaction can be illustrated by a consideration of the four parallel
reactions depicted in Figures 19 and 22. This reaction can give 16 stereoisomers
comprised of eight enantiomeric pairs (i.e. eight diastereomers ent-77 to ent-84 which
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are the enantiomers of the 8 diastereomeric aldol adducts 77 to 84). The rate constants
for these four parallel reactions are labeled in Figures 19 and 22. Due to the
enantiomeric relationship between the reactions of (8)-49 with (R)-41 and (R)-49 with
(8)-41, their rate constants are equal (i.e. kSR = kRS). Similarly, the reactions of (8)-49
with (8)-41 and (R)-49 with (R)-41 have equal rate constants (i.e. kss = kRR). In the
reactions of racemic substrates there will be competition between the enantiomers (R)-
41 and (8)-41 to react with the enantiomer (8)-49 and there will also be competition
between (R)-41 and (8)-41 to react with (R)-49. The relative rates of these competing
reactions can be measured and is expressed as the mutual kinetic enantioselection
(MKE),
where MKE = kSR/kss = kRS/RR
The term 'Mutual Kinetic Enantioselection' used in the description of
diastereoselective reactions between reaction partners that are both chiral and racemic
was originally coined by Heathcock and Gare. 10? Mutual kinetic 'resolution' was the
original term used to describe these diastereoselective reactions but since the process
involves the kinetic preference of one enantiomer of a racemic substrate to
preferentially react with one of the enantiomers of a racemic reagent the term
'enantioselection' was preferred. 104,108
Horeau determined that the mutual kinetic enantioselection (MKE) can be
accurately measured from the ratio of diastereomers from a reaction where both reaction
partners are racemic (method 1, Figure 23).109 In the reaction between racemic reaction
partners the ratio of product diastereomers is constant and independent of the degree of
conversion and the initial relative amounts of racemic reaction partners. A second
method to obtain the MKE is to react an 'enantiopure' reactant with an excess of a
racemic reaction partner (method 2, Figure 23). The use of excess racemate is to ensure
that the reaction is pseudo-first order in the enantiopure reactant which allows the
approximation to be made that the product distribution is a good reflection of the
relative rates of reaction (kSR/kss). Another method to potentially measure the mutual
kinetic enantioselection would be to react non-racemic with non-racemic and analyse
the product distribution. This method is not convenient since the product distribution is
not directly proportional to the MKE (method 3, Figure 23). A numerical method has to
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be employed where the reaction is modeled as four simultaneous second order reactions
and then the resultant product distribution can be used to obtain the respective rate
constants of these parallel reactions. 110
method 1 [sum of unlike products]kSR kRS
racemic + racemic = = = MKE
kss kRR [sum of like products]
method 2 [sum of unlike products]kSR
enantiopure + excess racemic = = MKE
kss [sum of like products]
method 3 [sum of unlike products]
if:non-racemic + non-racemic MKE[sum of like products]
Figure 23. Methods to measure the mutual kinetic enantioselection (MKE) based on
product distribution.
All like and unlike reactions between chiral reactants can display the
phenomenon of double stereodifferentiation. Reactions of an enantiopure reactant with
a racemic reactant should display some degree of kinetic resolution, and reactions
between two racemic reactants should exhibit some level of mutual kinetic
enantioselection (MKE). Examples of kinetic resolution are discussed below and
examples ofMKE are discussed in Section 1.5.2.4.
1.5.2.3. Examples ofkinetic resolution
Danishefsky et al. investigated the aldol reaction between (8)-92 and (8)-93 in
connection with the synthesis of epothilones (Scheme 7).111,112 The reaction gave the
desired adduct 95 but with poor yield and diastereoselectivity. It was suspected that this
was the mismatched reaction of these chiral reactants. By comparison, reaction of (R)-
92 with (8)-93 was highly diastereoselective and gave adduct 96 in 88% yield. For
epothilone synthesis, inversion of the stereogenic center at C-3 of adduct 96 was
necessary; however, attempts to invert this position using Mitsonobu type reactions
were unsuccessful. III
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Required C1-C8 fragment
a
H~
(8)-93
General structure of Epothilones
a a
tSua
94 (32%)
a aH a aH
:
tsuo
95(21%)
aH
tsuo
96 (88%)
0 OH a OH
tSua
97 (not observed)
(8)-93
(8)-93
(8)-92
(R)-92
matched rxn
mismatched rxn
a ali ali
tBuo~Me
H
a ali ali
tBuo~Me
H
excess racemic reactant 1 + enantiopure reactant __ enantiopure product
o ali OLi
tBuo~Me + (5)-93
H
o OH a aH
(±)-92 2 equiv. 1 equiv. 96
(70% single isomer)
Scheme 7. Double stereodifferentiation and kinetic resolution in the reaction of92 and
93.
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The highly diastereoselective reaction of (R)-92 with (8)-93 prompted the
question whether this matched pair was also kinetically favoured. Reaction of racemic
enolate 92 with enantiopure aldehyde (8)-93 selectively gave adduct 96 in good yield
(70%) (Scheme 7) demonstrating that the matched reaction was also the faster reaction.
The aldol reaction of enantiopure aldehyde (8)-98 with enantiopure Li-enolate
(8)-99 was reported by Calter et aL to give a single adduct 100 in 55% yield.29 It was
noted that the enantiopure adduct 100 can be applied to the synthesis of the
siphonariene class of marine polypropionates. I13,114 Presumably, in the hope that the
like reaction (i.e. reaction of (8)-98 with (8)-99) would also be the kinetically favoured
reaction in a kinetic resolution experiment, the reaction of (8)-99 with 1.1 equivalent of
racemic 98 was attempted. Unfortunately, a 1.2:1 mixture of 101 and 100, respectively
was obtained from which the desired 100 was isolated in 25% yield. This result suggest
the possibility of a kinetic preference for the unlike reaction; however the nature of the
reported experiment (i.e. a 1:1 stoichiometry without the conversion dependance of the
product ratio) does not allow for an unambiguous conclusion.
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(5)-98 1 equiv.
o OLi
Meo'N~Me
1 :
Me Me
(5)-99 1 equiv.
o 0 OH
Meo'N~_-_
1-- -
Me: : :
100
55% yield
(±)-98 1.1 equiv.
o
H
o OLi
MeO, ~Me
N -
1 :
Me Me
(5)-99 1 equiv.
•
o 0 OH
MeO'N~_::_
I : : :
Me: : =
100 (25% yield)
o 0 OH
Meo'NJl_~_~ /'--..
1_ I I I 1Me: :
101
100:101,1:1.2
siphonarienal
Scheme 8. Kinetic resolution experiment for reaction of (±)-98 with (S)-99.
In the attempt to obtain the anti,anti stereotriad (such as is found in adduct 106,
Scheme 9) in one step, Gennari et al. 115 investigated the TiCl4 promoted aldol reactions
of propionate derived sHyl ketene acetals to 3-(benzyloxy)-2-methylpropanal (103). The
reaction of the achiral enolsilane 102 to enantiopure aldehyde (R)-103 gave a single
adduct which upon reduction gave 104. The diastereoface selectivity for addition of 102
to aldehyde (R)-103 was anti-Fe1kin; unfortunately, the aldol relative topicity was syn
selective to give the syn,anti adduct 104 (Scheme 9). Due to the already favourable anti-
Felkin preference, it was decided to investigate the aldol reaction of the chiral
enolsilane 105 with 103 in the hope that double stereodifferentiation may induce an
anti-selective aldol relative topicity (Scheme 9).
The aldol reactions of (R)-103 and (8)-103 with enantiopure silyl ketene acetal
105 derived from (lR,2S)-N-methylephedrine propionate were conducted (Scheme 9).
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The reaction of (R)-103 with 105 occured with high diastereoselectivity (i.e. matched
reaction) to afford the syn,anti adduct 104. The reaction of (8)-103 with 105 occurred
with poor diastereoselectivity (i.e. mismatched reaction) to give a 1:1.3 mixture of ent-
104 and 106, respectively.
The possibility for kinetic resolution was examined by reaction of excess
racemic 103 with 104 which gave an ca. 10:1 mixture of 104 (65-70% ee) and 106,
respectively, in moderate Yield. llS This result implies an 8.5:1.5:1 mixture of 104, ent-
104 and 106, respectively and therefore a 3.4: 1 kinetic preference for reaction of 104
with (R)-103 compared to (8)-103.
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TBDMSO Me
>==<tSus H
102 (R)-103
OH
a. TiCI4, CH2CI2, -78 °c~
-----........~ HO ~ I OBn
b. Ra-Ni, H2' MeOH =
104 (syn,anti) 50% yield
d.r. : only 104
ent-104 (syn,anti)
+
105
NMe2
Mell!
H4" ~,Ph
o H Me
>==<TMSO H
105
(R)-103
o
HYoBn
(5)-103
104 (syn,anti) 60% yield
d.r. : only 104
OH
HolYosn
a. TiCI4, CH2CI2, -78°C
•
OH
~HO = = OBn
106 (anti,anti)
kinetic resolution
NMe2
Mel.!
H4" ~'Ph
o H Me
>==<TMSO H
combined yield 22%
d.r. : ent-104:106, 1:1.3
105 (±)-103
3 equiv.
104 (syn,anti)
58% yield (65-700/0 ee)
d.r.: 104:106, >10:1
Scheme 9. A study of the matched and mismatched aldol reactions of 103 with 105.
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1.5.2.4. Examples ofmutual kinetic enantioselection
To the best of my knowledge, reported examples of MKE in aldol reactions of
racemic aldehyde with racemic enolates are extremely rare. Only two examples will be
discussed. In both these reports the phenomenon of MKE was not specifically
discussed.
Bloch reported that the reaction of racemic 107 with racemic 108 led to the
formation of two observable diastereomers in a ratio of 64:36 (Scheme 10).116,117
Subjecting these diastereomers to heat promotes a retro Diels-Alder reaction and gave
racemic 111 in 95% yield. The relative configuration of diastereomer 111 was expected
because the relative topicity of the aldol reactions of Z-lithium enolate 107 with achiral
aldehydes have been shown to be highly syn-selective117 and the aldol reactions of Z-
lithium enolate 107 with a number of chiral aldehydes have been shown to be highly
Felkin selective to afford the 3,4-syn relative configuration. 116 It can be deduced that the
relative configuration for all four stereoisomers 109, ent-109, 110 and ent-110 is 2,3-
syn-3,4-syn because retro Diels-Alder of these stereoisomers gives only 111 and ent-
111. The absolute configurations at position C-1' of the four stereoisomeric aldol
adducts (109, ent-109, 110, ent-110) was not established. With the observation that the
aldol reaction of 107 and 108 gives two diastereomers with a ratio of 64:36, it can be
concluded that the ratio of the enantiomeric pairs (109 and ent-109) to (110 and ent-
110) is equal to 64:36 or 36:64; hence the MKE in the reaction is ca. 2 (Scheme 10).
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ali a aSiMe3 QSiMe3~ ~Ph = Ph 64'I 1 3 S' 36l' R'
(±)-107 (i) aldol 109 ent-109
•
or
a (ii) TMSCI a QSiMe3H~Ph ~Ph 36 64
S' 'I ~ ~ R'
(±)-108 110 ent-110
L1 !retro-Diels Alder
SSt + RR'
MKE =
RS' + SRI ~:3ha aSiMe3~Ph
109 + ent-109
1 3
64
MKE = =
110 + ent-110 36 111 ent-111
(2,3-syn-3,4-syn) (2,3-syn-3,4-syn)
Isolated yield of diastereomer 111 = 95%
Scheme 10. MKE of the aldol reaction of (±)-107 with (±)-108.
A key step in the total synthesis of erythromycin by Woodward et al.118-120 was
the aldol coupling of enantiopure fragments of (+)-112 with the 'amine free' Li-enolate
of (-)-113 (Scheme 11).118 This unlike reaction between enantiopure fragments gave a
mixture of diastereomers 114 which upon oxidation gave a single product (+)-115. The
similar reaction between racemic reactants gave a mixture of diastereomers (±)-114 and
(±)-116. Oxidation of this mixture gave a 5:1 mixture of (±)-115 and (±)-117,
respectively. Consequently, the MKE of the aldol reaction between (±)-112 and (±)-113
was 5:1 in favour of (+)-112 with (-)-113.
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Scheme 11. MKE in the aldol reaction of (±)-112 and (±)-113.
50
2. RESULTS AND DISCUSSION
2.1. THE THIOPYRANONE ROUTE TO POLYPROPIONATES
Cyclic sulfides have been widely used as templates to facilitate and control
various chemical transformations. Their popularity is largely derived from their ease of
preparation, versatile chemistry and the ready removal of sulfur from the final
product.121-124 There are numerous examples where thiopyran derived templates have
been succesfully employed in the sYnthesis of a variety of targets. 125-128 Recently, Ward
et a1.30,36 have proposed the use of aldol reactions of tetrahydro-4H-thioPYran-4-one
derived derivatives followed by desulfurization as a strategy for the synthesis of
polypropionates. The basis of the present research was to explore the stereoselectivity
of the two key aldol coupling steps inherent in this strategy (Figure 24) with the goal of
increasing the stereochemical diversity of polypropionate fragments that can be
synthesized and to gain a greater understanding of the stereochemical control elements
that govern product distribution.
The thiopYranone route to polypropionates can be illustrated by its application to
the synthesis of a hexapropionate 118 (Figure 24). The hexapropionate 118 is obtained
by a carboxylation and desulfurization of the parent hexapropionate synthon 119. It is
evident that sYnthon 119 can be considered as a scaffold* comprised of three
thiopYranone (122) monomers. The disconnection of hexapropionate synthon 119
reveals that it can readily be obtained from two aldol reactions. This disconnection also
. reveals a tetrapropionate sYnthon 120 that can be useful for the synthesis of
tetrapropionate fragments (Figure 25).
• The term scaffold is used in the context of a temporary structure to aid in the construction of the target
which is then later removed. In this case, the linked thiopyranone monomers are the scaffold which is
'removed' upon desulfurization to afford the target molecule.
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HO HO HO HO HO 0
\!lOH
118
HEXAPROPIONATE
~ DESULFURIZATIONDESYMMETRIZATIONREDUCTION
o 0 0
cY 6S
121 122
~ ALDOL
ALDOL
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HEXAPROPIONATE
SYNTHON
120
TETRAPROPIONATE
SYNTHON
121
Figure 24. A retrosynthetic analysis of an hexapropionate.
The hexapropionate synthon 119 is synthesized in two steps from 121 and 122.
Aldol reaction of 122 (or 120) with 121 is impractical and the protected reagent 125a
was selected as a synthetic equivalent of 121 (Figures 25 and 26). A practical advantage
of this approach is that both 122 and 125a are derived from the cyclic p-ketoester 124
which is easily prepared from the commercially available diester 123 (Figure 25). The
initial aldol reaction of 122 and 125a can produce up to four diastereomers 126a-129a.
The subsequent aldol reactions of 126a-129a with 125a can give up to 20 diastereomers
(16 enantiomeric pairs and 4 meso compounds) of hexapropionate synthon 132 (Figure
26). Thus single or consecutive aldol reactions using 122 and 125a as the only building
blocks promise to be efficient one step or two step approaches to stereochemically
diverse tetrapropionate 126a-129a and hexapropionate 132 synthons, respectively. The
success of such an approach will crucially depend on the extent to which the
diastereoselectivity of the aldol reactions can be controlled (Figures 25 and 26).
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Figure 25. The thiopyran route to tetrapropionates : The first aldol reaction.
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Figure 26. The thiopyran route to hexapropionates : The second aldol reaction.
To gain an appreciation of the challenge involved in the stereoselective
syntheses of these polypropionate synthons 126a-129a and 132, the stereochemical
control elements involved in the first and second aldol reactions should be considered.
The four diastereomers from the reaction of 122 and 125a arise from the combination of
the diastereoface selectivity for addition to the chiral aldehyde 125a and the relative
topicity of the aldol coupling. In Section 2.2 the results towards the diastereoselective
synthesis of each of the four diastereomers will be discussed. The diastereoselectivity of
the second aldol reaction involves the diastereoface selectivity for addition to the chiral
enol(ate) of 126a-129a, the diastereoface selectivity for addition to carbonyl of
aldehyde 125a, and the relative topicity of aldol coupling. Because the ketones 126a-
129a and the aldehyde 125a are chiral, the diastereoselectivity of their aldol reactions
will be modulated by double stereodifferentiation (cf. Section 1.2.5.1). Furthermore,
because the ketones 126a-129a and aldehyde 125a used in this study were racemic, the
diastereoselectivity of the aldol reaction is additionally influenced by mutual kinetic
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enantioselection (MKE) (cf. Section 1.5.2.2). The results of the investigation of the
diastereoselectivity of the second aldol reaction are discussed in Section 2.3.
Although polypropionates in nature are found in enantiopure form their
enantioselective synthesis is not the subject of this investigation. However, it has been
demonstrated that polypropionate synthons can be synthesized in enantioenriched form
with the use of enantioenriched substrate 125a. The synthesis of enantioenriched
substrate 125a and its application to the synthesis of enantioenriched aldols is a subject
of investigation within the Ward group.* Another approach to obtain enantioenriched
polypropionate synthons involves the desymmetrization of a meso diastereomer of 135
via an enantiotopic group selective reaction (Figure 27). There are four possible meso
diastereomers of 135. The desymmetrization of meso-135 has also been a topic of
investigation in the Ward group. t The great advantage of this approach is that easily
obtainable racemic substrates could be used in the synthesis of the four possible meso-
135 compounds.
o OP OP OP 0
meso-135
DESYMMETRIZATION
DESULFURIZATION
o OP OP OP 0
enantioenriched 136
eOOH
Figure 27. Enantioenriched polypropionates by desymmetrization of a meso-135.
Irrespective of which approach IS used to obtain enantioenriched
polypropionates it is imperative to have prior knowledge of the diastereoselectivities of
the first and second aldol coupling reactions. The importance of executing the first and
second aldol reactions diastereoselectively cannot be overemphasized. These issues are
addressed in the sections to follow.
• Work done by I. Alarcon and K. Akinnussi has led to the synthesis of enantioenriched 125a. The work
of I. Alarcon has led to synthesis of enantioenriched aldol 126a.
t Success in the desymmtrization of meso compounds 135 has been demonstrated by Dr. K. Saravanan
and H. M. Gillis.
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2.2. CONTROLLING THE DIASTEREOSELECTIVITY OF THE FIRST ALDOL
REACTION
The results of the efforts towards a diastereoselective synthesis of each of the
four diastereomers 126a-129a are discussed. The investigation comprised a study of the
effect of the aldehyde J3-substituent on reaction diastereoselectivity under various
reaction conditions.
2.2.1. The Diastereoselectivity of Aldol Reactions of Ketone 122 with
Aldehyde 125a
Section 2.2.1 contains previous contributions made by members of the Ward
group, and describes the progress made towards the diastereoselective synthesis of the
four possible diastereomers 126a-129a.
The aldol reaction between 125a and the lithium diisopropylamide generated
enolate 137a was first reported by Hayashi to give adduct 127a in 85% yield with
excellent diastereoselectivity (126a:127a = 1:50).40 In an effort to reproduce Hayashi's
results the required substrates 122 and 125a were synthesized 30,36,129 from readily
available dimethyl 3,3-thiodipropionate 123 and the aldol couplings were carried out
under the reported reaction conditions.4o Despite extensive experimentation, all attempts
by the Ward group36,130 to reproduce the yield and diastereoselectivity reported by
Hayashi for the reaction of 125a with 137a were unsuccessful (Table 6, entry 1). It was
initially suspected that the adducts 'profound tendency towards retroaldolization'
reported by Hayashi was responsible for the inability to reproduce the reported results.
However, it was demonstrated that both aldol adducts 126a and 127a were recovered
unchanged (>85% yield) after treatment with LDA under the reaction conditions
reported by Hayashi. 13 I Eventually use of an 'amine free' Li-enolate was investigated
based on a note in Woodward's erythromycin A synthesis indicating that an important
aldol coupling of a dithiadecalone proceeded in higher yield using an 'amine free' Li-
enolate generated from mesityllithium compared to the use of an LDA generated
enolate.1l8 The 'amine free' enolate 137c was generated by the addition of MeLi to the
enolsilane 137b. Fortunately the aldol coupling between aldehyde 125a and 137c
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reproducibly gave a readily separable* 9:1 mixture of adducts 127a and 126a,
respectively in 70% total isolated yield (Table 6, entry 2). That the behaviour of LDA
generated enolates and 'amine free' enolates are different is not unexpected because it is
well established that the i-Pr2NH product formed from the reaction of LDA with
ketones is associated with the enolate (e.g. 137a) and can affect the ensuing
chemistry.132 Nonetheless, there are few reports of the influence of this phenomenon on
aldol diastereoselectivity.
The aldol reaction of 125a with the putative Mg-enolate133,134 formed by the
reaction of 137c with MgBr2eOEh gave 127a with poor diastereoselectivity (Table 6,
entry 3).Similar reaction of 125a with the Ti(IV) enolate generated from reaction of
122 with TiCl4 and i-Pr2EtN gave 126a in poor yield and modest diastereselectivity
(Table 6, entry 4). The aldol reactions of 125a with the boron-enolates 137e and 137f
gave 127a selectively in good yield. (Table 6, entries 4 and 5). However, for large scale
preparation of aldol 127a the use of the 'amine free' Li-enolate 137c was preferred
since the adduct 127a could be directly crystallized from the crude reaction mixture.
~ 137b M = SiMe3MeLi 137c M = Li
122
~
" 0
OM~H + 6 •s S
125a 137
137a M =UoNHipr2 137d M =TiCI3
137e M = BBu2
137f M = B(Chx)2
126a
(1 ',3-syn-1',6"-syn)
"OH 0~
128a
(1 ',3-syn-1',6"-anti)
"OH 0
c:r6
127a
(1',3-anti-1',6"-syn
W6s S
129a
(1' ,3-anti-1',6"-anti)
Scheme 12. Aldol reaction between 125a and 137.
• The major aldol 127a was directly crystallized from the crude reaction mixture.
57
Table 6. The diastereoselectivity of aldol reactions between 125a and various enolates
137a, c-f.
Ratio of
Entry8 Enolate # Equiv Lewis acid Yieldb aldolsc
(#equiv) aldehyde (#equiv) (%)125a 126a 127a
1 137a 1.2 15-40 1 2.5
(1)
2 137c 1 70 1 9
(1.5)
3 137c 1 MgBr2-0Et2 77d,e 1 2.5
(2) (2)
4 137d 1.2 46f 3.6 1
(1)
5 137e 4 82g 1 10
(1)
6 137f 4 84g 1 15
(1)
8The results of entries 1 and 2 were obtained C. C. Man and Dr. C. Guo. Entry 3
obtained during this study and Entries 4-6 was obtained by Dr. P. K. Sasmal.
b Percentages represent the total isolated yield of all aldol products. Yield is calculated
with respect to the limiting reagent. C No aldols 128a and 129a were isolated for all
entries 1-6. d 137c was stirred with MgBr2eOEt2 for 5 minutes at -78°C followed by
the reaction with 125a for an additional 5 minutes at -78°C e The yield reported as
percentage conversion of aldehyde 125a to aldol product. f Reaction at -78°C for 5 h.
g Reaction at -78°C for 3 h.
The diastereoselectivity of Lewis-acid promoted reactions of enolsilane 137b
with aldehyde 125a were also investigated (i.e. Mukaiyama reactions).135,136 The
reactions promoted by BF3-OEt2 and SnCl4 gave mixtures of aldols 126a and 127a in
good yield but with modest diastereoselectivities (Table 7, entries 1 and 2). By contrast,
the TiCl4 promoted aldol reaction proceeded in high yield and with excellent
diastereoselectivity favouring aldol 126a.
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Table 7. Diastereoselectivity of Lewis acid promoted aldol reactions of 137b with 125a
Ratio of
Entrya Enolate # Equiv Lewis acid Yieldb aldols
(#equiv) aldehyde (#equiv) (%)125a
126a 127a
1 137b 1 BF3-OEt2 74c,d 1
(2) (3)
2 137b 1 SnCl4 72e 1 3
(2) (3)
3 137b 1 TiCl4 87c 16 1
(1.5) (1)
a Entries 1 and 2 was obtained in this study and entry 3 was obtained by C. C. Man
and C. GU036 and confIrmed by P. K. Sasmal. 129 b Percentages represent the total
isolated yield of all aldol products. Yield is calculated with respect to the limiting
reagent. C Reaction at -78°C for 1 hr. d The yield reported as percentage conversion
of aldehyde 125a to aldol product. e Reaction at O°C for 2 h.
In the aldol reactions of aldehyde 125a and enolates 137a-f there are four
diastereomeric adducts possible i.e. 126a-129a. There are two control elements that
influence the diastereoselectivity of this reaction which is the aldehyde diastereoface
selectivity and the relative topicity of the reaction. Appropriate models explaining the
observed relative topicities (l' ,3-syn or anti in aldols 126a-129a) given in Tables 6 and
7 are discussed, followed by a discussion of an appropriate model to rationalize the
observed aldehyde diastereoface selectivities (1' ,6"-syn or anti in aldols 126a-129a).
The observation that the relative topicities are anti-selective for the reactions
involving Li-, B- and Mg-enolates (Table 6, entries 1-5) can be rationalized by invoking
participation of the necessarily (E)-enolates* in 'closed' chairlike Zimmerman-Traxler
transition states (Figure 28). (cf. Section 1.2.1 for discussion of Zimmerman-Traxler
model). The trend that boron enolates are more selective than Li-enolates has been
attributed to the shorter B-O bond lengths compared to the Li-0 bond lengths present in
the 'closed' Zimmerman-Traxler transition state137,138 and may be responsible for the
* Note that the enolates 137a,c-f are cyclic E-enolates.
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observed higher selectivites obtained from boron enolates 137e and 137f (Table 6,
entries 5 and 6) compared to Li-enolate 137c (Table 6, entry 2).
OM
6s
137a,c-f
E-enolate
R =
RCHO
•
OH 0
R~
127a
l' ,3-anti selective
Figure 28. The Zimmerman-Traxler model predicts anti-selective relative topicity for
additions ofE-enolates 137a,c-fto 125a.
The Lewis acid promoted Mukaiyama reactions are believed to occur through
'open' transition states and the energetically favoured relative orientations of the
reaction partners in the transition state dictate the relative topicicity of the aldol reaction
(cf. Section 1.2.1 for discussion of topicity of Lewis Acid promoted aldol reactions).
Among the possible 4 diastereomeric products 126a-129a, the aldol reactions reported
in Table 7 each produced a mixture of only two products of 126a and 127a, and there
was a wide variation in the observed 126a:127a ratios. Reactions with BF3-0Etz and
TiCl4 are syn-selective (126a is major) and reaction with SnCl4 is anti-selective (127a is
major). The syn-selective aldol topicity obtained from the BF3-OEtZ and TiCl4promoted
reactions can be accounted for by a qualitative examination of the steric and electronic
interactions of the substituents in the 'open' transition states (TS) represented by
structures A-F (Figure 29). The most unfavourable steric and dipole-dipole interactions
occur in TS B, D and F and these are predicted to be highly disfavoured. TS A and E
both have moderately disfavoured steric and dipole-dipole interactions and these TS are
expected to be disfavoured relative to TS C. The work of Denmark and Heathcock81 ,139-
142 is in support of the above qualitative assessment where the factors which favour
staggered arrangements in open transition states such as depicted by C are discussed.
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TMS~C0
--- R H
--- S
t 0
favoured
OH 0
R~
S
126a
A (s*,d*)
~~TMSH 0/---S >t'---
R
0(5, d**)
B (s**, d**)
E (s*, d*)
----
---
C (s, d)
/
~OTMS1R HSot
F (5**, d)
1',3-syn
OH 0
R~
127a
1',3-anti
relative degree of steric
hindrance present
s least
s* moderate
s** most
relative degree of unfavourable
dipole-dipole interactions present
d least
d* moderate
d** most
Figure 29. A qualitative 'open' transition state model for BF3-OEt2 and TiCl4 promoted
reactions.
The Mukaiyama reaction promoted by SnCl4 gave l' ,3-anti relative topicity
predominantly (Table 7, entry 2). The l' ,3-syn selectivity of aldol reactions of (E)-
enolsilanes promoted by BF3-OEt2 and TiCl4 and the l' ,3-anti selectivity of reactions
promoted by SnCl4 was also observed by Denmark. 140 Unlike the reactions promoted by
BF3-0Eh and TiCI4, it is proposed that the reactions between 125a and 137b promoted
by SnCl4 occurs through a closed transition state where a chloride ligand facilitates the
reaction by removal of the silicon moiety (Figure 30). Rationale for the preference of
SnCl4 promoted reactions to occur through a 'closed' transition state were given by
Denmark.140 These reasons include the attenuated Lewis acidity of SnCl4 which would
lower the contribution of product from an 'open' transition state, the ability of SnCl4 to
coordinate to both enol and aldehyde oxygens, and the ability of the chloride counterion
in SnCl4 to remove the silicon moiety of the enolsilane. The ability of a Lewis acid to
coordinate to an enol oxygen has been proposed before.143-145 Furthermore, SnCl4 has
been shown to coordinate to both alkoxy and aldehyde oxygens in p-alkoxy aldehyde
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substrates*.96 Evidence for the participation of the counterion in the transition state was
the observation by Denmark that the selectivity of the aldol reaction is dependant on the
nature of the counterion where selectivity decreased in the order of CI > Br > I >
OTf. 140
6Me,
137b
E-enolsilane
125a
•
OH 0R01'ls)
127a
l' ,3-anti selective
Figure 30. Proposed 'closed' transition state for aldol reaction of 137b with 125a
promoted by SnCI4•
For all of the examples described thus far (Tables 6 and 7), the diastereoface
selectivity for addition to aldehyde 125a was very high resulting in 1,6"-syn aldol
products (i.e. 126a and 127a) exclusively. The various models used to rationalize and
predict the diastereofacial selectivity of addition of nucleophiles to chiral aldehydes
have been discussed in Section 1.2.4. Amongst these, the Felkin-Anh model is
appropriate to rationalize the observed l' ,6"-syn diastereoselectivity (Figure 31). Thus,
assuming the acetal carbon to be the large group, application of the Felkin-Anh model
to 125a suggests preferential addition to conformer A via the Burgi-Dunitz trajectory to
give products with l' ,6"-syn relative configuration (Figure 31). The product predicted
by the Felkin-Anh model is denoted as the 'Felkin' product.
* Notice that the arrangement of both oxygens of the enolsilane and aldehyde about Sn(IV) in the
transition state proposed in Figure 30 can be likened to the arrangement of both oxygens in a l3-alkoxy
aldehyde chelated to Sn(IV).
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Nu- 1° 1371 {\(:1HM=e-S H2C=§2-HLA-O C H LA-O ~ H ..
L S
0=0CH2
Felkin-Anh Model Conformer A 125a
~ ~
!\OH ~LyNu l'M S S S
1',6"-syn product (126a or 127a)
Felkin product
Figure 31. Felkin model applied to rationalize the observed selectivities for addition to
aldehyde 125a.
From this earlier work done by the Ward group it was established that two out of
the four possible diastereomers could be selectively prepared in good yield. The TiCl4
promoted aldol reaction afforded adduct 126a (l'3-syn-l ' ,6"-syn) and the reaction of
the'amine free' Li-enolate 137c with 125a selectively afforded adduct 127a (1 '3-anti-
l' ,6"-syn). The aldol adducts 128a and 129a were not detected under the reaction
conditions previously attempted. For the aldol reaction of 122 with 125a to be of
general utility towards the synthesis of tetrapropionate synthons(Figure 25) it was
essential to devise conditions to access the elusive aldol adducts 128a and 129a. Such
adducts would result from addition to aldehyde 8a with anti-Felkin diastereoface
selectivity leading to products with l' ,6"-anti relative configurations. The synthesis of
these elusive aldols 128a and 129a was an important objective of this study of the first
aldol reaction.
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Although the Felkin-Anh model can account for the diastereoselective formation
of l' ,6"-syn aldol adducts from reaction of enolates of 122 with 125a under various
reaction conditions (see Tables 6 and 7), the influence of the ketal substituent of 125a
towards the aldehyde diastereoface selectivity was not clear. To probe the influence of
the cis- and trans-ketal oxygens of aldehyde 125a on the aldehyde diastereoface
selectivity the cis- and trans-p-alkoxy aldehydes 125b and 125c were proposed as
substrates for the aldol reaction (Figure 32). The aldol reactions of these model
substrates would provide a greater understanding of the influence of the relative
configuration of the p-alkoxy substituent on the aldehyde diastereoface selectivity and
may provide insight towards obtaining the elusive l' ,6"-anti (anti-Felkin) aldol adducts
128a and 129a.
1\
aCHO
s
125a
* .. O~sc:te~o""""""'- **
Pi
125b
* • OMOMsc:::F~o
Pi
125c
hi~OMOM ........---- **s------tCHO
Pi
* oxygen in cis-orientation
** oxygen in trans-orientation
Figure 32. Proposed substrates 125b and 125c to investigate the relative configuration
of the p-alkoxy substituent on aldol diastereoselectivities.
2.2.2. Influence of the P-Alkoxy-Substituent on the Diastereoselectivity of
Aldol Reactions of Aldehyde 125
In the sections to follow, the synthesis and aldol reactions of aldehydes 125b
and 125c is presented and models to account for the observed aldol
diastereoselectivities are proposed.
64
2.2.2.1. Preparation ofaldehydes 125b and 125c
Reduction of 124 with NaBH4 has been previously reported.146 In my hands this
reaction gave modest yields of a 1.5-2:1 mixture of 138 and 139, respectively. Starting
B-ketoester 124 was not recovered and it was deduced that 124 was possibly unstable to
the basic reaction conditions, prompting the use ofNaCNBH3 as an alternative reducing
reagent. Reduction of ketones with NaCNBH3 is optimal between pH 3-4 and because
one equivalent of acid (H+) is consumed during the reduction, an additional proton
source must be provided to maintain this pH. 147 A modified method by Borch et a1. 147
involves reaction in the presence of indicators (bromocresol green or methyl orange)
with methanolic HCI added dropwise to maintain the appropriate indicator colour. In
my modification, the reduction was conveniently conducted in the presence of 1
equivalent of citric acid which maintained the optimal pH between 3-4.* With this
protocol the reduction of 124 was conveniently carried out on 40 g scale to provide
alcohols 138 and 139 in 49% and 24% isolated yield, respectively (Scheme 13). The
individually isolated alcohols 138 and 139 were converted to the corresponding MOM-
protected derivatives 140 and 141 in high yields, respectively, by reaction with MOMCI
and i-Pr2EtN in the presence of tetrabutylammonium iodide (BU4NI)!48 The LiAIH4
reductions of the individual esters 140 and 141 occurred without incident to give the
alcohols 142 and 143 in good yields.
Swem oxidation of alcohol 142 under standard reaction conditions149 resulted in
a poor yield of aldehyde 125b (40-60% isolated yield). However, the oxidation of 142
with a modified Swern procedure, with two equivalents of dimethyl sulfide as an
additive, gave 125b in excellent yield (89%).
Swem oxidation149 of alcohol 143 gave poor yields of 125c (20-50%) together
with a significant amount of a side product. Analysis of the 1H NMR spectrum of the
side product suggested structure 144 (Scheme 13). It was proposed that 144 was derived
from the reaction of the sulfur atom in 143 with the chlorodimethylsulfonium ion
• Citric acid is a tricarboxylic acid with three exchangeable hydrogens with pKal = 3.14, pKa2 = 4.77 and
pKa3 = 6.39. It is the pKal = 3.14 which is responsible for buffering the pH between 3-4 since as the 1
equivalent of NaCNBH3 reacts to consume one equivalent of H+ the conjugate base of citric acid is
generated internally and the reaction system is buffered around the pH of3.14.
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generated under Swern conditions (Scheme 33); quenching the reaction with water
converts 145 to 144. To minimize the putative transfer of the chloro-ligand from 145 to
144, two equivalents of dimethyl sulfide was added. Unfortunately, the use of this
modified Swern procedure did not lead to an improvement in yield of 125c (only 23%)
and 144 remained a major side product (25%). An alternative route to aldehyde 125c
was the reduction of ester 141 with DIBAL-H (Scheme 13). This reaction occurred
without incident to give consistent yields (>600/0) of 125c provided that care was taken
to ensure destruction of excess DIBAL-H prior to workup.ISO
0 OH OH
aC02Me NaCNBH3 aC02Me (yC02Me
• +
S S S
124 138 (49%) 139 (24%)
OMOM OMOM DMSO OMOM
>95% aC02Me 90% aCH20H (COClh aCHO
138 • • •MOMCI S LiAIH4 S DMS S
i-Pr2EtN i-Pr2EtN
BU4N1 140 142 125b (89%)
125c (69%)
QMOM
- CHOV
+
125c (23%)
OMOM
(yCH20H
S
II
o
144 (25%)
OMOM
VCHO
DMSO
(COClh
•
S LiAIH4
141lDIBAL-H
OMOM
N C02Me ·94%
~-) .
>95%
•
MOMCI
i-Pr2EtN
BU4N1
139
Scheme 13. Synthesis of MOM-protected aldehydes 125b and 125c.
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Figure 33. Undesired pathway during Swem oxidation
2.2.2.2. Diastereoselectivity ofaldol reactions of122 with aldehydes
125b and 125c
Reactions of the 'amine free' lithium enolate 137c with the aldehydes 125b and
125c (Table 8, entries 1 and 2) led to the diastereoselective formation of aldol adducts
with l',3-anti-l',3"-syn relative configurations (i.e. 127b and 127c, Scheme 14).
Reaction of 137c with 125c gave the adduct 127c exclusively in good yield (Table 8,
entry 2). The reaction of 125b with 137c led to the formation of 127b with modest
diastereoselectivity along with two other diastereomers. Significantly, this latter
reaction gave isolable amounts of aldol adduct 129b with the elusive l' ,3-anti-1 ' ,3"-anti
relative configuration establishing that the orientation of the ~-alkoxy group in 125
could modulate diastereoface selectivity for addition to the aldehydes.
Aldol adducts were obtained in poor yield from the TiCl4 mediated reaction of
125b with 137b (Table 8, entry 3). The low yield is attributed to the propensity of 125b
to undergo elimination in the presence of TiCI4. Though aldol 129b possessing the 1,3"-
anti relative configuration was obtained, the yield and diastereoselectivity for this
product were too poor to be of any practical value. By contrast, the TiC14 promoted
67
reaction between 125c and 137b gave 126c in good yield and with good
diastereoselectivity (Table 8, entry 4).
Mg (II) promoted aldol reactions of enolsilanes to a-heteroatom substituted
aldehydes are known and reports by Mukaiyama, Heathcock and Scolastico have
claimed that MgBr2eOEt2 effected chelation controlled addition of enolsilane to a-
alkoxy aldehydes. 141 ,151-155 This literature precedence combined with our experience
(work done by M. J. Hrapchak and myself) that MgBr2eOEt2 was uniquely able to effect
a highly selective chelation controlled addition of TMSCN to a-alkoxy aldehydes for
the diastereoselective formation of cyanohydrins156 led to the exploration of
MgBr2eOEh to promote the reactions of p-alkoxy aldehydes 125b and 125c with 137b.*
125b
125c
6S
137b M =SiMe3
137c M = Li
S
126b,c
(1',3-syn, 1',3"-syn)
128b,c
(1',3-syn, 1',3"-anti)
b series
R1 =H, R2 =OMOM
127b,c
(1',3-anti, 1',3"-syn
mS S
129b,c
(1' ,3-anti, 1',3"-anti)
c series
R1 =OMOM, R2 =H
Scheme 14. Aldol reaction of 125b and 125c with 137.
The aldol reactions promoted by MgBr2eOEt2 between 125b and 137b
proceeded with high aldehyde diastereoface selectivity since only the 1'-3"-anti
products 128b and 129b were obtained (Table 8, entry 5). The total isolated yield of
aldol adducts was 84% and the reaction was selective for the formation of aldol 128b.
The aldol 128b could be obtained in 570/0 yield by crystallization from the crude
* To the best of my knowledge the use of MgBr2eOEt2 to promote aldol reactions between enolsilanes and
p-alkoxy aldehydes have not been reported.
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reaction mixture. The resultant supernatant was subjected to chromatography to yield
the remaining 27% of combined aldols 128b and 129b.
Table 8. Investigation of the diastereoselectivity of aldol reactions of cis-MOM (125b)
and trans-MOM (125c)
Enolate Aldehyde Promoter Yielda Ratio of aldolsAldolEntry (#equiv) (#equiv) (#equiv) series 0/0 126 127 128 129
1 137c 125b b b 61 1 4 1.5
(2) (1)
2 137c 125c b 64 1c
(2) (1)
3 137b 125b TiCl4 b 27 1 1.3
(2) (1) (1t
4 137b 125c TiCl4 c 81 20 1 2
(2) (1) (1t,
5 137b 125b MgBr2eOEh b 84 3.5 1
(2) (1) (3)
6 137b 125c MgBr2eOEt2 c 74 4 7 1
(2) (1) (3)
a The combined isolated yield of all aldol products. b Reaction at -78°C for 5 minutes. C Reaction at
-78°C for Ihr.
The aldol reaction promoted by MgBr2eOEt2 between 125c and 137b proceeded
with lower aldehyde diastereoface selectivity giving the l'-3"-anti products 128c and
129c and the l'-3"-syn product 126c (Table 8, entry 6).
The ability of MgBr2.0Et2 promoted aldol reactions of P-alkoxy aldehydes 125b
and 125c to selectively give anti-Felkin adducts prompted an investigation of
MgBr2eOEh promoted reactions between 125a with enolsilane 137b (see Table 9).
The MgBr2eOEt2 promoted reactions between 125a and 137b resulted in the
exclusive formation of the anti-Felkin (1' ,6"-anti) adducts 128a and 129a (Table 9).
The diastereoselectivity increased with the number of equivalents of MgBr2·0Eh
(Table 9, entries 1-7) as was previously observed in our study156 of addition of
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'cyanide' (i.e. E4NCN, E4NAg(CN)2 and TMSCN) to a-alkoxy aldehydes. The
diastereoselective formation of aldol 128a was optimum with 3 equivalents of
MgBr2eOEt2 with no significant increase with greater amounts. By increasing the
aldehyde concentration the reaction time required for high conversion was greatly
reduced (Table 9, entries 8 and 9). With the use of three equivalents of MgBr2eOEt2 and
an aldehyde 125a concentration of 0.2 M complete conversion to aldol product was
achieved in 1 h. These optimized reaction conditions (entry 9) left little unreacted 125a
Table 9. The stoichiometry effect of MgBr2eOEt2 on the diastereoselectivity of the aldol
reaction of 125a with 137ba
0"00 137b ( 2 equiv.) 1\tyH MgBr2'0Et2 t16( a.5 - 5equiv.) +•S CH2CI2, aoc, 4 hrs
125a 128a 129a
(1',3-syn, 1',611-antl) (1 ',3-anti, 1',611-antl)
Entry
[125a] # equiv
0/0 conversionb 128a: 129a
M MgBr2eOEt2
1 0.04 0.5e 50 1.6:1
2 0.04 1.0 23 1.7 : 1
3 0.04 1.5 70 2.6 : 1
4 0.04 2.0 90 3.5 : 1
5 0.04 2.5 95 4.1 : 1
6 0.04 3.0 96 5.1 : 1
7 0.04 5.0 91 5.4: 1
8 0.08d 3.0 97 3.5 : 1
9 0.2d 3.0 98 (89f 3.0 : 1
a Unless otherwise indicated, all reported reaction times are 4 h at O°C. b The percentage of
125a converted to aldol products 128a and 129a as determined by IH NMR. C Reaction time
extended to 6 days at ambient temperature since no product was detected after 4 h.
d Reaction time of 1 hour. e The 89% reported in parenthesis is the combined isolated yield of
128a and 129a.
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(>1%) and allowed the expedient crystallization of 128a directly from the crude
reaction mixture. The remaining material in the supernatant was fractionated by
chromatography to afford a further 6% of 128a and 22% of 129a. A convenient
procedure for the preparation of aldol 128a had thus been developed.
2.2.2.3. Transition-state models used to rationalize
diastereoselectivities ofaldol reactions
Reactions of chiral aldehydes 125b and 125c with achiral enolates of 122 (137a-
137f) involved two stereocontrol elements: the relative topicity of the aldol reaction
(1' ,3-syn/anti selectivity) and the aldehyde diastereoface selectivity (1',3"-syn/anti
selectivity). Both 'closed' and 'open' transition state models are used to rationalize the
observed relative topicities of the aldol reactions given in Table 8, and are now
discussed. This will be followed by a discussion of the models used to account for the
observed aldehyde diastereoface selectivities of the aldol reactions given in Table 8.
The Zirnmerman-Traxler model as depicted earlier in Figure 28 can be applied
to rationalize the selective formation of 1' ,3-anti products from reactions of Li-enolate
137c with aldehydes 125b and 125c (Table 8, entries 1 and 2).
The open transition state model as depicted earlier in Figure 29 can be used to
rationalize the selective formation of l' ,3-sYfi products from reactions of 137b with
125b or 125c promoted by MgBr2eOEt2 (Table 8, entries 5 and 6) and for the reaction of
125c with 137b promoted by TiCl4 (Table 8, entry 4). It is not clear why the relative
topicity of the aldol reaction of 125b with 137b promoted by TiCl4 was selective for the
l' ,3-anti products 127b and 129b (Table 8, entry 3). However, the observed
predominance of 127b and 129b may not represent the true selectivity of this reaction
because 126b was not stable to TiCl4 (mainly elimination) and the low yield of aldol
products (27% combined isolated yield of aldols 127b and 129b) precluded a confident
assessment of the selectivity.
The stereochemical model recently proposed by Evans et al.98 that combines the
effects of· a substituent at the a-position (1,2- stereoinduction) and at the p-position
(1,3-stereoinduction) of the aldehyde is well suited to predict and rationalize the
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diastereoface selectivity of addition to the aldehyde in 125b and 125c (cf. Section
1.2.4.3).
The Evans' merged 1,2- and 1,3-stereoinduction model as applied to aldehyde
125b is shown in Figure 34. In conformer B the u-'methylene' substituent directs the
nucleophilic attack to favour l' ,3"-syn products (Felkin selectivity) however this
conformer B has an unfavourable dipole-dipole interaction. In conformer C the
unfavourable dipole-dipole interaction between the ~-methoxYmethoxy substituent and
Nu- Nu-
0 OMOM I I ~ IH~ HJr HH2C~H- ~~~ H H~OS
...----t" I
125b MOM-O c~ MOM-O t~
B C
~ ~
HO OMOM HO OM OM
~ NU~Nu l' S S
1',3"-syn 1',3"-anti
Felkin selectivity anti-Felkin selectivity
Figure 34. Merged 1,2- and 1,3-stereoinduction model used to rationalize the low
aldehyde diastereoface selectivity of addition to 125b.
the carbonyl group is removed and 1',3"-anti products are favoured, but this conformer
C presents an unfavourable steric interaction with the approaching nucleophile. For
aldehyde 125b these models illustrate that the u- and ~-substituents are in a non-
reinforcing relationship and that a low diastereoface selectivity for addition to the
aldehyde may result. This model accounts for the low aldehyde diastereoface selectivity
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(i.e. poor 1',3"-syn/anti product ratios) observed in the reactions of 125b with Li-
enolate 137c (1',3"-syn: -anti, (1+4) : 1.5, see Table 8, entry 1) and with enolsilane
137b in the presence of TiCl4 (l ',3"-syn: -anti, 1 : 1.3, see Table 8, entry 3).
The Evans' model applied to aldehyde 125c is shown in Figure 35. In conformer
D the orientation of the a- 'methylene' does not sterically impede the approach of the
Nu and the orientation of the p-methoxymethoxy substituent does not present an
unfavourable dipole-dipole interaction with the carbonyl group. The a- and p-
substituents are in a reinforcing relationship and the Evans' model predicts a high
Felkin aldehyde diastereoface selectivity favouring l' ,3"-syn products. Reactions of
125c with Li-enolate 137c (only one l' ,3"-syn product detected, Table 8, entry 2) and
with enolsilanes 137b in the presence of TiCl4 (1' ,3"-syn: -anti, 20 : (1 +2), see Table 8,
entry 4) are highly Felkin (1' ,3"-syn)· selective.
125c
D
•
~OM
Nu l' l_)
s
1',3"-syn
Felkin selectivity
Figure 35. Merged 1,2- and 1,3-stereoinduction model used to rationalize high Felkin
aldehyde diastereoface selectivity of addition to 125c.
The aldol reactions of 125b and 125c with 137b promoted by MgBr2eOEh were
highly selective for the formation of anti-Felkin (l' ,3"-anti) products (Table 8, entries 5
and 6). This is in contrast to the predominant Felkin selectivity (1' ,3"-syn) obtained
with the use of Li-enolate 137c and in TiCl4 promoted reactions with 137b (Table 8,
entries 1-4). This dramatic reversal of the aldehyde diastereoface selectivity from Felkin
selective in the presence of TiCl4 to anti-Felkin selective in the presence ofMgBr2eOEt2
strongly supports the hypothesis that MgBr2eOEt2 (and not TiCI4) is effecting chelation
controlled addition of enolsilane 137b to the aldehydes 125b and 125c. The reversal in
aldehyde diastereoface selectivity (i.e. from l' ,6"-syn to l' ,6"-anti selective) was also
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observed for the MgBr2eOEh promoted addition of 137b to 125a (Table 9). Chelation
models (Figures 36-38) are proposed to rationalize the anti-Felkin selectivities for the
MgBr2eOEt2 promoted addition of 137b to aldehydes 125b, 125c and 125a and are now
discussed.
MOM Nu
M »",hl9V yf'H
H
less stable conformer A
more hindered approach of Nu
OH OMOM
~
Nu l' l_)
s
1',3"-syn
125b
:Nu
:Nu
Axial and least hindered approach of Nu
D
MO'YIitt
oJVVV
P H
,:"-'---0 H
Mg
Nu
more stable conformer B
OH OMOM
NU~
S
1',3"-anfi
Figure 36. Proposed 'chelation controlled addition' model to rationalize high anti-
Felkin (l' ,3"-anti selective) aldehyde diastereoface addition to 125b.
Exclusive anti-Felkin aldehyde diastereoface selectivity was observed for the
MgBr2eOEt2 promoted addition of 137b to 125b to give products 128b and 129b only
(Table 8, entry 5). It is proposed that the six-membered Mg-chelated intermediate
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assumes a half-chair conformation (Figure 36). An axial approach of a nuc1eophile,
responsible for the formation l' ,3"-anti adducts, leads to the initial formation of a more
thermodynamically stable chair conformer B (Figure 36). Not only is a nucleophilic
more stable conformer A
•
OH OMOM
NU~
S
1',3"·syn
more hindered axial approach of Nu
MOM
..0Mg::: - - - -O=:r==--+-
125c
:Nu
:Nu
Least hindered approach of Nu
H
/o~~Mg
'r( H H
MOM Nu
less stable conformer B
OH OMOM
= 3" =NU~
I ~S)
1',3"·anti
Figure 37. Proposed 'chelation controlled addition' model to rationalize moderate anti-
Felkin (1' ,3"-anti selective) aldehyde diastereoface addition to 125c.
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approach which leads to the formation of 1' ,3"-syn adducts the more sterically hindered
approach, it is also the approach which leads to the initial formation of the less
thermodYnamically stable twist boat conformer A (Figure 36). Both the steric argument
as well as the resultant formation of the less stable conformer A disfavours the
formation of 1',3"-syn adducts, whilst the sterically less hindered axial approach
coupled with the resultant formation of a more thermodYnamically stable conformer B
is responsible for the high anti-Felkin selectivity.
The much more moderate anti-Felkin selectivity for addition to aldehyde 125c is
rationalized by the six-membered chelated intermediate model in Figure 37. The least
sterically hindered approach of a nucleophile to 125c leads to the 1',3"-anti products.
However, this approach leads to the initial formation of the less thermodYnamically
stable twist boat conformer B, and as a result the l' ,3"-anti selectivity will be
attenuated. The axial approach which gives l' ,3"-syn adducts leads to the formation of
the thermodYnamically more stable conformer A, but the axial approach is also more
sterically hindered; therefore the 1',3"-syn selectivity is attenuated. In contrast to 125b,
the faces of the aldehyde 125c are not decisively differentiated leading to lower
selectivity.
A similar six-membered chelated model in a half-chair conformation proposed
in Figure 36 is used to account for the anti-Felkin selectivity (see Table 9) of additions
to 125a in the presence of MgBr2eOEh (Figure 38).
125a
:Nu
H966
___.~ NU~
S
1',3"-anti
Axial and least hindered approach
Figure 38. Proposed 'chelation controlled addition' model for nucleophilic attack to
125a.
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Several arguments support my hypothesis of chelation controlled additions of
137b to aldehydes 125a, 125b and 125c in the presence of MgBr2-0Et2 but not with
TiCl4 and SnCI4• It has been established by NMR that the Lewis acids MgBr2-0Et2,
TiC14 and SnCl4 can form chelates with ~-alkoxy aldehydes; 157,158 however in a recent
study Evans et al. 159 demonstrated that the use of Lewis acids with two vacant
coordination sites do not necessarily result in a reaction via a chelated bidentate
intermediate. In that study it was shown that chelation control was unlikely in both the
TiCl4 and SnCl4 promoted reactions of 146 to 147 (Figure 39) since the high Felkin
selectivity (i.e. in favour of 148) for these examples was also obtained in the presence
of BF3-0Eh where chelation is prevented since BF3-OEh only has one vacant
coordination site. Furthermore, in that study the dramatic reversal of the aldehyde
diastereoface selectivity for addition of 147 to aldehyde 146 in the presence of 2.5
equivalents of Me2AICI or MeAICh (Figure 39) strongly suggested a chelated
intermediate in these reactions.
P = SiMe2tBu 3,4-syn 3,4-antiOTMS (Felkin product) (anti-Felkin product)
~tBu
OP 0 OP OH 0 OP OH 0
iPrYH
147 .~ ipr~tBu.. 'Pr tBu3 1
146 148 149
Lewis acid (equiv.) ratio (yield)
TiCI4 (1) 98 2 (71 )
SnCI4 (1) 99 1 (41 )
BF3"OEt2 (1) 96 4 (91)
Me2AICI2 (2.5) 3 97 (51)
MeAICI2 (2.5) 4 96 (71 )
Figure 39. A demonstration of the reversal of aldehyde diastereoface selectivity by
Evans et al. 159
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In the present study, chelation control is unlikely in both the TiCl4 and SnCl4
promoted reactions of 137b to 125a (Table 7, entries 2 and 3) since the exclusive Felkin
selectivity (l ,,6"-sYn) observed for these examples was also obtained in the presence of
the BF3-0Eh where chelation is prevented due to BF3-OEt2 having only one vacant
coordination site (Table 7, entry 1). Furthermore, in this study the dramatic reversal of
the aldehyde diastereoface selectivity for addition of 137b to aldehydes 125a, 125b and
125c in the presence of MgBr2-0Eh (Table 8, entries 5 and 6 and Table 9) strongly
supports a chelated intermediate in these reactions. The superior ability of MgBr2-0Et2
compared to SnCl4 and TiC14 to be chelated by p-alkoxy aldehydes has also been
previously noted by Keck et al. 157,158
2.2.2.4. Comparison ofthe diastereoselectivities ofthe 1st aldol
reaction with related acyclic examples
It is instructive to compare the diastereoselectivities obtained in this study of the
aldol reactions of enolsilane 137b with aldehydes 125b and 125c to those that were
reported by Evans et a1.38,160 for similar aldol reactions of the structurally related acyclic
aldehyde (150, 156) and enolate (151) analogues (Figures 40 and 41). The trans
aldehyde 125c and the related anti aldehyde 150 give very similar diastereoselectivities
under similar conditions (Figure 40). For example, the reaction of the lithium (E)-
enolate 137c with 125c and the reaction of (E)-enolate 151 with 150 are highly selective
for Felkin addition and for anti relative topicity to give the adducts 127c (exclusive) and
153 (86% ds),* respectively. The related Mukaiyama reactions of 137b with 125c
promoted by TiCl4 and 151 (M=TMS) with 150 promoted by BF3-0Eh are also highly
selective for Felkin addition, but with SYn relative topicity to give adducts 126c (87%
ds) and 152 (95% ds), respectively. Interestingly, the minor adduct 153 from the
Mukaiyama reaction of 151 (M = TMS) is also derived from Felkin addition, whereas
the minor adducts 128c and 129c from the reaction of 125c are from anti-Felkin
addition.
* Percent diastereoselectivity (ds) is defined here as the mole fraction of the designated diastereomer.
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The diastereoselectivities of the reactions of the cis aldehyde 125b and the related syn
aldehyde 156 are also similar but much lower than above. For example, the reactions of
137c with 125b and 151 (M=Li) with 156 gave only modest diastereoselectivity (Figure
41). In both cases, the major product arises from Felkin addition and anti relative
topicity to give adducts 127b (62% ds) and 159 (51 % ds). The anti/syn relative topicity
ratios among the Felkin adducts are also similar in the two reactions (i.e. 127b:126b,
4:1; 159:158, 4.5:1); however in this same reaction, the anti-Felkin syn adduct 160
(30% ds) is the second most abundant adduct from aldehyde 156, but the analogous
diastereomer 128b is not detected in the reaction of 125b. Due to the low yield (27%) of
the Mukaiyama reaction of 137b with 125b no confident detennination of
diastereoselectivity could be established for this reaction and no meaningful comparison
can be made to the selectivity obtained from the reaction of 151 (M=TMS) with 156.
79
Evans' study This study
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For M =Li, P =PMB
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M = Li M = TMS
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PO OH 0
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PO OH 0
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153
PO OH 0
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a The combined mole fraction of adduct 152 and 154 is 14%.
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Figure 40. The diastereoselectivity of aldol reactions of trans aldehyde 125c and anti
aldehyde 15038,160 as substrates are compared.
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Evans' study This study
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PO 0 ~i-pr MOMO 0 6i-prA(H &H S
151 137
156 • 158-161
S
.. 126b-129b
125b
For M =Li, P= PMB
For M =TMS, P = SiMe/-Bu
Product ratios taken Product ratios taken
from Evans' study from this study
M=Li M=TMS M=Li M=TMS
(BF3) (TiCI4)
PO OH 0 MOMO OH 0
~pr~~pr 11 70 15 (r6
158 126b
PO OH 0 MOMO OH 0
~pr~~pr 51 30 62 43 ¢r6
159 127b
PO OH 0 MOMO OH 0
i-pr~i-pr 30 cY'6
160 128b
PO OH 0 MOMO OH 0
~pr~~pr 8 23 57 ¢r6
161 129b
Figure 41. The diastereoselectivites when using cis aldehyde 125b and syn aldehyde
15638,160 as substrates are compared.
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2.2.3. Conclusion
Progress towards the execution of the first aldol reaction to diastereoselectively
synthesise all four possible adducts 126a-129a has been made. Prior work demonstrated
that two of the diastereomers 126a and 127a could be diastereoselectively synthesized
using various reaction conditions; 126a is selectively obtained from the reaction of
enolsilane 137b with 125a in the presence of TiCl4 and 127a is selectively obtained
with the reaction of Li-enolate 137c with 125a, This study demonstrated a
diastereoselective synthesis of a third adduct 128a with the reaction of 137b with 125a
in the presence of MgBr2-0Et2. The fourth adduct 129a can be obtained by
isomerization of easily accessible 128a (cf. Section 2.4.2).131
This study clearly demonstrated that the Felkin diastereoface selectivitities for
additions of 137b to aldehydes 125a, 125b and 125c mediated by TiCl4 or SnCl4 can be
rationalized using non-chelation control models such as Felkin-Anh and merged 1,2-
and 1,3-stereoinduction models. Support for non-chelation control was that Felkin
selectivity was also observed for the reaction of 137b to 125a mediated by the
monodenate BF3-OEt2 which precludes chelation; furthermore, the reactions of 137b
with aldehydes 125a, 125b and 125c mediated by MgBr2-0Et2 showed a dramatic
reversal in aldehyde diastereoface selectivity to anti-Felkin and strongly suggested
chelation control. The literature is divided on the ability of Lewis acids with two vacant
coordination sites to effect chelation control. There are reports which attribute the
selectivities of addition reactions to a-alkoxy and J3-alkoxy aldehydes mediated by
TiCl4 and SnCl4 to chelation control. 92,141,161,162 Evans has pointed out that these claims
of chelation controlled addition are purely based on product analysis and that there is no
direct evidence of a chelated intermediate.98 Furthermore, Evans has proposed
nonchelation models as a viable alternative to rationalize the selectivities of addition
reactions to aldehydes mediated by Lewis acids such as TiCl4 which have two vacant
coordination sites.98
The merged 1,2- and 1,3-stereoinduction model was successfully applied by
Evans et at38,98,160 to rationalize the diastereoface selectivity of addition to the a-alkyl-
J3-alkoxy aldehydes 150 and 156. Despite the presence of the sulfur atom and the
associated ring that restricts the number of possible transition states, the
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diastereoselectivities for aldol reactions of 125b and 125c·are strikingly similar to those
obtained with the related acyclic analogues 150 and 156 and can also be rationalized
using Evans' model. The validity of Evans' model is supported because the orientation
of the J3-alkoxy groups in 125b and 125c are fixed because of conformational rigidity.
This study demonstrated that the orientation of the J3-alkoxy substituent on
aldehydes 125b and 125c can modulate the aldehyde diastereoface selectivity.
Furthermore, when comparing the reactions of 125a to the reactions of 125b and 125c,
they suggest that the ketal group is a versatile stereocontrol element for aldehyde
diastereoface selectivity. Under nonchelating conditions (reactions using 19c or 19b +
TiCI4), 125a exhibits very high Felkin selectivity (similar to 125c but much higher than
125b) and under chelating conditions (reactions using 19b + MgBr2-OE12), 125a
exhibits very high anti-Felkin selectivity (similar to 125b but much higher than 125c).
2.3. THE DIASTEREOSELECTIVITY OF THE SECOND ALDOL REACTION -
An attractive aspect of the Thiopyran Route to Polypropionates is that
stereochemically rich intermediates (6 stereogenic centers with 36 possible
stereoisomers, see 132 Figure 26) can be obtained in only two steps from simple
precursors. The potential of these products as hexapropionate synthons for the synthesis
of polypropionate containing natural products depends on understanding and controlling
the diastereoselectivity of the aldol reaction of 125a with enolates derived from 126a-
129a. The determination of the diastereoselectivity of this second aldol reaction requires
the isolation and identification of the bisaldol adducts. The structure determination of
these adducts is no menial task and has been a continuous exercise within the Ward
group and this study (cf. Section 2.5). Besides simply ascertaining the identity of
bisaldol products from the second aldol reaction, contributions towards understanding
the diastereoselectivity of this aldol reaction must take into consideration the
stereochemical issues responsible for the observed selectivities.
In Figure 42 a reaction depicting the coupling between aldehyde 125a and an
enolate 162 derived from aldol 126a is used to illustrate the stereochemical issues
present in all aldol reactions between chiral enolates derived from 126a-129a with
chiral 125a. To address these stereochemical issues only two combinations of
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enantiomers of 125a and 162 need to be considered: the reaction of (68)-125a with
(6"8)-162* and the reaction of (6R)-125a with (6"S)-162t (see Figure 42). The
transition states for the reaction of (6"S)-162 with (6S)-125a and the transition states
for the reaction of (6"S)-162 with (6R)-125a are diastereotopic by comparison and the
rates of product formation for each reaction pair will be different; the result is that the
diastereoselectivities of these two reactions will be different. This phenomenon of
different diastereoselectivities for the reactions of two chiral reactants is termed 'double
stereodifferentiation' .
The two reactions depicted in Figure 42 can be defined as the like and unlike
reaction pair, where like refers to that reaction pair with identical absolute
configurations at designated positions (e.g. C-6 in 125a and C-6" in 162) and unlike
refers to that reaction pair with opposite absolute configurations at those positions. For
example, the reaction of (6S)-125a with (6"8)-162 is like as is the reaction of (6R)-
125a with (6"R)-162. Reactions of (6S)-125a with (6"R)-162 and of (6R)-125a with
(6"8)-162 are unlike. Due to their diastereotopic relationship, the diastereoselectivities
of the like and unlike reactions should be different and the reaction with the higher
diastereoselectivity is labeled as the 'matched' reaction, and the reaction with relatively
lower diastereoselectivity is labeled the 'mismatched' reaction.
• The reaction of (6R)-125a with (6"R)-162 is enantiomeric by comparison and will have the same
diastereoselectivity as reaction (68)-125a with (6"8)-162.
t The reaction of (68)-125a with (6"R)-162 is enantiomeric by comparison and will have the same
diastereoselectivity as reaction (6R)-125a with (6"8)-162.
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(a) (c)
like reaction r--'---.
6'0 0 MO P1 0 P2 P3 0c;rH o+itJ kss+ •8 S
...............
(6S)-125a (6'8)-162 (b)
OH OH OH OH
~~l ~#l ~~~ = 5 ~~~
~ "~ ~ "~
d.r. of like reaction = 163a 163b 163c 163d
unlike reaction
8JH MO P10 P2 P3 0o+itJ kRS+ •S 8 8
(6R)-125a (6'8)-162 164
OH OH OH OH
~~~ ~#~ ~~~ = 5 ~~~
~ "~ ~ "~
d.r. of unlike reaction = 164a 164b 164c 164d
kss L 163a-d P1 = H or protecting groupMKE =
-
=
kRS L 164a-d P2, P3 = protecting group
(a) aldehyde diastereoface selectivity: 1",6"-syn (Felkin) or 1",6"-anti (anti-Felkin)
(b) relative topicity of aldol: 1",5-anti or 1",5-syn
(c) enolate diastereoface selectivity: 3,5-cis or 3,5-trans
Figure 42. The like and unlike reactions of the aldol reaction between chiral 125a and
chiral162.
Racemic reactants were used in this study and thus all four reaction
combinations are possible. The like reactions are enantiotopic and produce enantiomeric
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products with equal facility (in an achiral environment). The unlike reactions are
similarly related. Each of the like and unlike reactions can produce 4 diastereomeric
adducts (i.e. the like reaction between (6S)-125a and (6"8)-162 can give 163a-d and the
unlike reaction between (6R)-8a and (6"8)-162 can give 164a-d). Therefore, in a
reaction between racemic reactants (±)-125a and (±)-162 there are 8 diastereomeric
products possible (see Figure 42). All products will be racemic.
Upon identification of products derived from the like and unlike combinations,
the diastereoselectivity of these individual reactions can be determined and expressed,
for example, by the d.r. (diastereomeric ratio) of like products and the d.r. of unlike
products, respectively (Figure 42). The matched and mismatched reaction pair can be
assigned from a comparison of the diastereomeric ratios of the like and unlike reactions.
The mutual kinetic enantioselection (MKE) for this reaction, which is the
relative preference of one enantioner of 125a to react with one enantiomer of 162, is
defined as the ratio of composite rate constants kss/kRs of the competing like and unlike
reactions (where kss = k163a + k163b + k163c + k163d and kRs = k164a + k164b + k164c + k164d).
Horeau109 showed that for the reaction between racemic reactants the MKE can be
measured from the ratio of the sum of the products from the like reaction with the sum
of products from the unlike reaction (Figure 42). In principle, the advantages of
conducting a reaction between racemic 125a and racemic 162 is that both the
diastereoselectivity of the individual like and unlike reactions and the MKE can be
obtained from an analysis of the product distribution of this reaction; the disadvantage
is that more products are possible making analysis difficult. Furthermore, an assessment
of the three stereochemical control elements (labelled as (a-c) in Figure 42) is also
obtained from the product distribution and can aid in the understanding of the factors
governing the diastereoselectivity of the aldol reaction.
There have been very few studies of aldol reactions of J3-hydroxy ketones;41,163-
165 to the best of my knowledge no reports other than Ward et a1.30 were found on
reactions of racemic aldehydes with racemic J3-hydroxy ketones. The results discussed
in Sections 2.3.1 and 2.3.2 are from the work of previous researchers in the Ward group
(i.e. Dr. C. Guo, Dr. P. K. Pradip and Mr. C. C. Man) where my contribution related to
the structure determination of isolated bisaldol adducts and their derivatives (cf. Section
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2.5.2). The previous work investigated the diastereoselectivity of aldol reactions of
125a with enolates derived from 126a and 127a (Section 2.3.1.) and of aldol reactions
of 125a with enolates of J3-methoxy ketones 166 and 167 derived from 126a and 127a,
respectively (Section 2.3.2). The present study investigates the diastereoselectivity of
aldol reactions of 125a with enolates derived from the remaining two aldol
diastereomers 128a and 129a (Section 2.3.3) and with enolates derived from J3-MOM
protected derivatives 172 and 173 derived from 128a and 129a, respectively. The
results are discussed with special attention to the effect of structure of the ketone
substrate on aldol diastereoselectivity. Determination of the structures of the bisaldol
adducts is presented and discussed separately in Section 2.5.
2.3.1. Aldol Reactions of (±)-125a with (±)-126a and (±)-127a.
Reactions of 125a with the Ti (IV) enolates of 126a and 127a gave bisaldol
products with higher diastereoselectivity and much improved yields compared to
reactions with the Li-enolate Li-alkoxide (prepared from 126a or 127a with tBuLi) (see
Schemes 15 and 16).30 The titanium enolates were synthesised by mixing of 126a or
127a with TiCl4 (1.1 equiv) to generate the titanate (yellow in colouration) followed by
the addition of diisopropylethylamine (i-Pr2EtN, 2.4 equiv) which gave a characteristic
red solution typical of titanium enolates. 163 Reaction of the titanium enolate of 126a
with 125a was highly diastereoselective 165a, 165b and 165c in 60%, 1% and 8%
isolated yields, respectively (Scheme 15). As mentioned earlier, an aldol reaction
between (±)-125a and (±)-126a can give up to eight diastereomers assuming there is no
isomerization of substrate 126a or bisaldol products during the reaction and workup.
Not only was the reaction between (±)-125a and (±)-126a highly diastereoselective for
(±)-165a, the reaction also occurred with remarkable mutual kinetic enantioselection
(MKE) in favour of the unlike reaction (unlike:like = [165a + 165b] : 165c of 7.5:1.)
That is both 165a and 165b result from the combinations of an enantiomer of 125a with
an enantiomer of 126a where the absolute configurations at C-6 of 125a and C-6" of
126a are unlike (i.e. (6R)-125a + (6"S)-126a and (6S)-125a + (6"R)_126a. 166 The
diastereoselectivity of the like and unlike reactions can be obtained from examination of
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Scheme 15. Aldol reactions of enolates derived from (±)-126a with (±)-125a.
the product distribution. The products 165a and 165b are derived from unlike reaction
and this reaction is higWy diastereoselective (d.r. for 165a:165b = 60:1). The only
product detected from the like reaction is 165c; however the yield of this product is too
low to draw any conclusion regarding the diastereoselectivity of this reaction.
The reaction between titanium enolate (±)-127a with (±)-125a led to the
diastereoselective formation of 165d in 60% isolated yield with minor bisaldols 165a
and 165e in 6% and 4%, respectively (Scheme 16). This reaction proceeded with
significant MKE favouring the coupling of unlike reaction partners (unlike:like = [165a
+ 165d] : 165e = 16.5:1). The diastereoselectivity of the unlike reaction partners was
high (d.r. for 165d:165a = 10: 1). The diastereoselectivity of the like reaction could not
be determined with confidence due to the low yield of 165e (the only like product
detected).
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d.r. unlike = 165d : 165a 10: 1
d.r. like = only 165e
MKE=
kRS
=
165a + 165d 16.5
-
=
-kss 165e 1
t?H
(±)-125a
o HOO~+~
(±)-127a
1. TiCI4 I CH2CI2 1eq
-78°C, 10 min
2. i-Pr2EtN 2.4 eq
-78°C, 2 h
3.125a 1.2eq
-78°C, 2.5 h
+
165e (4%)
Scheme 16. Aldol reaction of enolates derived from (±)-127a with (±)-125a.
2.3.2. Aldol Reactions of (±)-125a with (±)-166 and (±)-168.
In early work, all attempts to prepare ether derivatives of aldols 126a and 127a
failed. Consequently, aldols 126a and 127awere both diastereoselectively converted to
166 and 168, respectively, with DIBAL-H reduction, methylation of the resultant diols,
and thioketal hydrolysis (Scheme 17 and 18). The titanium enolate of 166 was
generated by addition of TiCl4 (1.1equiv) followed by the addition of i-Pr2EtN (1.2
equiv) at -78°C which generated the characteristic red solution typical of titanium
enolates. 163 Addition of 125a to the titanium enolate of 166 gave aldol adducts 167a
(36%) and 167b (24%). Reaction of 166 with LDA followed by addition of TMSCI
gave the corresponding trimethylsilyl enol ether which was treated with MeLi to give
the "amine free" Li-enolate of 166. Addition of 125a to the so prepared Li-enolate gave
167a (29%) and 167b (23%) (Scheme 17).
From the structures of the products obtained from the reaction of 125a with 166
it was evident that 167a is derived from an unlike reaction and 167b is from a like
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*reaction. Both the like and unlike reactions are highly diastereoselective since each
reaction led to the apparent formation of only one product. The level of MKE observed
for those reactions was modest with a slight preference for the unlike combination
(unlike:like = 167a:167b = 1.3-1.5:1) (Scheme 17).
d.r. unlike = -only 167a
d.r. like = only 167b
kSR 167a 1.5MKE=
-
=
=kRR 167b 1
(±)-126a
1. Li.A1H(dPrl2 j
2. Mel, NaH
3. H+ .
OMe OMe
OMe OMe
167b (24%)
167a (36%)
3. 125a 1.2 eq
-78°C, 2.5 h
1. TiCI4 I CH2CI2 1 eq
-78°C, 10 min
2. i-Pr2EtN 2.4 eq
-78°C, 2 h
o OMe OMe
+~
S S
(±)-166
8JH
S
(±)-125a
1. LDA, TMSCI
2.MeLi
3. 125a(±)-125a + (±)-166 167a (29%) + 167b (23%)
d.r. unlike = only 167a
d.r. like = only 167b
MKE= ~ =
kRR
167a 1.3
---=167b 1
Scheme 17. Aldol reaction of enolates derived from (±)-166 with (±)-125a.
The titanium-enolate of 168 was generated under conditions analogous to those
used for ketone 166. Addition of 125a to the titanium enolate of 168 gave aldol adducts
* For aldol reactions of 1253 with 166 or 168, the like and unlike reactions are assigned according to the
absolute configurations at position C-6 of 1253 and position C-3" of 166 and 168.
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169a (24%) and 169b (17%) (Scheme 18). Reaction of 125a with the 'amine-free' Li-
enolate of 168 gave 169a (21 %) and 169b (22%) (Scheme 18). The product structures
indicate that both the like reactions (which only gave 169a) and the unlike reactions
(which only gave 169b) are highly diastereoselective (Scheme 18). The MKE observed
in these reactions was low with a slight kinetic preference for the like reaction
(like:unlike = 169a:169b = 1-1.4:1) (Scheme 18).
d.r. like = only 169a
d.r. unlike = only 169b
kRR 169a 1.4
MKE=
-
=
=kSR 169b 1
OMe OMe
OMe OMe
169a (24%)
1. TiCI4 I CH2CI2 1eq
-78°C, 10 min
2. i-Pr2EtN 2.4 eq
-78°C, 2 h
3. 125a 1.2 eq
-78°C, 2.5 h(t)-168
o OMe OMe
+~
(t)-125a
(t)-127a
1. LiAIH(Oipr)2!
2. Mel, NaH
3. H+
WH
S
1. LDA, TMSCI
2. MeLi
3. 125a(t)-125a + (t)-168 169a (21 %) + 169b (22%)
d.r. like
d.r. unlike
= only 169a
= only 169b
MKE=
169a
169b
=
.... 1
1
Scheme 18. Aldol reaction of enolates derived from (±)-168 with (±)-125a.
To summarize the results of the previous work, aldol reactions of 125a with ~­
hydroxy ketones 126a and 127a were highly diastereoselective for the formation of one
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bisaldol adduct (Schemes 15 and 16). The formation of predominantly one diastereomer
is the result of high MKE where the favoured reaction (like or unlike) is also highly
diastereoselective. In contrast, the aldol reactions of 125a with enolates derived from
the 'protected' f)-hydroxy ketones 166 and 168 all gave two diastereomeric products in
modest yield (Schemes 17 and 18). The product structures established that one product
came from a like reaction and the other came from an unlike reaction. Thus, the
formation of two major products results from low MKE, where both the like and unlike
reactions are highly diastereoselective. This previous study concluded that a "free"
versus "protected" hydroxyl group in f)-hydroxyketone substrates significantly
influences the MKE of the aldol reaction.
The aim of the present study was to obtain a more comprehensive assessment of
the ability of a 'free' f)-hydroxyl versus a 'protected' f)-hydroxyl of a ketone to
influence the diastereoselectivity of the aldol reaction. To this end, the aldol reactions of
two new f)-hydroxy ketones 128a and 129a and their corresponding MOM protected
derivatives 172 and 174 were investigated. These results are discussed in the sections to
follow.
2.3.3. Aldol Reactions of (±)-125a with (±)-128a and (±)-129a.
Because of prior success in generating reactive titanium enolates from 126a and
127a (Section 2.3.1), the same conditions were initially used to generate a titanium
enolate of 128a. However, addition of 125a to the supposed titanium enolate of 128a
generated under these conditions did not give aldol adducts. Finally, after exploring a
number of variations one aldol adduct 170a (8%) was isolated under optimized reaction
conditions (Scheme 19). The optimal procedure involved stirring 128a with TiCl4 (1
equiv) at 0 °C for 20 minutes, which resulted in a fine yellow suspension presumably
the titanate intermediate. Addition of i-Pr2EtN (2.3 equiv) to this fine yellow suspension
at -78 °C gave a clear red solution within 10 minutes and then 125a was added. It was
suspected that the rate of enolate decomposition was faster than that of enolate
formation and that the amount of enolate formed in 10 minutes was greater than after 2-
3 h used for ketones 166 and 168. This low yielding reaction could not be improved
despite considerable effort.
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8tHS
1. TiCI4 I CH2CI2 1.1 eq
-78 DC, 5 min then
oDC, 20 min
2. i-Pr2EtN 2.3 eq
-78 DC, 10 min
•
3. 125a 1.2 eq
-78 DC, 2 h
(±)-125a (±)-128a 170a (80/0)
d.r. unlike = only 170a
d.r. like = not detected
MKE=
kRS
= only kRS
-kss
Scheme 19. Aldol reaction of enolate derived from (±)-128a with (±)-125a.
d.r. unlike = not detected
= 171a:171b 13:1
171b (3%)
171a (39°Jc,)
3.125a 1.2 eq
-78°C, 2 h
1. TiCI4 I CH2CI2 1.1 eq
-78 DC, 5 min then
oDC, 20 min
2. OlEA 2.3 eq
-78 DC, 10 min
(±)-129a
o H9o~+~
s s
d.r. like
(±)-125a
MKE = ~ = only kss
kRS
Scheme 20. Aldol reaction of enolate derived from (±)-129a with (±)-125a.
Using the same conditions, reaction of the titanium-enolate of 129a with 125a
gave adducts 171a (39%) and 171b (3%) (Scheme 20).* The structure of the products
* Recovered 129a and 125a was 47% and 700/0, respectively. Note that two equivalents of 125a was used.
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indicates that both adducts 171a· and 171b are derived from a like reaction.* The
diastereoselectivity of the like reaction was 13:1 in favour of the anti adduct 171a. It
follows that the MKE for this reaction was very high in favour of the like reaction
because no products from an unlike reaction were detected.
2.3.4. Aldol Reactions of (±)-125a with (±)-172 and (±)-174.
The methoxymethoxy (MOM) derivatives of 128a and 129a were prepared to
investigate the influence of an alkoxy versus an hydroxy group on aldol
diastereoselectivity (Schemes 21 and 22). The approach used in the previous study to
obtain p-alkoxy derivatives was indirect and required three steps (Section 2.3.2).
Subsequently, it was discovered by Dr. P. K. Sasmal that the hydroxy groups in 126a
and 127a could be readily protected as the corresponding MOM ethers by reaction with
MOMCI and i-Pr2EtN in the presence of B14NI. Similar reaction of 128a and 129a gave
the corresponding MOM-protected derivatives 172 and 174. This method provided a
direct route to obtain 'protected' p-hydroxyl derivatives without significant retroaldol or
elimination side reactions.
The Ti-enolates of 172 and 174 were generated uSIng the same procedure
employed for 166 and 168 (see Section 2.3.2). The reaction of the titanium enolate of
172 with 125a gave aldol adducts 173a (40%) and 173b (l3%).t Adduct 173a was
formed from the unlike reaction and adduct 173b was formed from the like reaction.
Because both the like and unlike reactions each produced only one product, it follows
that both reactions are highly diastereoselective. The MKE of this reaction is modest
and favours the unlike reaction (unlike:like = 173a:173b = 3.1:1).
The 'amine-free' Li-enolate of 172 was prepared as previously described for 166
and 168. Reaction of 125a with the 'amine free' Li-enolate of 172 gave aldols 173a
(12%), 173b (28%) and 173c (8%).t It is of interest that that the MKE for the aldol
* For aldol reactions of 125a with 128a and 129a, the like and unlike are assigned with respect to the
relative absolute configurations at C-6 of 125a and C-6" of 128a and 129a.
t Recovered 172 was obtained in 45% isolated yield. Two equivalents of 125a were used; 48% was
recovered by chromatography.
: The 'amine free' Li-enolate was generated by addition of MeLi to the TMS enol ethers of 172.
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reaction of the 'amine free' Li-enolate of 172 with 125a slightly favoured the like
reaction (like:unlike = [173a + 173c : 173b] = 1: 1.4). This is a reversal in the kinetic
preference of the reaction of the titanium-enolate of 172 with 125a (Scheme 21).
d.r. unlike = only 173a
d.r. like = only 173b
kRS 173a 3.1MKE=
-
=
=kss 173b 1
8JH
S
(±)-125a
(t)-128a
MOMCI
i-Pr2EtN
BU4NI
CH2CI2
~
o
~I\
o 90 0+~
{±)-172
1. TiCI4 I CH2CI2 1.1 eq
-78°C, 1 min
2. i-Pr2EtN 1.5 eq
-78°C, 1 h
•
3.125a 2 eq
-78°C, 3 h
173a (40%)
173b (13%)
d.r. unlike = 173a: 173c 1 : 2.3
d.r. like = only 173b
MKE=
kRS 173a + 173c 1
-
= =
kss 173b 1.4
(±)-125a + {±)-172
1. LOA, TMSCI
(172a, 100% conversion)
2. MeLi 1 eq
O°C, 10 min
•
3. 125a 3 eq
-78°C, 5 min
173a (12%) + 173b (28%)
173c (8%)
Scheme 21. Aldol reaction of enolate derived from (±)-172 with (±)-125a.
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The reaction of the titanium enolate of 174 with 125a proceeded in low yield to
give 175a (19%) and 175b (9%).* From the product structures it is apparent that 175a
results from a like reaction and 175b results from an unlike reaction. Because only one
like and one unlike product was detected, both reactions appear to be highly
diastereoselective. The reaction occurred with moderate MKE (like:unlike = 175a :
175b =2.1 : 1).
175a (19%)
1. TiCI4 I CH2CI2 1.1 eq
-78°C, 1 min
2. i-Pr2EtN1.5 eq
-78°C, 1hrs
..
3.125a 2 eq
-78°C, 3 hrs
(±)-129a
MOMCI
i-Pr2EtN
BU4N1
CH2CI2
~
o
~{\
o ? 0 0+~
S S
(±)-174
d.r. like = only 175a
d.r. unlike = only 175b 175b (9%)
kss 175a 2.1MKE=
-
=
=
kRS 175b
8tHS
(±)-125a
Scheme 22. Aldol reaction of enolate derived from (±)-174 with (±)-125a.
2.3.5. The Influence of the Stereochemical Control Elements on Aldol
Diastereoselectivity
It is informative to examine the various stereocontrol elements (i.e. the relative
topicity, aldehyde and enolate diastereoface selectivities) that contribute to the
diastereoselectivity in the aldol reactions discussed in sections 2.3.1-2.3.4 (Table 10).
For all reactions it was evident that the aldehyde diastereoface selectivity was highly
* Recovered 174 and 125a in 58% and 51% isolated yield, respectively.
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Felkin selective (all products are 1",6"-syn). For all reactions the relative topicity was
highly 1",5-anti selective. It was found that the enolate diastereoface selectivity (3,5-
cis/trans) appeared to be dependant on the l' ,3-syn/anti relative configuration of the ~­
hydroxyketone substrate. The l' ,3-anti ~-hydroxyketones 127a and 129a gave
predominantly 3,5-cis bisaldol adducts and the l' ,3-syn ~-hydroxyketone 126a gave
predominantly 3,5-trans adducts. The l' ,3-syn ketone 128a is an apparent violation of
the trend giving a 3,5-cis adduct; however, the very low yield in the reaction precludes
firm conclusion. The trends in the stereoselectivities for all these reactions are
summarized in Figure 43.
Table 10. Stereoselectivities of reactions of titanium enolates of 126a-129a with 125a
Entry ketone product ratios diastereoface selectivity relative
topicity
aldehyde enolate 1",5-syn:anti
1",6"syn:anti 3,5-cis:trans
1 126a 165a:165b:165c: all syn 1:68 1:6.7
60:1:8
2 127a 165a:165d:165e all syn 6:1 1: 11
1.5:15:1
3 128a 170a syn cis anti
4 It9a 171a:171b all syn 13:1 1:13
13:1
In Table 11 the relative configuration that characterizes the diastereoselectivity
of the reactions of enolates of ~-alkoxyketones166, 168, 172 and 174 are given. The
enolate diastereoface selectivity strongly favoured 3,5-trans adducts for all reactions
irrespective of the l' ,3-syn/anti relative configuration of the ~-alkoxyketone substrate.
For all aldol reactions the aldehyde diastereoface selectivity was exclusively Felkin (all
products are 1",6"-syn). The relative topicity of the aldol reactions was unselective and
this poor preference allowed the formation of the two major products where one product
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has 1",5-syn and the other product has 1",5-anti relative configuration. The trends in the
stereoselectivities for all these reactions are summarized in Figure 44.
aldol relative
topicity
predominantly 1",5-anti
enolate diastereoface
selectivity
1',3-anti substrate prefers 3,5-cis
l' ,3-syn substrate prefers 3,5-trans
aldehyde
diastereoface
selectivity
only 1",6"-syn
(Felkin)
Figure 43. Trends in stereoselectivities for reactions of 125a with enolates of 126a-
129a.
The aldol reactions of the four ~-hydroxy ketones 126a-129a were highly
diastereoselective. From an analysis of the stereoselectivities of these reactions it is
concluded that they all exhibit high diastereoface selectivities for both the aldehyde and
the enolate and high preference in the relative topicity (Table 10 and Figure 43).
Between the competing like and unlike reactions, the reaction where all three of these
stereocontrol elements are mutually reinforcing will be the kinetically favoured
reaction. This reaction is "matched" and will have the high diastereoselectivity. The
corresponding mismatched reaction should be slower and have lower
diastereoselectivity because at most the bias for only two stereoselectivities can be
accommodated. The diastereoselective formation of one major product from the aldol
reactions of the ~-hydroxy ketones is a consequence of having three strong
stereocontrol elements which leads to high diastereoselectivity and high kinetic
preference for the matched reaction.
The reactions of the related ~-alkoxy ketones 166, 168, 172 and 174 were
diastereoselective for the formation of two products. One product was derived from the
like reaction and the other was from the unlike reaction. Comparison of the structures of
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the two products reveals that the like and unlike reactions occurred with the same
aldehyde diastereoface selectivity (i.e. Felkin; 1",6"-syn) and the same enolate
diastereoface selectivity (i.e. 3,5-trans) but with opposite relative topicity (i.e. 1",5-syn
and 1",5-anti) (Figure 44). The fact that the two adducts are formed in comparable
amounts (i.e. with low MKE) suggests that the Ti(lV) enolate imposes only a weak bias
for the syn vs. anti aldol coupling. Consequently, the diastereoselectivity is dominated
by the face selectivities of the aldehyde and enolate thereby allowing both the like and
unlike reactions to proceed with high diastereoselectivity.
Table 11. Stereoselectivities of reactions of enolates of 166, 168, 172 and 174 with
125a
Entry ketone LilTi- product ratios diastereoface selectivity relative
enolate topicity
aldehyde enolate I",5-
1",6"- 3,5- syn:anti
syn:anti cis:trans
1 166 Li 167a:167b all syn all trans 1.3:1
1.3:1
2 166 Ti 167a:167b all syn all trans 1.5:1
1.5:1
3 168 Li 169a:169b all syn all trans ----1:1
~1:1
4 168 Ti 169a:169b all syn all trans 1.4:1
1.4:1
5 172 Li 173a:173b:173c all syn 1:5 1:3
1.5:3.5:1
6 172 Ti 173a:173b all syn all trans 3.1:1
3.1 :1
7 174 Ti 175a:175b all syn all trans 2.1:1
2.1 :1
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aldol
relative
topicity
unselective
enolate
diastereoface
selectivity
only 3,5-trans
aldehyde
diastereoface
selectivity
only 1",6"·syn
(Felkin)
Figure 44. Trends in stereoselectivities for reactions of enolates 166, 168, 172 and 174
with 125a
2.3.6. Comparison of the Diastereoselectivities of the 2nd Aldol Reaction
with Related Acyclic Examples.
Two related studies38,164 which also used 'free' and/or 'protected' ~-hydroxy
ketones as substrate in aldol reactions are discussed with special attention to the effect
of the J3-hydroxyl (free versus protected) on aldol diastereoselectivity.
The study by McCarthy et al. 164 compared the effect of the protecting group of
the ~-hydroxyl on the diastereoselectivity of the aldol reaction of the chiral (Z) Li-
enolate 176 with achiral 2-propanal (37). It was found that protection of the ~-hydroxyl
group effected a reversal in the enolate diastereoface selectivity (Table 12, compare
entry 1 with entries 2-7). Furthermore, it was found that the enolate diastereoface
selectivity increased with the use of silyl ether protecting groups (Table 12, entries 5-7).
Interestingly, the relative topicity of the aldol reactions of the 'protected' ~­
hydroxy ketones (entries 2-7) was relatively more selective than the reaction of the
'free' J3-hydroxy ketone (entry 1). This trend is in contrast to the results of this study
where the relative topicity of the aldol reactions of ~-hydroxyketones 126a-129a was
more selective than those of the reactions of the related ~-alkoxy ketones 166, 168, 172
and 174.
The study by Evans et al.38 of the aldol reaction of chiral (E) Li-enolates 180
with chiral aldehydes 150 provides a closer comparison to this study because both
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studies used chiral reactants and E-enolates* (Figure 45). The like reaction of
enantiopure (48)-150 with (1 '8)-180 was highly diastereoselective for 181. The unlike
reaction of enantiopure (4R)-150 with the same enolate (1'8)-180 was less selective and
gave 183 as the major product. The formation of one major product in each of the like
Table 12. The selectivities of the aldol reaction of Li-enolate 176 with 37.164
(a) (b)
'1H
37 176
•
OH 0 OP
"".~=2 A~1'/T 3 ~ 1 I -
177 (2,3-syn-1',2-trans)
178 (2,3-syn-1 ',2-cis)
(a) relative topicity 2,3-syn/anti
(b) enolate diastereoface selectivity 1',2-cis/trans
179 (2,3-anti)
Protecting group Product ratios Enolate d.s. Relative topicityEntry (P) 177:178:179 l',2-cis:trans 2,3-syn:anti
1 H 1:2.1 :0.8 2.1 :1 4:1
2 Bn 1.1:1: - 1: 1.1 all syn
3 MEM 1.4:1:0.1 1:1.4 24:1
4 BOM 2.0:1:0.2 1:2 15:1
5 TBS 4.5:1:0.4 1:4.5 13.8:1
6 TMS 6:1:0.7 1:6 10:1
7 TES 6.4:1 :0.8 1:6.4 9.3:1
* All enolates generated from cyclic ketones 126a-129a, 166, 168, 172 and 174 used in this study are
constrained to give only E-geometries.
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and unlike reactions is a consequence of the diastereoselectivity being dominated by a
high aldehyde diastereoface selectivity (favouring 3,4-syn) and a high preference in the
relative topicity (favouring 2,3-anti) where the low enolate diastereoface selectivity
imposes only a weak bias in the cis vs. trans relationship. Interestingly, these
selectivities are in contrast to the results of this study, where it was the high selectivity
for both the aldehyde- and enolate-diastereoface selectivities coupled with a weak bias
in the aldol relative topicity that was responsible for the major product in each of the
like and unlike reactions of the p-alkoxy ketones 166, 168, 172 and 174.
~"JlT5 r 3 H + OLi OTBSr+(y like
(a) (c)
.....--'----.
(48)-150 (1'8)-180 (b) 181
PMBO 0#H
(4R)-150
+
OLi OTBS
r+(y
(1'8)-180
unlike
181 : rem, 93 : 7
PMBO OH 0 OTB
182
rem = The combined fraction of
the remaining diastereomers
PMBO o OTB
(a) aldehyde diastereoface selectivity: 3,4-syn/anti
(b) relative topicity : 2,3-syn/anti
(c) enolate diastereoface selectivity: 1',2-cis/trans
183
182 : 183 : rem, 2 : 80 : 18
Figure 45. The selectivities of the like and unlike reaction of Li-enolate 180 with 150.38
The comparison of the selectivities of this study and those of related acyclic
examples leads to the conclusion that the p-hydroxyl group (free vs. protected) has a
considerable effect on the diastereoselectivity of the aldol reaction. Furthermore, the
selectivities of the stereochemical control elements (aldehyde-, enolate-diastereface
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selectivity and the relative topicity) of the reactions of cyclic chiral reactants (this
study) and the reactions of acyclic chiral reactants38,l64 are not influenced by the 13-
hydroxyl group (free vs. protected) in the same manner.
2.3.7 Conclusion
This study has provided additional examples to probe the effect of the 13-
hydroxy group (free vs. protected) on aldol diastereoselectivity. Reactions of 125a with
the'free' J3-hydroxy ketones examined previously (126a and 127a) and in this study
(128a and 129a) occurred with high MKE and were highly diastereoselective for
formation of one out of eight possible diastereomers. Similar reactions with the
'protected' J3-hydroxy ketones from previous work (166 and 168) and in this study (172
and 174) proceeded without significant MKE. These reactions were also highly
diastereoselective giving two products, one each from the like and unlike reactions.
Each of the stereocontrol elements (relative topicity, aldehyde- and enolate-
diastereoface selectivity) were strongly biased in the reaction of 'free' J3-hydroxy
ketones. However, similar reactions of the 'protected' J3-hydroxy ketones proceeded
with a much lower relative topicity. Comparison of the above results with those
reported38,l64 for aldol reactions of related acyclic substrates showed that aldol
diastereoselectivities of thiopytanone derived substrates are substantially different.
With respect to the thiopytan route to polypropionates, the present study has
increased the number of substrates available for use in the 2nd aldol reaction. New
bisaldols have been synthesized and are potential hexapropionate synthons to be used in
the synthesis of polypropionate containing natural products.
2.4. SYN-ANTIISOMERIZATION OF ALDOLS BY ENOLIZATION
2.4.1. Introduction
An aldol reaction of a ketone and an aldehyde can produce up to two new
stereogenic centers and several stereoisomeric products are possible. The ability to
produce each of the possible stereoisomers selectively, especially when coupling chiral
substrates, remains a significant challenge74,76 despite intensive investigations during
the past two decades.54,7l Isomerization of aldol products presents an alternative strategy
103
to access various aldol stereoisomers. Retroaldol-aldol and keto-enol tautomerism are
the two pathways through which isomerization of aldol adducts can occur (Figure 46).
The aldol reaction is readily reversible; fragmentation of the adduct via a C-C bond
breaking step (retroaldol) gives the precursor aldehyde and enol. Reformation of this C-
C bond via an aldol reaction can give the original aldol adduct or a different
stereoisomer. Alternatively, the aldol adduct can undergo an acid or base catalyzed
enolization to give the enol(ate) intermediate which upon ketonization can give the
original adduct or a stereoisomer where a stereogenic center adjacent to the ketone has
epimerized.
keto-enol
laUlomeris",r
keto-enol
"Ulomerism
o OHRyR'
"R
syn-aldol
retroald~
aldol Rl: +
"RJ
anti-aldol
~lroaldol­
aldol
Figure 46. Retroaldol-aldol and keto-enol tautomerism pathways for syn-anti
isomerization of an aldol adduct.
Th 1 f . .. f l' 167-173 d l' 133174175ere are severa reports 0 ISOmerIZatIon 0 cyc IC an acyc IC ' ,
aldols via a retroaldol-aldol mechanism. An example of a retroaldol-aldol· pathway for
isomerization of a cyclic aldol is taken from the work of Vandewalle172 (Figure 47). The
study involved the isomerization of perhydroazulenic hydroxyketones 184 and 185
under various basic conditions. It was found that treatment of aldol 184 with a variety of
bases (eg. NaOH, KOH, NaH, LDA) led to a mixture of all four aldols 184-187 (Figure
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47). The same result was obtained when aldol 185 was treated with the same plethora of
bases. It was determined that the equilibrium ratio of 184:185:186:187 was 7:43:35:14
under these basic conditions.
~HO 0
184
H%=>o
, /
~w
o
/
H%>
185
50HO 0
186 187
Figure 47. The retroaldol-aldol isomerization ofperhydroazulenic hydroxyketones 184-
187 under basic conditions.
Another example of retroaldol-aldol mechanism for aldol isomerization involves
the reaction of rapamycin with titanium (IV) isopropoxide reported by Holt et al. 174
This study showed that rapamycin (188) underwent isomerization in the presence of
titanium (IV) isopropoxide to give 189 in 60% isolated yield. Evidence for a retroaldol-
aldol mechanism was obtained by trapping the 'enol' intermediate with benzaldehyde in
a cross-over experiment to give 190 (Figure 48). Holt et al also reported titanium (IV)
isopropoxide mediated retroaldol-aldol isomerization of simple acyclic aldols. 174
In contrast to the many reports of isomerization of aldols via retroaldol-aldol, to
the best of my knowledge there are only two reported examples of isomerization of
aldols via an enolization mechanism. 165,176
105
MeO
188
rapamycin
Ti(OiPr)4
189
28-epirapamycin (60% yield)
1l
PhCHO ~
Ph~"'OH
, 0
MeO"
~
190
Figure 48. Isomerization ofrapamycin to 28-epirapamycin via a retroaldol-aldol
mechanism mediated by titanium isopropoxide.
Still et al. 176 studied the ion-driven isomerization of lasalocid A stereoisomers
(Figure 49). It was established that the syn,syn isomer of lasalocid A (191) (which has
low affinity for complexation to Ba2+) underwent isomerization to lasalocid A (192)
(which has higher affinity for Ba2+). In the presence of Ba(OH)2, lasalocid A (192) was
the only isomer detected and the absence of anti, anti or syn, anti isomers in the reaction
is consistent with an enolization mechanism. 176 However, the experiments reported are
insufficient to rule out a retro-aldol mechanism.
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Figure 49. Ba2+-mediated keto-enol tautomerism of syn,syn stereoisomer exclusively
gave naturally occurring Lasalocid A.
An example of isomerization of an aldol VIa an enolate intermediate was
reported by Albizati et al. 165 In this study the dianion 194 was generated from the anti
aldol 193a by reaction with 2 equivalents of LDA at -78°C (Scheme 23). The enolate
194 was stirred at room temperature for 1 hour resulting in a mixture of enolates 194
and 195 that upon quenching with NH4CI gave a mixture of the anti (193a) and syn
(193s) aldols. According to the authors, the possibility of obtaining 193s from a
retroaldol-aldol process was excluded because of the low propensity of 193a to undergo
retroaldol under these conditions.
~Ph
193a
LOA 2 equiv.
THF
-78°C ~Ph
194
~Ph + ~Ph
II
~Ph
193a 82 : 18 1935 195 194
Scheme 23. Syn/anti isomerization of 193a through the formation and protonation of
the enolate.
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Scattered examples of isomerization of p-hydroxy carboxylic acid derivatives by
an enolization mechanism via enoI177,178 and enolate118 intermediates have been
reported. An example of isomerization of a p-hydroxyester (cf. p-hydroxyketone) via
enolization was reported by Hanessian et al. 178 in their sYnthesis of avermectin B1a (198)
(Figure 50). A key step in their strategy required the isomerization of 2-epiavermectin
B1a (196) to obtain the natural occuring avermectin B1a (198) (Figure 50) Isomerizations
of avermectins had previously been studied by Pivnichny et al. 179 who showed that
treatment of 198 with methanolic potassium hydroxide resulted in a mixture of 198, 196
and the conjugated ~2-isomer 199. In a later study by Fraser-Reid et al. 180, 198 was
treated with methanolic aqueous sodium hydroxide to give the conjugated ~2-isomer
199 (70%) and 196 (25%). From these earlier studies it was clear that alternative
conditions had to be found to minimize the formation of 199 during the isomerization of
196. Hanessian et al. found that isomerization of 196 in the presence of a large excess of
imidazole in refluxing benzene gave the desired avermectin B1a (198) in 40% isolated
yield together with only 8% of ~2-isomer (199) and 34% of starting 2-epiavermectin
(196) which could be recycled (Figure 50).178
Isomerization of aldol products 201a-d was reported by Yan et al. (Scheme
24).177 Although not discussed by the authors, the reported data is clearly consistent
with an enolization mechanism. Benzaldehyde was added to a solution of the lithium
enolate of 200 at -78°C and after 30 minutes the reaction was quenched at to give a 1 :
4 : 5 : 0.05 mixture of 201a:201b:201c:201d, respectively (reaction condition A,
Scheme 24). In a second experiment the reaction mixture was stirred at -5°C for 30
minutes after quenching (reaction condition B, Scheme 24) and gave a 1 : 9 : < 0.05 : <
0.05 mixture of 201a:201b:201c:201d, respectively. Comparing the results from these
two experiments indicates that 201c is converted to 201b during the 30 min at -5°C
which is consistent with an enolization mechanism. This conclusion is further supported
by the lack of change in the relative amounts of products 201a and 201d during the
isomerization; a retroaldol-aldol mechanism would be expected to equilibrate among all
four isomers.
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Figure 50. Imidazole mediated keto-enol tautomerism of2-epiavennectin Bla.
An example of isomerization of a f3-hydroxy thioester via an enolate
intennediate was reported by Woodward et al. II8 Their approach to the total synthesis
of erythromycin required the intennediate 204 (Scheme 25). The f3-hydroxy thioester
202 was the precursor to 204 and differed in the configuration at C-2. The enolate 203
was generated by treatment of 202 with tBuLi and protonation of 203 selectively gave
the desired product 204 (90%) (Scheme 25).
To conclude, there are two general mechanisms by which aldols can undergo
isomerization. The products of isomerization can potentially distinguish which
mechanism is in operation because keto-enol tautomerism can interconvert only two
stereoisomers whereas a retroaldol-aldol mechanism can lead to the fonnation of all
possible stereoisomers.
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Scheme 24. Syn/anti isomerization of p-hydroxy carbonyl compounds of201.
(i) tBuLi
(CH2NMe2h
THF, -110°C
1 SCMe3 •
202
recovered 202 (8%) +
203
(ii) AcOH I
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Scheme 25. Isomerization of p-hydroxy thioester 203 by enolate formation.
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2.4.2. Imidazole Catalyzed Syn-Anti Isomerization of Aldols by Enolization
The propensity of imidazole to isomerize thiopyranone-derived aldols was first
observed by Dr. P. K. Sasmal during a failed attempt to protect the hydroxyl group in
127a by reaction with TBDMSCI in the presence of imidazole in CH2Ch; after 5 days
approximately 30% of 126a was detected and isolated from the reaction mixture. It was
proposed that imidazole was responsible for the isomerization of 127a and it was
decided to explore the generality of this phenomenon using 128a as substrate. Aldol
128a was selected for the study because three of the four possible diastereomers (126a,
127a and 128a) had been prepared stereoselectively on a large scale and a successful
isomerization of 128a to 129a would allow for a convenient route for the preparation of
the fourth diastereomer 129a from readily accessible 128a.
A solution of 128a (0.03 M) and imidazole (0.4 M) in CDCh was prepared and
monitored by 1H NMR at room temperature. Aldol 129a slowly formed and after
approximately 3 days the ratio of 128a:129a was 1.8:1 and remained constant for
several weeks. The aldols 128a and 129a were stable throughout the experiment with
negligible elimination or retroaldol; less than 5% of aldehyde 125a was detected by 1H
NMR spectroscopy (Figure 51). The equilibrium ratio of 1.8:1 was confirmed by
subjecting aldol 129a to the identical reaction conditions. The aldols 126a and 127a,
which should arise from retroaldol-aldol mechanism, were not detected during the
isomerizations of either 128a or 129a. Aldols 128a and 129a were not detected in the
isomerization of 127a. A solution of 122 and 125a in the presence of imidazole does not
give any aldol products under the conditions employed for isomerization. It was
concluded that the isomerizations of 126a-129a proceeded via keto-enol tautomerism
catalyzed by imidazole and not through a retroaldol-aldol mechanism.
Isomerization of an aldol by keto-enol tautomerism can be divided into two
distinct steps, enol formation and ketone formation, that are governed by different rate
constants. For example, enol 207 is formed from ketone 128a with rate constant kenol128a
and from ketone 129a with rate constant kenol129a. The enol 207 in turn is converted to
ketones 128a and 129a with rate constants kketo 128a and kketo 129a, respectively (Figure
51). This pair of reversible reactions with the corresponding four rate constants
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determines the rate at which the equilibrium is reached as well as the equilibrium ratio
of 128a:129a.
retroaldol
aldol
keto-enol
tautomerism
o HO 01\0¢to
127a
~eto127a
kenol127a~
HO HO 01\0
cYO
205k.,nol~
~ kketo126a
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retroaldol ~
aldol
keto-enol
tautomerism
o
6
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OH
6s 206 + HtgS 125a
~01128a
kketo 128a~
retroaldol
aldol
keto-enol
tautomerism
c!18
129ai<J<eto1~
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..
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Figure 51. Possible pathways for isomerization of aldols 126a-129a.
112
In these examples, the concentration of 207 is much lower than 128a and 129a
and the rate of isomerization can be described as proceeding without an intermediate
207. In this case, the rate constant k1 for conversion of 128a to 129a is a composite rate
constant equal to the product of rate constants kenoI 128a and kketo 129a (Figure 51).
Similarly, the rate constant k_1 for the reverse reaction is equal to the product of rate
constants kenol129a and kketo 128a. The rate constants k1 and k_1 can be easily obtained by
simply monitoring the rate of appearance or disappearance of the aldol substrates 128a
and 129a. By contrast, determination of the four individual rate constants requires a
more sophisticated approach that must involve direct or indirect detection of the enol
intermediate 207.
For a kinetically first order reversible reaction :
A ~ 8
It can be easily shown that for a system not at equilibrium (A *- Ae) :181
Ao-Ae
where Ao is the initial concentration of A, Ae is the concentration of A .at
equilibrium, and At is the concentration of A at time t. In this form, the equation
resembles that for an irreversible first order reaction of A with a rate constant kobs (= k1
+ k_1) but with the analytical concentration of A (i.e. At) replaced by the 'active'
concentration of A (i.e. At-Ae ; which is that fraction of A undergoing transformation).
Thus kobs is the first order rate constant for equilibration of a non-equilibrium system.
A plot of -In (AcAe) versus t gives a line with slope kobs and because
kobs = k1+ k.1 and Keq = k1/k..1 the constants k1 and k_1 can be readily derived.
Accordingly, the rate of isomerization (i.e. kobs) of 128a to 129a was determined by
monitoring their ratio by I H NMR spectroscopy as a function of time.
A plot of -In [(Rt - Re)/(Rt + 1)] versus t where Rt is the ratio of 128a/129a at time t and
Re is the equilibrium ratio of 128a/129a yields a line of slope kobs. Generally, at least
eight data points were obtained during the first two half-lives and these points gave a
113
line with R2 > 0.99. The 'half-life' for equilibration (tl/2) was calculated from the so
obtained kobs (t1l2 = 1n2lkobs).
Initially the effect of solvent on the rate and equilibrium constants for the
isomerization of 128a was examined (Table 13). The rates of isomerization in CDC!)
and benzene were ca. twice that in CD2Ch or CH30H and ca. ten times greater than in
acetone-d6 or DMF-d7•
Table 13. Solvent effect on imidazole catalysed isomerization on aldols 128aa
Entry Starting Solvent Keq b t1l2ckobs
aldol (128a:129a) (10-2 h-1) (h)
1 128a CDC!) 1.8:1 5.9d 12
2 CD2Ch 1.9:1 2.9 24
3 C6D6 1.5:1 5.3 13
4 acetone-d6 1.6:1 0.55 130
5 DMF-d7 2.1:1 0.43 160
6 CH30H 2.0:1 e ~1 day
7 129af CDC!) 1.8: 1 e e
a Room temperature; [imidazole] = O.3M; [aldol] = O.03M. b The slope of the line obtained by plotting-
In[(Rt-Re)/(Rt + 1)] vs. t where Rt is [128a]/[129a] at time t and Re is [128a]/[129a] at equilibrium (~8
data points over the initial 2 half-lives; R2 > 0.99). C Half-life = t1/2 = In 21kobs . d Data obtained by
extrapolation from the plot ofln(kobs) vs. In[imidazole]; see Table XX. e Not determined. f Isomerization
starting from aldol 129a confirmed that the equilibrium ratio of [128a]:[129a] was 1.8:1 in CDCh.
The syn diastereomer 128a was favoured in all solvents (see Table 13).
Relatively more of the anti diastereomer 129a was present at equilibrium in less polar
solvents (e.g. C6D6) compared to polar solvents (e.g. CH30H) but this effect was minor.
Qualitatively similar results were obtained in the isomerizations of 126a and 127a
(Table 14).
The effect of the base on the rate of isomerization of 128a in CDC!) was
investigated (Table 15). Isomerization in the presence of DMAP was more facile than
with imidazole. The reactions were markedly slower with Et3N or with N-
methylimidazole and isomerization was not observed in the presence of pYridine. The
poor solubility of 1,2,4-triazole (ca. 3 mg/mL, 0.04 M) in CDC!) likely contributed to
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the failure to observe isomerization with this base. Attempted isomerization under
Holt's conditions174 (Le. in the presence of Ti(Oipr)4) only gave the elimination product.
Table 14. Solvent effect on imidazole catalysed isomerization of aldols 126a and
127aa,b
Entry Starting Solvent Keq
aldol (126a:127a)
1 126a CDC!) 1.5:1
2 127a CDC!) 1.5:1
3 126a CD2Ch 1.6:1
4 127a CD2Ch 1.6:1
5 127a acetone-d6 2.0:1
6 127a C6D6 1.4:1
7 127a CH30H 1.7:1
a The data was obtained by Dr. Pradip K. Sasmal. b Room temperature;
[imidazole] = 0.3 ± O.IM; [aldol] = 0.03 ± 0.01 M.
Table 15. The effect of base on the rate of isomerization of 128a.a
Entrya Base [base] [128a] t1l2 b~bs
(M) (M) (h) (E-2 h-1)
1 imidazole 0.40 0.030 8.6 8.1
2 DMAP 0.40 0.030 3.6 19
3 Et3N 0.40 0.016 110 0.63
4 methylimidazole 0.40 0.040 289 0.24
5 pYridine 0.22 0.016 c
6 1,2,4-triazole 0.05 0.04 d
7 Ti(Oipr)4 0.036 0.018 e
a Room temperature; isomerizations in CDCh unless indicated otherwise; The Keq of
[128a]/[129a] was 1.8:1 for entries 1-4. b The slope of the line obtained by plotting-
In[(Rt-Re)/(Rt + 1)] vs. t where Rt is [128a]/[129a] at time t and Re is [128a]/[129a] at
equilibrium (~8 data foints over the initial 2 half-lives; RZ > 0.99). C No isomerization
observed after 200h. No isomerization observed after 140 h. The reported concentration
oftriazole is the observed solubility in CDCh (i.e. approx. 3mg/ml) as determined via
integration of IH NMR spectrum with aldol 128a used as the internal standard. e Reaction
in CHzClz at O°C for 5 h gave elimination product only (77% conversion).
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The effects of stoichiometry and concentration on the rate of imidazole mediated
isomerization of 128a were examined (Table 16). As expected, the rate of isomerization
was not dependant on the concentration of 128a (see entries 4, 5, 6), but the rate
increased with increasing concentration of imidazole (entries 3, 4 and 7). The reaction
order in imidazole was determined to be 1.3 from the slope of the line obtained by
plotting In kobs versus In [imidazole] using the data from entries 1,3,4 and 7 in Table
16.* This non-integer value implies a complex mechanism for enolization. 182
Table 16. The effect of stoichiometry and concentration on imidazole catalyzed
isomerization of 128a in CDCl]. a
Entry [imidazole] [128a] kobs t1/2
(M) (M) (E-2 h-1) (h)
1 0.10 0.015 1.5 48
2 0.20 0.016 3.6 19
3 0.20 0.030 3.6 19
4 0.40 0.030 8.1 8.6
5 0.40 0.060 7.7 9.0
6 0.40 0.120 7.8 8.9
7 0.80 0.030 21 3.2
a Room temperature; The Keq of [128a]/[129a] was 1.8: 1 for all entries.
The effect of stoichiometry and concentration on the rate of DMAP mediated
isomerization of 128a was also examined (Table 17). The rate was independent of the
concentration of 128a (entries 4, 5 and 6) but linearly dependant of the concentration of
DMAP (entries 3, 4 and 7). The reaction order in DMAP was determined to be 0.96
from the slope of the line obtained by plotting In kobs versus In [DMAP] using the data
in entries 2, 3, 4 and 7 in Table 17.t This value is within experimental error of the
expected simple first order dependance of base on enolization of 128a.
* Linear regression ofthe four data points used yielded a slope of 1.28 ± 0.13 (95% confidence interval).
t Linear regression of the four data points used yielded a slope of 0.96 ±0.23 (950/0 confidence interval).
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Table 17. The effect of stoichiometry and concentration on DMAP catalyzed
isomerization of 128a in CDC!).a
Entry3 [DMAP] [128a] kobs tl/2
(M) (M) (10-2 h-I) (h)
1 0.10 0.015 3.7 19
2 0.10 0.030 4.4 16
3 0.20 0.030 8.7 8.0
4 0.40 0.030 19 3.6
5 0.40 0.060 18 3.9
6 0.40 0.120 19 3.6
7 0.80 0.030 32 2.2
a Room temperature; The Keq of [128a]/[129a] was 1.8:1 for all entries.
To demonstrate the generality of the imidazole catalysed isomerization of aldols
via enolization, the related aldols 126b-129b and 126c-129c* (Figure 52) were
examined. The starting aldols used and the ratio of aldol adducts at equilibrium are
reported in Table 18. In each case only the starting aldol and the corresponding adduct
predicted from a keto-enol tautomerism pathway were present at equilibrium. In no case
were diastereomers that could only be derived from a retro-aldol pathway detected.
Similar to aldol series 126a-129a, the l' ,3-syn aldol diastereomer was favoured at
equilibrium for all cases and equilibrium was generally reached within one week.
To explore whether the sulphur atom in the cyclic aldols was essential for
isomerization the related cyclic aldols 194 and 209 were examined (Figure 53; Table
19). The isomerization of 194a and 209a led to similar equilibrium ratios of 1:2.0
(194s:194a)and 1:1.6 (209s:209a). However, the rates at which equilibrium was
reached differed substantially; the half-lives for the isomerizations of 194a and 209a
were 43 h and 15 h, respectively. Because the sulphur atom in aldols 209, the
corresponding HC-2/HC-4 and HC-4/HC-6 diaxial interactions present in aldols 194 are
absent in aldols 209. The absence of these sterically unfavourable 1,3-diaxial
interactions in aldols 209 may lead to transitions states (TS) of enolization with
* The aldol adducts 126b-129b and 126c-129c were synthesized as described in Section 2.2.2.2.
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relatively lower activation energies than the corresponding TS of aldols 194 and hence
faster rates of isomerization for 209 compared to 194.
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Figure 52. Imidazole catalysed isomerization of various aldols in CDC!).
The imidazole catalyzed isomerization of the acyclic aldol 208s141 was also
attempted (Figure 53). Isomerization of a 9: 1 mixture of 208s and 208a, respectively in
CDC!) in the presence of imidazole (0.4 M) at room temperature was very slow. The
rate of isomerization increased significantly in C6D6 solution in the presence of
imidazole (1.0 M) at 60°C (Table 19, entry 1). Under these conditions a 1:1.1
equilibrium mixture of 208s:208a was obtained after 13 days. A similar equilibrium
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ratio (208s:208a, 4:5) was obtained by Holt et al. in the presence of Ti(Oipr)4. 174
Despite the harsher conditions of elevated temperature, higher imidazole concentration
(1.0 M) and long reaction time, the amount of elimination products was negligible and
the minor presence of benzaldehyde (6%) indicated minimal retroaldol of both 208s and
208a.
Table 18. Examples of imidazole-catalysed keto-enol tautomerism of aldols 126b-129b
and 126c-129c in CDCh.a
entry starting [imidazole] aldols at equilibrium
aldol (M) (syn:anti)
1 126b 0.40 126b:127b (2.0: l)b
2 127b 0.40 126b:127b (2.0: l)b
3 128b 0.30 128b:129b (3.1:1)
4 129b 0.30 128b:129b (3.1: 1)
5 126c 0.30 126c:127c (1.1: 1)
6 127c 0.30 126c:127c (1.1:1)
7 128c 0.30 128c:129c (1.5:1)
a Isomerizations at room temperature; [aldol] = 0.3 ± 0.1 M; Equilibrium reached in
5-7 days unless otherwise indicated. b Equilibrium reached in 28 days.
The effect of the ~-hydroxy group on isomerization of aldols was studied (Table
20). Aldol 128a was chosen as model substrate because the rates of isomerization were
already established (Table 16) The isomerization of 172 in CDCb in the presence of 0.4
M imidazole gave a 3.7:1 equilibrium mixture of 172 and 174, respectively. The
isomerization of172 in 0.8 M imidazole gave a similar 3.9:1 equilibrium mixture of 172
and 174, respectively. At both concentrations of imidazole, the syn diastereomer 172
was far more predominant at equilibrium than the syn aldol 128a at equilibrium (Table
20, compare entries 1 and 4 with entries 2 and 5, respectively). The conversion of the
'hydroxyl' group in 128a to a MOM ether in 172 greatly reduced the rate of imidazole
catalyzed isomerization of 172 (Table 20, compare tl/2 values of entries 1 and 4 with
entries 2 and 5, respectively). These results suggests that the presence of a ~-hydroxyl
group facilitates the imidazole-catalyzed isomerization.
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Figure 53. Imidazole catalysed isomerization of various aldols in CDCh.
Table 19. Effect of structure on imidazole catalysed isomerization.a
Entry Starting Keq t1l2 kobs
aldol (anti:syn) (h) (10-2 h-1)
1 208sb 1.1 :1 41 1.7
2 194ac 2.0:1 43 1.6
3 209ac 1.6:1 15 4.8
a All reactions were carried out in CDCh at ambient temperature unless stated
otherwise. b A 9: 1 mixture of208s:208a was used. Reaction at 60°C in C6D6 for 13
days with imidazole concentration of 1.0 M. Approximately 6% of benzaldehyde was
present after 13 days. C Imidazole concentration 0.7 ± 0.1 M.
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Figure 54. Imidazole catalysed isomerization of aldols 128a, 172 and 174 in CDCh
Table 20. Imidazole catalyzed isomerization of J3-hydroxy (128a) vs. J3-alkoxy (172,
174) substrates.a
Entry Starting [imidazole] Keq kobs b t1l2
aldol (M) (syn:anti) (E-2 h-1) (h)
1 128a 0.4 1.8:1 8.1 8.6
2 172 0.4 3.7:1 0.18 380
3 174 0.4 3.7:1 0.21 330
4 128a 0.8 1.8:1 21 3.2
5 172 0.8 3.9:1 0.58 120
6 174 0.8 3.9:1 0.69 100
a For all entries, [aldol] = 0.03 M; Room temperature; isomerizations in CDCh. b For example, the slope
of the line obtained by plotting -In[(Rt-Re)/(R. + 1)] vs. t where Rt is [128a]/[129b] at time t and Re is
[128a]/[129a] at equilibrium (~8 data points over the initial 2 half-lives; R2 > 0.99).
The isomerization of 174 was also performed in CDCb at imidazole
concentrations 0.4 M and 0.8 M (Table 20, entries 3 and 6). The isomerizations of 174
resulted in equilibrium ratios identical to those obtained from the isomerizations of 172,
as expected (Table 20); however, the rates of isomerization for 174 differed slightly
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from those of 172. This unexpected difference in the measured rates of isomerization* is
attributed to experimental error in preparation of the imidazole solutions (i.e. estimated
erro~ in the imidazole concentrations is ± 0.01 M )t.
2.4.3. Imidazole Catalyzed Isomerization of a,a'-Disubstituted
Thiopyranones and Cyclohexanones
The aldols examined in the previous sections presented only one site for isomerization
by an enolization mechanism. Appropriately substituted aldols could isomerize at two
sites via regioisomeric enols and it was of interest to determine the regioselectivity of
such processes.
2.4.3.1. The effect ofalkyl vs. hydroxyalkyl substitution on the rate of
isomerization
The known183-189 aldols 210ac,at,sc,st were individually isomerized in CDCh in
the presence of imidazole (0.4 M) and gave the same equilibrium ratio in each case
(Figure 55). The diastereomers with a 1,3-cis relative configuration (210ac, 210sc) are
predominant at equilibrium (90%). This is expected because the cis- relative
configuration allows both substituents to occupy thermodynamically favoured
equatorial orientations in a cyclohexanone chair conformation. Among the two 1,3-cis
diastereomers the anti aldol 210ac predominated over the syn aldol 210sc at equilibrium
(Figure 55). This trend was also observed for the two trans diastereomers where the anti
aldol 210at was favoured over the syn aldol 210st (Figure 55).
During the isomerization of each of the four aldols 210, the relative
concentration of each of the components as a function of time was obtained by IH NMR
and this data is presented in Figures 56-59. In order to obtain rate constants for this four
component equilibration the change in concentration of the individual components as a
• From Table 20, compare rates 0.18 K 2 h-1 and 0.21 E-2 h- I obtained with 0.4 M imidazole; compare rates
0.58 K2 h-1 and 0.69 E-2 h- I obtained with 0.8 M imidazole
t Imidazole concentration of 0.4 M prepared by dissolving 16 ± 0.5 mg imidazole in 0.60 ± 0.01 mL
CDCI3; imidazole concentration of 0.8 M prepared by dissolving 32 ± 0.5 mg imidazole in 0.60 ± 0.01
mLCDCh.
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Figure 55. Isomerization of each of the four aldols 210 with [imidazole] = 0.4 Min
CDC!).
function of time has to be fitted to a chemical kinetics model. A hurdle in modeling
these equilibrations is that the experimental observations are concentration versus time
profiles, whereas the rate expressions involve changes in concentration versus time (i.e.
d[C]/dt). Therefore, to compare theory with experiment it is necessary to integrate the
rate expressions of the kinetic model to obtain concentration versus time profiles. The
rate constants are adjusted incrementally to obtain the best fit to the experimental data.
A software package which allows for the incremental adjustment of rate constants until
the predicted concentration versus time profiles match the experimental profiles has
been developed by F. J. Wiegert and R. J. McKinney.* Their program is based on fitting
the experimental data with Gear Algorithm Integration of Chemical Kinetic
Equations. 190-192 This program with a manual and further relevant references is available
* Central Research and Development Department, E. I. Du Pont de Nemours and Co. Experimental
Station 328; Wilmington, Delaware 19898
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for purchase from the Quantum Chemistry Program Exchange (QCPE Product Program
*number: QCMP022).
With the aid of this software package, the experimentally obtained concentration
versus time profiles were modeled according to the kinetic scheme depicted in Figure
55 to obtain the "best" rate constants. The concentration versus time profiles simulated
using these rate constants are depicted in Figures 56-59 as solid lines. The close fit of
the simulations to the observed data gives credence to the assumption that the rates of
isomerization are "first order" with respect to each individual aldol concentration at a
fixed concentration of imidazole. The eight composite rate constants derived from these
simulations are given in Figure 55. It must be noted that the data from all four
experimental concentration versus time profiles were incorporated when calculating the
set of composite rate constants. This same set of rate constants were used to simulate all
the profiles depicted as solid lines in Figures 56-59.
Using the same approach, three of the four possible diastereomers of 211 were
separately isomerized in CDC!] solution in the presence of imidazole (0.4 M and 0.8 M)
(Figure 60). As expected, equilibrium was achieved more rapidly (2 days) with 0.8 M
imidazole than with 0.4 M imidazole (4 days) (see Appendix Figures A1-A6).
Interestingly, the equilibrium ratios were .slightly different at the different imidazole
concentrations. Thus, the concentration of imidazole can influence the equilibrium ratio
(similar to a solvent effect), as observed previously with 172 (Table 8, compare entries
2 and 5). As observed for 210, the diastereomers of 211 with 1,3-cis relative
configuration were favoured over those with 1,3-trans relative configuration and anti
aldols were favoured over syn aldols.
Comparing the equilibrium ratios obtained for aldols 210 and 211 (see Figures
55 and 60) it is apparent that there is a larger difference in thermodynamic stability
amongst the four aldols 210 than amongst the four aldols 211. This is explained due to
the presence of the sulphur atom in 211, which reduces the relative steric interaction for
the axial substituent in the 1,3-trans diastereomers in aldols 211 compared to aldols 210.
* Quantum Chemistry Program Exchange, Department of Chemistry, Indiana University, 800 East
Kirkwood Ave, Bloomington, IN 47405-7102 (http://qcpe.chem.indiana.edu; email: qcpe@indiana.edu)
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Figure 56. Isomerization of a mixture 210st:210ac:210sc:210at (95:2: 1:2)
with a total aldol concentration of 0.014 M in the presence of imidazole (0.4 M)
in CDCb.
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Figure 57. Isomerization of a mixture 210st:210ac:210sc:210at (6:2: 1:91)
with a total aldol concentration of 0.014 M in the presence of imidazole (0.4 M)
inCDCb.
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Figure 58. Isomerization of a mixture 210st:210ac:210sc:210at (1 :6:91 :2)
with a total aldol concentration of 0.014 M in the presence of imidazole (0.4 M)
in CDCb.
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Figure 59. Isomerization of a mixture 21Oac:21Oat (99: 1)
with a total aldol concentration of 0.014 M in the presence of imidazole (0.4 M)
inCDCb.
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Percentages refer to the mole fraction at equilibrium.
Figure 60. Imidazole catalyzed isomerization of aldols 211.
Aldols 210 and 211 can isomerize at two sites via regioisomeric enols and it was
of interest to determine the regioselectivity of this isomerization. The composite rate
constants depicted in Figures 55 and 60 can be used to access the regioselectivity of the
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isomerization. For example, the rate constant k1 is the facility for isomerization of210at
by enolization towards the methyl group to give 210ac and the rate constant k2 is the
facility for isomerization by enolization towards the hydroxyalkyl group to give aldol
210sc (see Figure 55). These rates k1 and k2 have been redefined in Table 21 as kMe and
kOH, respectively, to reflect the direction of enolization. Therefore the ratio of kMe:koH is
an indication of the regioselectivity of the isomerization.
Upon examining the regioselectivity of isomerization it is apparent that the anti
aldols 210at and 210ac isomerize faster towards the methyl group (entries 1 and 2,
Table 21) and the sYn aldols 210st and 210sa isomerize faster towards the hydroxyalkyl
group (entries 3 and 4, Table 21). However, upon examination of the equilibrium ratio,
it is apparent that each adduct favours isomerization towards the more
thermodYnamically stable of the two possible isomerization products (Figure 55).
The regioselectivity for isomerization of aldols 211 at both concentrations of
imidazole (0.4 M and 0.8 M) follow the same trend as observed for aldols 210. The anti
aldols 211at and 211ac isomerize faster towards the methyl group (entries 5, 6, 9 and
10, Table 21) and the sYn aldols 211st and 211sa isomerize faster towards the
hydroxyalkyl group (entries 7, 8, 11 and 12). Similarly, the rates of isomerization for
each adduct 211 favours isomerization towards the more thermodYnamically stable of
the two possible isomerization products (Figure 60).
The sum of the rate constants (kMe + kOH) for each aldol adduct is an indication
of the facility of that adduct to isomerize. According to this measure (kMe + kOH), the
facility of each of the aldols 211 to isomerize was greater (x 3-15) than the
corresponding aldols 210 (Table 21, comparison of (kMe + kOH) values of entries 1, 2, 3,
4 with entries 5, 6, 7 and 8, respectively).
As expected, the facility ofeach of the aldols 211 to isomerize increased (x 2-3)
with an increase in the concentration of imidazole from 0.4 M to 0.8 M (Table 21,
compare (kMe + kOH) values of entries 5, 6, 7, 8 with entries 9, 10, 11 and 12,
respectively).
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Table 21. The regioselectivity of isomerization.
0 OH 0 OH 0 OHijPh VPh ~- - Ph.. ""'"-- = =
X kMe kOH "X/
anti,cis anti, trans syn,cis
entry [imidazole] Series aldol kMe koH kMe:koH kMe+koH
(M) X= 10-2 h-1 10-2 h-1 10-2 h-1
1 0.40 CH2 210at 1.2 0.15 8 : 1 1.35
2 210ac 0.14 0.022 6.4 : 1 0.36
3 210st 0.25 0.56 1 : 2.2 0.81
4 210sc 0.023 0.040 1 : 1.7 0.063
5 0.40 S 21lat 2.8 1.1 2.5 : 1 3.9
6 21lac 1.7 0.86 2: 1 2.56
7 21~st 0.43 2.8 1 : 6.5 3.23
8 211sc 0.15 0.80 1:5.3 0.95
9 0.80 S 211at 6.0 2.7 2.2: 1 8.7
10 211ac 4.9 2.4 2 : 1 7.3
11 211st 0.44 6.6 1 : 15 7.04
12 211sc 0.19 2.6 1 : 14 2.79
2.4.3.2. The effect ofthe hydroxyalkyl vs. alkoxyalkyl substitution on
the rate ofisomerization ofbisaldols
The bisaldols 165a,b,d, 212a-c and 213a-d were used as model substrates to
investigate the influence of hydroxy vs. alkoxy groups on isomerization. Each of the
purified aldols 165a, 165b and 165d were individually isomerized in CDC!) with
imidazole (0.4 M); in each case a 22 : 30 : 30 : 18 equilibrium mixture of 165b, 165a,
ent-165a* and 165d, respectively, was obtained (see Figure 61 and Appendix, Figures
* This compound is racemic. Presentation in this form as enantiomers facilitates comparison of rates for
all series (see Tables 22-24).
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A7-A9). Contrary to expectations, aldol 165a was the most stable despite a 3,5-trans
relative configuration necessitating the presence of an axial orientated substituent on the
'central' thiopyranone ring in a chair conformation. Perhaps the greater thermodynamic
stability of 165a originates from more favourable hydrogen bonding interactions
compared to those in aldols 165b and 165d. Interestingly the isomerization of 165d in
acetone with imidazole (1.0 M) for 8 days gave a 10 : 61 : 29 equilibrium mixture of
165d, 165a and 165b, respectively. The individual aldols were isolated by
chromatography to give 8%, 65% and 260/0 isolated yields of 165d, 165a and 165b,
respectively. In the Ward group, bisaldol 165b was previously obtained in low yield
(--1 %) from the aldol reaction between 125a and 126a (see Scheme 15). Therefore the
isomerization of 165d provides a convenient approach to afford 165b in reasonable
quantities.
Each of the purified aldols 212a-c were individually isomerized in CDCb with
imidazole (0.4 M); in each case a 46 : 23.5 : 23.5 : 7 equilibrium mixture of212a, 212b,
ent-212b* and 212c, respectively, was obtained (see Figure 61 and Appendix, Figures
AI3-A15). Aldol 212a, with a 3,5-cis relative configuration where both hydroxyalkyl
substituents can have equatorial orientations in a chair conformation, was predominant
at equilibrium. Interestingly, aldol 212c which also has a 3,5-cis relative configuration,
was the least stable aldol.
The composite rate constants for isomerization of aldols 165a, 165b and 165d
and aldols 212a-c in imidazole (0.4 - 0.8 M) were determined using the approach
described previously (Section 2.4.3.1 and Appendix, Figures A17-AI5). These rate
constants are given in Figure 61 and Table 22. The ratio of rate constants (k.2 : k.1) can
be used as a measure of the regioselectivity for isomerization of the bisaldols 165a and
212b. The aldol 165a isomerizes faster (x3) towards the side of the thiopyranone ring
with aI' ,3-syn relative configuration to give aldol 165d (Table 22, entries 1 and 2).
Contrary to the trend observed for aldols 210 and 211 (section 2.4.3.1), aldol 165a
isomerizes faster towards 165d which is thermodynamically less stable than the
alternative isomerization product 165b.
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Percentages refer to the mole fraction at equilibrium.
Rate constants for isomerization at 0.4 M imidazole (see Table 22)
Figure 61. Isomerization of aldols 165a, 165b and 165d and the corresponding bis-
MOM protected aldols 212a, 212b and 212c.
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The aldol 212b isomerizes faster (x1.7) towards the side of the thiopyranone
ring with l' ,3-anti relative configuration to give 212a (Table 22 entry 3) which is the
thermodynamically more stable of the two possible isomerization products (212a and
212c).
Table 22. The rates of isomerization ofaldols 165a, 165b, 165d and 212a-c.
Entry aldol [imidazole] rate constants (10-3 h-1) k..2 : k..1
series (M)
k1 k..l k2 k..2
1 165 0.40 6.0 4.2 20 12 2.9 : 1
2 165 0.80 14 10.3 45 27 2.6: 1
3 212 0.40 0.127 0.260 0.51 0.150 1 : 1.7
Each of the purified aldols 213a-d were individually isomerized in CDCb with
imidazole (0.4 M); in each case a 40 : 24 : 23 : 13 equilibrium mixture of 213a, 213b,
213c and 213d, respectively, was obtained (see Figure 62 and Appendix, Figures A16-
AI9). The composite rate constants for isomerization of aldols 213a-d were determined
using the previous approach (section 2.4.3.1) and are given in Figure 62. The
corresponding rate constants are relabeled as kMOM and kOH and the regioselectivity of
isomerization can be measured as the ratio of rates kMoM : kOH (Table 23). Noticeable
trends in regioselectivity of isomerization were apparent. The aldols 213a and 213b
with 1",5-syn relative configuration favour isomerization towards the hydroxylalkyl
side ofthe ketone (entries 1 and 2, Table 23), whereas the aldols 213c and 213d with
1' ,5-anti relative configuration favour isomerization towards the alkoxyalkyl side
(entries 3 and 4, Table 23). These trends in regioselectivity are identical to those found
for aldols 210 and 211 where the syn diastereomers favour isomerization towards the
hydroxyalkyl group and the anti diastereomers favour isomerization towards the methyl
group. These similar trends in regioselectivity of isomerization suggests that the
alkoxyalkyl group in aldols 213 has a similar influence on the regioselectivity as the
methyl group in aldols 210 and 211.
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213d (13%)
Figure 62. Isomerization of aldols 213a-d in with imidazole (OAM).
Table 23. The effect of a hydroxyalkyl vs. alkoxyalkyl substituent on regioselectivity of
isomerization.
kMOM
213b -~---- --"""--- 213c
entry aldol 1",5- kMoM koH kMoM : koH
syn/anti 10-3 h-1 10-3 h-1
1 213a syn 0.60 0.78 1 : 1.3
2 213b syn 1.04 1.31 1 : 1.3
3 213c anti 2.60 1.30 2.0: 1
4 213d anti 4.80 2.31 2.1 : 1
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Contrary to the trend observed for aldols 210 and 211, the rate constants for
isomerization of aldols 213 did not consistently favour the more thermodynamically
stable isomerization product. For example, aldol 213b clearly isomerizes faster towards
the thermodynamically less stable product 213d (k_1 < k_4, Figure 62).
Table 24. Comparison of the facility of aldols 165, 212 and 213 towards imidazole-
catalyzed isomerization.
Isomerization k1 k2 Isomerization
Product 1 ~ """"- Product 2
165,212 or 213
Facility of aldol to isomerize =(k1 + k2)
Entry Aldol [imidazole] k1 k2 .(k1 + k2)
M (10-3 h-1) (10-3 h-1) (10-3 h-1)
1 165b 0.40 6.0 6.0 12
2 165a 0.40 4.2 12 16.2
3 165d 0.40 20 20 40
4 165b 0.80 14 14 28
5 165a 0.80 10.3 27 37.3
6 165d 0.80 45 45 90
7 212a 0.40 0.127 0.127 0.254
8 212b 0.40 0.260 0.150 0.410
9 212c 0.40 0.51 0.51 1.02
10 213a 0.40 0.78 0.60 1.38
11 213b 0.40- 1.30 2.60 3.90
12 213c 0.40 1.04 1.31 2.35
13 213d 0.40 4.80 2.31 7.11
To examine the effect of alkoxy vs. hydroxy substitution on the facility of each
of the aldols to isomerize in the presence of imidazole, the sum of the rates (k1 + k2)
(see Table 24) of each of the aldols 165, 212 and 213 were calculated and are given in
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Table 24. As expected, the facility of each of the aldols 165a, 165b and 165d to
isomerize increased (x 2.3) with an increase in the imidazole concentration from 0.4 M
to 0.8 M. (Table 24, compare entries 1, 2, and 3 with 4, 5, and 6). In the presence of 0.4
M imidazole, the facility of aldols 165a, 165b and 165d to isomerize was ca. 40 times
greater than the corresponding bis-MOM protected aldols 212a-c. Clearly, the
protection of the hydroxy groups as MOM ethers inhibits the rate of isomerization. This
effect was previously observed when comparing the facility of aldols 128a with aldols
172 and 174 to isomerize (see Table 20). As expected, the facility of each of the mono-
MOM aldols 213a-d to isomerize was intermediate compared to that of bisaldols 165a,
165b and 165d and bis-MOM aldols 212a-c (Table 24, entries 10-13).
2.4.3.3. Other examples ofisomerization of a;a'-disubstituted
hydroxyalkyl thiopyranones
To further demonstrate the generality of the imidazole catalyzed isomerization
of aldols via enolization the bisaldols 165e, 170a and 171a were examined (see Figures
63-65). In each case only the starting aldol and those diastereomers predicted from a
keto-enol tautomerism pathway were present at equilibrium. In no case were
diastereomers that could only be derived from a retro-aldol pathway detected.
The isomerization of 165e in CH2Ch with imidazole (1.0 M) for 20 h at room
temperature gave a 29 : 60 : 11 mixture of 165e, 165f and 165c, respectively (Figure
63). The individual aldols were isolated by chromatography to give 30%, 44% and 15%
isolated yields of 165e, 165f and 165c, respectively. The bisaldol 165e was obtained
from aldol reaction of 125a with 127a in 4% isolated yield (Scheme 16).* The
isomerization of 165e gave 165f (44% isolated yield); at present this is the only route to
give 165f.3o This is an example where isomerization provides access to bisaldol
diastereomers that cannot directly be obtained from aldol reaction.
The aldol 170a was isomerized in CH2Ch with imidazole (0.40 M) for 6 days at
room temperature to give a 21 : 36 : 32 : 11 equilibrium mixture of 170a, 170b, 171c
and 171d, respectively (Figure 64). Aldol 170a was obtained from the aldol reaction
* Subsequently, the work of 1. Alarcon in the Ward group has shown that 165e can be obtained in good
yield from the aldol reaction of enantiopure 125a with enantiopure 127a.
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between 125a and 128a in 8% isolated yield (Scheme 18). Aldol 170a was also
available from the hydrolysis of the MOM group of 173c (Figure 96). The products of
isomerization 170b and 171c are also available from the hydrolysis of the MOM group
of 173a and 175b, respectively (Figures 97 and 98). However, at present isomerization
is the only route to 171d.
"s
165e (29%)
C2 anti
1~
S
165f (30%)
C1
1~
165f (30%)
C1
Percentages refer to the mole fraction after 20h.
165c (11 0/0)
C2 syn
Figure 63. Isomerization of 165e in CH2Ch with imidazole (1.0 M) for 20 h.
The bisaldol 171a was isomerized in CH2Ch with imidazole (0.80 M) for 15
days at room temperature to give a 13 : 31 : 19 : 37 equilibrium mixture of 171a, 171h,
170c and 170d, respectively (Figure 65). Aldols 171a and 171b are available from aldol
reaction of 125a with 129a in 39% and 3% isolated yields (Scheme 20}. The products of
isomerization 171b and 170c are also available from the hydrolysis of the MOM group
of 175a and 173b, respectively (Figures 90 and 91). However, at present isomerization
is the only route to 170d.
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Percentages refer to the mole fraction at equilibrium.
Figure 64. Isomerization of 170a in CH2Ch with imidazole (0.40 M) for 6 days.
0
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171b (31%)
1~ 1~
0
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"8/ "8
170c (19%) 170d (37%)
Percentages refer to the mole fraction at equilibrium.
Figure 65. Isomerization of 171a in CH2Ch with imidazole (0.80 M) for 15 days.
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2.4.4. Conclusion
It has been demonstrated that imidazole is an effective catalyst for the syn/anti
isomerization of a variety of aldols via a keto-enol tautomerization mechanism. These
isomerizations are high yielding with little or no detectable side products. arising from
elimination or retroaldol reactions. The rates of isomerization of u-substitituted (Section
2.4.2) as well as u,u' -disubstituted thiopYranones (Section 2.4.3) were investigated. It
was found that the rate of isomerization of thiopYranone derivatives (209 and 211) was
far greater than the corresponding cyclohexanone derivatives (194 and 210), which in
turn was much greater than an acyclic aldol (208). A 'free' J3-hydroxy group was shown
to facilitate the imidazole-catalyzed isomerization of aldols; the rate of isomerization of
the corresponding MOM ether derivatives was much slower. Successive MOM-
derivatization of bisaldols 165 progressively impedes the imidazole-catalyzed
isomerization (i.e. the facility of aldols to isomerize is in the order of 165 > 213 > 212).
It was demonstrated that imidazole-catalyzed isomerization of aldols is a useful tool to
obtain products (e.g. 165f, 170d and 171d) that are otherwise unobtainable through
aldol reactions (Section 2.4.3.3).
2.5. STRUCTURE DETERMINATION OF ALDOL ADDUCTS
2.5.1. Determination of the Relative Configurations of Aldols 126b-129b
and 126c-129c.
The aldols 126b-129b and 126c-129c (Figure 66) each have 4 contiguous
stereogenic centers and the relative stereochemical configurations to be assigned are the
syn/anti relative relationships at the positions C-1'/C-3, C-1'/C-3" and C-3"/C-4".
(Note: The determination of any three of the possible six relative relationships* will
unambiguously assign the relative configuration of the 4 contiguous stereogenic
centers). The synlanti relative configuration at C-3"/C-4" of each adduct 126b-129b and
126c-129c is assigned according to the corresponding configuration present in the
parent aldehyde 125b or 125c and was confirmed by the multiplicity and vicinal
* The six possible relative relationships in aldols 126b-129b and 126c-129c are the syn/anti relationships
about the positions C-I'/C-3, C-I'/C-3", C-3"/C-4", C-3/C-3", C-3/C-4" and C-I'/C-4".
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coupling constants observed for HC-4" in the corresponding 1H NMR spectrum. The
relative relationships at the positions C-l '/C-3 and C-3/C-3" were chosen as the
remaining two relationships to be assigned and the following strategy was used to
obtain these relationships.
The first step involved an unselective reduction of the aldol adduct to give a
mixture of the 3,4-syn (214) and 3,4-anti diols (215) (Figure 66). The advantage of an
unselective reduction is both diols can be isolated and their NMR spectroscopic
properties can be compared to ensure correct assignment of the 3A-relative
configuration (i.e. syn or anti). Assuming a chair conformation for the 3-substituted
tetrahydro-2H-thioPYran-4-01 fragment (where substituent is designated as the 'R'
moiety in Figure 66), three small vicinal coupling constants to HC-4 are expected for
diol 214 (3,4-syn), and one small and two large vicinal coupling constants to HC-4 are
expected for diol 215 (3,4-anti).
o OH OMOM
126b-129b or 126c-129c 214
J3-4 =1-4Hz
J4-5 = 1-4Hz
J4-5 =1-4Hz
I unselective+ reduction
OH OH OMOM
3
214
3,4-syn
+
215
3,4-anti
OMOM ~SpR OH
Pi
215
J3-4 = 8-11 Hz
J4-5 = 8-11 Hz
J4-5 =1-4Hz
Figure 66. Discriminating between the 3,4-syn and 3,4-anti diol derivatives.
To assign the C-l'/C-3 relative configuration of the aldol adduct the diol 215
was converted into the corresponding carbonate by reaction with 1,1 ' -
carbonyldiimidazole. Only the trans diol 215 (and not 214) was derivatized to give a
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trans-fused cyclic carbonate. A favourable property of a trans-fused carbonate is the
conformational rigidity, which allows for a straightforward interpretation of the vicinal
coupling constant between HC-4 and HC-4a. The trans-fused cyclic carbonate ensures
that the proton HC-4a always has an axial orientation, therefore an axial-equatorial
coupling (3-4 Hz) between HC-4a and HC-4 indicates that the R moiety has an axial
orientation and that the relative configuration is 4,4a-syn. An axial-axial coupling
between HC-4a and HC-4 (9-11 Hz) indicates that the R moiety has an equatorial
orientation and the relative configuration is 4,4a-anti. The assignment of the 4,4a-
syn/anti relative configuration in the carbonate derivative establishes the l' ,3-syn/anti
relative configuration in the precursor aldol.
OH OH OMOM
= 3
215
o
0)(0 OMOM
~S S
216
4,4a-syn
o
0)(0 OMOM
~S S
217
4,4a-anti
J4-4a = 3-4 Hz
J4-4a =8-11 Hz
Figure 67. Establishing the l' ,3-syn/anti relative configuration.
The C-3/C-3" relative configuration of an aldol adduct was established from the
sYmmetry of a triol (or bis-MOM) derivative prepared from the diol (214 or 215) with
identical relative configurations at C-3/C-4 and C-3"/C-4" (i.e. the relative
configurations of the derivative must be either 3,4-sYn-3",4"-sYn or 3,4-anti-3",4"-anti).
For example, for aldol adducts in the b series (i.e. adducts derived from 125b) which
have 3",4"-sYn relative configuration, the derived diol 214 (and not 215) with 3,4-sYn
relative configuration is converted to the triol (or bis-MOM) 218 or 219 (see Figure 68).
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The symmetry of this triol (or bis-MOM) product will then establish the C-3/C-3"
relative configuration. Isolation of a symmetric product 218* would establish the
relative configuration as 3,3"-syn, and an asymmetric product would establish the
relative configuration as 3,3"-anti (Figure 68). The assignment of this configuration in
the triol (or bis-MOM) derivative establishes the 3,3"-synjanti relative configuration in
the precursor aldol.
b series
OH OH OMOM
3
214
c series
OH OH OMOM
: 3
215
using MOMCII 01 EA
P=MOM
or
using H+
P=H
using MOMCII 01 EA
P=MOM
or
using H+
P=H
OP OH OP
3
218
OP OH OP
¢r6
219
220
cYDs S
221
symmetrical product
establishes
3,3"-syn
asymmetrical
product
establishes
3,3"-anti
symmetrical product
establishes
3,3"-syn
asymmetrical
product
establishes
3,3"-anti
Figure 68. Establishing the 3,3"-synjanti relative configuration.
• Symmetric trioIs gave 6 carbon signals and symmetric bis-MOM derivatives gave 8 carbon signals by
13CNMR.
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The following Figures 69-76 contain pertinent data used to establish the
configurations of the individual aldol adducts according to the aforementioned strategy,
together with reagents used and isolated yields. The Figures 69-76 are self explanatory
and only a few are accompanied by short commentary as deemed necessary.
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o OH OMOM
3
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J4-5 = 10Hz
J4-5 =4Hz
I MOMCIt DIEA
MOMO OH OMOM
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225 (82%)
H
8a R_O-(O
--.......~,.......,.-O J4-4a =4.5Hz
4a 4
H H J4a-Ba = 11 Hz
225
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Figure 69. Structure determination of 126b.
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Figure 70. Structure determination of 127b.
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Figure 71. Structure determination of 128b.
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Figure 72. Structure determination of 129b.
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Figure 73. Structure determination of 126c.
For aldols in the c senes only the 3,4-anti diol derivative was required as
substrate for subsequent conversion to triol and cyclic carbonate derivatives. Therefore
the 1,3-anti selective reducing reagent NaBH(OAc)3 was used in the reduction of 126c
to give the desired 237 (80% isolated yield) (Figure 73). 193,194
146
125c series
127c
~.50~S R H3
R
240
J3-4 =3Hz
J4-5 =8Hz
J4-5 = 3Hz
241 (46%)
J3-4 = 9Hz
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Figure 74. Structure determination of 127c.
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Figure 75. Structure determination of 128c.
Aldol 128c was used as substrate to successfully demonstrate both a 1,3-syn
selective reduction and a 1,3-anti selective reduction with the reagents DIBAL-H195 and
NaBH(OAc)3. 193,194, respectively (Figure 75).
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Figure 76. Structure determination of 129c.
Reduction of an enriched sample of 129c (128c:129c, 1: 1.5) gave a mixture of
three dials which were isolated to give dials 245, 249 and 250 (Figure 76). Dial 245 had
been previously isolated from similar reduction of a pure sample of 128c. The two
remaining dials 249 and 250 were not detected from the prior reduction of pure aldol
128c which provided evidence that these dials are derived from aldol 129c.
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2.5.2. Determination of the Relative Configurations of Bisaldols 165, 170,
171, 173 and 175
2.5.2.1. Bisaldol165d
Bisaldol165d was the major product obtained from aldol reaction of 127a with
aldehyde 125a (Scheme 16) and was found to be symmetric* as shown by the presence
of only 11 resonances in the BC NMR spectrum. Symmetric bisaldols can have Cs or C2
symmetry. Cs symmetric bisaldols can be distinguished from C2 symmetric bisaldols by
reduction to the corresponding triol; Cs symmetric bisaldols will give Cs symmetric
triols 253 and 254 whereas C2 symmetric bisaldols will give asymmetric triols 255
(Figure 77). Reduction of 165d with DIBAL-H gave a single symmetric triol 257 in
830/0 isolated yield indicating that bisaldol165d was Cs symmetric (Figure 78).30
0 OH OHRDR [H] R{rR R'C)R
• +
S S
165 253 254
Cs symmetric substrate Cs symmetric products
0 OHR'OR [H] R'(rR..
165 255
C2 symmetric substrate C1 symmetric product
Figure 77. The symmetry relationship between bisaldol substrate and triol product.
* Unsymmetric bisaldols have 21 resonances and symmetric bisaldols have 11 resonances in the 13C NMR
spectrum.
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Cs symmetric (11 Dc)
3,5-syn (J2-3 =5Hz; J2-3 =12Hz)
JDIBAL-H
256
Me~Me
p-TsOH
257 (83%)
Cs symmetric (11 DC)
3,4-syn -4,5-syn (HC-4 broad singlet)
258
4,8a-anti (Dmethyl = 24.1, 26.9)
258
conformer A
........
R'~88:\1'1 SH~;,a-
H 5'R.o 4Me-(-o
Me
258
conformer B
4a,8a-syn (HC-8a broad singlet)
Figure 78. Structure determination ofbisaldol165d.
In the IH NMR spectrum of 257, HC-4 is a broad singlet suggesting the 3,4,5 all
syn relative configuration for the central thiopyran ring. Reaction of 257 with
dimethoxypropane in the presence of p-TsOH gave the acetonide 258. In the 1H NMR
spectrum of 258, HC-8a was a broad singlet suggesting the presence of a cis-fused
tetrahydrothiopyrano[4,3-d]1,3-dioxin ring system as expected from the all cis 257.
Definitive evidence for the l' ,3-anti relative configuration in triol 257 was
obtained from the B C NMR of 258. The work of Rychnovsky et al. 196 clearly
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established that the relative configuration of 1,3-diols can be reliably assigned on the
basis of the BC chemical shifts of the methyl groups in the derived acetonide. In
general, acetonide derivatives of syn 1,3-diols have acetal methyl shifts near 19 and 30
ppm, acetonides from anti 1,3-diols have both acetal methyl shifts near 25 ppm. The
ketal methyl shifts of 258 appear at 24.1 and 26.9 ppm and clearly suggest a 4,8a-anti
relative configuration for 258. Thus, triol 257 is established to possess both a 3,4-cis
and aI'A-anti relative configuration thereby inferring aI' ,3-anti relative configuration
for the precursor bisaldol 165d.
There are only two possible bisaldols that satisfy the conditions of Cs symmetry
and 1',3-anti relative configuration (i.e. 165d and 256, Figure 78). The assigned
structure is firmly established because only 165d can result from an aldol reaction of
127a. To obtain 256 from 127a would require isomerization of 127a (or 165d) by a
retroaldol pathway. Such a process is ruled out because 127a is isolated intact from the
reaction mixture and different diastereomers of 127a (i.e. 126a, 128a and 129a) give
different bisaldols under identical reaction conditions.
2.5.2.2. Bisaldol165e
The bisaldol 165e was obtained as a minor product from the aldol reaction of
127a and 125a (Scheme 16). The product was symmetric as evidenced by the presence
of only 11 signals in its BC NMR spectrum; however, the triol 260 obtained by reaction
of 165e with DIBAL-H was asymmetric (21 signals in the triols BC NMR spectrum)
establishing the C2 symmetry ofbisaldol165e (Figure 79).
Reaction of 260 with dimethoxypropane in the presence of p-TsOH gave 261
and 262 in 70% and 30% isolated yields, respectively (Figure 79). NMR analysis of the
major acetonide 261 revealed a 6 Hz coupling constant between HC-4a and HC-8a
suggesting the presence of a cis-fused tetrahydrothiopyran[4,3-d] 1,3-dioxin ring system.
The BC chemical shifts for the acetal methyl groups in 261 (23.8 and 26.2 ppm)
indicated a 4' ,8a-anti relative configuration. Similar NMR analysis of the minor
acetonide 262 showed an 11 Hz coupling between HC-4a and HC-8a consistent with a
trans-fused ring system. The BC chemical shifts for the acetyl methyl groups in 262
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165e
C2 symmetric (11 DC)
~ DIBAL·H
260
asymmetric (21 DC)
261
4a,8a-syn (J4a-8a =6Hz)
262
4',4a-anti (J4'-4a = 10.5Hz)
4a-8a-anti (J4a-8a = 11 Hz)
8'-8a-syn (J8'-8a = 4.5Hz)
Me~Me
p-TsOH
261 (70%)
4',8a-anti (Dmethyl =23.8, 26.2)
+
262 (30%)
4',8a-syn (Dmethyl = 18.8, 30.2)
Figure 79. Structure determination ofbisaldol165e.
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(18.8 and 30.2 ppm) indicates a 4' ,8a-syn relative configuration. Thus, both 261 and
262 are shown to have a 4' ,4a-anti relative configuration establishing that 165e has a
l' ,3-anti relative configuration. Only two bisaldol structures are C2 symmetric and have
aI' ,3-anti relative configuration (165e and 259) but only 7b can result from reaction of
127a with 125a. (For a more detailed detailed discussion, see argument for 165a,
Section 2.5.2.1).
2.5.2.3. Bisaldol165c
The bisaldol 165c was obtained as a minor product from the aldol reaction of
126a and 125a (Scheme 15). The product was symmetric as evidenced by the presence
of only 11 signals in its BC NMR spectrum; however, the triol 264 obtained by reaction
of 165c with DIBAL-H was asymmetric (21 signals in the BC NMR spectrum)
establishing the C2 symmetry ofbisaldol165c (Figure 80).
Reaction of 264 with dimethoxypropane in the presence of p-TsOH gave 265 in
80% isolated yield. In the IH NMR of 265, HC-8a was a broad singlet, suggesting the
presence of a cis-fused tetrahydrothiopYran[4,3-d] 1,3-dioxin ring system (Le. 4a,8a-
syn). The 13C chemical shifts for the acetal methyl groups in 265 (19.7 and 30.0 ppm)
indicated a 4' ,8a-syn relative configuration. These relative configurations support a
4',4a-syn relative configuration in 265 which establishes the l' ,3-syn relative
configuration in the precursor bisaldol 165c. Only two bisaldol structures are C2
symmetric and have aI' ,3-syn relative configuration (165c and 263, see Figure 80) but
only 165c can result from reaction of 126a with 125a.
154
165c
C2 symmetric (11 DC)
~ DIBAL-H
264 (76%)
asymmetric (21 DC)
Me~Me
•
p-TsOH
263
265 (800/0)
4',8a-syn (Dmethyl = 19.7,30.0)
265 265
/\
R = (:Y\
S
['OOH
R' = CY"I
s
conformer A (minor) conformer B (major)
4a,8a-syn (HC-8a broad singlet)
Figure 80. Structure determination of bisaldol 165c.
2.5.2.4. Bisaldol165a
Bisaldol165a is the major product from aldol coupling of 126a with 125a and is
a minor product from aldol reaction of 127a with 125a (Schemes 15 and 16). The
presence of 21 signals in the 13C NMR spectrum confirmed that 165a was asymmetric.
Analysis of the vicinal coupling constants between HC-3 and H2C-2 (4 and 5.5 Hz) and
those between HC-5 and H2C-6 (4 and 9.5 Hz) in the IH NMR spectrum of 165a
indicated that the substituents at positions C-3 and C-5 of the thiopyranone ring were
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trans and that the conformer with an axial substituent at C-3 predominated (Figure 81).
Reduction of 165a with DIBAL-H gave triol 270 (78%) from which three carbonate
derivatives 268, 269 and 270 were isolated after reaction with 1,1'-carbonyldiimidazole
(Figure 81). The multiplicity and coupling constants for HC-8a (broad singlet) in the IH
NMR spectrum of the major product 270 suggests a cis-fused ring junction. A large
coupling constant between HC-4a and HC-5 (12 Hz) suggests that HC-4a has an axial
orientation with respect to the thiopyyanone ring (Figure 81). In the 1H NMR spectrum
of 269, HC-8a is a broad singlet and the small coupling constants between HC-8 and
H2C-7 suggests that HC-8a and HC-8 both have equatorial orientations with respect to
the thiopyyanone ring (Figure 81). Overall, this analysis suggests a relative
configuration of4' ,4a-sYfi-4a,8a-sYfi-8a,8 '-anti for carbonate 270.
1H NMR analysis of the minor carbonate 268 showed a large coupling constant
between HC-4a and HC-8a (10 Hz) indicating a trans-fused ring junction (Figure 81).
The large coupling between HC-4 and HC-4a (9 Hz) suggests that both hydrogens have
an axial orientation. An equatorial orientation for HC-8 is suggested by its small
coupling with HC-8a (4 Hz). This IH NMR analysis assigns the relative configuration
of 268 as 4,4a-anti-4a,8a-anti-8a,8-sYfi.
FrQm the relative configurations of the carbonate derivatives 268 and 270 it can
be concluded that 165a has 1',3-anti-3,5-anti-l",5-sYfi relative configuration. Although
there are four possible bisaldol diastereomers that would satisfy these conditions (165a,
170c, 171b, and 266), only 165a can arise from aldol reactions of 125a with 126a and
127a. Moreover, 165a is related to 165d and 165b by imidazole catalyzed isomerization
(see Figure 16). Thus the indicated structure is firmly established.
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Figure 81. Structure determination of bisaldol165a.
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2.5.2.5. Bisaldol165b
Bisaldol 165b was a very minor product (l % isolated yield) obtained from the
aldol reaction of 126a with 125a (Scheme 15) and was found to be symmetric as shown
by the presence of only 11 resonances in the BC NMR spectrum. Reduction of 165b
with DIBAL-H gave a single SYmmetric triol 272 in 71 % isolated Yield indicating that
bisaldol165b was Cs symmetric.
In the IH NMR spectrum of 272, HC-4 is a broad singlet suggesting the 3,4,5 all
syn relative configuration for the central thiopYran ring in 272 (Figure 82). Reaction of
272 with dimethoxypropane in the presence of p-TsOH gave the acetonide 273. In the
IH NMR spectrum of 273, HC-8a was a broad singlet suggesting the presence of a cis-
fused tetrahydrothiopYrano[4,3-d] 1,3-dioxin ring system as expected from the all cis
272.
Definitive evidence for the l' ,3-syn relative configuration in triol 272 was
obtained from the BC NMR of 273. The acetal methyl shifts of 273 of 19.7 and 30.4
ppm clearly suggest a 4,4a-syn relative configuration for acetonide 273. Thus, triol 272
is established to possess both a 3,4-syn and aI' ,4-syn relative configuration thereby
inferring aI' ,3-syn relative configuration for the precursor bisaldol165b.
There are only two possible bisaldols that satisfy the conditions of Cs sYmmetry
and 1',3-syn relative configuration (i.e. 165b and 271, Figure 82). The assigned
structure is established because only 165b can result from an aldol reaction of 126a.
Finally, the obtention of 165b from imidazole catalyzed isomerization of 165d firmly
established the indicated structure (see Figure 61).
158
165b
Cs symmetric (11 Dc)
3,5-syn (J2-3 =4.5Hz ; J 2-3 =11.5Hz)
JDIBAL-H
271
Me~Me
•
p-TsOH
272 (71%)
Cs symmetric (11 Dc)
3,4-syn -4,5-syn (HC-4 broad singlet)
273
4',8a-syn (Dmethyl =19.7, 30.4 ppm)
4a,8a-syn (HC-Sa broad singlet)
Imidazole catalyzed isomerization of 7a
165d
Cs
Figure 82. Structure determination ofbisaldol165b.
2.5.2.6. Bisaldol165j
165b
Cs
Bisaldol 165f was obtained from imidazole-catalyzed isomerization of bisaldol
165e (see Section 2.4.3.3) and was shown to be asymmetric on the basis of21 signals in
the Be NMR spectrum (Figure 83). A 3,5-syn relative configuration for 165f was
assigned on the basis of the coupling constants between HC-3 and H2C-2 (3.5, 11.5 Hz)
and between HC-5 and H2C-6 (3.5, 12 Hz) indicative of cis equatorial substituents on a
six-membered ring in a chair conformation (Figure 83). Structure 165f is firmly
159
established as keto-enol tautomerism of 165e (Figure 83) can produce only one
asymmetric diastereomer.
165f
asymmetric (21 be)
3,5-syn (J2-3 =3.5Hz ; J2-3 =11.5Hz
JS-6 =3.5Hz ; JS-6 =12Hz)
Imidazole catalyzed isomerization of 165e
Figure 83. Structure determination of bisaldol 165f.
2.5.2.7. Bisaldol171a
Bisaldol 171a is the major product from the aldol reaction of 129a with 125a
(Scheme 20). The presence of 21 signals in the BC NMR spectrum established that
171a was asymmetric. The relative configuration at C-3 and C-5 was established by
analysis of the IH NMR spectrum of 171a. The vicinal coupling constants between HC-
3 and H2C-2 (4.5 and 12 Hz) and between HC-5 and H2C-6 (3.5 and 11 Hz) suggests
that both HC-3 and HC-5 have an axial orientation within a six-membered ring in a
chair conformation thereby establishing the 3,5-cis relative configuration (Figure 84).
Bisaldol 171a was subjected to imidazole-catalyzed isomerization (see Section
2.4.3.3), which gave a 1:2.9:1.2:2.6 equilibrium mixture of 171a, 171b, 170c and 170d,
respectively (Figure 85). The bisaldols 171b, 170c and 170d were isolated and each was
determined to be asymmetric by BC NMR analysis. Obtaining a set of four asymmetric
diastereomers from keto-enol tautomerism of 171a is possible only if the C-l '/C-6' and
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C-1 "/C-6" relative configurations of 171a are different (i.e. l' ,6'-syn-1",6"-anti or
l' ,6' -anti-1 ",6"-syn). Assuming that the aldol reaction of 129a with 125a occurs
without isomerization, bisaldol products will retain the l' ,3-anti-1' ,6' -anti relative
configuration from the substrate 129a.* Thus, bisaldol 171a is shown to have 3,5-cis,
l' ,3-anti, 1',6'-anti and 1",6"-syn relative configurations. There are two possible
structures that satisfy these conditions; i.e. 171a and 171d (Figure 86).
H
I R ~o
H_s..........H, / 4~/ ---5--
S.-2--L , Rj ~i--
H
171a
J3-2 =12 Hz
J3-2 =4.5 Hz
JS-6 = 11.5 Hz
JS-6 = 3.5 Hz
3,5-cis
171a
Figure 84. Determination of the 3,5-cis relative configuration of 171a.
1',6'-anti 1',6'-syn
a
-----
----
171a 171b
j~ I~
a a
-----
----
's/
170c 170d
Figure 85. Imidazole-catalyzed keto-enol tautomerism of bisaldol 171a gave a mixture
of four asymmetric bisaldols 170c, 170d, 171a and 171b.
* This assumption is reasonable because unreacted 129a was recovered intact (47% isolated yield)
without detection of other diastereomers which could result from isomerization and because similar aldol
reactions of 125a with 126a, 127a or 128a give different bisaldol products.
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The two possible structures 171a and 171d differ only in the relative
configuration at positions C-1"/C-5 (Figure 86). The approach used to assign the C'l/C-
5 relative configuration is based on the analysis and comparison of BC NMR data of
monoaldols 126a-129a and bisaldols 165b, 165d and 171a (Figure 86). The assignment
of the signals in the BC NMR spectrum of 171a was made with the aid of two
dimensional homonulear (COSY) and heteronuclear (HMQC and HMBC) correlation
experiments. The BC NMR spectrum of 171a could be unambiguously assigned to two
spin systems. That is, the set of shifts for C-2, C-3, C-l', C-5', C-6', C-7', C-9' and C-
10' was distinguished from the the set for C-5, C-6, C-l", C-5", C-6", C-7", C-9" and
C-10"; however, this method does not allow for assignment of a given set of shifts to a
given spin system. To resolve this issue, the BC NMR spectrum of monoaldols 126a-
129a and bisaldols 165b (Cs syn) and 165d (Cs anti) were unambiguously assigned
using the above techniques. Comparison of the BC NMR chemical shifts for carbons 2,
3,1',5',6', 7',9' and 10' for 126a and 165b revealed a close correspondence (~8 < 0.9
ppm) for all carbons except C-2 and C-3 (Figure 87, part a). Similar comparison of the
chemical shifts for 127a and 165d gave a ~8 < 0.4 ppm (Figure 87, part b). Considering
the above, the two sets of chemical shifts corresponding to carbons 1', 5', 6' 7', 9' and
10' (prime labeled carbons) and carbons 1", 5", 6", 7", 9" and 10" (double prime
labeled carbons) in 171a were individually compared to the set of shifts for carbons 1',
5', 6' 7', 9' and 10' of monoaldol 129a (Figure 88, part c and d). As is clearly
illustrated in Figure 88, a close match is obtained for only one of the sets and on this
basis the chemical shifts for carbons 2, 3, 1', 5', 6' 7', 9' and 10' were assigned. The
remaining set of chemical shifts for 171a must correspond to carbons 5, 6, 1", 5", 6",
7", 9" and 10" of either 171a or 171d. Comparison of these chemical shifts with the
same carbons in 165b and 165d shows a much closer correspondence with 165d
(average 1~81 = 0.4 ppm) than with 165b (average 1~81 = 1.1 ppm) and on this basis
171a is assigned the indicated structure (Figure 89, part e and f).
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bC of labelled carbons of 129a match with
corresponding bC of 171a, ave.
Iilbl= 0.19 ppm, SO = 0.13 ppm
(part c, Figure 88)
129a
9"
10'
9'
171d t(1",5-syn) 171a t(1 ",5-anti)
10'
9'
165d (Cs anti)
bC of labelled carbons of 165b match poorly
with corresponding bC of171a, ave.l~bl= 1.14
ppm, SO =1.20 ppm (part e, Figure 89)
bC of labelled carbons of 165d match with
corresponding bC of 171 a, aveJ ilbl =
0.46 ppm, SO = 0.40 ppm (part f, Figure 89)
Notice that both 171a and 171d have 1',3-anti, 1',6'-anti, 3,5-cis, 1",6"-syn
relative configurations
Figure 86. Distinguishing between structures 171a and 171d by comparison of BC
NMR data of aldols 129a, 165b and 165d with B C NMR data of 171a.
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Figure 87. Comparison of the l3C NMR shifts of 126a with 165b, and 127a with 165d.
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Figure 88. Comparison of the BC NMR shifts of 129a with those of 171a.
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Figure 89. Comparison of the l3C NMR shifts of 165b and 165d with those of 171a.
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2.5.2.8. Bisaldols 171b and 175a
Bisaldol 171b was the minor product from the aldol reaction of ketone 129a
with aldehyde 125a (Scheme 20). The observation of 21 carbon resonances in the B C
NMR spectrum indicates that 171b is aSYmmetric. The vicinal coupling constants
between H2C-2 and HC-3 (4.5 and 10 Hz) and between H2C-6 and HC-5 (5.5 and 8.5
Hz) suggest that 171b has a 3,5-trans relative configuration with the substituent at C-5
being mostly in the axial orientation (Figure 90). Bisaldol 171b is related to 171a by
keto-enol tautomerism. Thus, assuming that 171b retains the 1',3-anti-l ',6'-anti relative
configuration of the precursor 129a (Figure 90) then only the indicated structure
satisfies the above data.
Coupling constants for 175a
J3-2 =6.5 Hz J S-6 =10.5 Hz
J3-2 =4 Hz JS-6 =4.5 Hz
Coupling constants for 171 b
J3-2 = 10Hz JS-6 = 8.5 Hz
J3-2 =4.5 Hz JS-6 =5.5 Hz
1',3-anti-1 "6'-anti
175a
t
125a
TiCI4 I i-Pr2EtN
(Scheme 22)
174
TiCI4
PhSH
171b (40%)
175a (38%)
MOMCI
i-Pr2EtN
BU4NI
..
100%
conversion
3,5-trans
~
o H9d"o
s~
1',3-anti-1 ',6'-anti
171b
t
125a
TiCI4 I i-Pr2EtN
(Scheme 20)
d"o9H 0~S '---r--' S
1',3-anti-1',6'-anti
129a
keto-enol
tautomerism
...... """-- 171a
(Figure 65)
Figure 90. Structure determination of 171b and 175a.
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Compound 175a was a major product from the aldol reaction of 174 with 125a
(Scheme 22). The vicinal coupling constants between H2C-2 and HC-3 (4 and 6.5 Hz)
and between H2C-6 and HC-5 (4.5 and 10 Hz) in 175a suggest a trans 3,5-disubstituted
thiopyranone ring in which the substituent at C-3 is mostly in an axial orientation.
Removal of the MOM ether in 175a by reaction with TiCl4 / PhSH gave 171b (Figure
90).
2.5.2.9. Bisaldols 170c and 173b
Bisaldol 170c was obtained from imidazole catalyzed keto-enol tautomerism of
bisaldol171a and is asymmeric based on the observation of 21 signals in its B C NMR
spectrum. The vicinal coupling constants between H2C-2 and HC-3 (5 and 6 Hz) and
between H2C-6 and HC-5 (4.5 and 11.5 Hz) in bisaldol 170c suggests a trans 3,5-
disubstituted thiopYranone ring with the substituent at C-5 mostly in the axial
orientation (Figure 91). The only possible bisaldols with a 3,5-trans relative
configuration that can arise from keto-enol tautomerism of 171a are 170c and 171b (see
Figure 65). Structure 170c is assigned as indicated because structure 171b (see Section
2.5.2.8) has been unambiguously assigned to a different product.
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Coupling constants for 173b
J3-2 =11 Hz JS-6 =4.5 Hz
J3-2 =5 Hz
1',3-syn-1 ',6'-anti
173b
JS-6 =4 Hz
TiCI4
PhSH
170c (34%)
173b (41%)
Coupling constants for 170c
J3-2 =11.5 Hz JS-6 =6 Hz
J3-2 =4.5 Hz JS-6 =5 Hz
3,5-trans
~
O~ 9 H 0 H9 01\0 keto-enol
- - tautomerism
........,..... 171a
(Figure 65)
1',3-syn-1 ',6'-anti
170c
t
125a
TiCI4 I i-Pr2EtN
(Scheme 21)
~
o
I\~
o O? 0c:ro
172
MOMCI
i-Pr2EtN
'II'
100%
conversion
l'o 9H 0~
1',3-syn-1 ',6'-anti
128a
Figure 91. Structure determination of bisaldol170c and 173b.
Compound 173b is obtained from aldol reaction of 172 with 125a. The vicinal
coupling constants between H2C-2 and HC-3 (5 and 11 Hz) and between H2C-6 and
HC-5 (4 and 4.5 Hz) in 173b suggests trans 3,5-disubstituted thiopyranone ring with the
substituent at C-5 mostly in the axial orientation (Figure 91). Removal of the MOM
ether in 173b by reaction with TiCl4 / PhSH gave 170c.
2.5.2.10. Bisaldol170d
Bisaldol 170d is obtained from keto-enol tautomerism of 171a (see Figure 65)
and is asymmetric based on the observation of 21 signals in its 13C NMR spectrum. The
vicinal couplings constants between H2C-2 and HC-3 (4.5 and 11.5 Hz) and between
H2C-6 and HC-5 (4.5 and 11.5 Hz) in 170d suggest a cis 3,5-disubstituted thiopyranone
in a chair conformation (Figure 92). Structure 170d is assigned as indicated because
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there is only one possible product with a 3,5-cis relative configuration that can arise
from keto-enol tautomerism of 171a.
Coupling constants for 170d
J3-2 =11.5 Hz J S-6 =11.5 Hz
J3-2 =4.5 Hz JS-6 =4.5 Hz
keto-enol
tautomerism
""'"(Figure 65)
170d
Figure 92. Structure determination of 170d.
2.5.2.11. Bisaldols 170a and 173c
171a
Bisaldol 170a was the only product isolated from the aldol reaction of 128a with
125a (Scheme 19). The presence of 21 signals in the 13C NMR spectrum established
that 170a was asymmetric. The vicinal coupling constants between HC-3 and H2C-2 (5
and 11.5 Hz) and between HC-5 and H2C-6 (4.5 and 12 Hz) in the IH NMR spectrum of
170a suggests that both HC-3 and HC-5 have an axial orientation within a six-
membered ring in a chair conformation, thereby establishing the 3,5-cis relative
configuration.
Bisaldol 170a was subjected to imidazole-catalyzed isomerization (see Figure
64) to give a 2.1:3.6:3.2:1 equilibrium mixture of 170a, 170b, 171c and 171d,
respectively. The bisaldols 170b, 171c and 171d were isolated and each was determined
to be asymmetric by 13C NMR. Obtaining a set of four asymmetric products from keto-
enol tautomerism of 170a is possible only if the C-l'/C-6' and C-l "/C-6" relative
configurations of 170a are different (i.e. 1',6'-syn-l",6"-anti or 1',6'-anti-l",6"-syn).
Assuming that the aldol reaction of 128a with 125a occurs without isomerization
bisaldol products will retain the l' ,3-sYfi-l ' ,6' -anti relative configuration from the
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substrate 128a.* Thus, bisaldol 170a is shown to have 3,5-cis, l' ,3-syn, l' ,6' -anti and
1",6"-syn relative configurations. There are two possible structures that satisfy these
conditions, 170a and 170d (Figure 93).
The structure 170a has been assigned as indicated because 170d has already
been unambiguously assigned to a different product (see Section 2.5.2.10). However,
the structure of 170a is also confirmed by analysis of the l3C NMR data using the
approach applied earlier (section 2.5.2.7) to assign the structure of 171a (Figure 93).
The assignment of the signals in the carbon spectrum of 170a was made with the aid of
two dimensional homonulear (COSY) and heteronuclear (HMQC and HMBC)
correlation experiments. The l3C NMR spectrum of 170a could be unambiguously
assigned to two spin systems. That is, the set of shifts for C-2, C-3, C-l', C-5', C-6', C-
7', C-9' and C-I0' was distinguished from the the set for C-5, C-6, C-l", C-5", C-6", C-
7", C-9" and C-I0"; however, this method does not allow for assignment of a given set
of shifts to a given spin system. To resolve this issue, the two sets of chemical shifts
corresponding to carbons 1', 5', 6' 7', 9' and 10' (prime labeled carbons) and carbons
1", 5", 6", 7", 9" and 10" (double prime labeled carbons) in 170a were individually
compared to the set of shifts for carbons 1', 5', 6' 7', 9' and 10' of monoaldol 128a
(Figure 94, part i and ii). As is clearly illustrated in Figure 94, a close match is obtained
for only one of the sets and on this basis the chemical shifts for carbons 2, 3, 1', 5', 6'
7', 9' and 10' were assigned. The remaining set of chemical shifts for 170a must
correspond to carbons 5, 6, 1", 5", 6", 7", 9" and 10" of either 170a or 170d.
Comparison of these chemical shifts with the same carbons in 165b and 165d shows a
much closer correspondence with 165d (average 1~81 = 0.5 ppm) than with 165b
(average 1~81 = 1.0 ppm) and on this basis 170a is assigned the indicated structure
(Figure 95, part iii and iv).
* This assumption is reasonable because unreacted 128a was recovered intact (57% isolated yield)
without detection of other diastereomers which could result from isomerization and because similar aldol
reactions of 126a, 127a or 129a with 125a give different bisaldol products.
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128a
9"
eSc of labelled carbons of 128a match with
corresponding eSc of 170a, ave.
I.6.eSl= 0.18 ppm, SO = 0.21 ppm
(part i, Figure 94)
10'
9'
170d t(1",5-syn)
eSc of labelled carbons of 165b match poorly
with corresponding eSc of 170a, ave.l.6.eSl = 0.97
ppm, SO = 1.15 ppm (part iii, Figure 95)
170a t(1 ",5-anti)
165d (Cs anti)
eSc of labelled carbons of 165d match with
corresponding eSc of 170a, ave.l.6.cSl = 0.28
ppm, SO = 0.30 ppm (part iv, Figure 95)
Notice that both 170d and 170a have 1',3-syn, 1',6'-anti, 3,5-cis, 1",6"-syn
relative configurations
Figure 93. Distinguishing between structures 170a and 170d by comparison of Be
NMR data ofaldols 128a, 165b and 165d with Be NMR data of aldol 170a.
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part i
prime labelled
ring system
double prime labelled
ring system
10"
128a 170a
~b = be (128a) - be (170a)
2-.----------------.
-1
C-1 C-5 C-G C-? C-g C-10
-2 -'-- ---l
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DEVIATION = 0.21
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2-r------------~
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Figure 94. Comparison of the 13C NMR shifts of 128a with those of 170a.
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Figure 95. Comparison of the B C NMR shifts of 165b and 165d with those of 170a.
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Coupling constants for 170a
J3-2 =11.5 Hz JS-6 =12 Hz
Coupling constants for 173c
J3-2 =12 Hz JS-6 =11 Hz
J3-2 =4.5 Hz JS-6 =5 Hz J3-2 =5 Hz JS-6 = 4.5 Hz
1',3-syn-1',6'-anti
173c
t 125aTiCI4 I i-Pr2EtN(Scheme 21)
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TiCI4
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170a (54%)
173c (46%)
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conversion
3,5-cis
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170a
t
125a
TiCI4 I i-Pr2EtN
(Scheme 19)
6'09H 0~
l' ,3-syn-1',6'-anti
128a
Figure 96. Structure determination of 170a and 173c.
Compound 173c was a minor product from the aldol reaction of 172 with 125a
(Scheme 21). The vicinal coupling constants between H2C-2 and HC-3 (4.5 and 12 Hz)
and between H2C-6 and HC-5 (5 and 11 Hz) in 173c suggest that both HC-3 and HC-5
have an axial orientation within a six-membered ring in a chair conformation thereby
establishing the 3,5-cis relative configuration (Figure 96). Removal of the MOM ether
in 173c by reaction with TiC14 / PhSH gave 170a (Figure 96).
2.5.2.12. Bisaldols 170b and 173a
Bisaldol 170b was obtained from imidazole catalyzed keto-enol tautomerism of
bisaldol170a (see Figure 64) and is asymmeric based on the observation of 21 signals
in its l3C NMR spectrum. The vicinal coupling constants between H2C-2 amd HC-3 (5
and 7 Hz) and between H2C-6 and HC-5 (4.5 and 11 Hz) in bisaldol 170b suggest a
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trans 3,5-disubstituted thiopyranone ring with the substituent at C-3 mostly in the axial
orientation. The only possible bisaldols with a 3,5-trans relative configuration that can
arise from keto-enol tautomerism of 170a are 170b and 171c (see Figure 64). This is
resolved since 170b also comes from 173a (which has aI' ,3-syn-1' ,6' anti relative
configuration) and there is only one possible structure that can be obtained from keto-
enol tautomerism of 170a which also has a 1',3-syn-1 ',6'anti relative configuration (see
Figure 97).
Coupling constants for 170bCoupling constants for 173a
J3-2 = 10.5 Hz JS-6 = 4.5 Hz
J3-2 =5.5 Hz J S-6 =4.5 Hz
J3-2 =7 Hz
J3-2 =5 Hz
JS-6 = 11 Hz
JS-6 =4.5 Hz
(Figure 64)
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01\0 9H 0 HO 01\0 keto-enol
- tautomerism
.........,.., 170a
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173a (32%) 1',3-syn-1"6'-anti
~ 3,5-trans
o ,....----.
~ 1\? 0 HO 0 0
- 5
1',3-syn-1',6'-anti
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t
125a
TiCI4 I i-Pr2EtN
(Scheme 21)
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MOMCI
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100%
conversion
170b
t'09H 00b6
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Figure 97. Structure determination of 170b and 173a.
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Compound 173a is obtained from aldol reaction of 172 with 125a. Compound
172 in turn is obtained from 128a and it can be concluded that 173a will have aI' ,3-
syn-l' ,6'anti relative configuration of 128a (Figure 97). As expected, the vicinal
coupling constants between H2C-2 and HC-3 (5 and 11 Hz) and between H2C-6 and
HC-5 (4 and 4.5 Hz) obtained from the IH NMR spectrum of 173a suggested a trans
3,5-disubstituted thiopyranone ring with the substituent at C-5 mostly in the axial
orientation (Figure 97).
2.5.2.13. Bisaldols 171c and 175b
Bisaldol 171c was obtained from imidazole catalyzed keto-enol tautomerism of
bisaldol 170a and is aSYmmeric based on the observation of 21 signals in its B C NMR
spectrum. The vicinal coupling constants between H2C-2 and HC-3 (4.5 and 11 Hz) and
between H2C-6 and HC-5 (5 and 4.5 Hz) in bisaldol 171c suggest a trans 3,5-
disubstituted thiopyranone ring with the substituent at C-5 mostly in the axial
orientation (Figure 98). The only possible bisaldols with a 3,5-trans relative
configuration that can arise from keto-enol tautomerism of 170a are 170b and 171c (see
Figure 64). Structure 171c is assigned as indicated because 170b has been
unambiguously assigned to a different product (see Section 2.5.2.12).
Compound 175b is obtained from aldol reaction of 174 with 125a. The vicinal
coupling constants between H2C-2 and HC-3 (4.5 and 7 Hz) and between H2C-6 and
HC-5 (5 and 9 Hz) in 175b suggests a trans 3,5-disubstituted thiopyranone ring (Figure
98). Removal of the MOM ether in 175b by reaction with TiCl4 / PhSH gave 171c.
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Coupling constants for 175b
J3-2 =7 Hz JS-6 =9 Hz
J3-2 =4.5 Hz JS-6 =5 Hz
Coupling constants for 171c
J3-2 =11 Hz JS-6 =5 Hz
J3-2 =4.5 Hz JS-6 =4.5 Hz
170a........
(Figure 64)
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Figure 98. Structure determination of 171c and 175b.
2.5.2.14. Bisaldol171d
Bisaldol 171d is obtained from keto-enol tautomerism of 170a and is
asymmetric based on the observation of21 signals in its BC NMR spectrum (see Figure
64). The vicinal couplings constants between H2C-2 and HC-3 (5 and 11.5 Hz) and
between H2C-6 and HC-5 (4.5 and 12 Hz) in 171d suggest a cis 3,5-disubstituted
thiopyranone in a chair conformation (Figure 99). Structure 171d is assigned as
indicated because there is only one possible product with a 3,5-cis relative configuration
that can arise from keto-enol tautomerism of 170a.
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Coupling constants of 171d
J3-2 = 11.5 Hz J5-6 = 12 Hz
J3-2 =5 Hz J5-6 =4.5 Hz
(Figure 64)
keto-enol
tautomerism
,.....
""""
171d 170a
Figure 99. Structure determination of 171d.
2.5.3. Determination of the Relative Configuration of Aldols 194,209, 210
and 211.
The relative configurations of aldols 194a and 194s have been established by
conformational analysis of these aldols in solution with the use of the House-Stiles rule.
Based on empirical evidence at the time, Stiles was the first to postulate that the syn-
anti relative configuration of an aldol can be assigned based on the magnitude of the
vicinal coupling constant J1'_2,197 and this method was later extended by House et al. 198
This empirical rule assumes the presence of intramolecular hydrogen bonding, which
will favour two conformations (Figure 100). The one dominant conformation for an
anti-aldol will place the HC-l' and HC-2 protons in an antiperiplanar arrangement with
a predicted Jl'-2 = 10Hz and the other conformation will place these protons in a
synclinal orientation with a predicted Jl'-2 = 2 Hz. Depending on the relative proportions
of these conformers it was postulated by House that anti aldols will have observed
vicinal coupling constants J1'-2 ranging between 6-9 HZ.198 However, both conformers
predicted for intramolecularly hydrogen bonded syn aldols will have synclinal
orientations where the expected vicinal couplings constants for both conformers are 2
Hz. For this reason House stated that the observed coupling constant J1'-2 for syn aldols
will range between 2-4 Hz and be much smaller than the expected couplings for anti
aldols. 198
The vicinal coupling constants J1'-2 of 9 and 2 Hz for aldols 194a and 194s,
respectively had been used by Mukaiyama to assign the syn/anti relative configuration
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based on the Stiles-House rule. 135 This assignment was later verified by X-ray
crystallographic analysis of structures of 194a and 194b reported by Noyori et al. which
showed that the Stiles-House rule can be applied to these substrates. 199 The syn/anti
configuration of structurally similar aldols 209a and 209s with vicinal coupling
constants of9 and 2 Hz, respectively were assigned by Hayashi using this rule.4o
°
OH l' ~1'~Ph ~Ph~,~ H~h~ ~~ H2 ~6 0, ,,0
194a H'antiperiplanar
synclinal
J1'-2 =10Hz J1'-2 =2Hz
°
OH ~ ~1'LP~ l' Ph H 0'1j Phtlt2~ ~: ~ ~Ph ° O'H"'O
194s
synclinal synclinal
J1'-2 =2Hz J1'-2 =2Hz
Figure 100. Intramolecular hydrogen bonded conformations for l' ,2-anti 194a and
l' ,2-syn 194s. 199
All four diastereomers 210at, 210ac, 210st and 210sc were isolated from aldol
reaction of benzaldehyde with Li-enolate of 2-methylcyclohexanone (Scheme 26).
Three diastereomers 211at, 211ac and 211st were isolated from aldol reaction of
benzaldehyde with Li-enolate of 3-methylthiopYranone (Scheme 26). The remaining
aldol 211sc was obtained from isomerization of a 1 : 7.2 : 4.4 mixture of 211at, 211ac
and 211st, respectively in the presence of imidazole (0.8 M) in CH2Ch at room
temperature. After 4 days a 2.4 : 2.8 : 1 : 2.1 mixture of 211at, 211ac, 211st and 211sc,
respectively was obtained. Aldol 211sc was isolated from this mixture by
chromatography.
The NMR data accumulated for the four aldols 210 correspond closely (within
±0.2 ppm) to that reported in the literatureI83-189. The vicinal coupling constants J1'-2
(see Table 25) derived from the obtained spectral data also matched closely (within ±1
Hz) with the reported values. 135,185,187,189 Furthermore, the 13C NMR data for the four
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aldols 210 closely matched (within +0.4 ±0.3 ppm)* the data reported by Duhamel et
al. 189 However, upon closer examination of the accumulated data it became evident that
the literature assignment of the relative configurations of 210sc and 210st were
incorrect (Table 25).
1. LDA 2 eq
-78°C, 30 min
•
2. PhCHO 1.2 eq
-78°C, 3 min
x=s
210at (31%) 210ac (16%)
210st (12%) 210sc (6%)
211at:211ac:211st 2.6: 1.5: 1
combined aldol yield 70%
Scheme 26. Synthesis of aldols 210 and 211.
Table 25. Comparison of reported and corrected relative configurations of210.
Entry J1'-2 Literature183-189 Corrected
1 9.5 anti,trans anti,trans
2 8.5 anti,cis anti,cis
3 3.0 Syn,CIS syn,trans
4 2.5 syn,trans syn,cis
To the best of my knowledge, Mukaiyama et al. was the first to assign the
relative configurations of the aldols 210. 135 The assignment of the l' ,2-syn/anti relative
configuration was based on the Stiles-House rule, which assigns larger HC-1'IHC-2
vicinal coupling constants to anti- and the smaller coupling constants to syn-relative
configurations (Table 25). However, the approach used to assign the 2,6-cis/trans
relative configuration of aldols 210 was not reported and it cannot be assumed that 13C
* The constant +0.4 ppm difference in carbon shift is most likely due to a 0.4 ppm difference in the
calibration of the CDCb triplet in the accumulated spectra and the reported spectra ofDuhamel et al.
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NMR data was used for this assignment since no BC data was reported by
Mukaiyama. B5 Subsequent reports of aldols 210 all refer to Mukaiyama's earlier
assignment but with no mention of the method used to assign the 2,6-cis/trans relative
configuration.183-189 The report by Duhamel et al. is the only one where both the IH and
BC NMR data for aldols 210 was given; no attempt was made to use the BC NMR data
to substantiate the previous 2,6-cis/trans assignments. 189
Mukaiyama's assignment of the l' ,2-syn/anti relative configurations in 210,
based on the Stiles-House rule, is further supported by the BC NMR chemical shifts for
C-l' (entry 8, Table 26). The anti aldols 12at and 12ac have C-l' shifts of 75.01 and
74.93 ppm, respectively, which are more downfield than the C-l' shifts for the syn
aldols 210st and 210sc of 71.62 and 70.97 ppm, respectively.
A thorough analysis of the IH)H coupling constants of aldols 210 has not been
reported in the literature. From the IH NMR of aldol 210ac, the vicinal coupling
constants between protons HC-2 and H2C-3 (5.5 and 13 Hz) and between HC-6 and
H2C-5 (6 and 13 Hz) suggested a 2,6-cis relative configuration where both protons HC-
2 and HC-6 are in the axial orientation (Table 26). From the IH NMR of aldol 210sc the
vicinal coupling constants between protons HC-2 and H2C-3 (6.5 and 12.5 Hz) and
between HC-6 and H2C-5 (5.5 and 12.5 Hz) also suggest a 2,6-cis relative configuration
(Table 26).
From the IH NMR of aldol 210at the vicinal coupling constants between protons
HC-2 and H2C-3 (5.5 and 9.5 Hz) and between HC-6 and H2C-5 (5 and 5.5 Hz) suggest
a 2,6-trans relative configuration where the methyl substituent is predominantly in the
axial orientation (Table 26). From the IH NMR of aldol 210st the coupling constants
between protons HC-2 and H2C-3 (5.5 and 10 Hz) and between HC-6 and H2C-5 (5 and
5.5 Hz) also suggest a 2,6-trans relative configuration where the methyl substituent is
predominantly in the axial orientation (Table 26). Therefore the 2,6-cis/trans relative
configuration of all four aldols 210 can be assigned from IH)H coupling constant
analysis.
Further support for the assignment of the 2,6-cis/trans relative configuration can
be found from a comparison of the IH and B C NMR shifts of the methyl substituent.
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Table 26. NMR data used to assign relative configuration of aldols 210 and 211
0 OH 0 OH
:67 ~1 l' Ph 4 l' Ph5 3 6 S 2
4 210 1 211
Entry Physical property 210anti,trans 210anti,cis 210syn,trans 210syn,cis
1 Jl'-2 9.5 8.5 3 2.5
2 IH)H J 2-3 9.5 13 10 12.5
3 coupling J 2-3 5.5 5.5 5.5 6.5constant
4 (Hz) J 5-6 5.5 13 5.5 12.5
5 J 5-6 5 6 5 5.5
6 IH shift HC-l' 4.86 4.80 5.32 5.38
7 (ppm) H3C 1.21 1.07 1.18 1.06
8 l3C shift C-l ' 75.01 74.93 71.62 70.97
9 (ppm) CH3 16.47 14.43 16.71 14.50
211anti,trans 211anti,cis 211syn,trans 211syn,cis
10 J 1'-3 9.5 8.5 4 3
11 IH)H J 2-3 6.5 12.5 9.5 12
12 coupling J 2-3 4 4.5 4 3.5
constant
13 (Hz) J 5-6 9 13 7 12
14 J 5-6 4.5 4.5 4.5 5
15 IH shift HC-l' 5.30 4.86 5.43 5.38
16 (ppm) H3C 1.27 1.15 1.26 1.14
17 l3C shift C-l ' 74.29 74.08 71.86 71.16
18 (ppm) CH3 15.55 14.70 15.97 14.72
Assuming that the cyclohexanone rings of aldols 210ac and 210sc are in a chair
conformation, their IH_IH vicinal coupling constants indicate that both aldols 210ac and
210sc have their methyl substituents in the equatorial orientation. Therefore it can be
predicted that these methyl groups have similar chemical environments. This similarity
in chemical environment is evident in the similar 1H (Table 26, entry 7) and l3C NMR
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shifts (Table 26, entry 9) of aldols 12ac and 12sc. A similar argument can be made for
aldols 210at and 210st where the methyl substituents are predominantly in the axial
orientation and are expected to have similar chemical environments. This expectation is
confirmed by the similar IH and 13C NMR shifts for the methyl groups in aldols of
aldols 210at and 210st (Table 26, entries 7 and 9).
The assignment of the relative configurations of the aldols 211 was based on an
analysis similar to that used to assign the relative configurations of the structurally
related aldols 210. The vicinal coupling constants between HC-l' and HC-3 were used
to assign the syn/anti relative configurations according to the House-Stiles rule (Table
26, entry 10). These assignmnents were corroborated by the 13C NMR shifts observed
for C-l'. The vicinal coupling constants between H2C-2 and HC-3 and between HC-5
and H2C-6 for each aldol were used to assign the 3,5-cis/trans relative configurations
(Table 26, entries 11-14). The assignment of the 3,5-cis/trans relative configuration was
further supported by the trends observed in the IH and l3C NMR shifts of the methyl
substituents. The shifts for the methyl groups in the cis aldols 211ac and 211sc were
similar, and the shifts for the methyl groups in the trans aldols 211at and 211st were
similar (Table 26, see entries 16 and 18).
2.5.4. Determination of the Relative Configurations of MOM-Protected
Derivatives of Aldols 165a, 165b and 165d
The assignment of the relative configurations of the mono-MOM (213a-d) and
bis-MOM (212a-c) derivatives of aldols 165a, 165b and 165d mentioned in Table 27 is
based on the assumption that the relative configurations of the aldols 165a, 165b and
165d was conserved during the derivatization reaction (Table 27, entries 1-4). Support
for this assumption follows from the isolation of recovered 165b from the derivatization
reaction in reasonable yield (20%) without detection of the isomerized aldols 165a and
165d (Table 27, entry 1). Similarly, derivatization of aldol 165d gave 45% of recovered
165d without detection of isomerized aldols 165b and 165a.
Although the relative configurations of aldols 213b and 213c is clear due to the
relationship of these aldols to the precursor 165a, the position of the MOM substituent
in 213b and 213c is ambiguous (i.e. whether the MOM group is on the syn,syn half or
on the anti,syn half of the aldol adduct). To resolve this issue, the 13C NMR shifts of the
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CHOR carbon of aldols 213b and 213c were compared to similar CHOR carbons in
165a, 165c and 165e (Figure 101): Thus the CHOR NMR shift for 213b of 67.08 ppm
compares favourably with the CHOR NMR shifts of 165c and the syn,syn half of 165a
suggesting a syn,syn configuration about the CHOR position in 213b (Figure 101).
Similarly, comparing the similar CHOR NMR shifts for 213c, 165c and the anti,syn
half of 165a suggest an anti,syn relative configuration about the CHOR position in 213c
(Figure 101).
Table 27. The synthesis of mono- and bis-MOM derivatives of aldols 165a, 165b and
165d.
MOMCI 10 or 20 eq
i-Pr2EtN 15 or 30 eq
substrate • products
BU4N1 1 or 2 eq
CH2CI2, rt, 6-20 hrs
165b R1 = R2 = H
212a R1 =R2 =MOM
213a R1 = MOM, R2 = H
165d R1 = R2 = H
212c R1 =R2 =MOM
213d R1 =MOM, R2 =H
165a R1 =R2 =H
212b R1 = R2 = MOM
213b R1 = H, R2 = MOM
213c R1 = MOM, R2 = H
entry substrate products
1 165b 212aa
2 165d 212c (83%)
3 165d 213d (47%)
4 165a 212b (44%)
a Combined isolated yield of212a and 213a is 80%.
recovered
substrate
165b (20%)
165d (45%)
213b (14%) 213c (35%)
* The carbons belonging to the two halves of the aldols 165a, 213b and 213c were assigned with the aid
of COSY, HMQC and HMBC experiments.
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66.20ppm
165c (C2 syn)
68.70ppm
165e (C2 anti)
syn,syn
half
~
67.08ppm
213b
syn,syn anti,syn
half half
~~
O~ OH 0 HO 01\0
67.42ppm 68.26ppm
165a anti,synhalf
I • ,
o HO 00
68.64ppm
213c
Figure 101. Determination of the position of the MOM-substituent in aldols 213b
and 213c by comparison of the CHOH NMR shifts in aldols 165a, 165c and
165e with shifts in 213b and 213c.
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3. EXPERIMENTAL
3.1. GENERAL METHODS
All solvents were distilled prior to use. Anhydrous solvents were distilled under
argon atmosphere as follows: Tetrahydrofuran (THF) from benzophenone potassium
ketyl; ether from benzophenone sodium ketyl; CH2Cb and toluene from CaH2; MeOH
from Mg(OMe)2; Et3N and TiCl4 were distilled from CaH2. All experiments involving
air- and/or moisture-sensitive compounds were conducted in oven dried round-bottom
flasks capped with rubber septa, and attached via a needle and connecting tubing to an
argon manifold equipped with mercury bubbler (ca. 5 mm positive pressure of argon).
Low temperature baths were ice/water (0 °C) and C02(s)/acetone (-78°C). Reaction
temperatures refer to that of the bath.
Preparative thin layer chromatography (PTLC) was carried out on glass plates
(20x20 cm) precoated (0.25 mm) with silica gel 60 F254. Materials were detected by
visualization under an ultraviolet lamp (254 nm) and/or by cutting a 1 cm vertical strip
from the plate and wetting this strip with a solution of phosphomolybdic acid (5%)
containing a trace of ceric sulfate in aqueous sulfuric acid (5% v/v), followed by
charring on a hot plate.
Concentration refers to removal of volatiles at water aspirator pressure on a
rotary evaporator followed by evacuation at 0.5-1 torr obtained with a vacuum pump.
Unless otherwise noted, all reported compounds were homogeneous by thin layer
chromatography (TLC) and by NMR.
Flash column chromatography (FCC) was performed according to Still et a1.200
with Merck Silica Gel 60 (40-63 J..lm). Medium pressure chromatography (MPC) was
performed as reported by Taber.2°1 Dry flash column chromatography was performed
according to Harwood.202 All mixed solvent eluents are reported as v/v solutions.
3.2. SPECTRAL DATA
High resolution mass spectra (HRMS) and low resolution mass spectra (LRMS)
were obtained on a VG 70E double focussing high resolution spectrometer; only partial
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data are reported. Electron impact (EI) ionization was .accomplished at 70 eV and
chemical ionization (CI) at 50 eV with ammonia as the reagent gas; only partial data are
reported. Infrared (IR) spectra were recorded on a Fourier transform interferometer
using a diffuse reflectance cell (DRIFT); only diagnostic and/or intense peaks are
reported. Unless otherwise noted, NMR spectra were measured in CDCl3 solution at
300,400, or 500 MHz for IH NMR and 75,100, or 125 MHz for l3C NMR signals due
to the solvent (l3C NMR) or residual protonated solvent (IH NMR) served as the
internal standard: CDCl3 (7.27 bH, 77.23 be); CD30D (3.31 bH, 49.15 bC); C6D6 (7.16
bH, 128.39 bC). The IH NMR chemical shifts and coupling constants were determined
assuming first-order behavior. Multiplicity is indicated by one or more of the following:
s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad), ap (apparent);
the list of coupling constants (J) corresponds to the order of the multiplicity assignment.
Couplings constants (J) are reported to the nearest 0.5 Hz. The IH NMR assignments
were made on the basis of chemical shift and. multiplicity and were confirmed, where
necessary, by 1D homonuclear decoupling, 2D lH/lH homonuclear shift correlation
(COSy)203 and/or 1D NOE experiments. The l3C NMR assignments were made on the
basis of chemical shift and multiplicity* as determined by J-modulation204 and were
confirmed, where necessary, by 2D lH/13C one bond correlation (HsQcio5 and 2D
lH/Be multiple bond correlation (HMBC)206 experiments.
3.3. GENERAL EXPERIMENTAL PROCEDURES
3.3.1. General Procedure A for Reduction of Esters
A solution of ester (1 equiv) in anhydrous ether or THF (l mLI mmol) was
added dropwise via SYringe to a stirred suspension of LiAIH4 (1.1 equiv) in ether (2-3.5
mLI mmol of LiAIH4) at °°c under argon. After 1 h, the reaction was quenched207 by
sequential dropwise addition of water (l mLI g of LiAIH4), 15% (w/v) sodium
hydroxide (l mLI g of LiAIH4), and water (3 mLI g of LiAIH4). The resultant gray
suspension was stirred until granular white flakes formed (ca. 1-1.5 h). The suspension
* Multiplicity of l3C NMR signals refers to the number of attached H's (ie. s = C, d = CH, t = CH2, q =
CH3)
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was filtered through Celite® washing with 1:1 ether/hexane. The combined filtrate and
washings were washed with brine, dried over Na2S04, and concentrated to give the
desired alcohol.
3.3.2. General Procedure B for Preparation of'Amine Free' Lithium
Enolate 137c.
Methyllithium (1-1.5 M in diethyl ether, 1 equiv) was added dropwise via a
sYringe to a stirred solution of the trimethylsilyl enol ether of the tetrahydro-4H-
thiopyran-4-one in ether (2 mLl romol of enol ether) at 0 °c under argon?08 The
reaction mixture was warmed to rt (note: the Li enolate precipitates from the solution)
and after 1 h, THF (2 mLI mmol of enol ether) was added via sYringe. After stirring for
5 min (note: enolate dissolves), the reaction mixture was cooled to -78°C.
3.3.3. General Procedure C for DIBAL-H Reduction of Aldols
DIBAL-H (1.5 M in toluene; 2 equiv) was added dropwise via a sYringe to a
stirred solution of the aldol in THF (10 mLI mmol of aldol) at -78°C under argon.
After 3 h, excess DIBAL was quenched by dropwise addition of MeOH (caution: H2
evolution). The mixture was diluted with saturated aqueous sodium potassium tartrate
and extracted with ethyl acetate (x3). The combined organic layers were washed with
brine, dried over Na2S04, and concentrated to give the crude diol(s).
3.3.4. General Procedure D for NaBH4 Reduction of Aldols
NaBH4 (2-3 equiv) was added to a stirred solution of the aldol in EtOH (10 mLI
mmol of aldol) at rt. After 1 h, the reaction was quenched by dropwise addition of 1 M
HCI until effervescence ceased (caution: H2 evolution). The reaction mixture was made
basic by addition of 15% NaOH (base added to hydrolyze cyclic borates that were
persistent for some examples) and, after 30 min, the mixture was diluted with brine and
extracted with ethyl acetate (x3). The combined organic layers were dried over Na2S04
and concentrated to give the crude mixture of cis and trans diols.
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3.3.5. General Procedure E for NaCNBH3Reduction of Aldols
NaCNBH3 (2 equiv) was added portion-wise (effervescence was observed) to a
stirred suspension of aldol and citric acid (2 equiv) in EtOH (5 mL/O.l mmol of aldol)
at 0 °C. The reaction mixture was allowed to warm to rt and, after 3 h, saturated
aqueous sodium potassium tartrate was added. After 40 min, the mixture was diluted
with water and extracted with CH2Ch (x3) and the combined organic layers were dried
over Na2S04 and concentrated to give the crude mixture of cis and trans diols.
3.3.6. General Procedure F for NaBH(OAc)3 Reduction ofAldoIs
A 0.33 M solution of NaBH(OAc)3 in acetic acid was prepared by portion-wise
addition of NaBH4 (25 mg, 0.66 mmol) to cold glacial acetic acid (2 mL) (caution: H2
evolution) followed by stirring for 5 min. NaBH(OAc)3 (0.33 M in acetic acid; 4 equiv)
was added dropwise via syringe over 30 seconds to a stirred solution of the aldol in dry
CH3CN (1 mL/O.l mmol of aldol) at 0 °C. After 90 min, the reaction mixture was added
to a vigorously stirred saturated aqueous sodium potassium tartrate solution. The
mixture was neutralized by addition of cold saturated aqueous NaHC03 and then was
diluted with water and extracted with CH2Ch (x3). The combined organic layer were
dried over Na2S04 and concentrated to give the crude diol(s).
3.3.7. General Procedure G for Preparation of Carbonates
A solution of diol and 1,1'-carbonyldiimidazole (3-6 equiv) in benzene (6 mLI
mmol of diol) was heated under reflux under argon. The reaction was monitored by
TLC (80% ethyl acetate in hexane) and, when the diol was consumed (ca. 4-20 h), the
mixture was diluted with water and extracted with CH2Ch (x3). The combined organic
layers were dried over Na2S04 and cQncentrated to give the crude carbonate.
3.3.8. General Procedure H for Preparation of Carbonates
For some 1,3-anti diols (from syn aldols) the formation of the cyclic carbonate
was slow and competitive with production of the biscarbamate derivative. Thus, when
the diol was consumed in reaction with 1,1'-carbonyldiimidazole as above (ca. 2-8 h),
the mixture was diluted with ethyl acetate and washed with water (x2). The organic
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phase was dried over Na2S04, concentrated, and dried under high vacuum (0.5 Torr)
overnight. The residue was taken up in toluene (6 mLI mmol of diol) and the solution
heated under reflux. When carbonate formation was complete (TLC, 80% ethyl acetate
in hexane) (20-48 h), the mixture was diluted with water and extracted with CH2Ch
(x3). The combined organic layers were dried Na2S04 and concentrated to give the
crude carbonate.
3.3.9. General Procedure I for Preparation of MOM Ethers
MOMCI (l0-20 equiv based on dial) was added dropwise to a stirred solution of
diol and i-Pr2EtN (2 equiv based on MOMCI) in CH2Ch (20 mLI mmol of diol) at rt.
After ca. 2.5 h (diol not detected by TLC: 50% ethyl acetate in hexane), the mixture was
diluted by HCI (20 mL, 1M), extracted with CH2Ch (x3) and the combined organic
layers were, dried over Na2S04, concentrated to give the crude MOM ether(s).
3.3.10. General Procedure J for Hydrolysis of MOM Ethers
A 2:1 (v/v) mixture of a solution of MOM ether dial in THF (0.05 M) and
aqueous HCI (6 M) was stirred at rt for 10-15 h. The reaction was cooled in an ice bath
and quenched by portion-wise addition of solid NaHC03 (caution:C02 evolution). The
mixture was diluted with water and extracted with CH2Ch (x3) and the combined
organic layers were dried over Na2S04 and concentrated to give the crude triol.
3.3.11. General Procedure K for Hydrolysis of MOM Ethers
TiCl4 (5 equiv) was added dropwise over 10 seconds to a stirred solution of
substrate in CH2Ch (50 mLI mmol) at -78 cC under argon. After 5 minutes a fine
yellow slurry developed. Thiophenol (10 equiv) was added dropwise over 10 seconds
and the resultant red-orange fine slurry was stirred for a further 10 minutes at -78 cC.
MeOH (0.5 mL) was added and the cooling bath was removed (reaction became
colourless upon addition of MeOH). The solution was stirred vigorously for 1 minute
followed by the addition of phosphate buffer (3 mL, pH 7). After 3 minutes, the mixture
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·was diluted with saturated Na2C03* and extracted with CH2Ch (3x). The combined
organic extracts were dried over Na2S04 and concentrated to give the crude product that
contained varying amounts of starting material.
3.3.12. General Procedure L for Preparation of MOM Ethers
BU4NI (0.03 equiv), i-Pr2EtN (5 equiv) and MOMCI (3 equiv) were sequentially
added to a solution of monoaldol substrate in CH2Ch (3 mLI mmol). The reaction was
monitored by TLC (50% ethyl acetate in hexane). Within the first day the reaction
colour was deep orange and complete conversion was usually obtained after 3 days. The
reaction was diluted with HCI and extracted with CH2Ch (x3). The organic extracts
were combined, dried over Na2S04 and concentrated to give crude product as a light
yellow oil.
3.3.13. General Procedure M for Preparation of MOM Ethers
BU4NI (1 equiv), i-Pr2EtN (15 equiv) and MOMCI (10 equiv) were sequentially
added to a solution of bisaldol in CH2Ch (50 mLI mmol) under argon. After a suitable
time (TLC monitoring) the reaction was diluted with citric acid (15 mL, O.IM) and
extracted with CH2Ch (3x20 mL).The organic extracts were combined, dried over
Na2S04 and concentrated to give crude product/s that contained varying amounts of
starting material.
3.4. EXPERIMENTAL PROCEDURES AND SPECTRAL DATA FOR
COMPOUNDS
Tetrahydro-thiopyran-4-one (122)
A solution of 124 (22.5 g, 0.13mol) in 50/0 H2S04 (60 mL) was heated under
reflux. The reaction was monitored by TLC (50% EtOAc in hexane). Starting material
* Saturated Na2C03 was used to extract PhSH into the aqueous phase.
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was consumed after 18 h. The reaction was diluted with cold dist water (0 °c, 40 mL)
and extracted with CH2Ch (3x). The combined organic extracts were washed with
saturated K2C03 (xl), dried over Na2S04 and concentrated to give a light yellow oil
which solidified upon standing (12.5 g). Hexane (300 mL) was added to the yellow
solid (12.5 g) and after heating the mixture to boiling, the cloudy hexane supernatant
was decanted from the insoluble yellow oil. This process was repeated (x 1). The
combined supernatants were cooled to 0 °c to yield white crystals (9.6 g, 64%).
Spectral data for the product was in accord with that previously reported.2°9
Methyl Tetrahydro-4-oxo-2H-thiopyran-3-carboxylate (124)
SyOMe
6 S 2 124
Anhydrous methanol (freshly distilled from Mg(OMe)2; 155.0 mL, 122.6g, 3.83
mol) was added dropwise by dropping funnel over 8 h to a stirred suspension of finely
cut sodium metal (40.0 g, 1.74 mol) in ether (l00 mL) and THF (200 mL) at 0 C under
argon (caution: H2 evolution). The mixture was stirred for 30 h at rt and a fine white
suspension was obtained. A solution of dimethyl 3,3'-thiodipropionate 123 (140 g,
0.679 mmol) in THF (50 mL) was then added dropwise over 4 h by dropping funnel to
the NaOMe suspension at O°C. The reaction mixture was stirred at rt for a further 20 h
and an orange coloured suspension was obtained. The reaction mixture was transferred
to a dropping funnel and added over 20 min to a solution of citric acid (l83g, 0.871
mol) in dist. water (800 mL) (pH = 5 after addition of suspension to citric acid solution)
at 0 °C. The organic layer was separated and washed with brine (x2) and the brine
extracts were combined and extracted with CH2Ch (x2). The separated aqueous layer of
the quenched mixture was extracted with CH2Ch (x4). The combined organic layers
were dried over Na2S04 and concentrated to give a clear oil which later solidified to a
white solid (116 g, 98%). Spectral data for the product was in accord with that
previously reported.210
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Methyl 1,4-Dioxa-8-thiaspiro[4.5]decane-6-carboxylate (124a).211
2 3
o~o
10 CJAOMe
9 S 7 124a
A solution of ~-ketoester124 (30 g, 0.17 mol), ethylene glycol (43 g, 0.69 mol)
andp-TsOH·H20 (1.7 g, 8.9 mmol) in benzene (800 mL) was heated under reflux for 16
h with removal of water via a Dean-Stark trap. The cooled (rt) reaction mixture was
concentrated under reduced pressure, diluted with ether, washed sequentially with
saturated aqueous NaHC03 (x2), water and brine, dried over Na2S04, and concentrated
to give the titled compound as a colorless oil (32-37 g, 85-98%) which was
homogeneous by TLC and NMR and was used without further purification:
IR Vmax 1733 cm- I ;
IH NMR (300 MHz, CDCb) 8 4.00-3.86 (4H, m), 3.71 (3H, s), 3.11 (lH, ap dd, J =
8.5, 13.5 Hz), 2.96-2.78 (3H, m), 2.67 (lH, dddd, J = 1.5, 3.5, 7, 13.5 Hz), 2.25 (lH,
ddd, J= 3.5, 7, 13.5 Hz), 1.82 (lH, ddd, J= 3.5, 9.5, 13.5 Hz);
13C NMR (75 MHz, CDCb) 8 171.0 (s), 107.2 (s), 65.1 (t), 64.7 (t), 51.8 (d), 51.2 (q),
36.0 (t), 29.6 (t), 26.7 (t);
HRMS m/z ca1cd for C9H140 4S 218.0613, found 218.0604 (El).
Anal. Calcd for C9H1404S: C, 49.53; H, 6.46. Found: C, 49.58; H, 6.39.
1,4-Dioxa-8-thiaspiro[4.5]decane-6-methanol (124b). 212
2 3
1\
o 0
10 aCH20H
9 S 7 124b
Following General procedure A, a solution of 124a (22.5 g, 103 mmol) in ether
was reduced with LiAIH4 in ether (200 mL) to give the titled compound as a pale
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yellow viscous oil (17.0-18.5 g, 86-94%) which was homogeneous by TLC and NMR
and was used without further purification.
IR Vrnax 3442 cm- I ;
IH NMR (300 MHz, CDC!)) () 4.03-3.97 (4H, m), 3.91 (lH, dd, J = 6.5, 11 Hz), 3.66
(lH, dd, J = 4.5, 11 Hz), 2.80-2.71 (3H, m), 2.65 (lH, ddd, J = 4, 7, 13.5 Hz), 2.25 (lH,
br s), 2.19-2.13 (lH, m), 2.07 (lH, ddd, J= 3.5, 7,13.5 Hz), 1.77 (lH, ddd, J= 4,9.5,
13.5 Hz);
13C NMR (75 MHz, CDC!)) () 109.5 (s), 64.7 (t), 64.4 (t), 62.3 (t), 47.0 (d), 35.1 (t),
29.3 (t), 26.6 (t);
HRMS m/z calcd for CgH140 3S 190.0664, found 190.0672 (El).
1,4-Dioxa-8-thiaspiro[4.5]decane-6-carboxaldehyde (125a).
2 3
/\
o 0
10 aCHO
9 S 7 125a
Swern oxidation: A solution ofDMSO (3.6 mL, 4.0 g, 51 mmol) in CH2Ch (2.0
mL) was added dropwise over 5 minutes via SYringe to a stirred solution of oxalyl
chloride (2.2 mL, 26 mmol) in CH2Ch (25 mL) at -78°C under argon. After 30 min at
-78 °C, a solution of alcohol 124b (3.27 g, 17.1 mmol) in CH2Ch (2 mL) was added
dropwise via SYringe over 3 minutes to the reaction mixture. After a further 30 min, i-
Pr2EtN (15 mL, 86 mmol) was added over 1 minute and the reaction mixture was
allowed to warm to 0 °C over 5 min. The reaction mixture was diluted with ice-cold
HCI (0 °C, 100 mL, 1 M) and the resultant mixture was quickly extracted with CH2Ch
(x3). The combined organic layers were dried over Na2S04, concentrated and
fractionated by DFC (5-10% ethyl acetate in hexane; gradient elution) to give the titled
aldehyde as a clear oil (2.09-2.60 g, 65-80%)
IR Vrnax 2840, 2737, 1721 cm- I ;
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IH NMR (300 MHz, CDCb) () 9.85 (IH, s), 4.07-3.94 (4H, m), 2.96 (IH, dd, J = 9.5,
13.5 Hz), 2.86 (IH, br d, J = 13.5 Hz), 2.81-2.72 (2H, m), 2.64 (IH, m), 2.08 (IH, ddd,
J= 3,6,13.5 Hz), 1.89 (IH, dd, J= 3.5,10,13.5 Hz);
13C NMR (75 MHz, CDCb) () 201.3 (d), 107.8 (s), 64.9 (t), 64.7 (t), 56.6 (d), 36.2 (t),
26.7 (t), 26.4 (t);
HRMS m/z calcd for CgH1 03S 188.0507, found 188.0512 (EI). Anal. Calcd for
CgH1203S: C, 51.04; H, 6.43. ound: C, 51.20; H, 6.58.
(3S*, 4R*)-Tetrahydro-4-(m thoxymethoxy)-2H-thiopyran-3-carboxaldehyde
(125b).
OMOMsaCHO
6 S 2 125b
Modified Swem oxid ion: A solution of DMSO (520J-lL, 570 mg, 7.30 mmol)
in CH2Ch (1.0 mL) was adde dropwise over 3 minutes via syringe to a stirred solution
of oxalyl chloride (318J.lL, 3. 5 mmol) in CH2Ch (8 mL) at -78°C under argon. After
30 min at -78 °C, a solution f alcohol 142 (701 mg, 3.65 mmol) and dimethyl sulfide
(536 J-lL, 7.29 mmol ) in CH2 h (1 mL) was added dropwise via SYringe over 3 minutes
to the reaction mixture. After an additional 3 min, i-Pr2EtN (1.91 mL, 10.9 mmol) was
added over 10 seconds and t e reaction mixture was allowed to warm to rt over 20
minutes with vigorous stirring The reaction mixture was diluted with 1 M HCl (60 mL)
and quickly followed by ext action with CH2Ch (3x). The combined organic layers
were dried over Na2S04, con entrated and fractionated by FCC (30% ethyl acetate in
hexane) to give the titled aIde yde as a clear oil (617 mg, 890/0).
IR Vmax 2823, 2722, 1726 cm 1;
IH NMR (300 MHz, CDCb) 9.63 (IH, s), 4.69 (IH, d, J = 7 Hz), 4.57 (IH, d, J = 7
Hz), 4.40 (IH, ddd, J = 2.5, 2. ,5 Hz), 3.31 (3H, s), 3.04 (IH, ap dd, J = 12.5, 12.5 Hz),
2.93 (lH, ap dd, J= 12, 12.5 z), 2.70-2.60 (2H, m), 2.41-2.26 (2H, m), 1.90-1.78 (IH,
m);
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13C NMR (75 MHz, CDCb) 202.1, 95.3, 70.6, 53.9, 46.9, 31.3, 23.2, 22.9;
HRMS m/Z calcd for CgH140 S 190.0664, found 190.0666 (EI).
(3S*, 4S*)-Tetrahydro-4-(m thoxymethoxy)-2H-thiopyran-3-carboxaldehyde
(125c).
OMOMS@CHO
6 S 2 125c
From Modified Swe oxidation of 143: Using the above procedure, 143 (761
mg) was converted into the tr s aldehyde 125c (170 mg, 23%).
From DIBAH reducti n of 141:150 Cold DIBAL-H (0.5 M in toluene; 26.2 mL,
13 mmol) was added dropwi e via syringe pump over 3 h to a stirred solution of the
ester 141 (1.581 g, 7.18 mmo ) in toluene (10 mL) at -78°C under argon. This addition
was achieved by having the 0 tput from the sYringe pump run down the side of a cold
finger condenser (dry-ice/ace one) mounted above the reaction mixture. After 3 h, the
reaction was quenched by the addition of cold MeOH (9 mL) via SYringe pump over 2 h
as above. The reaction mix e was allowed to warm to rt over several hours and then
ice cold 1 M HCI (50 mL) as added. After 10 min of vigorous stirring, the mixture
was diluted with brine and e tracted with CH2Ch (x3). The combined organic layers
were dried over Na2S04, con entrated and fractionated by MPC (30% ethyl acetate in
hexane) to give the alcohol 14 (193 mg, 14%) and the aldehyde 125c (939 mg, 69%):
IR Vmax 2824,2725, 1721 cm 1;
IH NMR (300 MHz, CDCb) 8 9.80 (lH, d, J = 1.5 Hz), 4.73 (lH, d, J = 7 Hz), 4.62
(lH, d, J = 7 Hz), 3.94 (1H, d d, J = 3.5, 8, 8 Hz), 3.35 (3H, s), 2.97 (lH, br d, J = 12.5
Hz), 2.86-2.66 (3H, m), 2.52 (1H, ddd, J = 3, 9, 13.5 Hz), 2.23 (lH, dddd, J = 3, 3.5,
7.5, 13 Hz), 1.85 (lH, dddd, J= 3,8,9, 13.5 Hz);
13C NMR (300 MHz, CDCb 8202.6 (d), 95.4 (t), 73.5 (d), 55.9 (q), 54.1 (d), 31.7 (t),
26.1 (t), 25.7 (t);
HRMS m/z calcd for CgH140 3 190.0664, found 190.0664 (EI).
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(1 'S*, 3S*, 6"R*)-3-[(1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl)hydroxymethyl]tetrahydro-4H-thiopyran-4-one (126a).
2" 3"
10" 5
6 126a
From aldol reaction of 137b and 125a (TiCI4). Freshly distilled TiCl4 (0.30 mL,
0.51 g, 2.7 mmol) was added dropwise over 1 min to a stirred solution of the aldehyde
125a (500 mg, 2.66 mmol) in CH2Cb (35 mL) at -78°C under argon. The resulting fine
yellow suspension was stirred for 10 min and then a solution of 137b (736 mg, 3.91
mmol) in CH2Cb (7.5 mL) was added dropwise via sYringe over 2 min whereupon the
yellow suspension turned to a clear dark orange and then red solution. After 1 h at
-78°C, the reaction was allowed to warm to rt over 30 min and then was quenched by
sequential addition of a solution of Et3N (80 mg, 0.79 mmol) and MeOH (100 mg, 3.1
mmol) in CH2Cb (1 mL) and then sat. NH4CI (5 mL). The mixture was diluted with
water, extracted with CH2Cb (x3) and the combined organic layers were dried over
Na2S04, concentrated, and fractionated by FCC (gradient elution 20-50% ethyl acetate
in hexane) to give the aldol 127a (18 mg, 5%) as a white solid and the aldol 126a (663
mg, 82%) as a white solid.
From aldol reaction of 137b and 125a (BF3·0Et2). Using the same procedure as
above but replacing TiCl4 with BF3·OEh, 125a (73 mg, 0.039 mmol) gave a 2: 1 mixture
of 126a and 127a (70%), respectively.
From aldol reaction of 137d with 125a. TiCl4 (0.030 mL, 52 mg, 0.28 mmol)
was added to a stirred solution of 3 (29 mg, 0.25 mmol) in CH2Cb (4 mL) at -78°C
under argon. After 5 min, i-Pr2EtN (0.052 mL, 39 mg, 0.30 mmol) was added and after
2 h at -78°C, a solution of 125a (56 mg, 0.30 mmol) in CH2Cb (0.5 mL) was added.
After 5 h, the reaction was quenched addition of aqueous N~Cl. The mixture was
diluted with water and extracted with CH2Cb (x3), and the combined organic layers
were dried over Na2S04, concentrated, and fractionated by FCC (20-50% ethyl acetate
in hexane; gradient elution) to give 126a (20 mg, 26%) and a 1: 1 mixture of Cs and Cl
bisaldols (26 mg, 20%).30
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IR Yrnax, 3507, 1703 cm- I ;
IH NMR (300 MHz, CDCh) 8 4.79 (lH, dd, J = 3, 8.5 Hz, HC-l' eJHC-I'IHC-3 = 8.5
Hz]), 4.10-3.96 (4H, m), 3.19-2.88 (7H, m), 2.81-2.67 (4H, m), 2.58-2.54 (IH, m), 2.11
(IH, ddd, J = 3, 5.5, 14 Hz), 1.93 (lH, ddd, J = 3, 3, 10.5 Hz), 1.73 (IH, ddd, J = 3.5,
11.5, 14 Hz);
13C NMR (75 MHz, CDCh) 8 210.1 (s), 109.8 (s), 66.1 (d), 64.6 (t), 64.2 (t), 56.0 (d),
46.2 (d), 44.2 (t), 35.6 (t), 32.6 (t), 31.2 (t), 26.4 (t), 26.3 (t);
HRMS m/z calcd for C13H2004S2 304.0803, found 304.0799. Anal. Calcd for
C13H2004S2: C, 51.29; H, 6.62. Found: C, 51.43; H, 6.44.
(1 'R*, 3S*, 3"R*, 4"R*)-3-[Hydroxy(4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl)methyl]tetrahydrothiopyran-4-one (126b).
MOMO OH 0
5" 5
6 126b
From aldol reaction of 137c and 125b (Li-enolate). Following the corresponding
procedure described for the synthesis of 127a, reaction of 125b (580 mg, 3.05 mmol)
with the 'amine-free' Li enolate 137c (following General procedure B, 137b (1.15 g,
6.11 mmol) gave 137c) gave a yellow oil (1.413 g) which contained a 4.1 :1.7:1 mixture
of aldols 127b, 129b, and 126b, respectively ctH NMR). Fractionation of the crude
product by MPC (25% ethyl acetate in hexane) gave 126b (88 mg, 9%), the 127b (220
mg, 24%), and a 1.1:1 mixture of the 129b and 127b aldols (258 mg, 28%).
IR Ymax 3496, 1701 cm- I ;
IH NMR (500 MHz, CDCh) 84.74 (lH, d, J= 7 Hz), 4.60 (IH, d, J= 7 Hz), 4.23 (IH,
br t, J= 5.5,5.5 Hz, HC-l' eJHC-I'IHC-3 = 5.5 Hz]), 3.96 (lH, ddd, J= 2, 2.5,5 Hz), 3.36
(3H, s), 3.07-2.85 (8H, m), 2.75-2.71 (2H, m), 2.57 (IH, br dd, J = 3, 13 Hz), 2.34-2.28
(2H, m), 1.90 (lH, dddd, J = 2.5, 3, 5.5, 11.5 Hz), 1.77 (IH, m);
13C NMR (125 MHz, CDCb) 8 211.37, 94.86, 73.92, 71.17, 56.36, 54.77,45.27,43.74,
31.57, 31.29, 31.23, 23.86, 22.49;
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HRMS m/z calcd for C13H2204S2 306.0960, found 306.0956 (EI).
(1 'R*, 3S*, 3"R*, 4"S*)-3-[Hydroxy(4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl)methyl]tetrahydrothiopyran-4-one (126c).
MOMO OH 0
5" 5
6 126c
Aldol reaction of 137b and 125c (TiCI4). Following the procedure described for
the synthesis of 126a using TiCl4 (0.018 mL, 31 mg, 0.16 mmol), the aldehyde 125c (30
mg, 0.16 mmol), and 137b (60 mg, 0.32 mmol) in CH2Ch (5 mL) gave, after work up, a
light orange oil (78 mg) which contained a 10:1 mixture of aldols 126c and 129c,
respectively, and ca. 8% of remaining 125c (lH NMR). The crude was fractionated by
MPC (35% ethyl acetate in hexane) to give a 20:2:1 mixture of aldols 126c, 129c, and
128c, respectively (40 mg, 81 %). A pure sample of 126c was obtained by fractionation
ofa portion of the above mixture by PTLC (50% ethyl acetate in hexane).
IR Vmax 3472, 1702 cm- I ;
IH NMR (400 MHz, CDCb) 8 4.84 (IH, ddd, J= 4, 5,8.5 Hz, HC-l' eJHC-l'/HC-3 = 8.5
Hz]), 4.73 (lH, d, J = 6.5 Hz), 4.63 (lH, d, J = 6.5 Hz), 3.47 (lH, ddd, J = 3.5, 9, 9,
Hz), 3.47 (3H, s), 3.17 (IH, d, J = 5 Hz, OH), 3.12 (2H, ap d, J = 5 Hz), 2.99-2.94 (2H,
m), 2.86 (IH, ap ddd, J= 5,5,8.5 Hz), 2.79 (lH, ddd, J= 2,3,13.5 Hz), 2.72-2.65 (3H,
m), 2.64 (lH, dd, J = 9.5, 13.5 Hz), 2.57 (lH, ddd, J = 3, 11, 13.5 Hz), 2.20 (IH, dddd,
J= 3, 3.5, 6, 13 Hz), 1.79 (IH, dddd, J= 3.5,9,11,13 Hz), 1.72 (IH, dddd, J= 3, 4, 9,
9.5 Hz);
13C NMR (100 MHz, CDCb) 8 210.29, 96.33, 76.79, 66.30, 56.55, 55.26,45.61,44.19,
33.32, 33.11, 31.50, 26.85, 26.24;
HRMS m/z calcd for C13H2204S2 306.0960, found 306.0962 (EI).
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(1 'S*, 3R*, 6"R*)-3-[(1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl)hydroxymethyl]tetrahydro-4H-thiopyran-4-one (127a).
10" 5
6 127a
From aldol reaction of 137b and 125a (SnCI4). A solution of SnCl4 (270 f.!L,
0.266 mmol, 1.0 M) in CH2Ch was added dropwise to a stirred solution of aldehyde
125a (25 mg, 0.133 mmol) in CH2Ch. The resulting fine white suspension was stirred
for 10 min at 0 °C and then a solution of 137b (50 mg, 0.266 mmol) in CH2Ch (0.5 mL)
was added dropwise via syringe over 10 seconds whereupon the white suspension
turned to a light orange coloured suspension (Note that the colour of a pure solution
enolsilane in CH2Ch is light orange). After stirring for 2 h at 0 °C the reaction was
quenched by the addition of phosphate buffer (10 mL, pH 7, 0.1 M) which gave a fine
white ppt. The mixture was passed through Celite® followed by washing with
phosphate buffer (20 mL), the filtrate was then extracted with CH2Ch (x3). The organic
extracts were combined, dried over Na2S04, concentrated, and fractionated by FCC
(50% ethyl acetate in hexane) to give a 3:1 mixture of 127a and 126a (29 mg, 72%),
respectively.
From aldol reaction of 137c and 125a (Li-enolate). A solution of 125a (2.32 g,
12.3 mmol) in THF (5 mL) was added rapidly via syringe to a solution of the 'amine
free' lithium enolate 137c (following General procedure B, 137b (3.48 g, 18.5 mmol)
gave 137c) at -78°C. After stirring for 5 min, the reaction was quenched by rapid
addition of a solution of glacial acetic acid (1.5 mL) in THF (5 mL). The reaction
mixture was removed from the cooling bath and CH2Ch (l00 mL) and water (50 mL)
were added. The aqueous layer was extracted with CH2Ch (x2) and the combined
organic layers were washed sequentially with aqueous NaHC03 and water, dried over
Na2S04, and concentrated to give a pale yellow semi-solid. Trituration of the crude
product with ether gave a yellowish powder that was recrystallized from benzene to
give the pure 127a (2.06 g, 55%; mp 148-149 °C). The ether from trituration and the
mother liquor from recrystallization were combined and concentrated and ketone 122
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(910 mg, 42%) was recovered by sublimation (rt, 0.5 Torr). The residue was
fractionated by FCC (10-50% EtOAc in hexane; gradient elution) to give recovered
aldehyde 125a (541 mg, 23%), the aldol 126a (270 mg, 7%), and aldol 127a (300 mg,
8%).
From aldol reaction of 137e (137f) with 125a. A solution of 122 (20 mg, 0.17
mmol) in CH2Ch (0.5 mL) was added toa stirred solution of BU2BOTf(1 Min CH2Ch;
0.26 mL) and i-Pr2EtN (0.090 mL, 67 mg, 0.52 mmol) in CH2Ch (5 mL) at -78°C
under argon. After 3 h, a solution of 125a (130 mg, 0.69 mmol) in CH2Ch (0.5 mL) was
added to the reaction mixture. After 3 h, the reaction was quenched by the sequential
addition of phosphate buffer (pH 7, 0.5 mL), methanol (3.5 mL), and 30% H20 2 (0.2
mL). The mixture was stirred at 0 °C for 15 min and then aqueous NaZS03 was added to
reduce the H20 Z• The mixture was diluted with water and extracted with CH2Ch (x3),
and the combined organic layers were dried over NaZS04, concentrated, and
fractionated by FCC (20-40% ethyl acetate in hexane; gradient elution) to give
recovered 125a (58 mg, 45%), 126a (4 mg, 8%), and 127a (39 mg, 74%). A similar
experiment using (c-C6Hll)2BCI in place of BU2BOTf gave a 15:1 mixture of 127a and
126a (44 mg, 84%), respectively.
IR Vmax 3488, 3409, 1711 cm-1;
IH NMR (300 MHz, CDCb) 84.50 (1H, dd, J= 4.5,6.5 lIz, HC-l'eJHC- 1'IHC-3 = 6.5
Hz]), 4.05-3.92 (4H, m), 3.08-2.58 (12H, m), 2.12 (IH, ddd, J = 4.5, 4.5, 9 Hz), 2.03
(IH, ddd, J= 3.5,6.5,13.5 Hz), 1.74 (1H, ddd, J= 4,9.5, 13.5 Hz);
13C NMR (75 MHz, CDCb) 8 211.5 (s), 109.3 (s), 69.3 (d), 64.4 (t), 64.3 (t), 55.5 (d),
47.0 (d), 44.4 (t), 35.5 (t), 34.3 (t), 31.4 (t), 27.4 (t), 26.5 (t);
HRMS m/z calcd for C13H2004SZ 304.0803, found 304.0801. Anal. Calcd for
C13HZ004S2: C, 51.29; H, 6.62. Found: C, 51.59; H, 6.55.
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(1 'R*, 3R*, 3"R*, 4"R*)-3-[Hydroxy(4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl)methyl]tetrahydrothiopyran-4-one (127b).
MOMO OH 0
5" 5
6 127b
From aldol reaction of 137b and 125b (TiCI4). The cis aldehyde 125b was
unstable in the presence of TiCl4 (elimination). Following the procedure described for
the synthesis ofl26a, 125b (73 mg, 0.38 mmol) gave the aldol 127b (11 mg, 9%), the
aldol 129b (15 mg, 12%), and recovered 125b (16 mg, 22%) after fractionation by MPC
(30% ethyl acetate in hexane).
IR Vmax 3508, 1700 cm- I ;
IH NMR (500 MHz, CDCb) 8 4.71 (IH, d, J= 7 Hz), 4.59 (IH, d, J= 7 Hz), 3.96 (IH,
ddd, J= 3, 6,7.5 Hz, HC-l' eJHC-IIIHC-3 = 6 Hz]), 3.89 (IH, ddd, J= 2.5,3,5 Hz), 3.41
(3H, s), 3.15-2.94 (7H, m), 2.90 (lH, br dd, J = 12, 13 Hz), 2.81-2.71· (2H, m), 2.64
(1H, br d, J= 13.5 Hz), 2.34 (1H, br ddd, J= 3.5, 4,13 Hz), 2.26 (lH, dddd, J= 2.5,4,
5,14.5 Hz), 2.14 (1H, dddd, J= 3,3.5,6,11 Hz), 1.77 (lH, dddd, J= 2.5,3.5,12,14.5
Hz);
13C NMR (125 MHz, CDCb) 8 211.84 (s), 94.89 (t), 74.97 (d), 74.37 (d), 56.39 (q),
54.06 (d), 45.12 (d), 45.05 (t), 35.20 (t), 31.69 (t), 31.15 (t), 24.98 (t), 23.09 (t);
HRMS m/z calcd for C13H2204S2 306.0960, found 306.0961 (EI).
(1 'R*, 3R*, 3"R*, 4"S*)-3-[Hydroxy(4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl)methyl]tetrahydrothiopyran-4-one (127c).
MOMO OH 0
5" 5
6 127c
Aldol reaction of 137c and 125c (Li-enolate). Following the procedure described for
the sYnthesis of 127a, reaction of the trans aldehyde 125c (525 mg, 2.76 mmol) with the
'amine-free' Li enolate 137c (following General procedure B, 137b (1.08 g, 5.73 mmol)
gave 137c) gave aldol 127c (542 mg, 64%) after fractionation by MPC (35% ethyl
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acetate in hexane). The presence of other aldol diastereomers was not detected by 1H
NMR of the crude product.
IR Vrnax 3516, 1701 cm- I ;
IH NMR (500 MHz, CDCb) 8 4.72 (1H, d, J= 6.5 Hz), 4.70 (1H, d, J= 6.5 Hz), 4.47
(1H, ddd, J= 2.5,4, 9.5 Hz, HC-1' eJHC- 1'/HC-3 = 9.5 Hz]), 3.61 (1H, ddd, J= 4, 10, 10.5
Hz), 3.43 (3H, s), 3.22 (1H, d, J = 4 Hz, OH), 3.03-2.93 (2H, m), 2.92-2.83 (2H, m),
2.82-2.65 (5H, m), 2.58 (1H, m, J= 2.5,3.5,4,13.5 Hz), 2.51 (lH, ddd, J= 2.5,3,13.5
Hz), 2.42 (1H, dddd, J = 3, 4, 4, 12.5 Hz), 1.77 (lH, dddd, J = 3, 3, 9.5, 10 Hz), 1.74
(1H, dddd, J = 3, 10.5, 12, 12.5 Hz);
13C NMR (125 MHz, CDCb) 8 212.35 (s, CO), 96.52 (t), 76.18 (d), 67.72 (d), 56.03
(q), 55.45 (d), 45.73 (d), 44.99 (t), 34.90 (t), 32.42 (t), 31.07 (t), 27.75 (t), 26.31 (t);
HRMS m/z calcd for C13H2204S2 306.0960, found 306.0954 (EI).
(1 'R*, 3R*, 6"R*)-3-[(1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl)hydroxymethyl]tetrahydro-4H-thiopyran-4-one (128a):
2" 3"
10" 5
6 128a
From aldol reaction of 137b and 125a (MgBr2). MgBr2·0Et2 (4.45 g, 17.4
mmol) was added to a stirred solution of aldehyde 125a (1.08 g, 5.74 mmol) in CH2Ch
(26 mL) at rt under argon. After 2 min, the resulting creamy off-white suspension was
placed in an ice bath and, after 15 min, a solution of 137b (2.16 g, 11.5 mmol) in
CH2Ch (1 mL) was added dropwise via sYringe over 3 min. After stirring 1 h at O°C,
the reaction mixture was poured onto ice-cold phosphate buffer (pH 7; 50 mL) with
vigorous stirring. The mixture was diluted with water and extracted with CH2Ch (x3).
The combined organic layers were dried over Na2S04 and concentrated to give an
orange colored oil which contained a 3: 1 mixture of 128a and 129a in addition to
ketone 122 and aldehyde 125a (ca. 3%). The relatively volatile 122 (621 mg, 47%
based on 137b) was easily recovered from the crude by sublimation at high vacuum (rt).
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The remaining residue was crystallized from methanol to give the aldol 128a (mp 152-
153°C; 1.07 g, 61 %). The mother liquor (ca. 4:1 mixture of 129a:128a) was
concentrated and fractionated by MPC (25-50% ethyl acetate in hexane; gradient
elution) to give 128a (101 mg, 6%) and 129a (381 mg,22%).
IR Vrnax 3497, 1706 cm- l ;
IH NMR (300 MHz, CDCb) 84.57 (lH, ddd,J= 2.5,3.5,7.5 Hz, HC-1' eJHc-I 1IHC-3=
3.5 Hz]), 4.10-3.89 (4H, m), 3.85 (lH, d, J = 2.5 Hz, OH), 3.13 (lH, dd, J = 11, 13.5
Hz), 3.0 (lH, ddd, J = 4, 10.5, 13.5 Hz), 2.91-2.57 (9H, m), 2.22-2.13 (lH, m), 2.07
(IH, ddd, J= 3.5, 7.5, 8 Hz), 1.82-1.71 (IH, m);
13C NMR (75 MHz, CDCb) 8209.1 (s), 110.8 (s), 69.7 (d), 64.8 (t), 64.1 (t), 55.3 (d),
46.2 (d), 44.1 (t), 34.9 (t), 29.7 (t), 29.4 (t), 29.3 (t), 26.7 (t);
HRMS m/z ca1cd for C13H2004S2 304.0803, found 304.0807. Anal. Calcd for
C13H2004S2: C, 51.29; H, 6.62. Found: C, 51.34; H, 6.66.
(1 'S*, 3R*, 3"R*, 4"R*)-3-[Hydroxy(4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl)methyl]tetrahydrothiopyran-4-one (128b).
MOMO OH 0
5"
6"
5
6 128b
Aldol reaction of 137b and 125b (MgBr2)' Following the procedure described
for the synthesis of 128a, the cis aldehyde 125b (573 mg, 3.01 mmol) gave an orange to
yellow colored oil on work up which contained a 4:1 mixture of aldols 128b and 129b
in addition to 122 and 125b (ca. 2%). The relatively volatile 122 (321 mg, 46% based
on 137b) was easily recovered from the crude at high vacuum (rt). The remaining
residue was crystallized from methanol to give 128b (525 mg, 57%) and the mother
liquor was fractionated by MPC (30% ethyl acetate in hexane) to give a 2.5:1 mixture of
129b and 128b (257 mg, 27%). A pure sample of 129b was obtained by fractional
crystallization of the above mixture from methanol resulting in a mother liquor enriched
in 129b (ca. 5: 1) which was further fractionated by PTLC (2% MeOH in CH2Ch,
multiple development).
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IR Vrnax 3464, 1697 em-I;
IH NMR (300 MHz, CDCb) D4.71 (IH, d, J = 6.5 Hz), 4.67 (lH, d, J = 6.5 Hz), 4.23
(lH, m), 4.20 (IH, ddd, J = 3.5, 5, 9 Hz, HC-l r eJHC- 1'IHC-3 = 3.5 Hz]), 3.43 (3H, s),
3.21 (IH, d, J = 5 Hz, OH), 3.11 (lH, dd, J = 10.5, 14 Hz), 3.06-2.82 (5H, m), 2.80-
2.66 (3H, m), 2.35-2.25 (2R, m), 2.10 (lH, dd, J= 2, 13.5 Hz), 1.83 (lR, dddd, J= 2,3,
9, 11 Hz), 1.73 (IH, m);
13C NMR (75 MHz, CDCb) D211.0, 96.3, 71.4,69.2, 56.3, 54.9,44.7,43.6, 31.9, 30.4,
29.9, 24.7,22.4;
HRMS m/z calcd for C13H2204S2 306.0960, found 306.0962 (El).
(1 'S*, 3R*, 3"R*, 4"S*)-3-[Hydroxy(4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl)methyl]tetrahydrothiopyran-4-one (128c).
MOMO OH 0
5" 5
6 128c
From aldol reaction of 137b and 125c (MgBr2). Following the procedure
described for the synthesis of 128a, the trans aldehyde 125c (206 mg, 1.08 mmol) gave
a 7:4:1 mixture of aldols 128c, 126c, and 129c, respectively (245 mg, 74%) after
fractionation by MPC (30% ethyl acetate in hexane). A pure sample of 128c was
obtained by further fractionation of a portion of the above mixture by PTLC (2%
methanol in CH2Ch). A pure sample of 129c could not be obtained. Extensive
fractionation of the above mixture by PTLC (2% methanol in CR2Ch) gave a 1.5:1
mixture of aldols 129c and 128c.
IR Vrnax 3483, 1701 em-I;
IH NMR (500 MHz, CDCb) D4.70 (lH, d, J= 6.5 Hz), 4.67 (lH, d, J= 6.5 Hz), 4.52
(lH, ddd, J = 3, 5, 8 Hz, HC-l r eJHC-l'IHC-3 = 3 Hz]), 3.95 (IH, ddd, J = 3, 6, 7 Hz), 3.40
(3H, s), 3.16 (IH, d, J = 5 Hz, OH), 3.09-2.87 (7H, m), 2.80-2.75 (2H, m), 2.43 (IH,
dddd, J= 1, 3.5, 7, 12.5 Hz), 2.32 (IH, ddd, J= 1, 6.5, 13.5 Hz), 2.20 (IH, dddd, J= 3,
3.5, 10, 13.5 Hz), 1.94-1.85 (2H, m);
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13C NMR (l00 MHz, CDCb) 8 211.45, 95.65, 74.40, 69.99, 55.95, 55.66,45.10,42.02,
30.86, 30.46,29.86,27.44,24.85;
HRMS m/z calcd for C13H2204S2 306.0960, found 306.0962 (EI).
(1 'R*, 3S*, 6"R*)-3-[(1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl)hydroxymethyl]tetrahydro-4H-thiopyran-4-one (129a).
2" 3"
10" 5
6 129a
From aldol reaction of 137b and 125a (MgBr2). See experimental procedure for
compound 128a.
IR Vrnax 3496, 1702 cm-1;
IH NMR (300 MHz, CDCb) 8 4.24 (lH, ddd, J= 3.5,3.5,7.5 Hz, HC-l' eJHc-I'/HC-3=
3.5 Hz]), 4.12-3.95 (4H, m), 3.93 (lH, d, J = 3.5 Hz, OH), 3.25 (IH, dd, J = 11.5, 14.5
Hz), 3.02 (lH, ddd, J= 4,10,13.5 Hz), 2.95-2.56 (9H, m), 2.41 (lH, ddd, J= 3, 7.5, 7.5
Hz), 2.15 (lH, ddd, J = 4, 9, 13.5 Hz), 1.79 (lH, ddd, J = 3.5, 7, 13.5 Hz);
13C NMR (75 MHz, CDCb) 8 210.1 (s), 110.5 (s), 72.9 (d), 64.7 (t), 64.2 (t), 54.7 (d),
46.4 (d), 44.2 (t), 34.5 (t), 33.2 (t), 30.0 (t), 29.4 (t), 26.8 (t);
HRMS m/z calcd for C13H2004S2 304.0803, found 304.0801.
(1 'S*, 3S*, 3"R*, 4"R*)-3-[Hydroxy(4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl)methyl] tetrahydrothiopyran-4-one (129b).
MOMO OH 0
5" 5
6 129b
From aldol reaction of 137b and 125b (MgBr2). See experimental procedure for
compound 128b.
IR Yrnax 3501, 1701 cm- I ;
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IH NMR (500 MHz, CDCb) () 4.72-4.69 (2H, m), 4.24 (1H, br s), 3.77 (IH, ddd, J =
3.5, 8.0, 10 Hz, HC-l' eJHC-l'/HC-3 = 3.5 Hz]), 3.42 (3H, s), 3.29 (IH, d, J = 10 Hz), 3.16
(IH, dd, J = 9.5, 13 Hz), 3.04-2.88 (6H, m), 2.83-2.67 (2H, m), 2.39-2.28 (2H, m), 2.22-
2.10 (2H, m), 1.82-1.73 (1H, m);
13C NMR (125 MHz, CDCb) () 211.41, 96.25, 74.14, 71.60, 56.28, 54.29,45.12,45.01,
35.10,31.95,31.14,25.73,22.66;
HRMS m/z calcd for C13H2204S2 306.0960, found 306.0956 (EI).
6 129c
55"
(1 'S*, 3S*, 3"R*, 4"S*)-3-[Hydroxy(4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yI)methyI] tetrahydrothiopyran-4-one (129c).
MOMQ QH 0
From aldol reaction of 137b and 125c (MgBr2). See experimental procedure for
compound 128c. From the 1.5:1 mixture* of 129c and 128c; spectral data for 129c was
deduced from that of the mixture by comparison with data for pure 128c.
IH NMR (500 MHz, CDCb) () 4.70 (2H, ap s), 4.07 (IH, ddd, J= 5,5,6.5 Hz, He-I'
eJHC-l'/HC-3 = 5 Hz]), 3.87 (lH, ddd, J = 3, 8, 8 Hz), 3.40 (3H, s), 3.33 (IH, d, J = 6.5
Hz, OH), 3.15-2.88 (5H, m), 2.85-2.68 (4H, m), 2.55 (lH, dd, J= 8,13.5 Hz), 2.51 (IH,
ddd, J= 2.5,9,12.5 Hz), 2.29 (IH, dddd, J= 3,3.5,8,13.5 Hz), 2.06 (IH, dddd, J= 3,
5, 8, 8 Hz), 1.83 (lH, dddd, J = 3, 8, 9, 13.5 Hz);
13c NMR (125 MHz, CDCb) () 212.62, 95.86, 74.92, 74.41, 56.24, 56.06,45.08,43.80,
34.10,31.78,31.06,29.98,25.86.
3,6-Dihydro-4-trimethylsilyloxy-2H-thiopyan (137b).208,213
560sTM2:
137b
* See experimental of 128c for origin of this mixture.
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A solution of 122 (5.34 g, 46.0 mmol), Et3N (64 mL, 46 g, 0.46 mol) and
TMSCI (29 mL, 25 g, 0.23 mol) in CH2Ch (50 mL) was stirred at rt under argon in a
capped vessel for 10 days. The reaction mixture was concentrated, diluted with ether,
and filtered through Celite®. The combined filtrate and ether washings were
concentrated and the residue placed under high vacuum (0.5 torr) for several hours to
give the titled compound as a yellow oil (8.0-8.5 g, 92-98%) which was homogeneous
by 1H NMR and was used without further purification. The material slowly decomposed
(mainly hydrolysis) upon storage under argon at -15°C. Thus, if the material was not
used directly a convenient method of storage involved making a solution of known
concentration in benzene (ca. 1 M) containing 2 equiv of Et3N. This solution could be
stored for months at -15°C with negligible decomposition. The product was recovered
as required by concentration of aliquots.
IH NMR (300 MHz, CDCb) 8 5.06-5.04 (lH, m), 3.15-3.14 (2H, m), 2.76-2.72 (2H,
m), 2.27-2.23 (2H, m), 0.17 (9H, s)
13C NMR (75 MHz, CDCh) 8 151.3 (s), 102.2 (d), 31.2 (t), 25.7 (t), 25.1 (t), 0.3 (q x3)
HRMS m/z calcd for CgH160SSi 188.0708, found 188.0705 (EI).
Methyl (3S*, 4R*)-tetrahydro-4-hydroxy-2H-thiopyran-3-carboxylate (138) and
. I (139) 146214Methyl (3R*, 4R*)-tetrahydro-4-hydroxy-2H-thlopyran-3-carboxy ate .'
OH 0 OH 0
5 dr'OMe 5 (rOMe
6 S 2 138 6 S 2 139
NaCNBH3 (14.0 g, 0.223 mol) was added in four equal portions at 5 minute
intervals to a stirred solution of p-ketoester 124 (40.0 g, 0.225 mole) and citric acid (48
g, 0.228 mole) in ethanol (200 mL) at 0 °C (Note: addition ofNaCNBH3is exothermic).
The ice-bath was removed and the reaction progress was monitored by TLC (50% ethyl
acetate in hexane); after ca. 40 minutes, 124 had been consumed. The reaction mixture
was concentrated and then taken up in ethyl acetate and washed with H20 and with
brine, dried over Na2S04, and concentrated to give the crude hydroxyesters (a 2:1
mixture of 138 and 139 by IH NMR) as a light yellow colored oil (32.6 g). [Note: If
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reaction was left for longer than 1 h, a gel-like suspension formed and this impeded the
removal of ethanol by rotary evaporation. In these cases, the mixture was diluted with
ethyl acetate and washed with brine (x3). The aqueous phases were extracted with ethyl
acetate and the combined organic layers dried over Na2S04, and concentrated to give
the crude hydroxyesters 138 and 139.] The crude product was fractionated by DFC (5-
50% ethyl acetate in hexane; gradient elution) to give the cis hydroxyester 138 as a
colorless oil (19.89 g, 49%):
IR Vrnax 3503, 1719 cm- I ;
IH NMR (300 MHz, CDCb) 84.17 (1H, ddd, J= 3,3,5.5 Hz), 3.72 (3H, s), 3.16 (lH,
dd, J = 10.5, 13 Hz), 3.10-2.90 (lH, m), 2.99 (lH, ddd, J = 3, 11.5, 14 Hz), 2.85 (lH,
ddd, J= 3,3, 10.5 Hz), 2.57 (lH, dd, J= 3,13.5 Hz), 2.32 (lH, dddd, J= 1.5,4, 5,13.5
Hz), 2.16 (lH, dddd, J= 3,5.5,5.5,14 Hz), 1.89 (lH, dddd, J= 3,3, 11, 14 Hz);
13C NMR (75 MHz, CDCb) 8 174.5 (s), 66.0 (d), 52.4 (q), 47.6 (d), 33.5 (t), 25.3 (t),
23.1 (t);
HRMS m/z calcd for C7H120 3S 176.0507, found 176.0508 (El);
and the trans hydroxy ester 139 as a colorless solid (9.85 g, 24%):
IR Vmax 3452, 1728 cm- I ;
IH NMR (300 MHz, CDCb) 8 3.72 (lH, ddd, J= 4,11, 11 Hz), 3.70 (3H, s), 3.00 (lH,
br s), 2.83 (lH, ddd, J = 2, 3, 12 Hz), 2.71-2.61 (3H, m), 2.62 (lH, ddd, J = 3, 11.5,
11.5 Hz), 2.28 (lH, dddd,J= 3.5, 3.5, 3.5,13.5 Hz), 1.68 (lH, dddd,J= 5,11,11,13
Hz);
13C NMR (75 MHz, CDCb) 8 174.0 (s), 70.3 (d), 52.3 (q), 52.0 (d), 35.3 (t), 29.8 (t),
27.7 (t);
HRMS m/z calcd for C7H120 3S 176.0507, found 176.0508 (EI).
210
Methyl (3S*, 4R*)-tetrahydro-4-(methoxymethoxy)-2H-thiopyran-3-carboxylate
(140).
MOMO 0
5~OMe
6 S 2 140
MOMCI (3.2 mL, 3.4 g, 42mmol) was added dropwise over 2 min to a stirred
solution of the 138 (3.76 g, 21.3 mmol) and i-Pr2EtN (7.4 mL, 5.5 g, 43 mmol) in
CH2Ch (20 mL) at 0° C. The reaction was allowed to stand at rt with periodic
monitoring by TLC (50% ethyl acetate in hexane). After 3 days (reaction complete by
TLC) the mixture was diluted with CH2Ch (200 mL), washed with 1 M HCI (2 x 150
mL) and H20 (150 mL), dried over Na2S04, and concentrated to give the titled MOM
ether (4.75 g, quantitative) which was homogeneous by IH NMR and TLC and was
used in the next step without further purification:
IR Vrnax 1738 cm- I ;
IH NMR (300 MHz, CDCb) 8 4.65 (IH, d, J = 7 Hz), 4.60 (IH, d, J = 7 Hz), 4.37-4.33
(IH, m), 3.71 (3H, s), 3.33 (3H, s), 3.17 (lH, dd, J= 12,13.5 Hz), 3.03-2.92 (IH, m),
2.77 (IH, ddd, J = 3, 3.5, 12 Hz), 2.61 (IH, ddd, J = 2, 3, 13.5 Hz), 2.38-2.25 (2H, m),
1.87-1.75 (IH, m);
I3C NMR (75 MHz, CDCb) 8 172.7,95.9,72.2,55.8,51.9,48.1,31.9,23.7,22.2;
HRMS m/z calcd for C9H1604S 220.0769, found 220.0768 (EI).
Methyl (3R*, 4R*)-tetrahydro-4-(methoxymethoxy)thiopyran-3-carboxylate (141).
MOMO 0
5~OMel~,/
6 S 2 141
Following the same procedure as described for the synthesis of 140, 139 (5.32 g,
30.2 mmol) was converted into the titled :MOM ether (7.0 g, quantitative) which was
homogeneous by 1H NMR and TLC and was used in the next step without further
purification.
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IR Vrnax 1736 em-I;
IH NMR (300 MHz, CDC!)) 8 4.69 (lH, d, J= 7 Hz), 4.63 (lH, d, J= 7 Hz), 3.80 (lH,
ddd, J = 4, 9, 10 Hz), 3.73 (3H, s), 3.34 (3H, s), 2.88-2.58 (5H, m), 2.42-2.32 (lH, m),
1.76 (lH, dddd, J= 4, 10, 10, 14 Hz);
13C NMR (75 MHz, CDC!)) 8 173.4, 95.7, 75.7, 55.7, 52.0, 50.2, 32.8, 29.7, 26.9;
HRMS m/z calcd for C9Hl604S 220.0769, found 220.0771 (EI).
(3'R*, 4'R*)-[Tetrahydro-4-(methoxymethoxy)-2H-thiopyran-3-yl]methanol (142).
MOMO
S@CH20H
6 S 2 142
Following General procedure A, a solution of cis ester 138 (2.423 g, 11.0 mmol)
in THF* was reduced with LiAIH4 in ether (50 mL) to give the alcohol 142 as a elear oil
(1.899 g, 90%) which was homogeneous by IH NMR and TLC and was used in the next
step without further purification.
IR Vmax 3426 em-I;
IH NMR (300 MHz, CDCb) 8 4.67 (lH, d, J = 6.5 Hz), 4.60 (lH, d, J = 6.5 Hz), 3.95
(lH, br t, J = 2.5, 2.5 Hz), 3.63 (lH, dd, J = 7.5, 11 Hz), 3.61 (lH, dd, J = 7.5, 11 Hz),
3.38 (3H, s), 2.96-2.71 (2H, m), 2.40-2.25 (3H, m), 2.18 (lH, dddd, J= 2,4,4,13 Hz),
2.03 (lH, m), 1.77 (lH, dddd, J= 2.5,4, 11.5, 14 Hz);
13C NMR (75 MHz, CDC!)) 8 95.8, 73.2, 64.2, 56.1,43.8,31.3,25.9,23.6;
HRMS m/z calcd for CgHl603S 192.0820, found 192.0820 (EI).
(3'R*, 4'S*)-[Tetrahydro-4-(methoxymethoxy)-2H-thiopyran-3-yl]methanol (143).
MOMO
sgCH20H
6 S 2 143
• THF, and not ether, was used due to improved solubility of ester.
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Following General procedure A, a solution of 139 (1.016 g, 4.62 mmol) in THF
was reduced with LiAIH4 in ether (20 mL) to give the alcohol 143 as a clear oil (832
mg, 94%) which was homogeneous by IH NMR and TLC and was used in the next step
without further purification.
IR Vrnax 3451 cm- l ;
IH NMR (300 MHz, CDCb) 8 4.73 (IH, d, J = 7 Hz), 4.60 (lH, d, J = 7 Hz), 3.82 (IH,
dd, J = 4.5, 11 Hz), 3.66 (lH, dd, J = 4.5, 11 Hz), 3.44 (IH, ddd, J = 3.5, 10, 10 Hz),
3.40 (3H, s), 2.75-2.53 (4H, m), 2.45 (IH, br s), 2.31 (IH, dddd, J= 3.5,4,4, 13 Hz),
1.96-1.87 (IH, m), 1.79-1.66 (lH, m);
13C NMR (75 MHz, CDCb) 8 95.5 (t), 77.8 (d), 64.7 (t), 56.0 (q), 46.3 (d), 33.4 (t),
30.1 (t), 27.4 (t);
HRMS m1z calcd for CgH160 3S 192.0820, found 192.0820 (EI).
(3S,5S)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-
(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (165a)
10"
165a
First prepared by Dr. C. Guo from aldol reaction of 126a with 125a and from
aldol reaction of 127a (anti,syn) with 125a.3o
From Isomerization of 165d (Cs anti): See experimental procedure of compound
165b.
-1
IR (DRIFT) Vmax 3512, 2919, 1706, 1426, 1259, 1110, 1050, 1040 cm .
IH NMR (500 MHz, CDCb) 84.88 (lH, ddd, J= 2,2, 9.5 Hz, HC-l'), 4.62 (IH, ddd, J
= 2, 2, 9 Hz, HC-l "), 4.15-3.93 (8H, m, H2CO x4), 3.29 (IH, d, J = 2 Hz, HOC-l "),
3.25-3.18 (2H, m, HC-5, HC-6; JHC-5-HC-6 = 4 Hz, J HC-5-HC-6 = 9.5 Hz, J HC-1"-HC-5 = 9 Hz),
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3.02-2.87 (4H, m, HC-2, HC-6, HC-7', HC-7"), 2.87 (lH, d, J = 2 Hz, HOC-I'), 2.86
(lH, ddd, 4, 5.5, 9.5 Hz; JHC-2-HC-3 = 4 Hz, JHC-2-HC-3 = 5.5 Hz, JHC-l"-HC-5 = 9.5 Hz)
2.86-2.70 (4H, m, HC-2, HC-7", HC-9', HC-9"), 2.65 (1H, ddd, J= 2.5,3,14 Hz, HC-
1'),2.57-2.50 (2H, m, HC-9', HC-9"), 2.20-2.12 (3H, m, HC-6", HC-10', HC-10"), 1.98
(lH, ddd, J= 1.5,3, 11.5 Hz, HC-6'), 1.78-1.70 (2H, m, HC-10', HC-10").
13
C NMR (125 MHz, CDC!)) 8 211.72 (s, C-4), 110.24 (s, C-5"), 110.07 (s, C-5'),
68.26 (d, C-1 '), 67.42 (d, C-1 "), 65.04 (t, CH20), 64.79 (t, CH20), 64.53 (t, CH20),
64.30 (t, CH20), 55.47 (d, C-3), 54.56 (d, C-5), 47.21 (d, C-6'), 45.64 (t, C-6"), 36.43 (t,
C-10' or C-10"), 36.01 (t, C-10" or C-10'), 34.29 (t, C-6), 34.11 (t, C-2), 26.72 (t, C-9' or
C-9"), 26.62 (t, C-9" or C-9'), 26.21 (t, C-T), 26.16 (t, C-7").
LRMS (FAB), m/z (relative intensity): 493 ([M+1]+, 17), 492 ([M]+, 7), 475 (6), 413
(12), 338 (41),282 (16), 189 (40), 99 (100).
HRMS m/z calcd for C21H3207S3 492.1310, found 492.1313 (EI).
(3R,5S)-rel-3-[(R)-(68)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl] -5-[(S)-
(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (165b)
10"
165b
Obtained by Dr. C. Guo from aldol reaction of 125a and 126a.3°
From isomerization of 165d (Cs anti) in acetone : Aldol 165d (46 mg, 0.093
mmol) was added to a solution of imidazole (680 mg, 10.0 mmol) in acetone (10 mL).
The reaction was stirred for 8 days at rt. The reaction was diluted with citric acid (60
mL, 0.1 M) and extracted with CH2Ch (x3). The organic extracts were combined, dried
over Na2S04 and concentrated and gave a 6.2 : 3.0: 1 mixture of 165a, 165b and 165d,
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respectively.* Fractionation with PTLC (multiple elutions with 20/0 MeOH in CH2Ch)
gave 165b (30 mg, 65%), titled compound 165b (12 mg, 26%) and 165d (4 mg, 8%).
From isomerization of 165d (Cs anti) in CH2Ch : Aldol 165d (73 mg, 0.159
mmol) was added to a solution of imidazole (408 mg, 6.0 mmol) in CH2Ch (3.0 mL).
The reaction was stirred for 14 days. Workup same as above procedure gave a 6.0:2.1:1
mixture of 165a, 165b and 165d, respectively. Fractionation with PTLC (3.5% MeOH
in CH2Ch) gave 165a (38 mg, 52%), titled compound 165b (14 mg, 19%) and 165d (7
mg,10%).
-I
IR (DRIFT) Vmax 3511, 2916, 1702, 1427, 1153, 1102, 1038, 734 cm .
1
H NMR (500 MHz, CDCb) 8 4.57 (2H, ddd, J= 2.5,4.5,6.5 Hz, HC-1', HC-1"), 4.09-
3.96 (8H, m, H2CO x4), 3.25 (2H, br d, J = 13.5 Hz, HC-2, HC-6), 3.09 (2H, ddd, J =
4.5, 6.5, 11.5 Hz, HC-3, HC-5 [JHC-2-HC-3 = 4.5, 11.5 Hz]), 3.06 (2H, d, J = 2.5 Hz, HO
x2), 2.98 (2H, dd, J = 9.5, 14 Hz, HC-7', HC-7"), 2.91 (2H, dd, J = 11.5, 13.5 Hz, HC-2,
HC-6), 2.78-2.71 (4H, m, HC-7', HC-7", HC-9', HC-9"), 2.64 (2H, m, HC-9', HC-9"),
2.11 (2H, ddd, J = 3.5, 4.5, 9.5 Hz, HC-6', HC-6"), 2.09 (2H, ddd, J = 3, 6.5, 14 Hz,
HC-10', HC-10"), 1.77 (2H, ddd,J= 3.5,10,14 Hz, HC-10', HC-10").
13
C NMR (125 MHz, CDCb) 8 213.92 (s, C-4), 109.89 (s x2, C-5', C-5"), 66.87 (d x2,
C-1', C-1"), 64.61 (t x2, CH20), 64.54 (t x2, CH20), 57.82 (d x2, C-3, C-5), 46.60 (d
x2, C-6', C-6"), 35.46 (t x2, C-10', C-10"), 34.26 (t x2, C-2, C-6), 27.54 (t x2, C-7', C-
7"), 26.79 (t x2, C-9', C-9").
LRMS (EI), m/z (relative intensity): 492 ([M]+, 1), 188 (14), 159 (11), 132 (73), 100
(10), 99 (100), 86 (24), 55 (8).
HRMS m/z calcd for C21H3207S3 492.1310, found 492.1311 (EI).
• 165d (11 mg, 0.022 mmol) was added to a solution of imidazole (34 mg, 0.5 mmol) in CD3COCD3 (0.5
mL) the ratio of aldol products were monitored until an equilibrium ratio was reached after 13 days which
gave 165a : 165b : 165d : of7.9 : 3.8 : 1.
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(3S,5S)-rel-3,5-bis[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (165c)
10"
165c
First prepared by Dr. P. K. Sasmal from aldol reaction of 125a with 126a.3o
From isomerization of 165e (C2anti)·: See experimental procedure of compound
165f.
-I
IR (DRIFT) Vmax 3514,2921, 1701, 1426, 1153, 1131, 1114, 1052 cm .
IH NMR (300 MHz, CDC!)) 0 4.79 (2H, d, J= 9.5 Hz, HC-1', HC-1"), 3.92-4.14 (8H,
m, H2CO x4), 3.22-3.14 (2H, m, HC-3, HC-5), 3.05 (2H, br s, HO x2), 3.01-2.88 (6H,
m), 2.77 (2H, ddd, J= 2.5, 13, 13 Hz), 2.69 (2H, ddd, J= 2.5,3, 14 Hz), 2.49 (2H, br d,
J= 13.5 Hz), 2.13 (2H, ddd, J= 3,4,14 Hz, H-10', H-10"), 1.75-1.84 (4H, m, H-6', H-
6", H-10', H-10").
13C NMR (75 MHz, CDC!)) 0 211.4 (s), 110.4 (s x2), 66.2 (d x2), 65.0 (t x2), 64.4 (t
x2), 55.4 (d x2), 47.1 (d x2), 36.1 (t x2), 34.4 (t x2), 26.7 (t x2), 25.7 (t x2).
LRMS (FAB), m/z (relative intensity): 493 ([M+1]+, 24), 492 ([M]+, 9),475 (7), 338
(52), 225 (26), 189 (49), 132 (12), 99 (100).
HRMS m/z calcd for C21H3207S3 492.1310, found 492.1307 (EI).
(3S,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-
(6R)-1 ,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (165d)
10"
165d
First prepared by C. C. Man from aldol reaction of 125a with 127a.3o NMR
assignment and analysis this work.
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-I
IR (DRIFT) Vmax, 3518,2918,2888, 1698, 1426, 1261, 1101 cm .
1H NMR (500 MHz, CDC!) 8 4.32 (2H, ddd, J= 5,6,6.5 Hz, HC-1', HC-l" [JHC-I'-HC-3
= 6 Hz]), 4.10-3.88 (8H, m, H2CO x4), 3.25 (2H, ddd, J = 5, 6, 12 Hz, HC-3, HC-5
[JHC-2-HC-3 = 5, 12 Hz]), 3.12 (2H, d, J = 6.5 Hz, HO x2), 3.04 (2H, dd, J = 12, 13 Hz,
HC-2, HC-6), 3.02 (2H, dd, J = 8.5, 14 Hz, HC-T. HC-T'), 2.91-2.83 (4H, m, HC-2,
HC-6, HC-7', HC-7"), 2.73-2.67 (4H, m, H2C-9', H2C-9"), 2.07 (2H, ddd, J= 3.5, 5,8.5
Hz, HC-6', HC-6"), 1.97 (2H, ddd, J = 5, 5.5, 14 Hz, HC-10', HC-10"), 1.73 (2H, ddd, J
= 5.5, 6.5, 14 Hz, HC-10', HC-10").
13
C NMR (125 MHz, CDC!) 8216.65 (s, C-4), 109.25 (s x2, C-5'), 69.29 (d x2, C-l'),
64.89 (t x2, CH20), 64.56 (t x2, CH20), 57.65 (d x2, C-3), 47.27 (d x2, C-6'), 36.33 (t
x2, C-2), 35.76 (t x2, C-10'), 27.93 (t x2, C-7'), 26.80 (t x2, C-9').
LRMS (FAB), m/z (relative intensity): 493 ([M+1]+, 69), 475 (31),305 (25),199 (37),
189 (38), 99 (100), 67 (37).
HRMS m/z calcd for C21H3207S3 493.1388 (M+H), found 493.1394 (FAB).
Anal. Calcd for C21H3207S3: C, 51.20; H, 6.55. Found: C, 51.29; H, 6.70.
(3R,5R)-rel-3,5-bis[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (165e)
10"
165e
First prepared by Dr. C. Guo from aldol reaction of 125a with 127a.3o Included
here for completeness only.
-I
IR (DRIFT) Vmax 3511, 2917, 1697, 1426, 1259, 1102, 1048 cm .
1
H NMR (300 MHz, CDCh) 84.65 (2H, br d, J= 8 Hz, H-1', HC-l"), 4.15-3.90 (8H,
m, H2CO x4), 3.13 (2H, br s, HO x2), 3.11-2.48 (l4H, m), 2.13 (2H, ddd, J= 3, 5,13.5
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Hz, HC-I0', HC-I0"), 2.03 (2H, ddd, J = 3, 3, 11 Hz, HC-6', HC-6"), 1.73 (2H, ddd, J =
3.5,12,13.5 Hz, HC-I0', HC-I0").
13
C NMR (75 MHz, CDC!)) 8 212.9 (s), 110.0 (sx2), 68.7 (d x2), 65.0 (t x2), 64.6 (t
x2), 55.0 (d x2), 47.2 (d x2), 36.4 (t x2), 33.9 (t x2), 26.8 (t x2), 26.7 (t x2).
LRMS (FAB), m/z (relative intensity): 493 ([M+1]+, 17), 492
([M]+, 6),475 (4), 338 (27), 189 (25), 132 (10), 99 (100), 67 (23).
HRMS m/z calcd for C21H3207S3 492.1310, found 492.1307 (FAB).
(3R,5S)-rel-3,5-bis[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl] tetrahydro-4H-thiopyran-4-one (165f)
10"
165f
From isomerization of 165e: Bisaldol 165e (13.5 mg, 0.027 mmol) was added
to a solution of imidazole (136 mg, 2.00 mmol) in CH2Ch (2.0ml). The reaction was
stirred for 20 h at rt. The reaction was diluted with citric acid (20 mL, O.IM) and
extracted with CH2Ch (x4). The organic extracts were combined, dried over Na2S04
and concentrated and gave a 3.0 : 6.2 : 1 mixture (12 mg) of 165e, 165f, and 165c,
respectively. Fractionation of the mixture by PTLC (2% MeOH in CH2Ch; multiple
elutions) gave 165c (2 mg, 15%), the titled compound 165f (6 mg, 44%) and 165e (4
mg,30%).*
-I
IR (DRIFT) Ymax 3518, 2917, 1694, 1427, 1153, 1131, 1101, 1042 cm .
I H NMR (500 MHz, C6D6) 8 4.69 (IH, ddd, J = 1.5, 3.5, 6 Hz, HC-l'), 4.17 (IH, ddd, J
= 3.5,7.5,10 Hz, HC-l"), 3.45-3.24 (6H, m, H2CO x4), 3.24-3.02 (9H, m, H2CO, HC-
2, HC-3, HC-5, HC-6, HC-7', H2C-7"), 3.13 (1H, d, J= 1.5 Hz, HOC-I'), 2.85 (IH, dd,
J = 11.5, 13 Hz, HC-2 or HC-6), 2.77 (IH, d, J = 10 Hz, HOC-l "), 2.72 (IH, br d, J =
* Isolated aldols are reported from higher to lower Rf on PTLC plate.
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13.5 Hz, HC-7), 2.58 (lH, m, J = 4, 8, 13 Hz, HC-9"), 2.52 (1H, ddd, J = 3.5, 3.5, 13
Hz, HC-2 or HC-6), 2.49 (1H, ddd, J= 3, 10.5, 13.5 Hz, HC-9'), 2.25-2.24 (2H, m, HC-
9', He-9"), 2.21 (1H, ddd, J = 3.5, 4, 9.5 Hz, HC-6'), 2.16 (1H, ddd, J = 3.5, 7, 7.5 Hz,
HC-6"), 1.63 (1H, ddd, J= 3,6,13.5 Hz, HC-10'), 1.48 (1H, ddd, J= 3.5,10.5,13.5 Hz,
HC-10'), 1.45-1.36 (2H, m, H2C-10"), 4.53 (1H, br d, J = 8.5 Hz, HC-1 '),4.17-3.89 (9H,
m, HC-1 ", H2CO x4), 3.33 (1H, ddd, J = 3.5, 4, 13.5 Bz, HC-2), 3.27 (lH, ddd, J = 3.5,
3.5,12 Hz, HC-5), 3.21 (1H, dd, J= 12,13 Hz, HC-6), 3.10 (lH, d, J= 1 Hz, HOC-I'),
3.09-2.50 (9H, m, HC-3, H2C-7', H2C-7", H2C-9', H2C-9"), 2.97 (lH, d, J = 9.5 Hz,
HOC-l "), 2.91 (IH, ddd, J = 3, 3.5, 13 Hz, HC-6), 2.85 (lH, dd, J = 11.5, 13.5 Hz, HC-
2), 2.22 (lH, ddd, J= 3,7.5,7.5 Hz, HC-6"), 2.16-2.07 (2H, m, HC-6', HC-10' or HC-
lO"), 1.88 (1H, ddd, J= 3,8.5,13.5 Hz, HC-10' or HC-10"), 1.78-1.71 (2H, m, HC-10',
HC-10").
13
C NMR (125 MHz, CDC!)) 8 215.52 (s, C-4), 110.25 (s, C-5" or C-5'), 109.02 (s, C-5'
or C-5"), 70.92 (d, C-1 '), 66.86 (d, C-1"), 64.90 (t, CH20), 64.84 (t, CH20), 64.31 (t,
CH20), 63.96 (t, CH20), 57.48 (d, C-5 or C-3), 57.00 (d, C-5 or C-3), 47.51 (d, C-6' or
C-6"), 46.63 (d, C-6' or C-6"), 37.08 (t), 35.81 (t), 35.54 (t), 34.62 (t), 29.28 (t), 26.81
(t), 26.67 (t), 26.56 (t).
LRMS (EI), m/z (relative intensity): 492 ([M]+, 1), 304 (8), 188 (15), 159 (12), 132
(73), 99 (100), 86 (24), 55 (21).
HRMS m/z calcd for C21H3207S3 492.1310, found 492.1310.
(3S,5R)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-
(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (170a)
10"
170a
From aldol reaction of 125a and 128a : TiCl4 (24 /-lL, 0.22 mmol) was added
dropwise to a stirred solution of 128a (60 mg, 0.20 mmol) in CH2Ch (1.5 mL) at -78°C
under argon. Upon addition of TiCl4 a yellow globular slurry developed which turned
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into a fine yellow suspension after 5 minutes of stirring at -78°C. The dry ice-acetone
bath was replaced with an ice-water bath and the suspension was then stirred for 20
minutes at 0 °C. The yellow suspension was recooled to -78°C using a dry ice-acetone
bath. After 10 minutes, i-Pr2EtN (78 f..lL, 0.45 mmol) was added dropwise over 10
seconds; upon addition the yellow suspension became a light red solution. After 5
minutes a deep red colour developed; the dry ice-acetone bath was replaced with an ice-
water bath and the solution was stirred for 30 minutes at 0 °c resulting in a deeper red
solution. The mixture was cooled to -78°C and a solution of aldehyde 125a (111 mg,
59 mmol) in CH2Ch (0.5 mL) was added dropwise over 10 seconds. The reaction
mixture was stirred for 20 minutes at 0 °c (during this period the deep red solution
/
turned light red) and then a mixture of MeOH:H20 (2: 1, 2 mL) was added with
vigorous stirring. After 10 seconds, NH4CI (5 mL, 1 M) was added and over 2 minutes
the mixture turned from light red to colourless. The mixture was diluted with distilled
H20 and extracted with ethyl acetate (x3). The combined organic extracts were dried
over Na2S04 and concentrated to give a light yellow oil (180 mg). The oil was
fractionated by MPC (40-80% ethyl acetate in hexane; gradient elution) to give
recovered aldehyde 125a (97 mg, 87%) and 128a (34 mg, 57%) and titled compound
170a (7.4 mg, 8%).
From hydrolysis of 173c : Following General procedure K for MOM hydrolysis,
aldol 173c (30.2 mg, 0.056 mmol) gave a mixture which was fractionated by PTLC
(80% ethyl acetate in hexane) to give recovered 173c (14.3 mg, 47%) and titled
compound 170a (15.1 mg, 54%).
-1
IR (DRIFT) Vmax 3508, 2914, 1697, 1426, 1106, 1044,891,731 cm .
IH NMR (500 MHz, CDCb) 84.39 (lH, ddd, J= 2.5,5,6.5 Hz, HC-1'), 4.21 (lH, ddd,
J= 5, 6.5, 6.5 Hz, HC-1"), 4.13-3.90 (8H, m, H2CO x4), 3.87 (lH, d, J= 2.5 Hz, HOC-
1'),3.23 (1H, ddd, J= 4,5,12 Hz, HC-5), 3.14 (1H, dd, J= 12,12 Hz, HC-6), 3.11-
3.06 (3H, m, HOC-1 ", HC-2, HC-3), 3.04 (lH, d, J = 13.5 Hz, HC-2), 2.99 (lH, dd, J =
8.5,14 Hz, HC-7"), 2.91 (1H, dd, J= 3,14 Hz, HC-7"), 2.88 (lH, ddd, J= 2, 4,12 Hz,
HC-6), 2.81 (lH, dd, J = 3, 13.5 Hz, HC-7'), 2.75-2.68 (5H, m, HC-7', HC-9', HC-9',
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HC-9", HC-9"), 2.20 (lH, ddd, J = 5.5, 5.5, 14 Hz, HC-10'), 2.20-2.14 (2H, m, HC-6',
HC-6"), 1.96 (lH, ddd, J = 5, 5, 13.5 Hz, HC-10"), 1.79 (lH, ddd, J = 6.5, 6.5, 14 Hz,
HC-10'), 1.72 (lH, ddd, J= 6.5,6.5,13.5 Hz, HC-10"), ain C6D6 (,),4.47 (lH, ddd, J
= 2.5,6,6.5 Hz, HC-1'), 4.35 (lH, ddd, J= 5,5.5,7.5 Hz, HC-1"), 3.85 (lH, d, J= 2.5
Hz, HOC-I'), 3.43-3.16 (9H, m, HC-2, H2C-2', H2C-2", H2C-3', H2C-3"), 3.22 (lH, ddd,
J = 4.5, 5, 12 Hz, HC-5), 3.18 (lH, ddd, J = 5, 6.5, 11.5 Hz, HC-3), 3.15 (lH, dd, J = 9,
14 Hz, HC-7"), 3.05 (lH, d, J = 7.5 Hz, HOC-1 "), 2.96 (lH, dd, J = 12, 13 Hz, HC-6),
2.95 (lH, dd, J= 11.5,13 Hz, HC-2), 2.92 (lH, br d, J= 14 Hz, HC-7"), 2.71 (lH, dd, J
= 3, 13.5 Hz, HC-7'), 2.64 (lH, dd, J = 8, 13.5 Hz, HC-7'), 2.54 (IH, ddd, J = 3, 4.5,
13.5 Hz, HC-6), 2.52-2.32 (4H, m, H2C-9', H2C-9"), 2.18 (lH, ddd, J = 4, 5.5, 9 Hz,
HC-6"), 2.22-2.15 (lH, m, HC-6'), 1.80 (IH, ddd, J= 5, 6, 13.5 Hz, HC-10'), 1.59 (lH,
ddd, J = 3.5, 6.5, 13.5 Hz, HC-10"), 1.51 (lH, ddd, J = 4, 9, 13.5 Hz, HC-10"), 1.48
(lH, ddd, J= 5, 7.5,13.5 Hz, HC-10').
13C NMR (125 MHz, CDCb) 8 213.68 (s, C-4), 110.73 (s, C-5'), 109.34 (s, C-5"),
70.08 (d, C-1 "), 69.94 (d, C-1'), 64.92 (t, CH20), 64.74 (t, CH20), 64.45 (t, CH20),
64.04 (t, CH20), 57.69 (d, C-3), 57.62 (d, C-5), 47.57 (d, C-6"), 46.22 (d, C-6'), 35.93
(t, C-6), 35.71 (t, C-10"), 35.13 (t, C-10'), 33.52 (t, C-2), 30.28 (t, C-7'), 28.37 (t, C-7"),
26.81 (t, C-9' or C-9"), 26.74 (t, C-9" or C-9'), ain C6D6, 213.82 (s, C-4), 111.03 (s, C-
5'), 109.93 (s, C-5"), 70.93 (d, C-1 '), 70.32 (d, C-1 "), 64.91 (t, CH20), 64.59 (t, CH20),
64.43 (t, CH20), 63.96 (t, CH20), 59.38 (d, C-3), 58.45 (d, C-5), 48.27 (d, C-6"), 47.44
(d, C-6'), 36.51 (t, C-6), 36.31 (t, C-10"), 35.89 (t, C-10'), 35.16 (t, C-2), 31.04 (t, C-7'),
28.83 (t, C-7"), 27.14 (t, C-9' or C9"), 26.99 (t, C-9" or C-9).
LRMS (El), m/z (relative intensity): 492 ([M]+, 1), 304 (6), 188 (10), 132 (83), 100
(10), 99 (100), 86 (21), 55 (17).
HRMS m/z calcd for C2lH3207S3 492.1310, found 492.1321 (El).
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(3S,5S)-rel-3-[(R)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-
(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (170b)
170b
From isomerization of 170a : Aldol 170a (13 mg, 0.0266 mmol) was added to a
solution of imidazole (54 mg, 0.80 mmol) in CH2Ch (2.0ml). The reaction was stirred
for 6 days at rt. The reaction was diluted with citric acid (30 mL, O.lM) and extracted
with CH2Ch (x3). The organic extracts were combined, dried over Na2S04 and
concentrated to give a 2.1 : 3.6 : 3.2 : 1 equilibrium mixture of 170a, 170b, 171c and
171d (15 mg). The mixture was fractionated by PTLC (80% ethyl acetate in hexane) to
give 170b (5 mg, 39%), 170a (3.0 mg, 23%) and a mixture of 171c and 171d (5.5 mg).
The mixture was further fractionated by PTLC (2% MeOH in CH2Ch; multiple
elutions) and gave 171c (3.5 mg, 26%) and 171d (1 mg, 7%).
From hydrolysis of 173a : Following General procedure K for MOM hydrolysis,
aldol 173a (11.7 mg, 0.022 mmol) gave a mixture which was fractionated by PTLC
(70% ethyl acetate in hexane) to give recovered 173a (3.7 mg, 32%) and titled
compound 170b (5.8 mg, 54%).
-1
IR (DRIFT) Vmax 3496, 2916, 1704, 1427, 1260, 1102, 1051,948 cm .
IH NMR (500 MHz, CDCh) 8 4.68 (1H, ddd, J= 1.5,2.5,9 Hz, HC-1"), 4.36 (lH, ddd,
J= 3.5, 4,8 Hz, HC-1'), 4.13-3.93 (9H, m, HOC-I", H2CO x4), 3.39 (lH, dd, J= 10,
13.5 Hz, HC-2), 3.33 (lH, dd, J = 5.5, 12.5 Hz, HC-6), 3.23 (lH, ddd, J = 5.5, 8.5, 9
Hz, HC-5), 3.14 (lH, d, J= 1.5 Hz, HOC-I"), 3.00 (lH, dd, J= 3,14 Hz, HC-7'), 2.96
(lH, ddd, J= 4,4.5, 10 Hz, HC-3), 2.95 (lH, dd, J= 11, 13.5 Hz, HC-7"), 2.88 (lH, dd,
J = 8.5, 12.5 Hz, HC-6), 2.85-2.75 (5H, m, HC-2, HC-7', HC-7", HC-9', HC-9"), 2.66
(lH, ffi, HC-9'), 2.51 (lH, br d, J= 12.5 Hz, HC-9"), 2.21-2.10 (3H, ffi, HC-6', HC-10',
HC-10"), 2.01 (lH, ddd, J = 2.5, 3.5, 11 Hz, HC-6"), 1.81 (lH, ddd, J = 3, 6.5, 13.5Hz,
HC-10'), 1.71 (lH, ddd, J= 3.5, 12, 13.5 Hz, HC-10").
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13C NMR (125 MHz, CDC!)) 8212.86 (s, C-4), 110.55 (s, C-5'), 110.28 (s, C-5"), 72.76
(d, C-l'), 67.35 (d, C-1"), 64.91 (t, CH20), 64.89 (t, CH20), 64.42 (t, CH20), 64.26 (t,
CH20), 55.00 (d, C-3), 52.78 (d, C-5), 46.71 (d, C-6"), 45.90 (d, C-6'), 36.28 (t, C-10"),
34.43 (t, C-10'), 31.93 (t, C-2), 30.70 (t, C-6), 30.07 (t, C-7'), 27.00 (t, C-9'), 26.70 (t, C-
9"), 26.24 (t, C-7").
LRMS (EI), m/z (relative intensity): 492 ([M]+, 0.2), 188 (12), 159 (8), 132 (41), 115
(8), 99 (100), 86 (24), 55 (10).
HRMS m/z calcd for C21H3207S3 492.1310, found 492.1316 (El).
(3R,5R)-reI-3-[(R)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyI]-5-[(S)-
(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyI]tetrahydro-4H-thiopyran-4-
one (170c)
10"
170c
From isomerization of 171a : Aldol 171a (72 mg, 0.15 mmol) was added to a
solution of imidazole (218 mg, 3.20 mmol) in CH2Ch (4.0ml). The reaction was stirred
for 15 days at rt. The reaction was diluted with citric acid (25 mL, O.lM) and extracted
with CH2Ch (x3). The organic extracts were combined, dried over Na2S04 and
concentrated and gave a 1.5 : 3.0 : 1 : 2.5 equilibrium mixture of 170c, 170d, 171a and
171b (65 mg). The mixture was fractionated by MPC (40-60% ethyl acetate in hexane;
gradient elution) to give the titled compound 170c (10 mg, 14%) along with 170d (23
mg, 32%), recovered 171a (4 mg, 5%) and 171b (24 mg, 34%).
From hydrolysis of 173b : Following general procedure K for MOM hydrolysis,
aldol 173b (9.5 mg, 0.018 mmol) gave a mixture which was fractionated by PTLC
(80% ethyl acetate in hexane) to give recovered 173b (4 mg, 41%) and titled compound
170c (3 mg, 34%).
-I
IR (DRIFT) Vmax 3501, 2915, 1705, 1427, 1260, 1106, 1036, 733 cm .
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I H NMR (500 MHz, CDCb) 8 4.69 (lH, ddd, J = 2.5, 3.5, 8 Hz, HC-1 "), 4.56 (lH, br
dd, J = 4.5, 7.5 Hz, HC-1 '), 4.13-3.94 (8H, m, H2CO), 3.88 (lH, br s, HOC-1 I), 3.25
(lH, dd, J= 11.5,13.5 Hz, HC-2), 3.11 (lH, d, J= 3.5 Hz, HOC-I"), 3.10 (lH, dd, J=
5, 13 Hz, HC-6), 3.03 (lH, ddd, J = 5, 6, 8 Hz, HC-5), 3.02 (lH, dd, J = 11.5, 14 Hz,
HC-T'), 3.01 (lH, ddd, J = 4.5, 4.5, 11.5 Hz, HC-3), 2.85-2.64 (8H, m, HC-2, HC-6,
H2C-T, HC-T', H2C-9', HC-9"), 2.56 (lH, br d, J= 13 Hz, HC-9"), 2.19 (lH, ddd, J=
3.5, 7.5,13 Hz, HC-10'), 2.16 (lH, ddd, J= 3, 4.5,13.5 Hz, HC-10"), 2.04 (lH, ddd, J=
2, 7.5, 8.5 Hz, HC-6'), 2.03 (lH, ddd, J = 3.5, 3.5, 11.5 Hz, HC-6"), 1.80 (lH, ddd, J =
3.5, 8.5, 13 Hz, HC-10'), 1.75 (lH, ddd, J = 3.5, 11.5, 13.5 Hz, HC-10").
13
C NMR (125 MHz, CDCb) 8 211.81 (s, C-4), 110.68 (s, C-5'), 110.04 (s, C-5"), 70.39
(d, C-1'), 68.73 (d, C-1"), 65.03 (1, CH20), 64.86 (1, CH20), 64.60 (1, CH20), 64.20 (t,
CH20), 54.82 (d, C-3), 53.55 (d, C-5), 47.41 (d, C-6' or C-6"), 47.29 (d, C-6" orC-6'),
36.42 (1, C-10"), 35.35 (t, C-10'), 31.10 (t, C-6), 29.79 (1, C-7'), 28.80 (1, C-2), 26.80 (1,
C-9' or C-9"), 26.78 (1, C-9' or C-9"), 26.58 (1, C-7").
LRMS (FAB), m/z (relative intensity): 493 ([M+1]+, 39),225 (20),199 (18),189 (33),
161 (17), 133 (18), 132 (24), 99 (l00).
HRMS m/z calcd for C21H3207S3 493.1388 (M+H), found 493.1392 (FAB).
(3R,5S)-rel-3-[(R)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-
(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (170d)
10"
170d
From isomerization of 171a : See experimental procedure for compound 170c.
-1
IR (DRIFT) Vmax 3508, 2916, 1704, 1427, 1263, 1108, 1039, 736 cm .
1
H NMR (500 MHz, CDCb) 8 4.54 (lH, br dd, J= 4,7 Hz, HC-1"), 4.13 (lH, ddd, J=
5,5.5,6 Hz, HC-1'), 4.10-3.93 (8H, m, H2CO x4), 3.58 (lH, d, J= 5 Hz, HOC-I'), 3.24
(lH, ddd, J = 3.5, 4.5, 13 Hz, HC-6), 3.18 (lH, br s, HOC-1 '), 3.16 (lH, ddd, J = 3.5,
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4.5,13 Hz, HC-2), 3.04 (lH, ddd, J= 4.5,7,11.5 Hz, HC-3), 3.04 (lH, ddd, J= 4.5,6,
11.5 Hz, HC-5), 2.95 (IH, dd, J= 11,13.5 Hz, HC-7"), 2.92 (lH, dd, J= 10,13.5 Hz,
HC-7), 2.92 (lH, dd, J = 11.5, 13 Hz, HC-6), 2.90 (lH, dd, J = 11.5, 13 Hz, HC-2),
2.80-2.65 (4H, m, HC-7', HC-7", HC-9', HC-9"), 2.63-2.53 (2H, m, HC-9', HC-9"), 2.36
(1H, ddd, J= 3, 5.5, 10 Hz, HC-6'), 2.20-2.07 (2H, m, HC-I0', HC-I0"), 2.13 (lH, ddd,
J= 3.5, 4,11 Hz, HC-6"), 1.79-1.70 (2H, m, HC-I0", HC-I0').
13
C NMR (125 MHz, CDCh) 8 212.53 (s, C-4), 111.45 (s, C-5'), 110.08 (s, C-5"), 72.44
(d, C-1'), 67.66 (d, C-l"), 64.69 (t, CH20), 64.42 (t, CH20), 64.21 (t, CH20), 63.51 (t,
CH20), 58.78 (d, C-3), 57.58 (d, C-5), 43.43 (d, C-6"), 45.00 (d, C-6'), 35.83 (t, C-10"),
35.32 (t, C-I0'), 34.58 (t, C-2), 34.43 (t, C-6), 30.47 (t, C-7'), 27.01 (t, C-7"), 26.74 (t,
C-9' or C-9"), 26.59 (t, C-9" or C-9').
LRMS (EI), m/z (relative intensity): 492 ([M]+, 1), 188 (17), 133 (17), 100 (13), 99
(100), 86 (35), 55 (28).
HRMS m/z calcd for C21H3207S3 492.1310, found 492.1317.
(3S,5R)-rel-3-[(R)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-
(6R)-1 ,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (171a)
10'10"
".,/ "9" S 7" 6 S 27'S 9' 171a
From aldol reaction of 129a with 125a : TiCl4 (27 f.1L, 0.25 mmol) was added
dropwise to a stirred solution of 129a aldol (69.4 mg, 0.228 mmol) in CH2Ch (2 mL) at
-78°C under argon. Upon addition of TiC14 a yellow globular slurry developed which
turned into a fine yellow suspension after 5 minutes of stirring at -78°C. The dry ice-
acetone bath was replaced with an ice-water bath and the suspension was then stirred
for 20 minutes at 0 °C. The yellow suspension was recooled to -78°C using a dry ice-
acetone bath. After 10 minutes, i-Pr2EtN (91 f.1L, 0.52 mmol) was added dropwise over
10 seconds; upon addition the yellow suspension became a light red solution. After 10
minutes of stirring a deep red colour developed. A solution of aldehyde (86 mg, 46
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mmol) in CH2Ch (0.3 mL) was added dropwise over 10 seconds. The reaction was
stirred for 2 h at -78°C (during this period the deep red solution turned light red). The
dry ice-acetone bath was removed and MeOH:H20 (2:1, 2 mL) was added with
vigorous stirring. After 10 seconds, NH4CI (5 mL, 1M) was added and over 2 minutes
the mixture turned from light red to colourless. The mixture was diluted with distilled
H20 and extracted with ethyl acetate (x3). The combined organic extracts were dried
over Na2S04 and concentrated to give a light yellow oil (160 mg). The oil was
fractionated by MPC (40-60% ethyl acetate in hexane; gradient elution) to give
recovered aldehyde 125a (60 mg, 70%), 129a (33 mg, 48%), the titled compound 171a
(44 mg, 39%) and 171h (3.2 mg, 3%).
-1
IR (DRIFT) Vmax 3511, 2916, 1697, 1426, 1261, 1102, 1047, 892cm .
1
H NMR (500 MHz, CDCh) 8 4.16 (lH, ddd, J= 4.5,7,8 Hz, HC-1"), 4.10 (lH, ddd, J
= 3.5, 4.5, 7.5 Hz, HC-1 '), 4.10-3.89 (8H, m, H2CO x4), 3.82 (1H, d, J = 4.5 Hz, HOC-
1'), 3.28 (1H, dd, J = 11.5, 13 Hz, HC-2), 3.23 (1H, ddd, J = 4.5, 4.5, 12 Hz, HC-5),
3.15 (lH, dd, J= 12, 13 Hz, HC-6), 3.06 (1H, d, J= 8 Hz, HOC-I"), 3.04 (1H, ddd, J=
3.5, 3.5, 11.5 Hz, HC-3), 2.98-2.95 (2H, m, H2C-7"), 2.94 (lH, ddd, J = 3.5, 3.5, 13 Hz,
HC-2), 2.85 (lH, ddd, J= 3.5, 4.5,13 Hz, HC-6), 2.81 (lH, dd, J= 2.5,14 Hz, HC-7'),
2.75 (lH, ddd, J = 3.5, 9, 12.5 Hz, HC-9'), 2.71-2.63 (3H, m, HC-9', H2C-9"), 2.54 (lH,
dd, J= 7,14 Hz, HC-7'), 2.44 (lH, ddd, J= 2.5,7,7.5 Hz, HC-6'), 2.19-2.12 (2H, m,
HC-6", HC-10'), 1.92 (lH, m, HC-10"), 1.80 (lH, ddd, J = 3.5, 7.5, 13.5 Hz, HC-10'),
1.72 (lH, m, HC-10").
13C NMR (125 MHz, CDCh) 8 214.16 (s, C-4), 110.32 (s, C-5'), 109.29 (s, C-5"), 72.51
(d, C-1 '), 70.35 (d, C-1 "), 64.77 (t, CH20), 64.67 (t, CH20), 64.28 (t, CH20), 64.06 (t,
CH20), 57.68 (d, C-5), 56.34 (d, C-3), 47.57 (d, C-6"), 45.91 (d, C-6'), 36.11 (t, C-2),
36.03 (t, C-6), 35.01 (t, C-10"), 34.49 (t, C-10'), 29.81 (t, C-7'), 28.67 (t, C-7"), 26.83 (t,
C-9'/C-9"), 26.71 (t, C-9"/C-9').
LRMS (FAB), m/z (relative intensity): 493 ([M+1]+, 23), 161 (27), 99 (l00), 83 (26),
71 (27), 69 (25), 57 (38), 55 (63).
HRMS m/z calcd for C21H3307S3 493.1388 (M+H), found 493.1384 (FAB).
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(3S,5S)-rel-3-[(R)-(6R)-1 ,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-
(6R)-1 ,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (171b)
10'10"
,,/ ""-
9" S 7" 6 S 27'S 9' 171b
From aldol reaction of 129a and 125a : See experimental procedure for
compound 171a.
From hydrolysis of 175a : Following General procedure K for MOM hydrolysis
aldol 175a (16.5 mg, 0.031 mmol) gave a mixture which was fractionated by PTLC
(70% ethyl acetate in hexane) to give recovered 175a (6 mg, 38%) and titled compound
171b (6 mg, 40%).
-1
IR (DRIFT) Vmax 3496, 2916, 1704, 1427, 1260, 1102, 1051,948 cm .
1
H NMR (500 MHz, CDCh) 8 4.68 (lH, ddd, J = 1.5, 2.5, 9 Hz, HC-1 "), 4.36 (1H, ddd,
J = 3.5, 4, 8 Hz, HC-1 '), 4.13-3.93 (9H, m, HOC-1 ", H2CO x4), 3.39 (lH, dd, J = 10,
13.5 Hz, HC-2), 3.33 (1H, dd, J = 5.5, 12.5 Hz, HC-6), 3.23 (lH, ddd, J = 5.5, 8.5, 9
Hz, HC-5), 3.14 (lH, d, J= 1.5 Hz, HOC-I"), 3.00 (lH, dd, J= 3,14 Hz, HC-7'), 2.96
(lH, ddd, J= 4,4.5,10 Hz, HC-3), 2.95 (1H, dd, J= 11, 13.5 Hz, HC-7"), 2.88 (lH, dd,
J = 8.5, 12.5 Hz, HC-6), 2.85-2.75 (5H, m, HC-2, HC-7', HC-7", HC-9', HC-9"), 2.66
(lH, ffi, HC-9'), 2.51 (lH, br d, J= 12.5 Hz, HC-9"), 2.21-2.10 (3H, m, HC-6', HC-10',
HC-10"), 2.01 (lH, ddd, J = 2.5, 3.5, 11 Hz, HC-6"), 1.81 (lH, ddd, J = 3, 6.5, 13.5 Hz,
HC-10'), 1.71 (lH, ddd, J= 3.5, 12, 13.5 Hz, HC-10").
13
C NMR (125 MHz, CDCh) 8212.86 (s, C-4), 110.55 (s, C-5'), 110.28 (s, C-5"), 72.76
(d, C-1 I), 67.35 (d, C-1 "), 64.91 (t, CH20), 64.89 (t, CH20), 64.42 (t, CH20), 64.26 (t,
CH20), 55.00 (d, C-3), 52.78 (d, C-5), 46.71 (d, C-6"), 45.90 (d, C-6'), 36.28 (t, C-10"),
34.43 (t, C-10'), 31.93 (t, C-2), 30.70 (t, C-6), 30.07 (t, C-7'), 27.00 (t, C-9'), 26.70 (t, C-
9"), 26.24 (t, C-7").
LRMS (EI), m/z (relative intensity): 492 ([M]+, 0.2),188 (12),159 (8),132 (41),115
(8),99 (100), 86 (24), 55 (10).
227
HRMS m/z calcd for C21H3207S3 492.1310, found 492.1316 (EI).
(3R,5R)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-
(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (171c)
10"
171c
From isomerization of 170a : See experimental procedure for compound 170b.
From hydrolysis of 175b : Following General procedure K for MOM hydrolysis
aldol 175b (8 mg, 0.015 mmol) gave a mixture which was fractionated by PTLC (70%
ethyl acetate in hexane) to give recovered 175b (2 mg, 24%) and titled compound 171c
(5 mg, 67%).
-I
IR (DRIFT) Vmax 3504, 2916, 1710, 1427, 1261, 1108, 1052, 734 cm .
IH NMR (500 MHz, CDC!)) 8 4.82 (lH, ddd, J = 0.5, 1, 9 Hz, HC-1 "), 4.23 (lH, ddd, J
= 3.5, 4,8.5 Hz, HC-1'), 4.15-3.93 (8H, m, H2CO), 3.90 (lH, d, J = 3.5 Hz, HOC-I'),
3.39 (lH, dd, J = 11, 13.5 Hz, HC-2), 3.17 (lH, ddd, J = 4, 4.5, 11 Hz, HC-3), 3.10 (lH,
dd, J = 4.5, 13.5 Hz, HC-6), 3.04-2.96 (2H, m, HC-7', HC-7"), 3.03 (lH, d, J = 1 Hz,
HOC-I"), 2.95 (lH, ddd, J= 4.5,5,9 Hz, HC-5), 2.87-2.74 (4H, m, HC-2, HC-7', HC-
9', HC-9"), 2.72-2.59 (3H, m, HC-6, HC-7", HC-9'), 2.54 (lH, br d, J = 13.5 Hz, HC-
9"),2.46 (lH, m, HC-6'), 2.21-2.14 (2H, m, HC-10', HC-10"), 2.00 (IH, ddd, J= 0.5,
3.5, 11 Hz, HC-6"), 1.82 (lH, ddd, J = 3, 6, 13.5 Hz, HC-10'), 1.74 (lH, ddd, J = 3.5,
12.5, 13.5 Hz, HC-10").
13C NMR (125 MHz, CDC!)) 8 211.26 (s, C-4), 110.46 (s, C-5'), 110.15 (s, C-5"), 72.86
(d, C-1'), 68.69 (d, C-1"), 65.12 (t, CH20), 64.87 (t, CH20), 64.54 (t, CH20), 64.28 (t,
CH20), 54.65 (d, C-5), 52.58 (d, C-3), 47.25 (d, C-6"), 45.50 (d, C-6'), 36.43 (t, C-10"),
33.91 (t, C-10'), 33.80 (t, C-2), 32.23 (t, C-6), 29.44 (t, C-7'), 26.99 (t, C-9'), 26.76 (t, C-
9"), 26.22 (t, C-7").
228
LRMS (EI), m/z (relative intensity): 492 ([Mt, 1), 188 (15),159 (16),133 (11),132
(68), 99 (100), 86 (23), 55 (14).
HRMS m/z calcd for C21H3207S3 492.1310, found 492.1307.
(3R,5S)-rel-3-[(8)-(68)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl] -5-[(8)-
(6R)-1 ,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4H-thiopyran-4-
one (171d)
10"
171d
From isomerization of 170a : See experimental procedure for compound 170b.
1
H NMR (500 MHz, CDCh) 8 4.59 (1H, ddd, J= 2,5,5 Hz, HC-1"), 4.15 (lH, ddd, J=
3.5, 3.5, 7.5 Hz, HC-1'), 4.10-3.95 (8H, m, H2CO x4), 3.98 (1H, d, J= 3.5 Hz, HOC-I'),
3.29 (lH, dd, J = 11.5, 13 Hz, HC-2), 3.19 (1H, d, J = 2 Hz, HOC-I"), 3.17 (lH, ddd, J
= 3.5, 4.5,12.5 Hz, HC-6), 3.09 (lH, ddd, J= 4.5,5,10.5 Hz, HC-5), 3.05-2.91 (3H, m,
HC-6, HC-2, HC-7"), 3.00 (lH, ddd, J = 3.5, 5, 11.5 Hz, HC-3), 2.84 (lH, dd, J = 2.5,
13.5 Hz, HC-7'), 2.84-2.61 (5H, m, HC-7", H2C-9', H2C-9"), 2.54 (lH, dd, J = 7, 13.5
Hz, HC-7'), 2.46 (lH, ddd, J= 2.5,7, 7.5 Hz, HC-6'), 2.16 (lH, ddd, J= 3.5,9, 13.5 Hz,
HC-10'), 2.10 (lH, ddd, J = 3.5, 5, 9 Hz, HC-6"), 2.07 (lH, ddd, J = 3, 6.5, 13.5 Hz,
HC-10"), 1.82 (lH, ddd, J= 3.5,7.5, 13.5 Hz, HC-10'), 1.77 (lH, ddd, J= 3.5, 10, 13.5
Hz, HC-10").
13C NMR (125 MHz, CDCh) 8212.97 (s, C-4), 110.40 (s, C-5'), 109.80 (s, C-5"), 73.16
(s, C-1 '), 67.58 (d, C-1 "), 64.81 (t, CH20), 64.64 (t, CH20), 64.57 (t, CH20), 64.33 (t,
CH20), 58.08 (d, C-5), 55.34 (d, C-3), 46.57 (d, C-6"), 46.57 (d, C-6'), 35.51 (t, C-10"),
35.35 (t, C-2), 34.51 (t, C-10'), 32.60 (t, C-6), 30.09 (t, C-7'), 27.66 (t, C-7"), 26.93 (t,
C-9'), 26.78 (t, C-9").
LRMS (EI), m/z (relative intensity): 492 ([M]+, 1), 304 (5), 286 (6), 188 (9), 156 (6),
132 (53), 99 (100), 86 (23).
HRMS m/z calcd for C21H3207S3 492.1310, found 492.1321 (EI).
229
(3R)-rel-3-[(R)-(6R)-1 ,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl] tetrahydro-4H-thiopyran-4-one (172)
~
2' 3' 0(\~~
10' l_~ l' l_) 5
9' S 7' 2 S 6 172
Following General procedure L for MOM protection, aldol 128a (1.043 g, 3.426
mmol) upon workup gave a light yellow oil which later solidified (1.432g) when dried
under vacuum (0.5 torr). The solid (1.432 g) was suspended in ethyl acetate (10 mL)
and refluxed for 8 minutes and a. yellow saturated solution was obtained. Product 172
crystallized from solution upon standing at rt for 4 h, the mixture was then stored
overnight (12 h) in a refrigerator (5°C). The fine needle-like crystals were washed with
cold hexane (0 °C) and gave pure crystals of 172 (1. 1909, 99%).
-I
IR (DRIFT) Vmax 2957, 1707, 1164, 1149, 1097, 1055, 1034, 894 cm .
1
H NMR (500 MHz, CDC!)) 84.88 (1H, dd, J= 3,3 Hz, HC-l'), 4.69 (IH, d, J= 6.5
Hz, HC02), 4.63 (IH, d, J = 6.5 Hz, HC02), 3.97 (1H, m, H2CO), 3.90-3.82 (2H, m,
H2CO), 3.77 (IH, m, H2CO), 3.36 (3H, s, H3CO), 3.30 (1H, ddd, J = 3, 5.5, 10.5 Hz,
HC-3), 3.02-2.87 (5H, m, H2C-2, H2C-6, HC-7'), 2.86 (IH, ddd, J= 2.5, 13, 13 Hz, HC-
9'),2.83 (IH, ddd, J= 3,3,13 Hz, HC-7'), 2.77 (IH, ddd, J= 4, 4, 13.5 Hz, HC-5), 2.68
(1H, ddd, J = 5.5, 11.5, 13.5 Hz, HC-5), 2.51 (1H, ddd, J = 3, 3.5, 4, 13.5 Hz, HC-9'),
2.43 (IH, ddd, J= 3, 3,12 Hz, HC-6'), 2.07 (IH, ddd, J= 2.5, 4, 13.5 Hz, HC-I0'), 1.73
(1H, ddd, J= 3.5, 13, 13.5 Hz, HC-I0').
13
C NMR (125 MHz, CDC!)) 8 208.88 (s, C-4), 108.92 (s, C-5'), 97.52 (t, OCH20),
71.77 (d, C-l '), 64.46 (t, CH20), 64.23 (t, CH20), 56.22 (q, CH30), 55.78 (d, C-3),
50.88 (t, C-6'), 44.46 (t, C-5), 37.09 (t, C-I0'), 32.12 (t, C-2), 30.29 (t, C-6), 28.07 (t, C-
7'), 27.02 (t, C-9').
LRMS (EI), m/z (relative intensity): 348 ([M]+, 2), 286 (18), 224 (10), 159 (13), 133
(24), 132 (65), 99 (100), 55 (14).
HRMS m/z calcd for CIsH240SS2 348.1065, found 348.1062.
230
(3R)-rel-3-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]3,6-dihydro--2H-thiopyran-4-yloxy]-trimethylsilane
~
2' 3' 0
I\~~MS
10' l_:J l' lJ 5
9' 8 7' 2 '8 6 172a
BuLi (2.7 mL, 4.0 mmol) in hexane was added dropwise over 4 minutes to a
solution of i-Pr2NH (0.60 mL, 4.3 mmol) in THF (8 mL) at 0 °C. The solution was then
stirred for a further 5 minutes at 0 °C and then cooled to -78°C. A solution* of ketone
172 (347 mg, 0.995 mmol) and TMSCI (1.26 mL, 9.95 mmol) in THF (2 mL) was
added dropwise over 4 minutes to the above LDA solution. The reaction was stirred for
30 minutes at -78°C. Et3N (2.80 mL, 20 mmol) was added and the cooling bath was
removed. After stirring for 1 minute, saturated NaHC03 (10 mL) was added and after 2
minutes, the mixture was diluted 'Yith distilled H20 (40 mL) and extracted with CH2Ch
(3x50 mL). The combined organic layers were dried over Na2S04 and concentrated to
give 172a as an orange oil that solidified under vacuum (0.5 torr) (431 mg, 100%; 98%
pure by IH NMR).
1
H NMR (500 MHz, CDC!)) 8 5.05 (lH, br d, J = 6.5 Hz, HC-5), 4.59 (lH, d, J = 6.5
Hz, HC02), 4.57 (1H, dd, J = 2.5, 5.0 Hz, HC-1'), 4.49 (lH, d, J = 6.5 Hz, HC02),
3.94-3.81 (4H, m, H2CO x2), 3.28 (3H, s, H3CO), 3.23 (lH, ddd, J = 2.5, 2.5, 16 Hz,
HC-6), 2.96 (lH, dd, J= 9.5,13.5 Hz, HC-7"), 2.87-2.70 (5H, m), 2.59 (lH, m, HC-3),
2.49 (lH, br d, J = 13.5 Hz, HC-9"), 2.45 (1H, ddd, J = 4.5, 5.0, 9.5 Hz, HC-6"), 2.02
(lH, ddd, J = 3, 5, 13.5 Hz, HC-10"), 1.65 (lH, ddd, J = 3.5, 11.5, 13.5 Hz, HC-10"),
0.13 (9H, s, (H3C)3Si).
13C NMR (125 MHz, CDC!)) 8 152.71 (s), 109.24 (s), 104.14 (d), 97.93 (t), 74.72 (d),
64.37 (t), 64.14 (t), 56.28 (q), 50.71 (d), 43.75 (d), 36.89 (t), 29.49 (t), 27.28 (t), 27.20
(t), 25.25 (t), 0.52 (q x3).
• Gentle heating to facilitate its dissolution. This solution was allowed to cool to rt before addition of
TMSCI.
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(38,5S)-rel-3-[(8)-(68)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl] -5-[(8)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (173a)
~
2" 3" 0 3' 2'~I\
: 0 0
3 -
10"
173a
From aldol reaction of 125a and 172 (Ti enolate): TiCl4 (15 ~L, 0.137 mmol)
was added dropwise over 5 seconds to a solution of ketone 172 (43.1 mg, 0.124 mmol)
in CH2Ch (2 mL) at -78°C (a chunky-globular yellow precipitate formed). The
reaction was stirred for 1 minute and gave a fine yellow suspension. i-Pr2EtN (32 ~L,
0.19 mmol) was added dropwise over 5 seconds and the reaction was stirred for 1 hat
-78°C. Upon addition of i-Pr2EtN the yellow suspension changed to a red solution and
any remaining precipitate slowly dissolved during the 1 hr period. A solution of
aldehyde 125a (47 mg, 0.25 mmol) in CH2Ch (0.5 mL) was added dropwise over 1
minute and the reaction was stirred for 3 h at -78°C (the solution remained red during
the 3 h). MeOH:H20 (2:1, 2 mL) was added with vigorous stirring and the cooling bath
was removed. After 10 seconds, NH4CI (5 mL, 1 M) was added and the over 1 minute
the colour changed from red to light yellow. The mixture was diluted with distilled H20
(40 mL) and extracted with CH2Ch (3x30 mL). The combined organic layers were
dried over Na2S04 and concentrated to give a light yellow oil (110 mg). The oil was
fractionated by MPC (40% ethyl acetate in hexane) to give recovered aldehyde 125a
(23 mg, 48%), recovered ketone 172 (20 mg, 46%), titled compound 173a (28 mg,
41%) and 173b (9 mg, 13%).
From aldol reaction of 125a and 172 (Li-enolate) : A solution of MeLi in hexane
(1.5M, 0.6 mL, 0.90 mmol) was added dropwise over 30 seconds to a stirred solution of
enolsilane 172a (370 mg, 0.88 mmol) and a spatula point of 1,10-phenanthroline in
THF (3 mL) at 0 °C. The resultant deep red solution was stirred for 5 minutes at 0 °C
and was then cooled to -78°C. A solution of aldehyde 125a (332 mg, 1.76 mmol) in
THF (0.5 mL) was added dropwise over 15 seconds and the resultant yellow solution
232
was stirred for 2 minutes at -78°C. A solution of acetic acid (85 mg, 1.4 romol) in THF
(1 mL) was added to the vigorously stirred reaction mixture and the cooling bath was
removed. After 30 seconds a solution ofMeOH (2 mL) and phosphate buffer (1 mL, pH
7, 0.1 M) was added. After 1 minute, the mixture was diluted with additional phosphate
buffer (50 mL) and extracted with CH2Ch (4x40 mL). The combined organic extracts
were dried over Na2S04 and concentrated to give a light orange oil (682 mg). The oil
was fractionated by FC (40-70% ethyl acetate in hexane; gradient elution) to give
recovered aldehyde 125a (206 mg, 62%), ketone 172 (115 mg, 37%), titled compound
173a (59 mg, 12%), 173b (132 mg, 28%) and 173c (38 mg, 8%).
-1
IR (DRIFT) Vmax 3504, 2913, 1696, 1427, 1261, 1152, 1032, 894 cm .
1
H NMR (500 MHz, CDCh) 8 4.89 (IH, ddd, J = 1.5, 2, 9 Hz, HC-1 "), 4.71 (lH, d, J =
6.5 Hz, HC02), 4.69 (1H, dd, J = 3, 3 Hz, HC-1'), 4.64 (1H, d, J = 6.5 Hz, HC02),
4.14-3.95 (6H, m, HCO x6), 3.92 (lH, ddd, J= 7, 7, 7.5 Hz, HCO), 3.87 (lH, ddd, J=
7, 7.5, 7.5 Hz, HCO), 3.36 (3H, s, H3CO), 3.25 (1H, d, J = 1.5 Hz, HOC-l "), 3.15-2.92
(6H, m, H2C-2, H2C-6, HC-7', HC-7",), 3.13 (1H, ddd, J= 3,5.5,10.5 Hz, HC-3), 2.95
(IH, ddd, J= 4.5,4.5,9 Hz, HC-5), 2.86 (lH, ddd, J= 2.5,13,13 Hz, HC-9'), 2.83-2.75
(3H, m, HC-7', HC-7", HC-9"), 2.55-2.49 (2H, m, HC-9', HC-9"), 2.46 (1H, ddd, J= 3,
3, 11.5 Hz, HC-6'), 2.12 (lH, ddd, J = 2.5, 5, 13.5 Hz, HC-I0"), 2.09 (lH, ddd, J = 2.5,
4,13.5 Hz, HC-10'), 1.81 (1H, ddd, J= 2,3,11 Hz, HC-6"), 1.74 (lH, ddd, J= 3.5,13,
13 Hz, HC-10'), 1.64 (1H, ddd, J= 3.5, 12, 13.5 Hz, HC-10").
13
C NMR (125 MHz, CDCh) 8 210.56 (s, C-4), 110.27 (s, C-5"), 108.90 (s, C-5'),
97.96 (t, OCH20), 73.81 (d, C-1 '), 66.47 (d, C-1 "), 64.95 (t, CH20), 64.68 (t, CH20),
64.43 (t, CH20), 64.11 (t, CH20), 56.35 (q, CH30), 54.98 (d, C-3), 54.75 (d, C-5),
51.04 (d, C-6'), 46.57 (d, C-6"), 37.03 (t, C-10'), 36.20 (t, C-I0"), 30.85 (t, C-2), 30.66
(t, C-6), 28.96 (t, C-7'), 27.15 (t, C-9'), 26.62 (t, C-9"), 26.11 (t, C-7").
LRMS (EI), m/z (relative intensity): 536 ([M]+, 1), 474 (7), 412 (5), 286 (8), 100 (11),
99 (100), 86 (15), 55 (19).
HRMS m/z calcd for C23H360gS3 536.1572, found 536.1579 (EI).
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(3R,5R)-rel-3-[(R)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]-5-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (173b)
~
a 3' 2'~{\
0 0 0
10"
173b
From aldol reaction of 125a and 172 : See both experimental procedures of
compound 173a.
-1
IR (DRIFT) Vmax 3506, 2895, 1710, 1428, 1261, 1167, 1040, 896 cm .
1
H NMR (500 MHz, CDCb) 84.90 (lH, ddd, J = 3, 4,9 Hz, HC-1 "), 4.79 (lH, d, J =
6.5 Hz, HC02), 4.71 (lH, dd, J = 2, 3 Hz, HC-1 '), 4.67 (lH, d, J = 6.5 Hz, HC02),
4.17-3.92 (6H, m, HCO x6), 3.85-3.77 (2H, m, HCO x2), 3.55 (lH, ddd, J = 2, 5, 11
Hz, HC-3), 3.38 (3H, s, H3CO), 3.06 (lH, dd, J = 11, 14 Hz, HC-2), 3.05 (lH, dd, J =
4.5, 14 Hz, HC-6), 3.01-2.93 (3H, m, HC-2, HC-7', HC-T'), 2.99 (lH, d, J = 3 Hz,
HOC-l "), 2.89 (IH, ddd, J = 2.5, 11, 13 Hz, HC-9'), 2.90-2.80 (2H, m, HC-5, HC-7'),
2.81 (lH, ddd, J= 3,11,13.5 Hz, HC-9"), 2.67 (lH, ddd, J= 2.5,4, 14 Hz, HC-6), 2.65
(lH, br d, J= 12 Hz, HC-T'), 2.58 (lH, br d, J= 13.5 Hz, HC-9"), 2.52 (lH, br d, J=
13 Hz, HC-9'), 2.45 (lH, ddd, J = 2, 3, 11.5 Hz, HC-6'), 2.20 (lH, ddd, J = 3, 4.5, 14
Hz, HC-10"), 2.06 (lH, ddd, J = 2.5, 4, 12 Hz, HC-10'), 2.05 (lH, ddd, J = 3.5, 4, 11
Hz, HC-6"), 1.77 (lH, ddd, J = 3.5, 11, 14 Hz, HC-10"), 1.74 (lH, ddd, J = 3.5, 11, 12
Hz, HC-10').
13C NMR (125 MHz, CDCb) 8 210.08 (s, C-4), 110.18 (s, C-5"), 108.86 (s, C-5'),
98.07 (t, OCH20), 73.26 (d, C-1 '), 68.84 (d, C-1 "), 65.07 (t, CH20), 64.94 (t, CH20),
64.57 (t, CH20), 64.32 (t, CH20), 56.31 (q, CH30), 54.52 (d, C-5), 54.06 (d, C-3),
51.44 (d, C-6'), 46.61 (d, C-6"), 37.41 (t, C-I0'), 36.42 (t, C-10"), 32.07 (t, C-6), 31.62
(t, C-2), 28.76 (t, C-7'), 27.14 (t, C-9'), 26.76 (t, C-9"), 26.03 (t, C-7").
LRMS (El), m/z (relative intensity): 536 ([M]+, 1), 286 (11), 159 (9), 133 (24), 132
(62), 99 (100), 86 (15), 55 (12).
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HRMS m/z calcd for C23H360gS3 536.1572, found 536.1581 (EI).
(3S,5R)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]-5-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl] tetrahydro-4H-thiopyran-4-one (173c)
~
o 3' 2'~{\
90 0
3 -
10"
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From aldol reaction of 125a and 172 (Li enolate) : See experimental procedure
of compound 173a.
-1
IR (DRIFT) Vmax 3520, 2914, 1697, 1427, 1099, 1034,892,731 cm .
1 .
H NMR (500 MHz, CDC!)) () 4.75 (lH, d, J = 6.5 Hz, HC02), 4.68 (lH, dd, J = 3, 3
Hz, HC-1 '), 4.66 (1H, d, J = 6.5 Hz, HC02), 4.24 (1H, ddd, J = 4.5, 5.5, 6.5 Hz, HC-
1"), 4.07-3.89 (6H, m, HCO x6), 3.86-3.73 (2H, m, HCO x2), 3.56 (lH, ddd, J = 3, 4.5,
12 Hz, HC-3), 3.39 (3H, s, H3CO), 3.12 (IH, d, J= 5.5 Hz, HOC-I"), 3.11 (1H, ddd, J
= 5, 6.5, 11.5 Hz, HC-5), 3.05-2.73 (8H, m, H2C-2, H2C-6, HC-7', HC-7", HC-9', HC-
9"), 2.55 (lH, m, HC-9"), 2.50 (1H, m, HC-9'), 2.39 (1H, ddd, J = 3, 3.5, 12 Hz, HC-6'),
2.09 (lH, ddd, J = 3, 5, 13.5 Hz, HC-10"), 2.08-2.01 (2H, m, HC-6", HC-10'), 1.72 (lH,
ddd, J= 3.5, 13, 13 Hz, HC-10'), 1.68 (1H, ddd, J= 3.5, 12, 13.5 Hz, HC-10").
13
C NMR (125 MHz, CDC!)) () 213.06 (s, C-4), 109.71 (s, C-5"), 108.91 (s, C-5'),
97.40 (t, OCH20), 71.85 (d, C-1'), 69.01 (d, C-1"), 64.64 (t, CH20), 64.64 (t, CH20),
64.62 (t, CH20), 64.23 (t, CH20), 57.92 (d, C-5), 57.41 (d, C-3), 56.32 (q, CH30),
50.94 (d, C-6'), 47.55 (d, C-6"), 37.28 (t, C-10'), 36.55 (t, C-10"), 35.33 (t, C-6), 34.99
(t, C-2), 27.92 (t, C-7'), 27.31 (t, C-7"), 27.04 (t, C-9'), 26.72 (t, C-9").
LRMS (FAB), m/z (relative intensity): 537 ([M+1]+, 23), 507 (15), 506 (23), 505 (87),
475 (26), 315 (11), 132 (11), 99 (100).
HRMS m/z calcd for C23H370gS3 537.1651 (M+H), found 537.1654 (FAB).
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(38)-rel-3-[(R)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]tetrahydro-4H-thiopyran-4-one (174)
~
2' 3' 0I\~~10' l_6~t1'_l_j 5
9' S 7' 2 S 6 174
Following General procedure L for MOM protection, aldol 129a (311.5 mg,
1.023 mmol) upon workup gave a light yellow oil (360 mg) which was fractionated by
MPC (35% ethyl acetate in hexane) to give the titled compound as a white solid (343
mg,96%).
-1
IR (DRIFT) Vmax 2909, 1708, 1428, 1264, 1153, 1032, 916, 730 cm .
1
H NMR (500 MHz, CDCb) 8 4.78 (1H, d, J = 7 Hz, HC02), 4.58 (IH, d, J = 7Hz,
HC02), 4.57 (1H, dd, J = 2, 8 Hz, HC-l'), 4.12-4.02 (3H, m, H2CO), 3.91 (IH, m,
H2CO), 3.13 (1H, ddd, J = 1.5, 5.5, 13.5 Hz, HC-2), 3.03 (IH, ddd, J = 4, 5.5, 8 Hz,
HC-3), 2.98 (1H, dd, J = 4, 13.5 Hz, HC-2), 2.95-2.89 (IH, m, HC-5), 2.93-2.91 (2H, br
s, H2C-6), 2.89-2.76 (3H, m, H2C-7', HC-9'), 2.62 (IH, m, HC-5), 2.53 (IH, br d, J =
13.5 Hz, HC-9'), 2.38 (IH, ddd, J = 2, 3.5, 11 Hz, HC-6'), 2.14 (1H, ~dd, J = 3, 5, 13.5
Hz, HC-I0'), 1.75 (IH,ddd, J= 3.5,12, 13.5 Hz, HC-I0').
13C NMR (125 MHz, CDCb) 8 209.38 (s, C-4), 108.43 (s, C-5'), 96.67 (t, OCH20),
76.42 (d, C-l'), 64.63 (t, CH20), 64.35 (t, CH20), 56.47 (q, CH30), 54.80 (d, C-3),
50.67 (d, C-6'), 43.01 (t, C-5), 36.63 (t, C-I0'), 33.68 (t, C-2), 31.09 (t, C-6), 28.93 (t,
C-7'), 26.86 (t, C-9').
LRM8 (El), m/z (relative intensity): 348 ([M]+, 3), 286 (18), 159 (14), 133 (25), 132
(66), 99 (100), 86 (12), 55 (19).
HRMS m/z calcd for ClsH240SS2 348.1065, found 348.1067.
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(3S,5S)-rel-3-[(R)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]-5-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (175a)
~
o 3' 2'~I\
0 0 0
10"
175a
From aldol reaction of 125a and 174 (Ti enolate) : Following the same
experimental procedure as described for compound 173a, the aldol reaction between
ketone 174 (58 mg, 0.17 mmol) and aldehyde 125a (94 mg, 0.50 mmol) upon workup
gave an oil (175 mg). The oil was fractionated by FCC (40-60% ethyl acetate in hexane;
gradient elution) and gave recovered aldehyde 125a (48 mg, 51 %), recovered ketone
174 (34 mg, 58%), titled compound 175a (17 mg, 19%) and 175b (8 mg, 9%).
-1
IR (DRIFT) Vmax 3515, 2914, 1705, 1427, 1261, 1130, 1033, 734 cm .
1
H NMR (500 MHz, CDCh) 8 4.72 (1H, ddd, J = 2, 2, 11 Hz, HC-1 "),4.71 (lH, d, J =
6.5 Hz, HC02), 4.66 (1H, d, J = 6.5 Hz, HC02), 4.52 (1H, dd, J = 1.5, 8 Hz, HC-1 '),
4.13-3.87 (8H, m, H2CO x4), 3.38 (3H, s, H3CO), 3.21 (lH, ddd, J= 2,4.5,13 Hz, HC-
2), 3.18-3.05 (4H, m, HOC-l ", HC-3, HC-5, HC-6), 3.02-2.73 (8H, m, HC-2, HC-6,
H2C-7', H2C-7", HC-9', HC-9"), 2.58-2.49 (2H, m, HC-9', HC-9"), 2.46 (lH, ddd, J =
1.5, 3, 11.5 Hz, HC-6'), 2.15-2.09 (2H, m, HC-10', HC-10"), 2.07 (lH, ddd, J = 2, 3,
10.5 Hz, HC-6"), 1.76 (lH, ddd, J= 3.5,12.5,13.5 Hz, HC-10'), 1.71 (lH, ddd, J= 3.5,
11.5, 14 Hz, HC-10"), ain C6D6 (,),5.04 (lH, ddd, J= 2,3,7.5 Hz, HC-1 "),4.74 (lH,
d, J = 6.5 Hz, HC02), 4.65 (IH, d, J = 6.5 Hz, HC02), 4.59 (IH, dd, J = 1.5, 8.5 Hz,
HC-l '), 3.68 (1H, ddd, J = 7, 7, 7 Hz, HCO), 3.54 (lH, ddd, J = 5.5, 7, 7 Hz, HCO),
3.48-2.95 (8H, m, HCO x6, H2C-6), 3.32 (lH, ddd, J = 4.5, 7.5, 10.5 Hz, HC-5), 3.24
(3H, s, H3CO), 3.21 (1H, ddd, J = 4, 6.5, 8.5 Hz, HC-3), 3.18 (lH, d, J = 2 Hz, HOC-
1"), 3.02 (IH, dd, J = 10.5, 13 Hz, HC-7"), 2.99 (lH, dd, J = 11.5, 13.5 Hz, HC-7'), 2.88
(1H, ddd, J = 1.5, 6.5, 13.5 Hz, HC-2), 2.77 (1H, dd, J = 4, 13.5 Hz, HC-2), 2.74-2.64
(2H, m, HC-9', HC-7'), 2.57 (lH, ddd, J= 2.5, 11, 13.5 Hz, HC-9"), 2.56 (IH, ddd, J=
1.5, 3.5, 11.5 Hz, HC-6'), 2.30 (1H, ddd, J = 3, 3.5, 10.5 Hz, HC-6"), 2.25 (lH, br d, J =
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13.5 Hz, HC-9"), 2.18 (lH, br d, J = 13.5 Hz, HC-9'), 1.74-1.67 (2H, m, HC-10', HC-
lO"), 1.62 (lH, ddd, J = 3.5, 12.5, 13 Hz, HC-10'), 1.53 (1H, ddd, J = 3.5, 11, 14.5 Hz,
HC-10").
13C NMR (125 MHz, CDCh) 0 211.21 (s, C-4), 110.34 (s, C-5"), 108.65 (s, C-5'),
97.18 (t, OCH20), 76.92 (d, C-1 '), 67.04 (d, C-1 "), 64.86 (t, CH20), 64.69 (t, CH20),
64.34 (t, CH20), 64.31 (t, CH20), 56.06 (q, CH30), 55.31 (d, C-3), 54.01 (d, C-5),
49.77 (d, C-6'), 46.42 (d, C-6"), 37.24 (t, C-10'), 35.95 (t, C-10"), 33.99 (t, C-6), 33.23
(t, C-2), 29.03 (t, C-7'), 26.92 (t, C-9' or C-9"), 26.78 (t, C-9" or C-9'), 26.38 (t, C-7").
LRMS (El), m/z (relative intensity): 536 ([Mt, 1), 286 (11), 159 (14), 133 (21), 132
(57), 99 (100), 86 (18), 55 (16).
HRMS m/z calcd for C23H360SS3 536.1572, found 536.1566 (El).
(3R,5R)-rel-3-[(S)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]-5-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (175b)
~
2" 3" 0 3' 2'~I\
90 0
3 -
10" l' 10'
175b
From aldol reaction of 125a and 174 : See experimental procedure for
compound 175a.
1H NMR (500 MHz, CDCh) 0 4.73 (lH, d, J= 6.5 Hz, HC02), 4.70 (lH, d, J= 6.5 Hz,
HC02), 4.50-4.45 (2H, m, HC-1', HC-1"), 4.13-3.90 (8H, m, H2CO x4), 3.39 (3H, s,
H3CO), 3.26-3.19 (2H, m, HC-2, HC-3), 3.17 (1H, d, J= 4.5 Hz, HOC-I"), 3.05 (lH,
ddd, J = 4.5, 7, 9 Hz, HC-5), 3.03 (1H, dd, J = 11.5, 14 Hz, HC-7"), 2.96-2.73 (7H, m,
HC-2, H2C-6,HC-7', HC-7', HC-9', HC-9"), 2.67 (1H, ddd, J= 2.5,2.5, 14 Hz, HC-7"),
2.60 (1H, br d, J= 13.5 Hz, HC-9'), 2.56-2.49 (2H, m, HC-6', HC-9"), 2.17-2.11 (2H,
m, HC-10', HC-10"), 2.03 (1H, ddd, J= 2.5.3,11.5 Hz, HC-6"), 1.77 (lH, ddd, J= 2.5,
11, 14 Hz, HC-10'), 1.73 (1H, ddd, J = 3.5, 13, 13.5 Hz, HC-10"), ain C6D6 (, ), 4.72
(lH, d, J = 6.5 Hz, HC02), 4.70 (lH, d, J = 6.5 Hz, HC02), 4.56 (lH, ddd, J = 3, 5.5, 7
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Hz, HC-l "), 4.52 (IH, dd, J = 2.5, 7 Hz, HC-l'), 3.60-3.20 (8H, m, HzCO x2), 3.33 (IH,
ddd,J= 4.5,7,7 Hz, HC-3), 3.25-3.17 (IH, m, HC-7"), 3.24 (lH, d,J= 5.5 Hz, HOC-
1"),3.23 (3H, s, H3CO), 3.11 (IH, ddd, J= 5,7,9 Hz, HC-5), 3.10-3.01 (2H, m, HC-2,
HC-7'), 2.86 (IH, br d, J= 13 Hz, HC-7'), 2.77 (lH, ddd, J= 2.5,2.5,14 Hz, HC-7"),
2.74 (IH, ddd, J = 3.5, 3.5, 10.5 Hz, HC-6'), 2.73-2.56 (6H, m, HC-2, HzC-6, HC-6',
HC-9', HC-9"), 2.31 (lH, br d, J = 13.5 Hz, HC-9'), 2.21 (IH, br d, J = 13.5 Hz, HC-
9"),2.12 (IH, ddd, J= 3,3,11 Hz, HC-6"), 1.75 (lH, ddd, J= 3, 5.5, 13.5 Hz, HC-I0'),
1.73 (IH, ddd, J= 3, 4.5,13.5 Hz, HC-I0"), 1.65-1.57 (2H, m, HC-I0', HC-I0").
13C NMR (l25 MHz, CDCb) 8 211.74 (s, C-4), 109.92 (s, C-5"), 108.67 (s, C-5'),
97.96 (t, OCHzO), 77.99 (d, C-l'), 68.83 (d, C-l"), 65.08 (t, CHzO), 64.71 (t, CHzO),
64.53 (t, CHzO), 64.29 (t, CHzO), 56.48 (q, CH30), 54.58 (d, C-5), 54.43 (d, C-3),
49.54 (d, C-6'), 47.72 (d, C-6"), 36.99 (t, C-I0"), 36.24 (t, C-I0'), 33.78 (t, C-2), 33.51
(t, C-6), 28.94 (t, C-7'), 26.94 (t, C-9'), 26.76 (t, C-9"), 26.65 (t, C-7"), a in C6D6,
211.15 (s, C-4), 110.35 (s, C-5"), 109.19 (s, C-5'), 98.55 (t, OCHzO), 78.98 (d, C-l'),
69.87 (d, C-l "), 65.04 (t, CHzO), 64.66 (t, CHzO), 64.51 (t, CHzO), 64.17 (t, CHzO),
56.25 (q, CH30), 55.40 (d, C-5), 55.02 (d, C-3), 50.11 (d, C-6'), 48.75 (d, C-6"), 37.53
(t, C-I0"), 36.93 (t, C-I0'), 33.99 (t, C-2), 33.90 (t, C-6), 29.52 (t, C-7'), 27.50 (t, C-7"),
27.29 (t, C-9'), 27.09 (t, C-9").
LRMS (El), m/z (relative intensity): 536 ([M]+, 1), 286 (9), 159 (11), 133 (15), 132
(50), 99 (l00), 86 (18), 55 (21).
HRMS m/z calcd for CZ3H360gS3 536.1572, found 536.1576 (El).
(2R,6R)-rel-2-[(S)-Hydroxyphenylmethyl]-6-methylcyclohexanone (21Oac)
~PhSU3 1
4 210ac
BuLi (4.0 mL, 10 mmol, 2.5 M) in hexane was added dropwise over 5 minutes
to a solution of i-PrzNH (1.5 mL, 11 mmol) in THF (10 mL) at 0 °C. The solution was
stirred for a further 5 minutes at 0 °C and then cooled to -78°C. A solution of 2-
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methylcyclohexanone (557 mg, 4.97 romol) in THF (0.5 mL) was added dropwise over
30 seconds to the above LDA solution and stirred for a further 30 minutes.
Benzaldehyde (0.60 mL, 6.00 romol) was then added over 10 seconds. After 3 minutes,
the reaction was poured onto ice-cold NH4CI(20 mL, 0.1 M) with vigorous stirring.
The mixture was diluted with distilled H20 (60 mL) and extracted with CH2Ch (3x40
mL). The combined organic layers were dried over Na2S04 and concentrated to give a
clear oil that was a 9:21 :46:24 mixture of 210sc, 210st, 210at and 210ac (1.32 g),
respectively as determined by IH NMR. The oil was fractionated by MPC (10-30%
ethyl acetate in hexane; gradient elution) to give 210sc (65 mg, 6%; 95% diastereomeric
purity by IH NMR), the titled compound 210ac (173 mg, 16%; 98% diastereomeric
purity by IH NMR), 210at (336 mg, 31 %; 95% diastereomeric purity by IH NMR) and
a 5:1 mixture of 210st and 210ac, respectively (130 mg, 12%). To obtain highly
enriched samples, 10 mg of each of the above enriched samples were further purified by
PTLC (2% MeOH in CH2Ch) to give samples with >99% diastereomeric purity by IH
NMR.
1
H NMR (500 MHz, CDCb) 8 7.38-7.26 (5H, m, ArH), 4.80 (IH, dd, J = 3, 8.5 Hz,
HC-I'), 3.91 (1H, d, J = 3 Hz, HO), 2.64 (lH, dddd, J = 1, 5.5, 8.5, 13 Hz, HC-2), 2.47
(1H, dddq, J= 1,6,13,6.5 Hz, HC-6), 2.12 (1H, ddddd, J= 3,3,3,6,13 Hz, HC-5),
1.77 (IH, m, HC-4), 1.69-1.56 (2H, m, HC-3, HC-4), 1.39 (IH, dddd, J = 4, 13, 13, 13
Hz, HC-5), 1.33 (1H, dddd, J= 4, 13, 13, 13 Hz, HC-3), 1.07 (3H, d, J= 6.5 Hz, H3C).
13C NMR (125 MHz, CDCb) 8 216.97 (s, C-I), 141.35 (s, Ar), 128.57 (d x2, Ar ),
128.05 (d, Ar), 127.22 (d x2, Ar), 74.93 (d, C-I'), 57.89 (d, C-2), 46.42 (d, C-6), 37.39
(t, C-5), 32.10 (t, C-3), 25.16 (t, C-4), 14.43 (q, CH3).
(2S,6R)-rel-2-[(R)-Hydroxyphenylmethyl]-6-methylcyclohexanone (210at)
~PhSV3 1
4 210at
For synthesis and isolation see experimental procedure for compound 210ac.
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1
H NMR (500 MHz, CDC!)) 8 7.39-7.28 (5H, m, ArH), 4.86 (lH, dd, J = 3, 9.5 Hz,
HC-1 '), 3.42 (lH, d, J = 3 Hz, HO), 2.76 (1H, ddd, J = 5.5, 9.5, 9.5 Hz, HC-2), 2.70
(lH, ddq, J = 5, 5.5, 7 Hz, HC-6), 1.96 (lH, m, HC-5), 1.74-1.63 (3H, ffi, HC-4, HC-4,
HC-5), 1.55 (1H, m, HC-3), 1.37 (1H, m, HC-3), 1.21 (3H, d, J = 7 Hz, H3C).
13C NMR (125 MHz, CDC!)) 8 218.16 (s, C-1), 141.51 (s, Ar), 128.73 (d x2, Ar),
128.32 (d, Ar), 127.19 (d x2, Ar), 75.01 (d, C-l'), 54.88 (d, C-2), 44.48 (d, C-6), 34.23
(t, C-5), 30.09 (t, C-3), 20.26 (t, C-4), 16.47 (q, CH3).
(2R,6R)-rel-2-[(R)-Hydroxyphenylmethyl]-6-methylcyclohexanone (210sc)
~PhSU3 1
4 210sc
For synthesis and isolation see experimental procedure for compound 210ac.
1H NMR (500 MHz, CDC!)) 8 7.37-7.23 (5H, m, ArH), 5.38 (lH, dd, J = 2.5, 3 Hz,
HC-l'), 3.15 (lH, d, J= 3 Hz, HO), 2.61 (1H, dddd, J= 1.5,2.5,6.5,12.5 Hz, HC-2),
2.50 (lH, dddq, J = 1.5, 5.5, 12.5, 6.5 Hz, HC-6), 2.12 (lH, ddddd, J = 2.5, 2.5, 3.5, 5.5,
13 Hz, HC-5), 1.86-1.75 (2H, m, HC-3, HC-4), 1.74 (IH, dddd, J = 3.5, 12.5, 12.5, 13
Hz, HC-3), 1.60 (1H, ddddd, J= 3.5,4.5,12.5,12.5, 13 Hz, HC-4), 1.40 (lH, dddd, J=
3.5, 12.5, 12.5, 13 Hz, HC-5), 1.06 (3H, d, J= 6.5 Hz, H3C).
13C NMR (125 MHz, CDC!)) 8 216.76 (s, C-l), 141.81 (s, Ar), 128.36 (d x2, Ar),
127.15 (d, Ar), 125.96 (d x2, Ar), 70.97 (d, C-1'), 57.43 (d, C-2), 46.34 (d, C-6), 37.65
(t, C-5), 27.05 (t, C-3), 25.13 (t, C-4), 14.50 (q, CH3).
(2S,6R)-rel-2-[(S)-Hydroxyphenylmethyl]-6-methylcyclohexanone (210st)
~PhSV3 1
4 210st
For synthesis and isolation see experimental procedure for compound 210ac.
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1
H NMR (500 MHz, CDCb) () 7.39-7.24 (5H, m, ArH), 5.32 (lH, br d, J = 3 Hz, HC-
I'), 2.84 (1H, br s, HO), 2.77 (lH, ddd, J = 3, 5.5, 10 Hz, HC-2), 2.60 (lH, ddq, J = 5,
5.5, 7 Hz, HC-6), 1.92 (lH, m, HC-5), 1.83 (1H, m, HC-3), 1.74-1.65 (2H, m, HC-4,
HC-4), 1.71 (1H, m, HC-5), 1.69 (1H, m, HC-3), 1.18 (3H, d, J= 7 Hz, H3C).
13
C NMR (125 MHz, CDCb) () 217.96 (s, C-1), 141.85 (d, Ar), 128.45 (d x2, Ar),
127.41 (d, Ar), 126.07 (d x2, Ar), 71.62 (d, C-1'), 53.86 (d, C-2), 45.21 (d, C-6), 33.68
(t, C-5), 25.87 (t, C-3), 20.03 (t, C-4), 16.71 (q, CH3).
(3S,6S)-rel-Tetrahydro-3-[(R)-hydroxyphenylmethyl]-5-methyl-4H-thiopyran-4-
one (21Iat)
~Ph
4 21lat
Following the same procedure as described for the synthesis of 210ac, the aldol
reaction of 2-methylthiopyranone (196 mg, 1.51 mmol) and benzaldehyde (230 f-lL,
2.26 mmol) upon workup gave a light yellow oily 1 : 2.6 : 1.5 mixture of 211st, 211at,
211ac, respectively as determined by IH NMR. The oil was fractionated by FCC (25%
ethyl acetate in hexane) and two fractions were obtained. The first fraction was an oily
4.4 : 1 : 7.2 mixture of 211st, 21lat and 211ac, respectively (106 mg, combined aldol
yield 30%). The second fraction was an oil which later solidified upon standing
consisting of a 1 : 10 : 1 mixture of 211st, 21lat and 211ac, respectively (143 mg,
combined aldol yield 40%). A portion of the second fraction (57 mg) was dissolved in
the minimum amount of hot CH2Chihexane (1:2, 1.5 mL). Upon cooling to 0 °C
crystals of the titled compound 21lat (43 mg) were obtained.
-I
IR (DRIFT) Vmax 3445, 2912, 1706, 1454, 1039, 1024, 768, 701 cm .
1
H NMR (500 MHz, CDCb) 8 7.43-7.32 (5H, m, ArH), 5.30 (lH, dd, J = 3.5, 9.5 Hz,
HC-1'), 3.09 (lH, ddq, J= 4.5,9,6.5 Hz, HC-5), 3.01 (1H, ddd, J= 4,6.5,9.5 Hz, HC-
3), 3.01 (lH, ddd, J = 2, 4.5, 13 Hz, HC-6), 2.73 (lH, d, J = 3.5 Hz, HO), 2.72 (lH, dd,
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J = 4, 14 Hz, HC-2), 2.70 (IH, dd, J = 9, 13 Hz, HC-6), 2.46 (IH, ddd, J = 2, 6.5, 14
Hz, HC-2), 1.27 (3H, d, J = 6.5 Hz, H3C).
13
C NMR (125 MHz, CDCh) () 213.02 (s, C-4), 141.16 (s, Ar), 129.02 (d x2, Ar),
128.75 (d, Ar), 127.04 (d x2, Ar), 74.29 (d, C-l'), 58.02 (d, C-3), 45.55 (d, C-5), 37.68
(t, C-6), 32.89 (t, C-2), 15.55 (q, CH3).
LRMS (EI), m/z (relative intensity): 236 ([M]+, 1), 130 (100), 129 (26), 107 (36), 97
(39), 87 (33), 79 (27), 77 (30).
HRMS m/z calcd for C13HI60 2S 236.0871, found 236.0869 (EI).
(3R,6S)-rel-Tetrahydro-3-[(R)-hydroxyphenylmethyl]-5-methyl-4H-thiopyran-4-
one (21Isc)
ffPh
5 S 3
4 21lsc
A 4.4:1:7.2 mixture of 211st, 21lat and 21lac (37.6 mg)*, respectively was
added to a solution of imidazole (109 mg, 1.6 mmol) in CH2Ch (2 mL) and the solution
was stirred for 4 days at rt. The solution was diluted with citric acid (20 mL, 0.1 M) and
extracted with CH2Ch (3 x20 mL). The organic extracts were combined, dried over
Na2S04 and concentrated to give a 4:2.8: 1:2.1 mixture of 211at, 211ac, 21lst and
211sc, respectively (35.3 mg, 94% mass recovery) as determined by I H NMR.
Fractionation by PTLC (2% MeOH in CH2Ch) gave 21lsc (10.1 mg, 27%), 21lat (10.8
mg, 29%), 21lst (7.1 mg, 19%) and 21lat (9.5 mg, 25%).t
-1
IR (DRIFT) Ymax 3532, 2971, 2929, 1706, 1451, 1070, 1016, 703 cm .
1
H NMR (500 MHz, CDCh) () 7.39-7.25 (5H, m, ArH), 5.38 (lH, br dd, J = 1.5, 3 Hz,
HC-1'), 3.12 (lH, d, J= 1.5 Hz, HO), 3.07 (lH, dd, J= 12, 12.5 Hz, HC-2), 3.01 (lH,
ddd, J = 3, 3.5, 12 Hz, HC-3), 2.92 (lH, ddq, J = 5, 12, 6.5 Hz, HC-5), 2.88 (lH, ddd, J
* See experimental procedure for compound 211at for the origin of this mixture.
t Aldols are reported in order from higher to lower Rfo
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= 3, 5, 13 Hz, HC-6), 2.73 (lH, dd, J = 12, 13 Hz, HC-6), 2.68 (lH, ddd, J = 3, 3.5, 12.5
Hz, HC-2), 1.14 (3H, d, J= 6.5 Hz, H3C).
13
C NMR (125 MHz, CDC!)) () 214.12 (s, C-4), 140.98 (s, Ar), 128.61 (d x2, Ar),
127.56 (d, Ar), 125.94 (d x2, Ar), 71.16 (d, C-1'), 60.09 (d, C-3), 49.31 (d, C-5), 39.07
(t, C-6), 30.85 (t, C-2), 14.72 (q, CH3).
LRMS (EI), m/z(relative intensity): 236 ([Mt, 5), 189 (35), 130 (100), 107 (52),105
(30), 97 (41), 79 (53), 77 (54).
HRMS m/z calcd for C13H1602S 236.0871, found 236.0875 (EI).
(3R,6S)-rel-Tetrahydro-3-[(S)-hydroxyphenylmethyl]-5-methyl-4H-thiopyran-4-
one (21Iac)
~Ph
5 S 3
4 21lac
For synthesis and isolation see experimental procedure for compound 211sc.
-I
IR (DRIFT) Vmax 3524, 2974, 2904, 1695, 1453, 1290, 1050, 701 cm .
1
H NMR (500 MHz, CDCh) () 7.40-7.30 (5H, m, ArH), 4.86 (lH, dd, J= 3.5, 8.5 Hz,
HC-1 '), 3.54 (lH, d, J = 3.5 Hz, HO), 3.09 (lH, ddd, J = 4.5, 8.5, 12.5 Hz, HC-3), 2.91
(1H, ddq, J = 4.5, 13, 6.5 Hz, HC-5), 2.90 (lH, ddd, J = 3, 4.5, 14.5 Hz, HC-6), 2.73
(lH, dd, J= 13, 14.5 Hz, HC-6), 2.66 (lH, dd, J= 12.5, 13.5 Hz, HC-2), 2.44 (lH, ddd,
J = 3, 4.5, 13.5 Hz, HC-2), 1.15 (3H, d, J = 6.5 Hz, H3C).
13C NMR (125 MHz, CDC!)) () 214.19 (s, C-4), 140.46 (s, Ar), 128.87 (d x2, Ar),
128.48 (d, Ar), 127.20 (d x2, Ar), 74.08 (d, C-1'), 60.62 (d, C-3), 49.37 (d, C-5), 39.04
(t, C-6), 34.29 (t, C-2), 14.70 (q, CH3).
LRMS (EI), m/z (relative intensity): 236 ([M]+, 4), 189 (23), 130 (100), 107 (45), 97
(46), 88 (37), 79 (30), 77 (28).
HRMS m/z calcd for C13H1602S 236.0871, found 236.0874 (EI).
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(3S,6S)-rel-Tetrahydro-3-[(S)-hydroxyphenylmethyl]-5-methyl-4H-thiopyran-4-
one (211st)
ffPh
5 S/3
4 211st
For synthesis and isolation see experimental procedure for compound 211st.
-1
IR (DRIFT) Vmax 3389,2920, 1701, 1452, 1036, 1025, 766, 701 cm .
1
H NMR (500 MHz, CDCh) 8 7.41-7.27 (5H, m, ArH), 5.43 (lH, dd, J= 4,4 Hz, HC-
1'),3.13 (lH, ddd, J= 1,9.5,13 Hz, HC-2), 3.07 (1H, ddd, J= 1,4.5,13.5 Hz, HC-6),
3.07 (lH, ddd, J = 4,4,9.5 Hz, HC-3), 2.89 (lH, ddq, J = 4.5, 7, 7 Hz, HC-5), 2.72 (lH,
d, J = 4 Hz, HO), 2.71 (1H, ddd, J = 2, 4, 13 Hz, HC-2), 2.67 (lH, ddd, J = 2, 7, 13.5
Hz, HC-6), 1.26 (3H, d, J = 7 Hz, H3C).
13
C NMR (125 MHz, CDCh) 8 213.70 (s, C-4), 140.98 (s, Ar), 128.78 (d x2, Ar),
127.98 (d, Ar), 126.16 (d x2, Ar), 71.86 (d, C-1 I), 56.63 (d, C-3), 46.57 (d, C-5), 36.63
(t, C-6), 29.62 (t, C-2), 15.97 (q, CH3).
LRMS (EI), m/z (relative intensity): 236 ([M]+, 3), 130 (100), 107 (40), 97 (33), 88
(38), 79 (60), 77 (57), 55 (33).
HRMS m/z calcd for C13HI60 2S 236.0871, found 236.0871 (EI).
(3R,5S)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]-5-[(S)-(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]tetrahydro-4H -thiopyran-4-one (212a)
~ ~
2" 3" 0 0 3' 2'I\~ ~(\
o 0 0 0 0 0 0
10" 10'
212a
Following General procedure M for MOM protection, after 4 days the substrate
165b aldol (15 mg, 0.031mmol) gave a 4: 1 mixture of 212a and 213a, respectively. The
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mixture was fractionated by PTLC (2% MeOH in CH2Ch) to give titled compound
212a (5.4 mg, 30%) and a 2.5:1 mixture of212a and 213a (12.4 mg), respectively.
-1
IR (DRIFT) Vmax 2915, 1708, 1427, 1261, 1155, 1103, 1032, 892 cm .
1
H NMR (500 MHz, CDCb) 8 4.66 (2H, d, J = 6 Hz, HC02 x2), 4.63 (2H, d, J = 6 Hz,
HC02 x2), 4.55 (2H, dd, J = 3, 6.5 Hz, HC-1', HC-1 "), 4.07-3.84 (8H, m, H2CO x4),
3.35 (6H, S, H3CO x2), 3.08 (2H, ddd, J= 3, 5.5, 9 Hz, HC-3, HC-5), 3.01-2.94 (4H, m,
H2C-2, H2C-6), 2.91-2.82 (4H, m, H2C-7', H2C-7"), 2.77 (2H, ddd, J= 3,11,13.5 Hz,
HC-9', HC-9"), 2.58 (2H, ddd, J = 3.5, 5.5, 13.5 Hz, HC-9', HC-9"), 2.11 (2H, ddd, J =
4.5, 6.5, 9 Hz, HC-6', HC-6"), 2.05 (2H, ddd, J= 3,5.5,13.5 Hz, HC-lO', HC-lO"), 1.67
(2H, ddd, J= 3.5,11,13.5 Hz, HC-10', HC-10").
13
C NMR (125 MHz, CDCb) 8 208.33 (s, C-4), 109.18 (s x2, C-5', C-5"), 98.60 (t x2,
OCH20), 72.26 (d x2, C-l', C-l "), 64.80 (t x2, CH20), 64.55 (t x2, CH20), 59.79 (d x2,
C-3, C-5), 56.78 (q x2, CH30), 49.44 (d x2, C-6', C-6"), 35.96 (t x2, C-lO', C-10"),
31.17 (t x2, C-2, C-6), 29.10 (t x2, C-7', C-7"), 26.82 (t x2, C-9', C-9").
LRMS (EI), m/z (relative intensity): 580 ([M]+, 1), 518 (9), 133 (30), 132 (69), 100 (9),
99 (100), 86 (13), 55 (12).
HRMS m/z calcd for C2s14009S3 580.1834, found 580.1831 (EI).
(3S,5S)-rel-3-[(R)-(68)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]-5-[(S)-(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]tetrahydro-4H-thiopyran-4-one (212b)
~ ~
2" 3" 0 0 3' 2'{\~ ~{\
o 0 0 0 0 0 0
10" 10'
212b
Following General procedure M for MOM protection hut using 20 equiv of
MOMCI and 30 equiv i-Pr2EtN, after 20 h the substrate 165a (32 mg 0.065 mmol) gave
a 3: 1:2.5 mixture of 212b, 213b and 213c, respectively. The mixture was fractionated
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by PTLC (50% ethyl acetate in hexane; multiple elutions) to give titled compound 212b
(16.6 mg, 44%), 213b (5.0 mg, 14%) and 213c (12.2 mg, 350/0).*
-1
IR (DRIFT) Vmax 2914, 1708, 1428, 1261, 1153, 1097, 1032, 890 cm .
IH NMR (500 MHz, CDCh) 84.72 (1H, d, J= 5.5 Hz, HCOC-1"), 4.71 (IH, d, J= 6
Hz, HCOC-I '), 4.63 (1H, d, J = 5.5 Hz, HCOC-I "), 4.56 (1H, d, J = 6 Hz, HCOC-I '),
4.53 (IH, d, J= 4,6 Hz, HC-I"), 4.16 (IH, dd, J= 3.5, 4 Hz, HC-I'), 4.08-3.92 (8H, ,
HC-2', HC-2", HC-3', HC-3"), 3.37 (3H, S, H3COCOC-I"), 3.36 (3H, s, H3COCOC-l'),
3.00 (IH, ddd, J= 4.5,5.5,6 Hz, HC-5), 3.13-2.95 (5H, ,H2C-2, HC-3, HC-6,HC-7'),
2.91-2.69 (6H, , HC-6, HC-7', H2C-7", HC-9', HC-9"), 2.56-2.48 (2H, , HC-9', HC-9"),
2.28 (IH, ddd, J= 3.5, 4, II Hz, HC-6'), 2.15-2.09 (1H" HC-IO'), 2.11 (IH, ddd, J= 4,
4, II Hz, HC-6"), 1.69 (IH, ddd, J = 3.5, 12.5, 13.5 Hz, HC-IO"), 1.65 (IH, ddd, J =
3.5, 12, 13 Hz, HC-10').
13C NMR (125 MHz, CDCh) 8 208.72 (s, C-4), 109.07 (s, C-5'), 108.80 (s, C-5"), 98.41
(t, CH20C-I"), 97.28 (t, CH20C-I'), 74.55 (d, C-1'), 72.30 (d, C-1"), 64.82 (t, CH20),
64.62 (t, CH20), 64.59 (t, CH20), 64.58 (t, CH20), 57.49 (d, C-3), 57.03 (d, C-5), 56.82
(q, CH30COC-I"), 56.44 (q, CH30COC-I'), 49.75 (d, C-6'), 49.04 (d, C-6"), 36.11 (t,
C-IO"), 35.98 (t, C-IO'), 31.13 (t, C-6), 29.42 (t, C-2), 28.63 (t, C-7'), 28.29 (t, C-7"),
26.84 (t, C-9' or C-9"), 26.76 (t, C-9" or C-9').
LRMS (EI), m/z (relative intensity): 580 ([M]+, I), 456 (10), 133 (25), 132 (65), 100
(8), 99 (100), 86 (14), 55 (8).
HRMS m/z calcd for C2sH4009S3 580.1834, found 580.1828 (EI).
* Aldols are reported in order from high to lower Rf .
247
(38,5R)-rel-3-[(R)-(68)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]-5-[(S)-(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]tetrahydro-4H-thiopyran-4-one (212c)
~ ~
2" 3" 0 0 3' 2'I\~ ~{\
o 0 0 0 00 0
10"
212c
Following General procedure M for MOM protection but with 2.5 times higher
concentration, after 20 h the substrate 165d (24 mg, 0.049 mmol) gave a white solid that
was fractionated by PTLC (60% ethyl acetate in hexane) to give titled compound 212c
(24 mg, 83%).
-1
IR (DRIFT) Vmax 2913, 1716, 1427, 1152, 1098, 1033, 890, 734 cm .
1
H NMR (500 MHz, CDCb) 8 4.70 (2H, d, J = 6.5 Hz, HC02 x2), 4.60 (2H, d, J = 6.5
Hz, HC02 x2), 4.12 (2H, dd, J = 4.5, 5 Hz, HC-1', HC-1"), 4.05-3.91 (8H, m, H2CO
x4), 3.37 (6H, S, H3CO x2), 3.12 (2H, ddd, J = 4, 4.5, 12.5 Hz, HC-3, HC-5), 3.04 (2H,
dd, J= 12.5, 13 Hz, HC-2, HC-6), 3.00 (2H, br d, J= 14 Hz, HC-7', HC-7"), 2.90 (2H,
br d, J= 13 Hz, HC-2, HC-6), 2.81 (2H, dd, J= 9.5, 14 Hz, HC-7', HC-7"), 2.74 (2H,
ddd, J = 3, 10.5, 13.5 Hz, HC-9', HC-9"), 2.59 (2H, br d, J = 13.5 Hz, HC-9', HC-9"),
2.30 (2H, ddd, J = 3.5, 5, 9.5 Hz, HC-6', HC-6"), 2.07 (2H, ddd, J = 3, 6, 13.5 Hz, HC-
10', HC-10"), 1.64 (2H, ddd, J= 3.5, 10.5, 13.5 Hz, HC-10', HC-10").
13C NMR (125 MHz, CDCb) 8 207.24 (s, C-4), 109.06 (s x2, C-5', C-5"), 98.28 (t x2,
OCH20), 75.13 (d x2, C-1', C-1"), 64.93 (t x2, CH20), 64.51 (t x2, CH20), 59.72 (d x2,
C-3, C-5), 56.70 (q x2, CH30), 48.39 (d x2, C-6', C-6"), 35.72 (t x2, C-10', C-10"),
34.27 (t x2, C-2, C-6), 29.10 (t x2, C-7', C-7"), 26.89 (t x2, C-9', C-9").
LRM8 (EI), m/z (relative intensity): 580 ([M]+, 1), 518 (4),456 (10), 133 (20), 132
(60), 100 (9), 99 (100), 86 (22).
HRMS m/z calcd for C2sH4009S3 580.1834, found 580.1839 (EI).
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213a
10'
2 7'7" 6
10"
(3R,5S)-rel-3-[(R)-(68)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]-5-[(8)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (213a)
~
o 3' 2'~I\
0 0 0
Following General procedure M for MOM protection but using 20 equiv of
MOMCI and 30 equiv i-Pr2EtN, after 6 h the substrate 165b (13 mg 0.027 mmol) gave a
1:1:2 mixture of products 165b, 212a and 213a, respectively. The mixture was
fractionated by PTLC (50% ethyl acetate in hexane; multiple elutions) to give recovered
165b (3 mg, 21 %) and a 1:2 mixture of 212a and 213a (12 mg, 80% total yield),
respectively. This mixture was further fractionated by PTLC (2% MeOH in CH2Ch;
multiple elutions) to give titled compound 213a (3 mg, 180/0).
1
H NMR (500 MHz, CDCh) 8 4.69 (1H, d, J = 6 Hz, HC02), 4.66 (1H, d, J = 6 Hz,
HC02), 4.64 (lH, m, HC-l "), 4.10-3.86 (8H, m, H2CO x4), 3.36 (3H, s, H3CO), 3.24-
3.18 (2H, m), 3.05 (1H, d, J = 2 Hz, HOC-l "), 3.05-2.70 (llH, m), 2.69-2.56 (2H, m),
2.14 (lH, ddd, J = 4, 4, 10 Hz, HC-6' or HC-6"), 2.11-2.03 (3H, m, HC-6' or HC-6",
HC-lO', HC-lO"), 1.73 (lH, ddd, J = 3.5, 10.5, 14 Hz, HC-lO' or HC-lO"), 1.68 (lH,
ddd, J= 3.5, 9.5, 13 Hz, HC-lO' or HC-lO").
(3S,5S)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]-5-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (213b)
~
o 3' 2'~I\
0 0 0
10"
213b
For synthesis and isolation see experimental procedure for compound 212b.
-1
IR (DRIFT) Vmax cm .
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I H NMR (500 MHz, CDCb) 8 4.72 (1H, ddd, J= 2.5,3,8 Hz, HC-l"), 4.70 (IH, d, J=
5.5 Hz, HC02), 4.58 (lH, d, J = 5.5 Hz, HC02), 4.39 (1H, dd, J = 4, 6 Hz, HC-l'),
4.12-3.94 (8H, m, H2CO x4), 3.35 (3H, s, H3CO), 3.20 (1H, ddd, J = 1, 5, 13 Hz, HC-
6),3.15 (lH, d, J= 2.5 Hz, HOC-1 "),3.13 (IH, ddd, J= 5,8,8.5 Hz, HC-5), 3.03 (lH,
m, HC-2), 2.97 (1H, dd, J= 10,14 Hz, HC-7"), 2.92 (1H, ddd, J= 5, 5.5, 6.0 Hz, HC-
3), 2.92 (lH, dd, J = 8.5, 13 Hz, HC-6), 2.92-2.87 (1H, m, HC-2), 2.84 (lH, ddd, J = 2,
3, 14 Hz, HC-7"), 2.82-2.73 (4H, m, H2C-7', HC-9', HC-9"), 2.61-2.52 (2H, m, HC-9',
HC-9"), 2.18 (1H, ddd, J= 4,5.5,9 Hz, HC-6'), 2.18-2.11 (2H, m, HC-I0', HC-10"),
2.06 (IH, ddd, J= 3, 3,10 Hz, HC-6"), 1.73 (lH, ddd, J= 3.5,10.5,13 Hz, HC-I0"),
1.70 (IH, ddd, J= 3.5,10.5,13 Hz, HC-10').
13
C NMR (125 MHz, CDCb) 8 210.73 (s, C-4), 110.17 (s, C-5"), 108.72 (s, C-5'),
97.45 (t, OCH20), 73.96 (d, C-l I), 67.08 (d, C-1 "), 64.88 (t, CH20), 64.80 (t, CH20),
64.69 (t, CH20), 64.42 (t, CH20), 58.47 (d, C-3), 56.21 (q, CH30), 53.77 (d, C-5),
49.98 (d, C-6'), 46.40 (d, C-6"), 36.16 (t, C-I0'), 35.85 (t, C-I0"), 32.02 (t, C-2), 31.44
(t, C-6), 28.37 (t, C-7'), 26.86 (t, C-9' or C-9"), 26.79 (t, C-9' or C-9"), 26.66 (t, C-7").
LRMS (EI), m/z (relative intensity): 536 ([M]+, 1), 188 (8), 133 (15), 132 (50), 100
(10), 99 (100), 86 (18), 55 (11).
HRMS m/z calcd for C23H360gS3 536.1572, found 536.1561 (EI).
(3S,5S)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-[(S)-
(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]tetrahydro-4H-
thiopyran-4-one (213c).
10"
213c
For synthesis and isolation see experimental procedure for compound 212b.
-1
IR (DRIFT) Vmax 3518, 2913, 1711, 1427, 1153, 1133, 1108, 1034 cm .
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1
H NMR (500 MHz, CDCh) 84.69 (1H, ddd, J= 2.5,3,3.5 Hz, HC-l'), 4.68 (IH, d, J
= 6 Hz, HC02), 4.65 (lH, d, J = 6 Hz, HC02), 4.47 (IH, dd, J = 4.5, 5 Hz, HC-l"),
4.14-3.91 (8H, m, H2CO x4), 3.37 (3H, s, H3CO), 3.21 (IH, ddd, J = 4.5, 5, 9.5 Hz,
HC-5), 3.07 (IH, dd, J= 9.5, 13.5 Hz, HC-6), 3.04-2.92 (5H, m, HOC-I', HC-2, HC-3,
HC-6, HC-7'), 2.88-2.69 (5H, m, HC-2, H2C-7", HC-9', HC-9"), 2.66 (1H, ddd, J = 2, 3,
13.5 Hz, HC-7'), 2.53 (1H, m, HC-9'), 2.50 (IH, m, HC-9"), 2.16 (IH, ddd, J = 3, 4,
13.5 Hz, HC~10'), 2.10 (lH, ddd, J = 3.5, 4.5, 11 Hz, HC-6"), 2.07 (lH, ddd, J = 3, 4,
13.5 Hz, HC-I0"), 2.01 (IH, ddd, J= 2.5,3,11.5 Hz, HC-6'), 1.74 (IH, ddd, J= 3.5,13,
13 Hz, HC-I0'), 1.69 (lH, ddd,J= 3.5,13,13 Hz, HC-I0").
13
C NMR (125 MHz, CDCh) 8210.97 (s, C-4), 110.07 (s, C-5'), 108.97 (s, C-5"), 98.62
(t, OCH20), 72.79 (d, C-l"), 68.51 (d, C-l'), 65.10 (t, CH20), 64.64 (t, CH20), 64.60 (t,
CH20), 64.60 (t, CH20), 57.34 (d, C-5), 56.79 (q, CH30), 54.69 (d, C-3), 49.14 (d, C-
6"),47.48 (d, C-6'), 36.69 (1, C-I0"), 36.33 (1, C-I0'), 32.75 (1, C-2), 31.44 (1, C-6),
28.27 (1, C-7"), 26.78 (t, C-9' or C-9"), 26.75 (1, C-9" or C-9'), 26.29 (1, C-7').
LRMS (El), m/z (relative intensity): 536 ([Mt, 1), 188 (8), 133 (11), 132 (44), 100
(10), 99 (100), 86 (20), 54 (13).
HRMS m/z ealed for C23H360SS3 536.1572, found 536.1578 (El).
(3S,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yl(methoxymethoxy)methyl]-5-[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
ylhydroxymethyl]tetrahydro-4H-thiopyran-4-one (213d)
~
o 3' 2'~r-\
0 0 0
10"
-1
IR (DRIFT) Vmax 3520,2917, 1701, 1427, 1100, 1034, 891, 735 em .
1
H NMR (500 MHz, CDCh) 84.72 (1H, d, J= 6.5 Hz, HC02), 4.59 (IH, d, J= 6.5 Hz,
HC02), 4.18 (IH, ddd, J = 4.5, 6.5, 8 Hz, HC-l "), 4.07-3.90 (8H, m, H2CO x4), 4.00
(IH, dd, J = 5, 5 Hz, HC-l'), 3.38 (3H, s, H3CO), 3.23 (IH, ddd, J = 4.5, 4.5, 12 Hz,
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HC-5), 3.22 (lH, ddd, J = 4.5, 5, 12 Hz, HC-3), 3.17-2.91 (6H, m, H2C-2, HC-6, HC-7',
H2C-7"), 2.87 (lH, ddd, J= 3.5,3.5,13 Hz, HC-6), 2.79 (lH, dd, J= 10,14 Hz, HC-7'),
2.78-2.65 (3H, m, HC-9', H2C-9"), 2.59 (lH, br d, J = 13.5 Hz, HC-9'), 2.30 (IH, ddd, J
= 3.5, 5,10 Hz, HC-6'), 2.17 (lH, ddd, J= 3.5,6.5,7.5 Hz, HC-6"), 2.07 (IH, ddd, J=
3, 5.5, 13.5 Hz, HC-I0'), 1.93 (lH, ddd, J = 4, 7, 13 Hz, HC-I0"), 1.73 (IH, ddd, J =
4.5, 8, 13 Hz, HC-I0"), 1.65 (lH, ddd, J= 3.5,11, 13.5 Hz, HC-I0').
13 .
C NMR (l25 MHz, CDCb) () 213.35 (s, C-4), 109.12 (s, C-5"), 108.96 (s, C-5'),
98.16 (t, OCH20), 74.88 (d, C-l '), 70.34 (d, C-l "), 65.00 (t, CH20), 64.93 (t, CH20),
64.59 (t, CH20), 64.39 (t, CH20), 60.22 (d, C-3), 57.52 (d, C-5), 56.77 (q, CH30),
48.89 (d, C-6'), 47.76 (d, C-6"), 36.09 (t, C-6), 35.89 (t, C-I0'), 35.72 (t, C-2), 35.59 (t,
C-I0"), 29.05 (t, C-7'), 28.69 (t, C-7"), 26.86 (t, C-9' or C-9"), 26.84 (t, C-9" or C-9').
LRMS (El), m/z (relative intensity): 536 ([Mt, 1), 158 (6), 133 (l2), 132 (41), 100
(11), 99 (l00), 86 (12), 55 (8).
HRMS m/z calcd for C23H3608S3 536.1572, found 536.1571 (EI).
5
6 223
5"5
6 222 and 6"
5"
(I'S*, 3R*, 3"R*, 4S*, 4"R*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl]methyl])tetrahydro-2H-thiopyran-4-ol (222) and (1 'S*, 3R*, 3"R*,
4R*, 4"R*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl]methyl])tetrahydro-2H-thiopyran-4-ol (223).
MOMO OH OH MOMO OH QH
Following General procedure D, the NaBH4 reduction of aldol 126b (50 mg,
0.16 mmol) gave the trans alcohol 223 (14 mg, 28%) and the cis alcohol 222 (22 mg,
43%) after fractionation of the crude product by DFC (10-60% ethyl acetate in hexane;
gradient elution).
Data for 222:
IR Vrnax 3397, 2926, 1427, 1210, 1150, 1093, 1028, 922 cm- I ;
IH NMR (500 MHz, CDCb) () 4.73 (IH, d, J = 7 Hz, H2CO), 4.62 (IH, d, J = 7 Hz,
H2CO), 4.17 (lH, ddd, J = 1, 2, 4 Hz, HC-4), 3.93 (IH, ddd, J = 1, 2, 4 Hz, HC-4"),
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3.83 (IH, dd, J= 4,6 Hz, HC-l'), 3.40 (3H, s, H3CO), 3.16-2.90 (4H, m, HC-2, HC-2",
HC-6, HC-6"), 2.54 (lH, br d, J = 13 Hz, HC-2/HC-2"), 2.38 (lH, br d, J = 13 Hz, HC-
2"/HC-2), 2.36-2.30 (2H, m, HC-5", HC-6"), 2.28 (lH, dddd, J = 2, 2.5, 3, 13 Hz, HC-
6),2.14 (IH, dddd, J = 2,3,3, 14 Hz, HC-5), 2.04-1.99 (2H, m, HC-3, HC-3"), 1.94
(lH, dddd, J = 2.5, 4, 13, 14 Hz, HC-5), 1.79 (IH, m, HC-5");
13C NMR (125 MHz, CDCh) 8 95.11 (t), 77.67 (d), 74.22 (d), 69.84 (d), 56.37 (q),
44.29 (d), 43.86 (d), 35.78 (t), 31.43 (t), 24.34 (t), 22.69 (t), 22.14 (t), 21.94 (t);
LRMS (EI), m/z (relative intensity): 308 ([M]+, 68), 290 (34), 159 (33), 129 (56), 101
(53), 100 (100), 99 (99), 67 (29).
HRMS m/z ealed for C13H2404S2 308.1116, found 308.1112 (EI).
Data for 223:
IR Vrnax 3433, 2927, 1429, 1277, 1149, 1095, 1028,918 em-I;
IH NMR (500 MHz, CDCh) 8 4.70 (IH, d, J = 7 Hz, H2CO), 4.66 (IH, d, J = 7 Hz,
H2CO), 4.16 (IH, dd, J= 3.5,7 Hz, HC-1'), 3.92 (1H, br ddd, J= 2.5,3,3.5 Hz, HC-
4"),3.63 (1H,ddd,J=4, 10, 10 Hz, HC-4), 3.41 (3H,s,H3CO), 3.01 (IH, brdd,J= 11,
12.5 Hz, HC-2"), 2.95 (lH, br dd, J = 12.5, 12.5 Hz, HC-6"), 2.71-2.55 (5H, m), 2.35-
2.27 (3H, m, HC-5, HC-5"), 1.99 (1H, dddd, J = 2.5, 3, 7, 11 Hz, HC-3"), 1.92 (IH,
dddd, J= 3,3.5, 10, 10 Hz, HC-3), 1.81-1.70 (2H, m, HC-5, HC-5");
13C NMR (125 MHz, CDCh) 8 95.44 (t), 74.25 (d), 72.37 (d), 70.40 (d), 56.24 (q),
47.64 (d), 44.42 (d), 37.40 (t), 31.65 (t), 27.35 (t), 27.05 (t), 24.74 (t), 22.55 (t);
LRMS (EI), m/z (relative intensity): 308 ([M]+, 50), 290 (25), 159 (42), 129 (65), 117
(52), 101 (50), 100 (100), 99 (93).
HRMS m/z ealed for C13H2404S2 308.1116, found 308.1115 (EI).
(Is, 3'R*, 3" S*, 4'R*, 4" S*)-Bis[tetrahydro-4-(methoxymethoxy)-2H-thiopyran-3-
yl]methanol (224).
MOMO OH OMOM
5' 5"
6" 224
253
Following General procedure I for MOM ether formation, the diol 222 (7 mg,
0.02 mmol) gave the titled 224 (4 mg, 50%) after fractionation by PTLC (50% ethyl
acetate in hexane):
IH NMR (500 MHz, CDCb) & 4.75 (2H, d, J = 7 Hz, H2CO), 4.62 (2H, d, J = 7 Hz,
H2CO), 3.97-3.95 (2H, br s, HC-4', HC-4"), 3.75 (1H, t, J= 5.5 Hz, HC-l'), 3.57 (IH, br
s, HOC-l '), 3.41 (6H, S, H3CO x2), 3.02 (2H, dd, J = 12, 13 Hz, HC-2', HC-2"), 2.95
(2H, ddd, J = 2, 13, 13 Hz, HC-6', HC-6"), 2.51 (2H, br d, J = 13 Hz, HC-2', HC-2"),
2.36-2.30 (2H, m, HC-5', HC-5"), 2.30-2.24 (2H, m, HC-6', HC-6"), 2.02-1.97 (2H, m,
HC-3', HC-3"), 1.76 (2H, dddd, J= 1.5,2,12.5,13 Hz, HC-5', HC-5");
13C NMR (125 MHz, CDCb) & 95.02 (t x2), 76.41 (d), 74.48 (d x2), 56.41 (q x2),
43.58 (d x2), 31.60 (t x2), 23.54 (t x2), 22.39 (t x2);
LRMS (EI), m/z (relative intensity): 352 ([M]+, 33), 334 (27), 159 (56), 129 (47), 101
(44), 100 (71), 99 (100),67 (23).
HRMS m/z calcd for ClsH2S0SS2 352.1378, found 352.1374 (EI).
(3'S*, 4R*, 4aR*, 4'R* 8aR*)-4a,7,8,8a-Tetrahydro-4-[tetrahydro-4-
(methoxymethoxy)-2H-thiopyran-3-yl]-4H,5H-thiopyrano[4,3-d]-1,3-dioxin-2-one
(225).
MOMO
5'
6'
8
7 225
Following General procedure H, the trans diol223 (9 mg, 0.029 mmol) gave the
titled carbonate (8 mg, 82%) after fractionation by PTLC (70% ethyl acetate in hexane):
IR Vrnax 2922, 1743, 1234, 1181, 1124, 1112, 1093, 1027 cm- I ;
IH NMR (500 MHz, CDCb) 8 4.72 (IH, d, J = 7 Hz, H2CO), 4.61 (IH, d, J = 7 Hz,
H2CO), 4.53 (1H, dd, J= 4.5,6.5 Hz, HC-4 eJHC-4IHC-4a= 4.5 Hz]), 4.31 (IH, ddd, J=
4.5, 11, 11 Hz, HC-8a), 3.68 (IH, br s, HC-4'), 3.44 (3H, s, H3CO), 3.16 (IH, dd, J =
12.5, 14 Hz, HC-2'), 3.00 (IH, dd, J = 11.5, 12.5 Hz, HC-6'), 2.78 (IH, ddd, J = 2.5,
254
12.5, 14 Hz, HC-5, HC-7), 2.75-2.65 (2H, m, HC-5, HC-7), 2.59-2.49 (3H, ffi, HC-4a,
HC-8), 2.33-2.22 (4H, m, HC-3', HC-5', HC-2', HC-6'), 1.92 (lH, dddd, J = 4, 11, 12.5,
12.5 Hz, HC-8), 1.82-1.74 (lH, m, HC-5');
13C NMR (125 MHz, CDCh) 8 147.78 (s), 95.62 (t), 80.23 (d), 77.43 (d), 73.16 (d),
56.57 (q), 44.13 (d), 42.88 (d), 34.24 (t), 31.29 (t), 28.19 (t), 27.06 (t), 24.45 (t), 21.96
(t);
LRMS (EI), m/z (relative intensity): 334 ([M]+, 100),289 (16), 227 (47),139 (42),137
(41),129 (31),101 (36),99 (84).
HRMS m/z calcd for C14H220SS2 334.0909, found 334.0911 (EI).
55"55"
(1 'S*, 3S*, 3"R*, 4R*, 4"R*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl]methyl])etrahydrothiopyran-4-o1 (226) and (1'S*, 3S*, 3" R*, 4S*,
4"R*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl]methyl])tetrahydro-2H-thiopyran-4-o1 (227).
MOMO OH QH MOMO OH OH
Following General procedure D, the NaBH4 reduction of aldol 127b (252 mg,
0.823 mmol) gave the trans alcohol 227 (73 mg, 29%) and the cis alcohol 226 (124 mg,
49%) after fractionation by MPC (40% ethyl acetate in hexane).
Data for 226:
IR Yrnax 3378, 2922, 1426, 1286, 1151, 1091, 1030, 923 em-I;
IH NMR (500 MHz, CDCh) 8 4.77 (1H, d, J = 7 Hz, H2CO), 4.66 (lH, d, J = 7 Hz,
H2CO), 4.17 (lH, dddd, J = 3, 3, 4.5, 6 Hz, HC-4), 4.02 (IH, ddd, J = 1.5, 2, 3 Hz, HC-
4"),3.97 (1H, ddd, J= 2.5,3, 7 Hz, HC-1'), 3.55 (lH, d, J= 2.5 Hz, HOC-I'), 3.43 (3H,
s, H3CO), 3.13 (IH, d, J = 4.5 Hz, HOC-4), 3.08 (IH, dd, J = 11.5, 13.5 Hz, HC-2"),
3.02-2.90 (3H, m, HC-2, HC-6, HC-6"), 2.50 (1H, br d, J= 13.5 Hz, HC-2"), 2.45-2.29
(4H, m, HC-2,HC-5", HC-6, HC-6"), 2.15 (IH, dddd, J = 3, 6, 6, 14 Hz, HC-5), 2.07
(IH, dddd, J = 3, 3, 7, 10 Hz, HC-3), 1.98 (IH, dddd, J = 1.5, 3, 3, 11.5 Hz, HC-3"),
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1.94 (lH, dddd, J = 3, 3.5, 10.5, 14 Hz, HC-5), 1.80 (lH, dddd, J = 2, 3.5, 12.5, 14 Hz,
HC-5");
13C NMR (125 MHz, CDCh) 8 94.98, 77.17, 76.17, 67.63,56.48,44.13,42.53,34.23,
31.40, 27.33, 24.12, 22.98, 22.53;
LRMS (El), m/z (relative intensity): 308 ([M]+, 71), 290 (20), 159 (31), 129 (54), 117
(33), 101 (48), 100 (100), 99 (96).
HRMS m/z ealed for C13H2404S2 308.1116, found 308.1119 (El).
Data for 227:
IR Vrnax 3431, 2928,1428,1153,1095,1072,1024,919 em-I;
IH NMR (500 MHz, CDCh) 8 4.99 (lH, s, HO), 4.79 (1H, d, J = 7 Hz, H2CO), 4.68
(1H, d, J = 7 Hz, H2CO), 4.30 (lH, s, HO), 4.09 (lH, br s, HC-4"), 3.80 (lH, d, J = 9.5
Hz, HC-1'), 3.62 (lH, ddd, J= 4,10,10 Hz, HC-4), 3.44 (3H, s, H3CO), 3.15 (lH, dd, J
= 12, 14 Hz, HC-2"), 2.93 (1H, ddd, J = 2.5, 13, 13 Hz, HC-6"), 2.69-2.60 (2H, m, H2C-
6), 2.51 (lH, dd, J= 2, 14 Hz, HC-2), 2.42 (1H, dd, J = 2, 14 Hz, HC-2"), 2.39 (lH,
dddd, J = 3.5, 3.5, 3.5, 14 Hz, HC-5"), 2.34-2.26 (3H, m, HC-2, HC-5, HC-6"), 2.01
(1H, br d, J= 12 Hz, HC-3"), 1.88-1.77 (2H, m, HC-3, HC-5"), 1.74 (1H, dddd, J= 5.5,
11, 11, 14 Hz, HC-5);
13C NMR (125 MHz, CDCh) 8 94.82, 82.02, 77.49, 73.80, 56.61,46.36,43.40, 36.12,
31.37,29.57,27.47,22.39,21.86;
LRMS (El), m/z (relative intensity): 308 ([M]+, 72), 159 (46), 129 (69), 117 (52), 101
(48), 100 (100), 99 (100), 67 (33).
HRMS m/z ealed for C13H2404S2 308.1116, found 308.1117 (El)
(3'S*, 3"S*, 4'R*, 4"R*)-Bis[tetrahydro-4-hydroxy-2H-thiopyran-3-yl]methanol
(228).
HO OH OH
5' 5"
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From 226: Following General procedure J for hydrolysis of MOM ethers, 226
(20 mg, 0.065 mmol) gave the titled triol (10 mg, 58%) after fractionation by MPC
(80% ethyl acetate in hexane).
From 230: Following General procedure J for hydrolysis of MOM ethers, 230
(31 mg, 0.10 mmol) gave the titled triol (17 mg, 64%) after fractionation by MPC (80%
ethyl acetate in hexane):
IR Vmax 3356, 2913, 1425, 1285, 1179, 1053, 924, 732 cm- I ;
IH NMR (400 MHz, CDCb) 8 4.25-4.21 (lH, br s, HC-4'/HC-4"), 4.16 (lH, dd, J= 2,
8.5 Hz, HC-1), 4.08 (lH, ddd, J = 3, 3, 7.5 Hz, HC-4"/HC-4'), 3.88 (lH, s, HOC-I),
3.18 (lH, dd, J = 12, 13.5 Hz, HC-2'/HC-2"), 3.11 (lH, ddd, J = 2.5, 13, 13 Hz, HC-
6/'HC-6"), 2.90 (lH, ddd, J = 2.5, 9.5, 12.5 Hz, HC-6"/HC-6'), 2.84 (lH, br s, HOC-
4'/HOC-4"), 2.78 (lH, br dd, J = 8.5, 14 Hz, HC-2"/HC-2'), 2.78 (lH, br s, HOC-
4"/HOC-4'), 2.50 (lH, ddd, J = 3.5, 7.5, 13 Hz, HC-6"/HC-6'), 2.41 (lH, dd, J = 3, 14
Hz, HC-2"/HC-2'), 2.32 (lH, br d, J = 13 Hz, HC-2'/HC-2"), 2.30-2.25 (lH, m, HC-
6'/HC-6"), 2.20-2.05 (3H, m, HC-5"/HC-5'), 2.03-1.94 (2H, m, HC-5"/HC-5'), 1.94-1.89
(lH, m, HC-5'/HC-5");
13C NMR (l00 MHz, CDCb) 8 77.04 (d), 71.34 (d), 68.89 (d), 43.27 (d), 42.19 (d),
35.78 (t), 33.68 (t), 27.76 (t), 24.95 (t), 22.09 (t), 21.31 (t);
LRMS (EI), m/z (relative intensity): 264 ([M]+, 72), 228 (10), 157 (20), 129 (48), 117
(54), 101 (43), 100 (100), 99 (51).
HRMS m/z calcd for CllH200 3S2 264.0854, found 264.0856 (EI).
(3'S*, 4R*, 4aS*, 4'R* 8aS*)-4a,7,8,8a-Tetrahydro-4-[tetrahydro-4-
(methoxymethoxy)-2H-thiopyran-3-yl]-4H,5H-thiopyrano[4,3-d]-1,3-dioxin-2-one
(229).
MaMa
5'
6'
257
8
7 229
Following General Procedure G, the trans diol 227 (18 mg, 0.058 mmol) gave
the titled carbonate (14 mg, 71 %) after fractionation by FCC (70% ethyl acetate in
hexane):
IR Vmax 2924, 1749, 1217, 1156, 1118, 1095, 1033, 916 cm- I ;
IH NMR (500 MHz, CDCb) 8 4.72 (IH, d, J = 7 Hz, H2CO), 4.66 (IH, d, J = 7 Hz,
H2CO), 4.20 (lH, dd, J = 4, 10 Hz, HC-4 eJHC-4/HC-4a = 10 Hz]), 4.01 (IH, ddd, J = 4,
11, 11 Hz, HC-8a), 3.94-3.92 (1H, br s, HC-4'), 3.43 (3H, s, H3CO), 3.17 (IH, dd, J =
11.5, 13.5 Hz, HC-2'), 3.03 (lH, ap dd, J = 11, 12.5 Hz, HC-6'), 2.83 (IH, ddd, J = 2.5,
3, 13.5 Hz, HC-5), 2.79 (IH, ddd, J= 2,12.5, 14 Hz, HC-7), 2.72 (IH, dddd, J= 2.5,3,
4, 14 Hz, HC-7), 2.48 (lH, dd, J = 11, 13.5 Hz, HC-5), 2.50-2.44 (IH, m, HC-8), 2.40
(IH, br d, J= -13.5 Hz, HC-2'), 2.36-2.30 (2H, m, HC-5', HC-6'), 2.22-2.17 (IH, m, HC-
3'),2.20 (IH, dddd, J= 3, 10, 11, 11 Hz, HC-4a), 1.91 (1H, dddd, J= 4, 11, 12.5, 12.5
Hz, HC-8), 1.86-1.77 (lH, m, HC-5');
13C NMR (125 MHz, CDCb) 8 148.83, 95.71, 84.85, 79.36, 73.60, 56.54,46.82,42.24,
33.11, 32.20, 29.55, 27.07, 23.76,22.89;
LRMS (EI), m/z (relative intensity): 334 ([M]+, 100), 271 (33), 227 (53), 139 (46), 137
(61), 99 (83), 85 (32),67 (46).
HRMS m/z calcd for C14H220SS2 334.0909, found 334.0903 (EI).
6 231
55"5
6 230 and 6"
5"
(1'R*, 3S*, 3"R*, 4R*, 4"R*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl]methyl)tetrahydro-2H-thiopyran-4-o1 (230) and (1 'R*, 3S*, 3"R*,
4S*, 4"R*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl]metbyl)tetrahydro-2H-tbiopyran-4-o1 (231).
MOMO QH QH MOMO QH OH
Following General procedure D, the NaBH4 reduction of aldol 128b (34 mg,
0.11 mmol) gave the trans alcohol 231 (9 mg, 26%) and the cis alcohol 230 (17 mg,
49%).
Data for 230:
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IR Vmax 3401, 2928, 1426, 1201, 1149, 1095, 1037, 923 em-I;
IH NMR (500 MHz, CDC!)) cS 4.66 (lH, d, J = 6 Hz, H2CO), 4.64 (lH, d, J = 6 Hz,
H2CO), 4.17 (lH, br ddd, J = 2, 2,4 Hz, HC-4), 4.04 (lH, ddd, J = 2.5, 2.5, 5.5 Hz, HC-
4"),3.86 (lH, dd, J= 1.5, 10 Hz, HC-1'), 3.42 (3H, s, H3CO), 3.24-3.15 (2H, m), 2.91
(lH, ddd, J= 2, 12, 13.5 Hz), 2.70 (lH, dd, J= 10.5,13.5 Hz, HC-2"), 2.37 (lH, dddd,
J= 1,3.5,5,13.5 Hz), 2.28 (lH, dd,J= 2.5,13 Hz), 2.26-2.15 (4H, m), 1.96 (lH, dddd,
J = 2.5, 3, 10, 10.5 Hz, HC-3"), 1.93-1.78 (3H, m);
13C NMR (125 MHz, CDC!)) cS 96.06, 76.49, 72.52, 71.19, 56.08,43.10,42.56,35.14,
31.17,25.72,23.25,22.09,20.75;
LRMS (EI), m/z (relative intensity): 308, ([Mt, 83), 290 (24), 159 (52), 129 (48), 117
(39), 101 (51), 100 (100), 99 (81).
HRMS m/z ealed for C13H2404S2 308.1116, found 308.1114 (EI).
Data for 231:
IR Vmax 3430, 2927, 1427, 1281, 1147, 1103, 1041, 917 em-I;
IH NMR (500 MHz, CDC!)) cS 4.68 (lH, d, J = 6.5 Hz, H2CO), 4.64 (lH, d, J = 6.5
Hz, H2CO), 4.22 (lH, dd, J= 2,10 Hz, HC-1'), 4.11 (lH, ddd, J= 2,2.5,2.5 Hz, HC-
4"), 3.73 (lH, ddd, J = 4, 10, 10 Hz, HC-4), 3.42 (3H, s, H3CO), 2.80-2.66 (3H, m),
2.95 (lH, br dd, J = 12.5, 12.5 Hz, HC-6"), 2.61 (lH, dddd, J = 3, 3, 3, 13.5 Hz), 2.54
(lH, ddd, J = 2.5, 2.5, 14 Hz), 2.38-2.32 (2H, m), 2.30-2.22 (3H, m), 1.92 (lH, dddd, J
= 3, 3, 10.5, 10.5 Hz, HC-3"), 1.82 (lH, dddd, J= 2,3.5, 10.5, 10.5 Hz, HC-5"), 1.80-
1.67 (3H, m);
13C NMR (125 MHz, CDC!)) cS 96.28, 72.98,70.13,67.93,56.21,47.69,43.44,37.90,
31.57,27.95,26.51,25.37,23.09;
LRMS (EI), m/z (relative intensity): 308 (79), 290 (21), 159 (57), 129 (65), 117 (48),
101 (48), 100 (100), 99 (82).
HRMS m/z ealed for C13H2404S2 308.1116, found 308.1113 (EI).
259
(3'S*, 4S*, 4aS*, 4'R* 8aS*)-4a,7,8,8a-Tetrahydro-4-[tetrahydro-4-
(methoxymethoxy)-2H-thiopyran-3-yl]-4H,5H-thiopyrano[4,3-d]-1,3-dioxin-2-one
(232).
MOMO
o
O~O
5'
6'
8
7 232
Following General procedure G, the trans diol 231 (30 mg, 0.097 mmol) gave
the carbonate (20 mg, 61 0/0) after fractionation by FCC (40% ethyl acetate in hexane):
IR Vrnax 1745,1427,1368,1234,1177,1113,1027,918 em-I;
IH NMR (500 MHz, CDCh @ 40°C) 8 4.78 (1H, d, J= 7 Hz, H2CO), 4.71 (IH, d, J=
7 Hz, H2CO), 4.48 (1H, dd, J = 3.5, 9 Hz, HC-4 eJHC-4/HC-4a = 3.5 Hz]), 4.33 (IH, ddd,
J= 4, 11, 11 Hz, HC-8a), 3.92 (1H, br s, HC-4'), 3.41 (3H, s, H3CO), 3.04-2.98 (IH, m,
HC-6'), 2.88 (lH, dd, J = 10.5, 13 Hz, HC-2'), 2.79 (IH, ddd, J = 2.5, 12.5, 14 Hz, HC-
7),2.75-2.68 (IH, m, HC-7), 2.66-2.56 (3H, m, HC-4a, H2C-5), 2.52 (1H, dddd, J= 3,
3.5, 4, 13 Hz, HC-8), 2.45-2.33 (3H, m, HC-5 ', HC-6', HC-2'), 2.23 (IH, dddd, J = 2.5,
3, 9, 9.5 Hz, HC-3'), 1.93 (IH, dddd, J = 4, 11.5, 12.5, 13 Hz, HC-8), 1.91-1.84 (IH, m,
HC-5');
13C NMR (125 MHz, CDCh) 8 147.82 (s), 96.80 (t), 80.07 (d), 77.26 (d), 73.36 (d),
56.30 (q), 43.18 (d), 42.94 (d), 34.46 (t), 32.20 (t), 28.77 (t), 27.62 (t), 27.15 (t), 23.93
(t);
LRMS (EI), m1z (relative intensity): 334 ([M]+, 82), 227 (39), 139 (57), 138 (38), 137
(53), 101 (47), 99 (100), 67 (78).
HRMS m1z calcd for C14H220SS2 334.0909, found 334.0910 (El).
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6 234
55"5
6 233 and 6"
5"
(l'R*, 3R*, 3"R*, 4S*, 4"R*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl]methyl])tetrahydro-2H-thiopyran-4-o1 (233) and (1 'R*, 3R*, 3"R*,
4R*, 4' 'R*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl]methyl)tetrahydro-2H-thiopyran-4-o1 (234).
MOMO QH OH MOMO QH QH
Following General procedure E, the NaCNBH3 reduction of aldol 129b gave the
trans alcohol 234 (13 mg, 29%) and the cis alcohol 233 (18 mg, 41 %) after fractionation
by MPC (40% ethyl acetate in hexane).
Data for 233:
IR Vrnax 3346,2921, 1423, 1209, 1143, 1107, 1043, 926 cm- I ;
IH NMR (400 MHz, CDCb) () 3.51 (lH, d, J = 6.5 Hz, H2CO), 4.64 (IH, d, J = 6.5
Hz, H2CO), 4.34 (1H, br t, J = 1.5 Hz, HC-4), 4.25 (IH, d, J = 4.5 Hz, HOC-I'), 4.14
(IH, ddd, J = 2.5, 3, 5.5 Hz, HC-4"), 3.87 (IH, s, HOC-4), 3.74 (1H, ddd, J = 2.5, 4.5,
8.5 Hz, HC-I'), 3.41 (3H, s, H3CO), 3.41 (IH, dd, J= 12, 13 Hz, HC-2), 3.17 (1H, ddd,
J = 2.5, 13, 13 Hz, HC-6), 2.93 (lH, ddd, J = 2.5, 12, 13 Hz, HC-6"), 2.77 (1H, dd, J =
10.5, 13.5 Hz, HC-2"), 2.37 (IH, ddd, J = 3.5, 3.5, 13 Hz, HC-6"), 2.30-2.13 (4H, m,
HC-2"HC-5, HC-5", HC-6), 2.12-2.04 (2H, m, HC-2, HC-3"), 1.90 (IH, br d, J= 12 Hz,
HC-3), 1.88-1.74 (2H, m, HC-5, HC-5");
13C NMR (100 MHz, CDCb) 8 96.05 (t), 76.51 (d), 72.92 (d), 65.90 (d), 56.18 (q),
43 .43 (d), 42.24 (d), 34.86 (t), 31.33 (t), 26.77 (t), 25.96 (t), 23.22 (t), 22.50 (t);
LRMS (EI), m1z (relative intensity): 308 ([M]+, 69), 290 (43), 159 (46), 129 (56), 117
(37), 101 (54), 100 (100), 99 (82).
HRMS m/z calcd for C13H2404S2 308.1116, found 308.1115 (EI).
Data for 234:
IR Vrnax 3429, 2925, 1428, 1177, 1149, 1091, 1037, 918 cm- I ;
IH NMR (500 MHz, CDCb) 8 4.82 (lH, s, HOC-4), 4.77 (IH, d, J = 7 Hz, H2CO),
4.69 (lH, d, J= 7 Hz, H2CO), 4.33 (1H, d, J= 8 Hz, HOC-I'), 4.30 (IH, ddd, J= 2,2,4
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Hz, HC-4"), 3.66 (IH, ddd, J = 4, 10, 10 Hz, HC-4), 3.60 (1H, ddd, J = 5, 8, 8 Hz, HC-
1'), 3.46 (3H, s, H3CO), 3.20 (IH, dd, J = 11.5, 13.5 Hz, HC-2"), 2.95 (IH, ddd, J = 2.5,
13, 15 Hz, HC-6"), 2.69 (IH, ddd, J = 2.5, 12.5, 13.5 Hz, HC-6), 2.62 (IH, ddd, J = 4,
4, 13.5 Hz, HC-6), 2.42-2.26 (6H, m), 2.14 (lH, dddd, J = 2,2,4.5, 12 Hz, HC-5"), 1.89
(IH, m), 1.80-1.70 (2H, m);
13C NMR (500 MHz, CDCb) 3 95.23, 80.42, 74.05, 72.45, 56.92, 47.43, 43.75, 36.47,
31.17, 30.05, 27.55, 26.28, 22.56;
LRMS (£1), m/z (relative intensity): 308 ([M]+, 46), 290 (41), 159 (74), 129 (89), 117
(54), 101 (59), 99 (100), 85 (46).
HRMS m/z calcd for C13H2404S2 308.1116, found 308.1124 (£1).
(Is, 3'S*, 3"R*, 4'R*, 4"S*)-Bis[tetrahydro-4-hydroxy-2H-thiopyran-3-
yl]methanol (235).
HO OH OH
5' 5"
6" 235
Following General procedure J for hydrolysis of MOM ethers, diol 233 (13 mg,
0.042 mmol) gave the titled triol (8 mg, 710/0) after fractionation by MPC (80% ethyl
acetate in hexane):
IR Vmax 3367, 2917, 1423, 1274, 1202, 1135, 1061, 925 cm- I ;
IH NMR (400 MHz, CDCb) 3 4.30 (2H, ddd, J = 2.5,3,6 Hz, HC-4', HC-4"), 4.11
(lH, br t, J = 6 Hz, HC-l), 4.11 (IH, br s, HOC-I), 3.13 (2H, br s, HOC-4', HOC-4"),
3.07 (2H, dd, J= 10,13.5 Hz, HC-2', HC-2"), 3.02 (2H, ddd, J= 3,11,13.5 Hz, HC-6',
HC-6"), 2.40 (2H, dddd, J = 1, 3.5, 5, 13.5 Hz, HC-6', HC-6"), 2.31 (2H, ddd, J = 1, 2,
13.5 Hz, HC-2', HC-2"), 2.16 (2H, dddd, J = 3, 5, 6, 14 Hz, HC-5', HC-5"), 2.10-2.03
(2H, dddd, J = 2, 3, 6, 10 Hz, HC-3', HC-3"), 1.93 (2H, dddd, J = 2.5, 3.5, 11, 14 Hz,
HC-5', HC-5");
13C NMR (100 MHz, CDCb) 3 76.61 (x2), 67.82, 42.29 (x2), 34.44 (x2), 27.03 (x2),
23.70 (x2);
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LRMS (EI), m/z (relative intensity): 264 ([Mt, 66), 129 (47), 117 (51), 101 (44), 100
(100), 99 (49), 87 (54), 57 (47).
HRMS m/z calcd for C11H2003S2 264.0854, found 264.0859 (EI).
(3'8*, 4S*, 4aR*, 4'R* 8aR*)-4a,7,8,8a-Tetrahydro-4-[tetrahydro-4-
(methoxymethoxy)-2H-thiopyran-3-yl]-4H,5H-thiopyrano[4,3-d]-1,3-dioxin-2-one
(236).
MOMO
5'
6'
8
7 236
Following General procedure G, the trans diol 234 (14 mg, 0.045 mmol) gave
the titled carbonate (12 mg, 79%) after fractionation by FCC (35% ethyl acetate in
hexane):
IR Vmax 1753, 1428, 1220, 1197, 1158, 1095, 1029, 918 cm- I ;
IH NMR (500 MHz, CDCh) 8 4.72 (1H, d, J = 6.5 Hz, H2CO), 4.70 (lH, d, J = 6.5
Hz, H2CO), 4.25 (lH, br s, HC-4'), 4.13 (lH, dd, J = 8, 8.5 Hz, HC-4 eJHC-4IHC-4a = 8.5
Hz]), 3.99 (1H, ddd, J = 4, 11, 11 Hz, HC-8a), 3.41 (3H, s, H3CO), 3.06 (lH, dd, J = 11,
13 Hz, HC-2'), 3.06-3.00 (lH, m, HC-6'), 2.80 (1H, ddd, J = 2.5, 12.5, 14 Hz, HC-7),
2.73 (1H, dddd, J= 2.5,3,4,14 Hz, HC-7), 2.63 (1H, ddd, J= 2,3.5,14 Hz, HC-5),
2.55 (IH, dd, J = 11, 14 Hz, HC-5), 2.48 (IH, dddd, J = 3, 3.5, 4, 13 Hz, HC-8), 2.41
(1H, dddd, J = 3, 3, 4, 14.5 Hz, HC-5'), 2.31 (1H, ddd, J = 2, 3, 13 Hz, HC-6'), 2.24
(IH, br d, J = 2, 2.5, 13 Hz, HC-2'), 2.18 (1H, dddd, J = 3.5, 8.5, 11, 11 Hz, HC-4a),
2.05 (1H, dddd, J = 2.5, 3, 8, 11 Hz, HC-3'), 1.92 (1H, dddd, J = 4, 11, 12.5, 13 Hz,
HC-8), 1.76 (IH, dddd, J= 1.5,4, 12.5, 14.5 Hz, HC-51);
13C NMR (125 MHz, CDCh) 8 149.44 (s), 96.32 (t), 82.98 (d), 78.57 (d), 70.37 (d),
56.32 (q), 48.25 (d), 42.65 (d), 32.92 (t), 31.98 (t), 30.84 (t), 27.14 (t), 24.25 (t), 22.41
(t);
LRMS (EI), m/z (relative intensity): 334 ([M]+, 86), 271 (70), 227 (22), 201 (26), 139
(41), 137 (45), 99 (100), 67 (78).
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HRMS m/z calcd for C14H220SS2 334.0909, found 334.0911 (EI).
(l'S*, 3R*, 3"R*, 4R*, 4"S*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl]methyl])tetrahydro-2H-thiopyran-4-o1 (237).
MOMQ OH QH
5" 5
6 237
Following General procedure F, the NaBH(OAc)3 reduction of aldol 126c (21
mg, 0.069 mmol) gave the trans alcohol 237 (17 mg, 80%) after fractionation by PTLC
(60% ethyl acetate in hexane):
IR Vrnax 3432, 2927, 1429, 1279, 1147, 1095, 1027, 916 cm-I;
IH NMR (400 MHz, CDC!]) () 4.72 (1H, d, J= 6.5 Hz, H2CO), 4.72-4.68 (lH, m, HC-
1'),4.64 (lH, d, J= 6.5 Hz, H2CO), 3.78 (1H, br ddd, J= 3.5,8,8 Hz, HC-4), 3.56 (lH,
ddd, J = 3.5, 8, 8 Hz, HC-4"), 3.45 (3H, s, H3CO), 2.92-2.75 (5H, m), 2.69 (lH, dd, J =
13.5, 14 Hz), 2.67 (1H, dd, J = 13.5, 14 Hz), 2.59-2.49 (2H, m), 2.22-2.13 (2H, m),
1.93-1.85 (5H, m);
13C NMR (100 MHz, CDC!]) () 96.20, 75.70, 68.79, 67.00, 56.41, 45.81, 44.76, 34.88,
32.41, 26.48,26.48,26.17, 25.50;
LRMS (EI), m/z (relative intensity): 308 ([M]+, 88), 159 (41), 129 (94), 117 (65), 101
(57), 100 (100), 99 (66), 67 (35).
HRMS m/z calcd for C13H2404S2 308.1116, found 308.1115 (EI).
(lr, 3'S*, 3"R*, 4'S*, 4"R*)-Bis[tetrahydro-4-hydroxy-2H-thiopyran-3-
yl] methanol (238).
HO OH OH
5' 5"
6' 6" 238
Following General procedure J for hydrolysis of MOM ethers, diol 237 (20 mg,
0.065 mmol) gave the titled triol (13 mg, 75%) after trituration with CH2Ch.
IR Vrnax 3377, 2925, 1429, 1280, 1029,956 cm-I;
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IH NMR (500 MHz, CD30D) 8 4.77 (IH, t, J = 6 Hz, HC-l), 3.66 (2H, ddd, J = 3.5,
7.5, 8 Hz, HC-4', HC-4"), 2.85 (2H, br d, J = 13.5 Hz, HC-2', HC2"), 2.76 (2H, dddd, J
= 1, 3.5, 6.5, 12.5 Hz, HC-6', HC-6"), 2.60 (2H, dd, J = 8.5, 13.5 Hz, HC-2', HC-2"),
2.48 (2H, ddd, J = 2.5, 9.5, 12.5 Hz, HC-6', HC-6"), 2.15 (2H, dddd, J = 2.5, 3.5, 7.5,
13.5 Hz, HC-5', HC-5"), 1.78-1.71 (4H, m, HC-3', HC-3", HC-5', HC-5");
13C NMR (75 MHz, CD30D) 8 69.2 (x 2), 67.5, 47.4 (x 2), 35.8 (x 2),27.1 (x 2),26.5
(x 2);
LRMS (EI), m/z (relative intensity): 264 ([M]+, 76), 129 (87), 117 (l00), 100 (94), 99
(46), 87 (52), 83 (41), 57 (63).
HRMS m/z calcd for CllH200 3S2 264.0854, found 264.0858 (EI).
(3'S*, 4R*, 4aR*, 4'S* 8aR*)-4a,7,8,8a-Tetrahydro-4-[tetrahydro-4-
(methoxymethoxy)-2H-thiopyran-3-yl]-4H,5H-thiopyrano[4,3-d]-1 ,3-dioxin-2-one
(239).
MOMO
5'
6'
8
7 239
Following General procedure H, the trans diol 237 (23 mg, 0.075 mmol) gave
the titled carbonate (l2 mg, 48%) after fractionation by PTLC (800/0 ethyl acetate in
hexane):
IR Vmax 2922, 1749, 1386, 1244, 1182, 1089, 1026,916 cm- I ;
IH NMR (500 MHz, CDC!]) 8 5.08 (lH, dd, J = 2, 7 Hz, HC-4 eJHC-4IHC-4a = 7 Hz]),
4.73 (lH, d, J= 7 Hz, H2CO), 4.68 (lH, d, J= 7 Hz, H2CO), 4.26 (lH, ddd, J= 4.5,11,
11 Hz, HC-8a), 3.56 (lH, ddd, J = 4, 10, 10.5 Hz, HC-4'), 3.39 (3H, s, H3CO), 2.86-
2.48 (llH, m, H2C-2', HC-4a, H2C-5, HC-5', H2C-6', H2C-7, HC-8), 1.99 (IH, dddd, J=
2, 3, 10, 11 Hz, HC-3'), 1.87 (lH, dddd, J = 4.5, 11, 12.5, 12.5 Hz, HC-8), 1.72 (IH, m,
J = 3.5, 10.5, 13, 13 Hz, HC-5 ');
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13C NMR (125 MHz, CDCb) 8 148.28, 96.16, 77.88, 77.85, 76.50, 56.15,45.75,41.92,
34.95, 34.27,28.70,27.98,27.60,26.92;
LRMS (EI), m/z (relative intensity): 304 ([M]+, 69), 272 (38), 201 (37), 139 (59), 101
(40), 99 (100), 85 (49),67 (60).
HRMS m/z calcd for C14H220SS2 334.0909, found 334.0906 (EI).
5
OH OH
5"
MOMO
5"
1'S*, 3S*, 3"R*, 4R*, 4"S*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl]methyl)tetrahydro-2H-thiopyran-4-o1 (240) (1 'S*, 3S*, 3"R*, 4S*,
4"S*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl]methyl)tetrahydro-2H-thiopyran-4-o1 (241).
MOMQ OH QH
3 -
l' = 4 5
Following General procedure D, the NaBH4 reduction of aldol 127c (310 mg,
1.01 mmol) gave the trans alcohol 241 (143 mg, 46%) and the cis alcohol 240 (85 mg,
27%) after fractionation by DFC (10-70% ethyl acetate in hexane).
Data for 240:
IR Vmax 3429, 2926, 1426, 1146, 1103, 1050, 1026,924 cm- I ;
IH NMR (500 MHz, CDCb) 8 4.69 (IH, d, J = 6.5 Hz, H2CO), 4.64 (IH, d, J = 6.5
Hz, H2CO), 4.51 (lH, ddd, J= 4.5,5.5,9 Hz, He-I'), 4.13 (lH, dddd, J= 3,3,4.5,8
Hz, HC-4), 3.48 (IH, d, J = 5.5 Hz, HOC-1 I), 3.47 (lH, ddd, J = 4, 10.5, 10.5 Hz, HC-
4"), 3.44 (3H, s, H3CO), 3.30 (IH, d, J = 4.5 Hz, HOC-4), 2.93 (IH, ddd, J = 3, 9.5, 13
Hz, HC-6), 2.82 (lH, dd, J = 9, 13.5 Hz, HC-2), 2.72-2.59 (4H, m, H2C-2", H2C-6"),
2.46 (1H, ddd, J = 3.5, 7, 13.5 Hz, HC-6), 2.39 (1H, dd, J = 3, 13.5 Hz, HC-2), 2.27
(lH, dddd, J= 3.5, 3.5, 4.5,13 Hz, HC-5"), 2.12 (lH, dddd, J= 3,7, 8,13.5 Hz, HC-5),
2.05 (1H, dddd, J= 3, 3, 9, 9 Hz, HC-3), 1.98 (1H, dddd, J= 3,3.5,9.5,13.5 Hz, HC-
5), 1.89-1.76 (2H, m, HC-3", HC-5");
13C NMR (125 MHz, CDCb) 8 96.28 (t), 76.83 (d), 69.32 (d), 68.45 (d), 56.16 (q),
45.87 (d), 41.73 (d), 34.03 (t), 33.78 (t), 27.31 (t), 27.19 (t), 26.22 (t), 24.67 (t);
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LRMS (EI), m/z (relative intensity): 308 ([M]+, 75), 159 (24), 129 (53), 117 (52), 101
(54), 100 (100), 99 (71), 67 (36).
HRMS m/z calcd for C13Hz404SZ 308.1116, found 308.1120 (EI).
Data for 241:
IR Vrnax 3379, 2928, 1428, 1147, 1103, 1047, 1028,914 cm-I;
IH NMR (500 MHz, CDCb) 8 4.96 (1H, br s, HOC-4), 4.66 (lH, d, J = 6.5 Hz,
HzCO), 4.64 (lH, d, J = 6.5 Hz, HzCO), 4.30 (lH, d, J = 3.5 Hz, HOC-1 '), 4.15 (lH,
ddd, J= 2.5,3.5,10 Hz, HC-1'), 3.61 (lH, ddd, J= 4,9,10.5 Hz, HC-4), 3.43 (lH, ddd,
J = 4, 10, 11 Hz, HC-4"), 3.42 (3H, s, H3CO), 2.73-2.54 (6H, m), 2.48 (lH, ddd, J =
2.5, 3.5, 14 Hz), 2.33 (lH, dddd, J = 3.5, 4, 4.5, 13 Hz, HC-5"), 2.31-2.25 (2H, m),
1.88-1.71 (4H, m, HC-3, HC-3", HC-5, HC-5");
13C NMR (125 MHz, CDCb) 8 96.30 (t), 77.12 (d), 75.29 (d), 73.96 (d), 55.93 (q),
46.76 (d), 45.49 (d), 36.69 (t), 34.65 (t), 28.74 (t), 27.97 (t), 27.56 (t), 26.27 (t);
LRMS (EI), m/z (relative intensity): 308 ([M]+, 75), 290 (10), 246 (17), 228 (21), 159
(35), 129 (33), 117 (36), 100 (100).
HRMS m/z calcd for C13Hz404SZ 308.1116, found 308.1112 (EI).
(3'R*, 3"R*, 4'S, 4"S*)-Bis[tetrahydro-4-(methoxymethoxy)-2H-thiopyran-3-
yl]methanol (242); (3'S*, 3"S*, 4'S*, 4"S*)-Bis[tetrahydro-4-(methoxymethoxy)-
2H-thiopyran-3-yl](methoxymethoxy)methane (243).
MOMO OH OMOM
243
5"5'
:2:
o
:2:
MOMQ 0 OMOM
242 6'
5"5'
6'
Following General procedure I for MOM ether formation, diol 241 (19 mg,
0.062 mmol) gave, after fractionation by PTLC (60% ethyl acetate in hexane), the
bisMOM ether 242 (10 mg, 46%) and the trisMOM ether 243 (11 mg,45%).
Data for 242
IR Vrnax 3488, 2930, 1429, 1277, 1147, 1097, 1029, 916 cm-I;
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IH NMR (500 MHz, CDCh) (3 4.78 (lH, d, J = 7 Hz, H2CO), 4.73 (lH, d, J = 6.5 Hz,
H2CO), 4.70 (1H, d, J = 6.5 Hz, H2CO), 4.67 (1H, d, J = 7 Hz, H2CO), 4.35 (lH, ddd, J
= 1.5, 2, 9.5 Hz, HC-1), 3.84 (lH, ddd,J = 3, 8, 8 Hz, HC-4'/HC-4"), 3.76 (lH, d, J =
1.5 Hz, HO), 3.58 (lH, ddd, J = 4, 10.5, 10.5 Hz, HC-4"/HC-4'), 3.43 (3H, s, H3CO),
3.41 (3H, s, H3CO), 2.87 (lH, br d, J = 13.5 Hz, HC-2'/HC-2"), 2.83 (lH, m, HC-6'/HC-
6"),2.76 (lH, dd, J = 11.5, 13.5 Hz, HC-2"/HC-2'), 2.70 (lH, ddd, J = 3, 11, 13 Hz,
HC-6"/HC-6'), 2.62 (lH, ddd, J = 3.5, 4, 13 Hz, HC-6"HC-6'), 2.55-2.49 (2H, m, HC-
2"/ HC-2', HC-6'/HC-6"), 2.39 (1H, dddd, J = 3, 3.5, 4, 13 Hz, HC-5"/HC-5'), 2.33-2.25
(2H, m, HC-2'/HC-2", HC-5'/HC-5"), 1.95 (lH, dddd, J = 3, 8, 8, 9.5 Hz, HC-3'/HC-3"),
1.89-1.82 (2H, m, HC-3"/HC-3', HC-5'/HC-5"), 1.78 (lH, dddd, J = 4, 10, 11, 13 Hz,
HC-5"/HC-5');
13C NMR (125 MHz, CDCh) (3 96.63 (t), 95.00 (t), 77.92 (d), 76.83 (d), 69.96 (d),
56.14 (q), 55.98 (q), 46.28 (d), 43.64 (d), 35.02 (t), 31.20 (t), 27.94 (t), 27.58 (t), 26.38
(t), 25.87 (t);
LRMS (EI), m/z (relative intensity): 352 ([M]+, 70), 275 (36), 159 (82), 129 (79), 101
(57), 100 (100), 99 (86), 67 (31).
HRMS m/z ealed for ClsH280SS2 352.1378, found 352.1373 (EI).
Data for 243
IR vrnax2933, 2821,1431,1211,1146,1095,1029,916 em-I;
IH NMR (500 MHz, CDCh) (3 4.74 (lH, d, J = 7 Hz, H2CO), 4.72 (lH, d, J = 7 Hz,
H2CO), 4.70 (1H, d, J = 7 Hz, H2CO), 4.69 (lH, d, J = 7 Hz, H2CO), 4.67 (lH, d, J = 7
Hz, H2CO), 4.66 (lH, d, J = 7 Hz, H2CO), 4.47 (lH, dd, J = 2.5, 6.5 Hz, HC-1), 3.71
(1H, ddd, J = 3.5, 7.5, 7.5 Hz, HC-4'/HC-4"), 3.49 (lH, ddd, J = 4, 10, 10 Hz, HC-
4"/HC-4'), 3.41 (3H, s, H3CO), 3.39 (3H, s, H3CO), 3.37 (3H, s, H3CO), 3.02 (lH, br
dd, J = 3, 13 Hz, HC-2'/HC-2"), 2.83 (lH, br ddd, J = 3, 8.5, 13 Hz, HC-6'/HC-6"),
2.70-2.56 (4H, m, H2C-6"/H2C-6', H2C-2"/HC-2'), 2.50-2.40 (3H, m, HC-5"/HC-5, HC-
6/HC-6", HC-2'/HC-2"), 2.26 (lH, dddd, J = 3, 3, 8.5, 13.5 Hz, HC-5/HC-5"), 2.07 (1H,
dddd, J = 3, 6.5, 7.5, 7.5 Hz, HC-3/HC-3"), 1.93-1.85 (2H, m, HC-5'/'HC-5", HC-
3"/HC-3'), 1.75 (lH, dddd, J= 4,10, 10, 13.5 Hz, HC-5"/HC-5');
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13C NMR (125 MHz, CDC!)) 8 98.43 (t), 96.65 (t), 96.16 (t), 77.06 (d), 76.98 (br d),
75.02 (br d), 56.19 (q), 56.02 (q), 55.73 (q), 46.07 (d), 44.80 (br d), 34.67 (t), 32.00 (br
t), 27.94 (t), 27.91 (br t), 27.43 (t), 25.58 (br t);
LRMS (El), m/z (relative intensity): 396 ([M]+, 10),289 (21), 272 (21), 257 (26), 173
(100), 159 (41), 129 (32), 99 (42).
HRMS m/z calcd for C17H3206S2 396.1640, found 396.1646 (El).
(3'S*, 4R*, 4aS*, 4'S* 8aS*)-4a,7,8,8a-Tetrahydro-4-[tetrahydro-4-
(methoxymethoxy)-2H-thiopyran-3-yl]-4H,5H-thiopyrano[4,3-dJ-l ,3-dioxin-2-one
(244).
MOMO
5'
6'
8
7 244
Following General procedure G, the trans diol 241 (11 mg, 0.036 mmol) gave
the titled carbonate (9 mg, 75%) after fractionation by DFC (10-60% ethyl acetate in
hexane; gradient elution):
IR Vmax 2920, 1746, 1236, 1164, 1094, 1029 cm- I ;
IH NMR (500 MHz, CDCh) 8 4.74 (IH, dd, J = 1, 11 Hz, HC-4 eJHC-4IHC-4a = 11
Hz]), 4.73 (IH, d, J= 6.5 Hz, H2CO), 4.70 (1H, d, J= 6.5 Hz, H2CO), 4.10 (IH, ddd, J
= 4, 11, 11 Hz, HC-8a), 3.66 (1H, ddd, J = 4, 10.5, 10.5 Hz, HC-4'), 3.38 (3H, s,
H3CO), 2.81-2.40 (4H, m), 2.65 (1H, ddd, J = 2, 3.5, 14 Hz), 2.63-2.40 (5H, m), 2.12
(1H, dddd, J = 3.5, 11, 11, 11 Hz, HC-4a), 1.97-1.87 (2H, m, HC-8, HC-3'), 1.68 (IH,
m, HC-5');
13C NMR (125 MHz, CDC!)) 8 148.26,96.36,80.31,79.74,75.08,55.99,45.31,39.32,
35.17,33.11,28.18,27.68,27.05,25.93;
LRMS (El), m/z (relative intensity): 334 ([M]+, 64), 289 (34), 227 (39), 139 (56), 137
(41), 99 (100), 85 (47), 67 (64).
HRMS m/z calcd for C14H220SS2 334.0909, found 334.0907 (El).
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(1 'R*, 3S*, 3"R*, 4R*, 4"S*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl]methyl)tetrahydro-2H-thiopyran-4-ol (245).
MOMQ QH QH
- - -
- 3" - 3 -5"~5
6" ~S) 2" 2~S) 6 245
Following General procedure C, the DIBAH reduction of aldol 128c (25 mg,
0.81 mmol) gave, after fractionation by PTLC (80% ethyl acetate in hexane), the trans
diol246 (2.5 mg, 10%) and the cis diol245 (21 mg, 84%):
IR Vmax 3419, 2925, 1427, 1276, 1149, 1097, 1033, 1070 cm- I ;
IH NMR (500 MHz, CDCh) 8 4.82 (lH, d, J = 7.5 Hz, H2CO), 4.66 (IH, d, J = 7.5
Hz, H2CO), 4.57 (lH, br s, HO), 4.19 (lH, br s, HC-4), 3.99 (lH, br s, HO), 3.92 (IH,
dd, J = 1.5, 8.5 Hz, HC-l'), 3.66 (IH, ddd, J = 3.5, 10, 10 Hz, HC-4"), 3.43 (3H, S,
H3CO), 3.27 (IH, dd, J= 12.5,13 Hz), 3.19 (lH, ddd, J= 3,13,13 Hz), 2.75-2.67 (2H,
m), 2.61 (IH, ddd, J = 3, 11, 14 Hz), 2.40 (lH, dddd, J = 3, 3, 6, 13 Hz), 2.32 (IH, dd, J
= 10, 14 Hz), 2.24 (lH, br d, J = 13 Hz), 2.20-2.14 (2H, m), 1.98 (lH, dddd, J = 3, 9,
10, 10 Hz), 1.93-1.82 (2H, m), 1.79 (lH, dddd, J= 3.5, 10.5,10.5, 13.5 Hz);
13C NMR (500 MHz, CDCh) 8 94.76, 80.48, 80.03, 70.91, 56.45, 45.81, 43.30, 35.30,
32.61,28.71,26.92,22.20,20.77;
LRMS (EI), m/z (relative intensity): 308 ([M]+, 93), 159 (37), 129 (60), 117 (47), 101
(58), 100 (100), 99 (83), 67 (35).
HRMS m/z calcd for C13H2404S2 308.1116, found 308.1113 (EI).
5
6 246
5"
(1 'R*, 3S*, 3"R*, 4S*, 4"S*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl]methyl])tetrahydro-2H-thiopyran-4-ol (246).
MOMQ QH OH
Following General procedure F, the NaBH(OAc)3 reduction of aldol 128c (30
mg, 0.11 mmol) gave the trans alcohol 246 (24 mg, 72%) after fractionation of the
crude product by PTLC (90% ethyl acetate in hexane):
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IR Vrnax 3426, 2928, 1430, 1278, 1147, 1097, 1035, 917 em-I;
IH NMR (500 MHz, CDCh) 8 4.80 (lH, d, J = 7 Hz, H2CO), 4.69 (lH, d, J = 7 Hz,
H2CO), 4.31 (lH, dd, J= 2.5,9 Hz, HC-1'), 3.84 (lH, br s, HOC-I'), 3.73 (lH, ddd, J=
3, 8, 9 Hz, HC-4), 3.71 (1H, ddd, J = 4, 9.5, 10 Hz, HC-4"), 3.42 (3H, s, H3CO), 2.80-
2.70 (4H, m, HC-2, HC-2", HC-6, HC-6"), 2.65-2.56 (2H, m, HC-6, HC-2"), 2.50 (lH,
ddd, J = 2.5, 2.5, 14 Hz, HC-6"), 2.40 (lH, dddd, J = 3, 3.5, 6.5, 13.5 Hz, HC-5), 2.37-
2.30 (2H, m, HC-2, HC-5"), 1.97 (lH, dddd, J = 3, 8, 9, 9 Hz, HC-3), 1.83 (lH, dddd, J
= 3.5, 9, 10.5, 13.5 Hz, HC-5), 1.77-1.72 (2H, m, HC-3", HC-5");
13C NMR (125 MHz, CDC!)) 8 95.14, 79.75, 71.16, 69.78, 56.25, 48.10, 44.90, 37.66,
32.27, 28.25, 28.00, 26.51, 26.36;
LRMS (EI), m/z (relative intensity): 308 ([M]+, 78), 159 (45), 129 (94), 117 (60), 101
(52), 100 (100), 99 (71), 67 (36).
HRMS m/z calcd for C13H240 4S2 308.1116, found 308.1119 (EI).
(3'S*, 3"S*, 4'S*, 4"S*)-Bis[tetrahydro-4-hydroxy-2H-thiopyran-3-yl]methan01
(247).
HO OH OH
5' 5"
247
Following General procedure J for hydrolysis of MOM ethers, 246 (24 mg,
0.078 mmol) gave the titled triol (16 mg, 76%) as a white solid after trituration of the
crude product with CH2Ch:
IR Vrnax 3374,3284,2932,2907,2505, 1427, 1052, 1025 em-I;
IH NMR (500 MHz, CD30D) 8 4.33 (lH, dd, J= 2,9 Hz, HC-1'), 3.71 (lH, ddd, J=
3.5, 9, 9 Hz, HC-4), 3.54 (lH, ddd, J = 4, 10.5, 10.5 Hz, HC-4"), 2.71-2.52 (6H, m, HC-
2, HC-6, H2C-2"" H2C-6"), 2.50 (lH, ddd, J = 2.5, 3, 14 Hz, HC-6), 2.34-2.27 (2H, m,
HC-2, HC-5"), 2.21 (lH, dddd, J = 3, 3.5, 6, 13.5 Hz, HC-5), 1.76 (lH, dddd, J = 3, 9,
9, 9 Hz, HC-3), 1.75-1.62 (3H, ffi, HC-3", HC-5, HC-5");
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13C NMR (125 MHz, CDOD) 8 74.10 (d), 72.97 (d), 70.16 (d), 49.36 (d), 47.24 (d),
38.95 (t), 36.70 (t), 29.04 (t), 28.77 (t), 27.30 (t), 27.28 (t);
LRMS (EI), m/z (relative intensity): 264 ([Mt, 93), 129 (90), 117 (99), 100 (l00), 99
(49), 87 (51), 83 (39), 67 (36).
HRMS m/z calcd for CIIH2003S2 264.0854, found 264.0862 (EI).
(3'S*, 4S*, 4aS*, 4'S* 8aS*)-4a,7,8,8a-Tetrahydro-4-[tetrahydro-4-
(methoxymethoxy)-2H-thiopyran-3-yl]-4H,5H-thiopyrano[4,3-d]-1,3-dioxin-2-one
(248).
MOMO
5'
6'
8
7 248
Following General procedure H, the trans diol 246 (24 mg, 0.078 mmol) gave
the titled carbonate (20 mg, 77%) after fractionation by PTLC (800/0 ethyl acetate in
hexane):
IR Vmax 2922, 1745, 1428, 1241, 1182, 1099, 1038,918 em-I;
IH NMR (500 MHz, CDC!)) 8 4.74 (IH, dd, J= 6,6 Hz, HC-4 eJHC-4IHC-4a= 6 Hz]),
4.71 (IH, d, J = 7 Hz, H2CO), 4.67 (IH, d, J = 7 Hz, H2CO), 4.39 (IH, ddd, J = 4.5, 11,
11 Hz, HC-8a), 3.70 (lH, ddd, J = 3, 7.5, 7.5 Hz, HC-4'), 3.37 (3H, s, H3CO), 2.86 (IH,
br d, J = 12.5 Hz, HC-2'), 2.82-2.77 (lH, m), 2.75 (lH, ddd, J = 2.5, 12.5, 14 Hz, HC-
7),2.71 (lH, dddd, J= 1.5,4,4, 14 Hz, HC-7), 2.67-2.59 (2H,), 2.55-2.41 (5H,), 2.19
(IH, dddd, J= 3.5,6, 7.5, 7.5 Hz, HC-3'), 1.92-1.83 (2H, m, HC-5', HC-8);
13C NMR (125 MHz, CDC!)) 8 148.5, 97.15, 81.01 (br), 76.57, 75.41 (br), 56.02,
42.44,42.08 (br), 33.93, 32.40 (br), 30.86 (br), 27.92, 26.99, 25.34 (br);
LRMS (EI), m/z (relative intensity): 334 ([M]+, 100), 139 (58),137 (42),101 (39), 100
(44), 99 (90), 85 (48), 67 (52).
HRMS m/z calcd for C14H220SS2 334.0909, found 334.0908 (EI).
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(1 '8*,38*, 3"S*, 4R*, 4"R*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-
thiopyran-3-yl]methyl])tetrahydro-2H-thiopyran-4-ol (249) (I'S*, 3S*, 3"S*, 4S*,
4" R*)-3-(Hydroxy[4-(methoxymethoxy)tetrahydro-2H-thiopyran-3-
yl]methyl])tetrahydro-2H-thiopyran-4-ol (250).
MOMQ QH OH MOMQ QH QH
- - - - -
- 3" - 3 - 3" - 3 -
5" 4" l' 4 5 5"~5
6" S 2" 2 S 6 249 and 6" ~S) 2" 2"S) 6 250
Following General procedure C, the DlBAH reduction of a 1.5:1 mixture of the
aldols 129c and 128c (3 mg, 0.01 mmol), respectively gave 246 (1 mg, 300/0), 249 (1
mg, 30%), and 250 (1 mg, 30%).
Data for 249:
IR Vmax 3389, 2918, 1428, 1149, 1098, 1033, 924 cm- I ;
IH NMR (500 MHz, CDCh) () 4.81 (1H, d, J = 7 Hz, H2CO), 4.67 (IH, d, J = 7 Hz,
H2CO), 4.67 (IH, d, J = 1.5 Hz, HOC-l I), 4.32 (IH, ddd, J = 2, 3, 3 Hz, HC-4), 3.96
(1H, s, HOC-4), 3.83 (1H, ddd, J= 1.5,3,8 Hz, HC-l'), 3.68 (IH, ddd, J= 3.5, 9.5, 9.5
Hz, HC-4"), 3.42 (3H, s, H3CO), 3.39 (IH, dd, J = 11.5, 13 Hz, HC-2), 3.18 (IH, ddd, J
= 2.5, 13, 13 Hz, HC-6), 2.76-2.65 (2H, m, HC-2", HC-6"), 2.63 (IH, ddd, J = 3, 11,
13.5 Hz, HC-6"), 2.42 (1H, dddd, J= 3,3.5,5.5, 13.5 Hz, HC-5"), 2.36 (IH, dd, J= 10,
13.5 Hz, HC-2"), 2.27 (1H, br d, J= 13 Hz, HC-6), 2.19 (1H, dddd, J= 2.5,3,3,11 Hz,
HC-5), 2.18-2.11 (2H, m, HC-2, HC-3"), 2.02 (1H, dddd, J = 2, 3, 3, 11.5 Hz, HC-3),
1.84 (IH, dddd, J= 3.5,9.5, 11, 13.5 Hz, HC-5"), 1.83-1.75 (IH, m, HC-5);
13C NMR (125 MHz, CDCh) () 94.87, 80.35, 79.75, 65.94, 56.43, 45.84, 42.73, 34.67,
32.80, 29.17, 26.95, 26.33, 22.50;
LRMS (El), m/z (relative intensity): 308 ([Mt, 53), 159 (30), 129 (57), 117 (42), 101
(51), 100 (100), 99 (66), 67 (36).
HRMS m/z calcd for C13H2404S2 308.1116, found 308.1112 (El).
Data for 250:
IR Vrnax 3394, 2926, 1429, 1147, 1100, 1067, 1034, 915 cm- I ;
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IH NMR (500 MHz, CDC!)) 8 4.72 (lH, d, J = 6.5 Hz, H2CO), 4.69 (lH, d, J = 6.5
Hz, H2CO), 3.76 (lH, ddd, J = 3.5, 8, 9.5 Hz, HC-4), 3.75 (lH, dd, J = 3.5, 7 Hz, HC-
1'), 3.62 (lH, ddd, J = 4, 9, 10.5 Hz, HC-4"), 3.41 (3H, s, H3CO), 2.87 (lH, br d, J =
13.5 Hz, HC-2), 2.81-2.73 (lH, m, HC-6), 2.72-2.60 (4H, m, HC-2, HC-2", H2C-6"),
2.57 (lH, ddd, J = 3, 10, 13 Hz, HC-6), 2.40 (lH, dd, J = 11, 13.5 Hz, HC-2"), 2.36
(lH, dddd, J = 3, 3.5, 7, 13.5 Hz, HC-5), 2.27 (lH, dddd, J = 3, 4, 4, 13 Hz, HC-5"),
2.10 (lH, dddd, J= 3.5,3.5,8,8 Hz, HC-3), 2.02 (1H, dddd, J= 3.5, 7.5, 9,11 Hz, HC-
3"), 1.85 (lH, dddd, J = 3, 9.5, 10, 13.5 Hz, HC-5), 1.77 (1H, dddd, J = 4, 10, 10.5, 13
Hz HC-5")·, ,
13C NMR (125 MHz, CDC!)) 8 95.71, 81.12, 76.02, 74.48, 56.05, 48.84, 44.32, 36.95,
32.69,31.01,30.20,27.47,26.18;
LRMS (EI), m/z (relative intensity): 308 ([Mt, 56), 159 (35), 129 (87), 117 (55), 101
(52), 100 (100), 99 (70), 67 (42).
HRMS m/z calcd for C13H2404S2 308.1116, found 308.1118 (EI).
(Is, 3'S*, 3"R*, 4'S*, 4"R*)-Bis[tetrahydro-4-hydroxy-2H-thiopyran-3-
yl]methanol (251).
HO OH OH
5'~5"
6' ~s) 2' 2~S) 6" 251
Following General procedure J for hydrolysis of MOM ethers, diol 250 (14 mg,
0.045 mmol) gave the titled triol (9 mg, 75%) after fractionation by MPC (800/0 ethyl
acetate in hexane):
IR Vrnax 3345, 2925, 2848, 1429, 1336, 1283, 1068, 1034 cm- I ;
IH NMR (500 MHz, CD30D) 8 3.86 (1H, t, J= 5.5 Hz, HC-1), 3.66 (2H, ddd, J= 3.5,
10, 10 Hz, HC-4', HC-4"), 2.71 (2H, dd, J = 3, 13.5 Hz, HC-2', HC-2"), 2.64-2.58 (4H,
m, H2C-6', H2C-6"), 2.54 (2H, dd, J= 10.5,13.5 Hz, HC-2', HC-2"), 2.22 (2H, dddd, J=
3.5,4,4, 13 Hz, HC-5', HC-5"), 2.02 (2H, dddd, J= 3, 5.5,10,10.5 Hz, HC-3', HC-3"),
1.74-1.66 (2H, m, HC-5', HC-5");
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13C NMR (125 MHz, CD30D) 8 79.30 (d), 72.33 (d x2), 49.52 (d x2), 37.75 (t x2),
31.08 (t x2), 27.86 (t x2);
LRMS (El), m/z (relative intensity): 264 ([M]+, 53), 129 (86), 101 (34), 100 (100), 99
(49), 87 (47), 85 (36), 67 (38).
HRMS m/z calcd for CIIH2003S2 264.0854, found 264.0856 (El).
(3'S*, 4S*, 4aR*, 4'S* 8aR*)-4a,7,8,8a-Tetrahydro-4-[tetrahydro-4-
(methoxymethoxy)-2H-thiopyran-3-yl]-4H,5H-thiopyrano[4,3-d]-t,3-dioxin-2-one
(252).
o
MOMQ O~O
- 3' - 4 -5'~8
6' ~s) 2' 5"'s) 7 252
Following General procedure G, the trans diol250 (4 mg, 0.013 mmol) gave the
titled carbonate (4 mg, 92%) after fractionation by PTLC (70% ethyl acetate in hexane):
IR Vrnax 2920, 1751, 1225, 1190, 1116, 1093, 1031, 919 cm- I ;
IH NMR (500 MHz, CDCh) 8 4.68 (2H, ap s, H2CO), 4.12 (IH, dd, J = 1.5, 10 Hz,
HC-4 eJHC-4IHC-4a = 10 Hz]), 3.97 (IH, ddd, J = 4.5, 11, 11 Hz, HC-8a), 3.75 (lH, ddd,
J = 4, 10, 10.5 Hz, HC-4'), 3.37 (3H, s, H3CO), 2.90 (lH, dd, J = 11.5, 13.5 Hz, HC-2'),
2.83 (IH, ddd, J= 2.5,3, 13 Hz, HC-5), 2.77 (1H, ddd, J= 3, 12.5, 14 Hz, HC-7), 2.71
(IH, ddd, J= 3.5, 4.5, 14 Hz, HC-7), 2.68-2.61 (3H" HC-4a, H2C-6'), 2.55 (IH, dddd, J
= 3.5, 3.5, 4,13.5 Hz, HC-5'), 2.51 (IH, br d, J= 13.5 Hz, HC-2'), 2.44 (IH, dddd, J=
3, 3.5, 4.5, 13 Hz, HC-8), 2.41 (IH, dd, J = 11, 13 Hz, HC-5), 2.12 (IH, dddd, J = 1.5,
3, 10, 11.5 Hz, HC-3'), 1.88 (1H, dddd, J= 4.5, 11, 12.5, 13 Hz, HC-8), 1.75 (IH, dddd,
J = 5, 10.5, 10.5, 13.5 Hz, HC-5');
13C NMR (125 MHz, CDCh) 8 148.73, 96.38, 86.60, 80.50, 76.78, 56.21,45.01,42.36,
34.67,33.04,31.57,28.87,27.18,27.02;
LRMS (El), m/z (relative intensity): 334 ([Mr, 100), 272 (85), 271 (86), 201 (44), 139
(57), 137 (38), 99 (75), 67 (42).
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HRMS m/z calcd for Cl4H2205S2 334.0909, found 334.0909 (EI).
(3R,4s,5S)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-
[(S)-(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4-hydroxy-
2H-thiopyran (257)
10"
257
Prepared by C. C. Man from reduction of 165d (Cs anti) with DIBAL-H.3o
Included here for completeness only.
-I
IR (DRIFT) Vmax 3460, 2952, 2916, 1426, 1160, 1107, 1045 cm .
IH NMR (300 MHz, C6D6) 8 5.10 (lH, br s, HC-4), 4.32 (lH, br d, J = 3, 7 Hz, HC-1',
HC-1"), 3.50-3.18 (15H, m, HO x3, H2CO x4, H2C-3, H2C-5), 3.12 (2H, dd, J= 10,14
Hz, HC-7', HC-7"), 2.84 (2H, br d, J= 14 Hz, HC-7', HC-7"), 2.58 (2H, ddd, J= 3,11,
14 Hz, HC-9', HC-9"), 2.32 (2H, br d, J= 14 Hz, HC-9', HC-9"), 2.20-2.00 (4H, m, HC-
3, HC-5, HC-6', HC-6"), 1.71 (2H, ddd, J= 3,5.5,13.5 Hz, HC-10', HC-10"), 1.58 (2H,
ddd, J= 3.5, 11, 13.5 Hz, HC-10', HC-10").
13
C NMR (75 MHz, CDCb) 8 110.0 (s x2), 70.5 (d x2), 64.6 (t x2), 64.4 (d), 64.2 (t
x2), 47.1 (d x2), 46.1 (d x2), 35.8 (t x2), 26.6 (t x2), 26.6 (t x2), 24.7 (t x2).
LRMS (EI), m/z (relative intensity): 494 ([M]+, 14), 414 (10), 273 (11), 255 (12), 189
(14),161 (17), 132 (70),117 (19),99 (100).
HRMS m/z ca1cd for C21H3407S3 494.1467, found 494.1467 (EI).
Anal. Calcd for C21H3407S3: C, 50.99; H, 6.93. Found: C, 51.12; H, 7.01.
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(aR,6S)-rel-a-[(4S,4aS,8S,8aR)-4-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yltetrahydro-2,2-dimethyl-4H,5H-thiopyrano[4,3-d]-1,3-dioxin-8-yl]-1,4-dioxa-8-
thiaspiro[4.5]decane-6-methanol (258)
2" 3" X 3 2
ol""b 0 9 HO 0/\0
4a - 8'
10" 6" 1":: 8a :: ex 6
258
Prepared by Dr. C. Guo from reaction of XX with dimethoxypropane in the
presence ofp-TsOH.3° Included here for completeness only.
-1
IR (DRIFT) Vmax 3515, 2915, 1425, 1258, 1222, 1167, 1107, 1066, 1046, 1028 cm .
1
H NMR (300 MHz, C6D6) 8 4.68 (lH, br s, HC-8a), 4.35 (lH, ddd, J = 2.5, 3, 8.5 Hz,
HC-a), 3.93 (lH, dd, J = 5.5, 5.5 Hz, HC-4'), 3.29 (lH, d, J = 3 Hz, HO), 3.41-2.80
(l4H, m), 2.74 (lH, br d, J = 14 Hz), 2.68-2.51 (3H, m), 2.45 (1H, dd, J = 4, 13 Hz),
2.25-2.17 (4H, m), 1.93 (lH, ddd, J = 3, 5.5, 8.5 Hz, HC-4a), 1.80-1.50 (4H, m), 1.49
(3H, s), 1.35 (3H, s).
13
C NMR (75 MHz, C6D6) 8 110.9 (s), 109.3 (s), 101.6 (s), 72.1 (d), 69.6 (d), 64.9 (t
x2), 64.5 (t), 64.4 (t), 63.9 (d), 50.4 (d), 47.3 (d), 44.9 (d), 44.6 (d), 37.0 (t), 36.7 (t),
29.0 (t), 28.6 (t), 27.4 (t), 27.0 (t), 26.9 (q), 26.8 (t), 25.5 (t), 24.1 (q).
LRMS(EI), m/z (relative intensity): 534 ([M]+, 6),458 (4), 189 (8), 159 (14), 132 (53),
99 (100), 86 (12), 67 (17).
HRMS m/z calcd for C24H3807S3 534.1780, found 534.1783 (EI).
(3R,5R)-rel-3,5-bis[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-
tetrahydro-4-hydroxy-2H-thiopyran (260)
10"
260
Prepared by Dr. C. Guo from reduction of 165e (C2 anti) with DIBAL-H.3o
NMR assignment and analysis this work.
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-I
IR (DRIFT) Vmax 3435, 2919, 1427, 1259, 1158, 1133, 1107, 1044 cm .
1H NMR (500 MHz, CDCb) D4.57 (1H, d, J = 9 Hz, HC-4), 4.35 (lH, br d, J = 3 Hz,
HC-1' or HC-1"), 4.32 (lH, d, J= 7.5 Hz, HC-1" or HC-1'), 4.10-3.94 (8H, m, H2CO
x4), 3.39 (3H, br s, HO x3), 3.07-2.99 (3H, m), 2.89 (lH, dd, J = 10, 13 Hz), 2.86-2.77
(2H, m), 2.74 (1H, ddd, J = 2.5, 3, 14 Hz), 2.61 (lH, ddd, J = 2.5, 3, 14 Hz), 2.55-2.49
(2H, m), 2.24 (1H, dd, J = 3, 13 Hz), 2.18-2.09 (5H, m), 2.04-2.01 (2H, m), 1.76-1.70
(2H, m).
13C NMR (75 MHz, CDCb) D110.2 (s), 110.1 (s), 70.7 (d), 68.6 (d), 68.5 (d), 64.8 (t),
64.7 (t), 64.2 (t x2), 47.4 (d), 46.8 (d), 42.2 (d), 40.5 (d), 36.5 (t), 36.1 (t), 26.7 (t), 26.6
(t x2), 25.3 (t), 25.7 (t), 25.6 (t).
LRMS (EI), m/z (relative intensity): 494 ([M]+, 7), 273 (20), 189 (12), 161 (14), 159
(16), 132 (62), 117 (17), 99 (100).
HRMS m/z calcdfor C21H3207S3 494.1467, found 494.1467 (EI).
Anal. Calcd for C21H3207S3: C, 50.99; H, 51.02. Found: C, 6.93; H, 6.89.
(as,6R)-rel-a-[(4S,4aS,8R,8aR)-4-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yltetrahydro-2,2-dimethyl-4H,5H-thiopyrano[4,3-d]-1 ,3-dioxin-8-yl] -1,4-dioxa-8-
thiaspiro[4.5]decane-6-methanol (261)
2(-\" X 31\
o 0 0 9 H9 0 0
4a - 8' -
10" 6" 1" :: 8a a:: 6 10
- -
............ ............
9" S 7" 5' S 7' 7 S 9 261
Prepared by Dr. C. Guo from reaction of 260 with dimethoxypropane in the
presence ofp-TsOH.3o NMR assignment and analysis this work.
, -1
IR (DRIFT) Vmax 3509, 2915, 1427, 1378, 1260, 1223, 1161, 1110, 1046 cm .
1H NMR (500 MHz, CDCb) D4.55 (lH, d, J= 9.5 Hz, HC-a), 4.21 (lH, dd, J= 3,3.5
Hz, HC-4'), 4.12-3.99 (3H, m), 3.97-3.91 (5H, m), 3.74 (lH, dd, J = 3, 6 Hz, HC-8a),
3.14 (1H, s, HO), 3.05-2.75 (6H, m), 2.72 (1H, br d, J= 14 Hz), 2.58-2.47 (3H, m), 2.30
(1H, dd, J= 3.5,13 Hz), 2.21-2.15 (2H, m, HC-10, HC-10"), 2.10 (lH, dddd, J= 3.5, 4,
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6, 12 Hz, HC-4a), 2.06-1.97 (2H, m), 1.97-1.89 (2H, m, HC-6", HC-8'), 1.78-1.68 (2H,
m, HC-10, HC-1 Oil), 1.32 (3H, s, H3C), 1.31 (3H, S, H3C).
13
C NMR (75 MHz, CDCh) () 110.4 (s), 108.9 (s), 101.0 (s), 70.6 (d), 67.8 (d), 65.0 (t),
64.8 (t x2), 64.3 (t), 64.2 (d), 51.2 (d), 46.3 (d), 40.4 (d), 39.9 (d), 37.4 (t), 36.4 (t), 27.4
(t), 27.0 (t), 26.8 (t x2), 26.2 (q), 25.7 (t), 25.4 (t), 23.8 (q).
LRMS (EI), m/z (relative intensity): 534 ([M]+, 10),458 (6), 281 (6), 189 (9), 159 (14),
132 (50), 117 (6), 99 (100).
HRMS m/z calcd for C24H3807S3 534.1780, found 534.1776 (EI).
(as,6R)-rel-a-[(4S,4aS,8R,8aS)-4-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yltetrahydro-2,2-dimethyl-4H,5H-thiopyrano[4,3-d]-1,3-dioxin-8-yl]-1,4-dioxa-8-
thiaspiro[4.5]decane-6-methanol (262)
2" 3" X 3 2
o~ 0 0 H90/\o
4a 8'-
10"
262
Prepared by Dr. C. Guo from reaction of 260 with dimethoxypropane in the
presence ofp-TsOH.30 NMR assignment and analysis this work.
-1
IR (DRIFT) Vmax 3513, 2915, 1425, 1378, 1308, 1167, 1107, 1065, 1046cm .
1
H NMR (500 MHz, CDCh) () 4.84 (lH, br dd, J = 2.5, 9.5 Hz, HC-a), 4.26 (IH, d, J =
2.5 Hz, HO), 4.22-4.17 (1H, m), 4.13-4.09 (1H, m), 4.03-3.85 (6H, m), 3.93 (lH, dd, J
= 1.5, 10.5 Hz, HC-4'), 3.89 (lH, dd, J = 4.5, 11 Hz, HC-8a), 3.14 (lH, dd, J = 12, 14
Hz), 3.00 (IH, dd, J = 12, 14 Hz), 2.98-2.83 (3H, m), 2.65 (1H, ddd, J = 2.5, 2.5, 14
Hz), 2.55-2.43 (IH, m), 2.33 (IH, dd, J = 11.5, 14 Hz), 2.05-2.07 (lH, dddd, J = 2.5,
10.5, 11, 11 Hz, HC-4a), 1.84 (lH, dd, J = 3, 3.5, 13.5 Hz, HC-10 or HC-10"), 2.08-
2.01 (3H, m, HC-6", HC-8', HC-10 or HC-I0"), 1.86 (IH, dd, J = 3, 11.5 Hz, HC-6'),
1.76 (lH, ddd, J = 3.5, 13, 13.5 Hz, HC-10 or HC-10"), 1.72 (lH, ddd, J = 4, 13, 13.5
Hz, HC-1 0 or HC-l Oil), 1.39 (3H, s, H3C), 1.33 (3H, S, H3C).
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13
C NMR (75 MHz, CDCh) 8 110.5 (s), 110.3 (s), 102.8 (s), 68.7 (d), 68.6 (d), 67.4 (d),
65.4 (t), 65.1 (t), 65.0 (t), 64.4 (t), 50.4 (d), 47.6 (d), 40.9 (d), 38.4 (t), 38.2 (t), 37.9 (d),
31.3 (t), 30.2 (q), 29.3 (t), 27.1 (t), 27.0 (t), 26.8 (t), 26.7 (t), 18.8 (q).
LRMS (EI), m/z (relative intensity): 534 ([M]+, 7), 458 (4), 189 (7), 159 (14), 132 (57),
99 (100), 86 (12), 67 (11).
HRMS m/z calcd for C24H3807S3 534.1780, found 534.1779 (EI).
(3S,5S)-rel-3,5-bis[(S)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-
tetrahydro-4-hydroxy-2H-thiopyran (264)
10"
264
Prepared by Dr. C. Guo from reduction of 165c (C2 syn) with DIBAL-H.3°
Included here for completeness only.
-1
IR (DRIFT) Vmax 3501, 2917, 1427, 1260, 1131, 1116, 1048, 1035 em .
I H NMR (300 MHz, CDCh) 84.79 (1H, d, J= 10.5 Hz, H-4), 4.15-3.94 (9H, m, H-1'
or H-1", H2CO x4), 3.87 (lH, br d, H-1' or H-1"), 3.22 (lH, dd, J= 3.5,13.5 Hz), 3.09
(1H, dd, J = 12, 14 Hz), 3.04-2.88 (2H, m), 2.84-2.69 (4H, m), 2.65-2.59 (2H, m), 2.54-
2.48 (2H, m), 2.16-2.10 (3H, m), 2.02-1.92 (3H, m), 1.83-1.70 (2H, m).
13
C NMR (75 MHz, CDCh) 8 110.3 (s), 109.9 (s), 71.1 (d), 67.8 (d), 65.0 (d), 64.9 (t),
64.7 (t), 64.4 (t), 64.3 (t), 46.7 (d), 45.9 (d), 42.7 (d), 41.2 (d), 36.5 (t), 35.6 (t), 26.6 (t
x2), 26.5 (t), 25.8 (t), 23.4 (t), 22.7 (t).
LRMS (EI), m/z (relative intensity): 494 ([M]+, 8), 273 (12), 188 (16), 159 (15), 131
(71), 117 (15), 99 (100).
HRMS m/z calcd for C21H3407S3 494.1467, found 494.1467 (EI).
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(as,6R)-rel-a-[(4S,4aR,8S,8aS)-4-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yltetrahydro-2,2-dimethyl-4H,5H-thiopyrano[4,3-d]-1,3-dioxin-8-yl]-1,4-dioxa-8-
thiaspiro[4.5]decane-6-methanol (265)
2" 3" X 3 2
6"0 0 0 H90/\o
4a 8'-
10"
265
Prepared by Dr. C. Guo from reaction of 264 with dimethoxypropane in the
presence of p-TsOH.3° Included here for completeness only.
-1
IR (DRIFT) Vmax 3529, 2921, 1426, 1260, 1198, 1170, 1151, 1112, 1046 cm .
1
H NMR (300 MHz, C6D6) 8 5.01 (lH, d, J = 10 Hz, HC-a), 4.23 (lH, d, J = 9.5 Hz,
HC-4'), 4.06 (lH, br s, HC-8a), 3.67-3.58 (lH, m), 3.40-3.50 (6H, m), 3.33-3.24 (lH,
m), 3.25-3.16 (3H, m), 3.11-2.99 (3H, m), 2.88 (1H, br dd, J = 8,13.5 Hz, HC-5'), 2.71-
2.50 (5H, m), 2.26-2.15 (5H, m), 1.81-1.66 (2H, m), 1.64-1.44 (2H, m), 1.42 (3H, s),
1.30 (3H, s).
13C NMR (75 MHz, C6D6) 8 111.0 (s), 109.6 (s), 100.0 (s), 72.7 (d), 69.8 (d), 66.3 (d),
65.2 (t), 65.1 (t), 64.4 (t), 64.0 (t), 48.3 (d), 45.2 (d), 42.5 (d), 37.4 (t), 37.2 (d), 36.1 (t),
30.4 (q), 30.0 (t), 27.1 (t x2), 26.9 (t), 24.6 (t), 22.3 (t), 19.7 (q).
LRMS (EI), m/z (relative intensity): 534 ([M]+, 26), 458 (10), 189 (14), 159 (14), 132
(60), 99 (100), 86 (11), 67 (14).
HRMS m/z calcd for C24H3807S3 534.1780, found 534.1775 (EI).
(3R,4R,5R)-rel-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-
[(S)-(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4-hydroxy-
2H-thiopyran (267)
10"
267
281
Prepared by Dr. C. Guo from reaction of 165a with DIBAL-H.3o Included here
for completeness only.
-I
IR (DRlFT) Vmax 3500, 2917, 1427, 1261, 1158, 1133, 1110, 1042 cm .
1
H NMR (300 MHz, CDCh) 84.72 (1H, d, J= 10 Hz, HC-l'), 4.23 (1H, br s, HC-l"),
4.18 (IH, dd, J = 1.5, 8 Hz, HC-4), 4.14-3.94 (10H, m), 3.13 (IH, dd, J = 3, 14 Hz),
3.06-2.93 (3H, m), 2.86-2.75 (3H, m), 2.61-2.49 (4H, m), 2.25 (lH, ddd, J = 2, 3, 10
Hz), 2.20-2.12 (4H, m), 1.94-2.06 (2H, m), 1.78-1.68 (2H, m).
13C NMR (75 MHz, CDCh) 8 110.6 (s), 110.5 (s), 71.0 (d), 67.8 (d x2), 65.1 (t), 64.9
(t), 64.4 (t), 64.3 (t), 46.9 (d), 46.1 (d), 42.8 (d), 41.2 (d), 36.5 (t), 36.3 (t), 26.8 (t), 26.7
(t), 26.5 (t), 25.8 (t), 24.4 (t), 24.3 (t).
LRMS (EI), m/z (relative intensity): 494 ([M]+, 7), 476 (4), 273 (11), 189 (13), 159
(12), 132 (60), 117 (15), 99 (100).
HRMS m/z calcd for C21H3407S3 494.1467, found 494.1462 (EI).
(4R,4aR,8S,8aR)-rel-4-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl-8-[(S)-(6R)-1,4-
dioxa-8-thiaspiro[4.5]dec-6-yl(hydroxy)methyl]tetrahydro-4H,5H-thiopyrano[4,3-
d]-1,3-dioxin-2-one (268)
10"
268
Prepared by Dr. C. Guo from the reaction of 267 with 1,1'-
carbonyldiimidazole.3o NMR assignment and analysis this work.
-I
IR (DRIFT) Vmax 3504, 2917, 1754, 1427, 1337, 1255, 1157, 1113, 1044 cm .
I H NMR (500 MHz, CDC!)) 84.89 (IH, br dd, J= 2.5,8 Hz, HC-1'), 4.49 (IH, br d, J
= 9 Hz, HC-4 [JHC-4-HC-4a = 9 Hz]), 4.24 (IH, dd, J= 4,10 Hz, HC-8a [JHC-8a-HC-4a = 10
Hz]), 4.13-3.92 (8H, m, H2CO x4), 3.40 (IH, br s, HO), 3.18-3.10 (2H, m), 2.98 (IH,
dd, J= 11,13.5 Hz, HC-7'), 2.92 (IH, ddd, J= 2,13, 13.5 Hz), 2.82-2.68 (4H, m), 2.57-
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2.42 (6H, m), 2.27 (1H, ddd, J = 2.5, 3, 11 Hz, HC-6'), 2.14 (lH, br dd, J = 2, 11 Hz,
HC-6"), 2.13-2.08 (2H, m, HC-10', HC-10"), 1.78-1.69 (2H, m, HC-10', HC-10").
13C NMR (75 MHz, CDCh) 8 147.7 (s), 110.5 (s), 108.0 (s), 82.4 (d), 78.8 (d), 65.9 (d),
65.2 (t), 65.0 (t), 64.9 (t), 64.6 (t), 48.2 (d), 47.5 (d), 39.4 (d), 37.7 (t), 36.1 (t), 34.9 (d),
30.3 (t), 30.1 (t), 26.8 (t), 26.7 (t x2), 26.2 (t).
LRMS (EI), m/z (relative intensity): 520 ([M]+, 6), 475 (13), 458 (2), 159 (19), 132
(52), 99 (100), 86 (12), 54 (14).
HRMS m/z calcd for C22H320gS3 520.1259, found 520.1257 (EI).
(aR,6S)-rel-a-[(4S,4aR,8S,8aS)-4-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yltetrahydro-2,2-dimethyl-4H,5H-thiopyrano[4,3-d]-1,3-dioxin-8-yl]-1,4-dioxa-8-
thiaspiro[4.5]decane-6-methanol (269)
2"3"=*: 32
01\0 0 0 HO 00
4a 8'
10" 8a :: a 6 10
",/
9" S 7" 5' S 7' 7 S 9 269
Prepared by Dr. C. Guo from the reaction of 267 with dimethoxypropane in the
presence ofp-TsOH.3° Included here for completeness only.
-1
IR (DRIFT) Vmax 3515, 2921, 1427, 1260, 1199, 1171, 1106, 1048 em .
1
H NMR (300 MHz, CDCh) 84.78 (IH, d, J = 10 Hz, HC-a), 4.36 (lH, br s, H-8a),
4.25 (IH, d, J = 8.5 Hz, HC-4'), 4.14-4.09 (2H, m), 4.04-3.89 (7H, m), 3.21-3.12 (2H,
m), 3.06-2.91 (2H, m), 2.82 (lH, dd, J = 12, 13.5 Hz), 2.77-2.52 (5H, m), 2.38 (lH, br
d, J = 13.5 Hz), 2.21-2.11 (2H, m), 2.06-1.97 (3H, m), 1.98-1.88 (2H, m), 1.81-1.69
(2H, m), 1.44 (3H, s), 1.39 (3H, s).
13C NMR (75 MHz, CDCh) 8 110.6 (s), 109.1 (s), 99.7 (s), 71.2 (d), 68.2 (d), 66.9 (d),
65.2 (t), 65.1 (t), 64.3 (t), 64.1 (t), 45.9 (d), 45.0 (d), 41.2 (d), 36.4 (t), 36.0 (d), 35.4 (t),
30.1 (q), 29.3 (t), 26.8 (t x2), 25.6 (t), 24.6 (t), 22.4 (t), 20.1 (q).
LRMS (EI), m/z (relative intensity): 534 ([M]+, 28), 458 (11), 326 (7), 199 (10), 189
(15), 159 (15), 132 (65), 99 (100).
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HRMS m/z calcd for C24H3807S3 534.1780, found 534.1782 (EI).
(4S,4aR,8S,8aS)-rel-4-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl-8-[(R)-(6S)-1,4-
dioxa-8-thiaspiro[4.5]dec-6-yl(1-imidazolecarbonyloxy)methyl]tetrahydro-4H,5H-
thiopyrano[4,3-d]-1,3-dioxin-2-one (270)
~N
o N-!J
2" 3" )l o=( 3' 2'
o~ 0 0 0 0/\0
4a 8'
10" 8a :: l' 6' 10'
9" S 7" 5 S/7 7' S 9' 270
Prepared by Dr. C. Guo from reaction of 267 with 1,1 '-carbonyldiimidazole.3o
NMR assignment and analysis this work.
-1
IR (DRIFT) Vmax 2917, 1755, 1752, 1392, 1283, 1241, 1211, 1099 cm .
1
H NMR (500 MHz, CDCb) 8 8.41 (IH, br s, ArH), 7.51 (1H, s, ArH), 7.22 (lH, s,
ArH), 6.26 (1H, d, J= 10.5 Hz, HC-l'), 4.62 (IH, br d, J= 9.5 Hz, HC-4), 4.59 (1H, br
s, HC-8a), 4.10-3.85 (6H, m), 3.80-3.73 (1H, m), 3.70-3.63 (1H, m), 3.19 (IH, dd, J =
2.5, 15 Hz, HC-7), 3.09 (1H, dd, J= 3, 14 Hz, HC-7"), 3.04 (1H, dd, J= 12.5,13 Hz,
HC-7'), 2.95 (1H, br d, J = 12 Hz, HC-4a), 2.83-2.56 (H, m), 2.51 (IH, br d, J = 10.5
Hz, HC-8), 2.48 (1H, br d, J= 14 Hz), 2.36 (lH, br d, J= 15 Hz, HC-7), 2.31 (lH, dd, J
= 2, 12.5 Hz, HC-6'), 2.25 (1H, ddd, J = 3, 9, 9.5 Hz, HC-6"), 2.15 (IH, ddd, J = 2.5, 3,
11 Hz, HC-I0' or HC-10"), 2.01-1.92 (IH, m, HC-I0' or HC-10"), 1.78-1.65 (2H, m,
HC-I0', HC-I0").
13C NMR (75 MHz, CDCb) 8 148.7 (s), 148.1 (s), 125.2 (d), 117.8 (d), 108.5 (s), 108.2
(s), 81.7 (d x2), 74.2 (d), 64.9 (t), 64.7 (t), 64.3 (t), 64.0 (t), 46.1 (d), 44.9 (d), 39.5 (d),
35.9 (t), 35.2 (t), 33.4 (d), 28.8 (t), 26.8 (t), 26.5 (t), 26.2 (t), 24.6 (t), 21.6 (t).
LRMS (EI), m/z (relative intensity): 614 ([M]+, 15), 481 (5), 159 (8), 132 (46), 99
(100), 86 (11), 69 (11), 67 (10).
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(38,4s,5R)-rel-3-[(R)-(68)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]-5-
[(8)-(6R)-1,4-dioxa-8-thiaspiro[4.5]dec-6-ylhydroxymethyl]tetrahydro-4-hydroxy-
2H-thiopyran (272)
10"
272
Prepared by Dr. C. Guo from the reaction of 165b with DIBAL-H.3o Included
here for completeness only.
-1
IR (DRIFT) Vmax 3510, 1427, 1338, 1261, 1159, 1133, 1111, 1043 cm .
I H NMR (300 MHz, CDCh) 8 4.24 (2H, dd, J= 3,5.5 Hz, HC-1', HC-1"), 4.07 (lH, br
s, HC-4), 4.05-3.95 (8H, m, H2CO x4), 3.03 (2H, dd, J = 13, 13.5 Hz, HC-2, HC-6),
2.96 (2H, dd, J = 9.5, 14 Hz, HC-7', HC-7"), 2.82-2.58 (6H, m), 2.47 (2H, dd, J = 2.5,
13.5 Hz, HC-2, HC-6), 2.09-2.19 (4H, m, HC-6', HC-6", HC-10', HC-10"), 1.88-1.92
(2H, dddd, J = 2, 2.5, 5.5, 13 Hz, HC-3, HC-5), 1.79 (2H, ddd, J = 3.5, 10, 13.5 Hz,
HC-10', HC-10").
13C NMR (75 MHz, CDCh) 8 109.0 (s x2), 72.3 (d x2), 72.0 (d), 64.8 (t x2), 64.6 (t
x2), 48.0 (d x2), 46.4 (d x2), 35.5 (t x2), 27.5 (t x2), 26.8 (t x2), 22.6 (t x2).
LRMS (EI), m/z (relative intensity): 494 ([M]+, 7), 476 (4), 273 (11), 189 (14), 159
(14), 132 (60), 117 (15), 99 (100).
HRMS m/z calcd for C21H3407S3 494.1467, found 494.1470 (EI).
273
1010"
(aR,6S)-rel-a-[(4S,4aR,8R,8aS)-4-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-
yltetrahydro-2,2-dimethyl-4H,5H-thiopyrano[4,3-d]-1,3-dioxin-8-yl]-1,4-dioxa-8-
thiaspiro[4.5]decane-6-methanol (273)
2"3"* 32
0/\0 0 0 HO 6'0
4a 8'
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Prepared by Dr. C. Guo form the reaction of 272 with dimethoxypropane in the
presence ofp-TsOH.3o Included here for completeness only.
-1
IR (DRIFT) Vmax 3516, 2919, 1426, 1261, 1200, 1158, 1104, 1039 cm .
1
H NMR (300 MHz, C6D6) 84.55 (lH, d, J= 9.5 Hz, HC-41), 4.43 (lH, dd, J= 2.5,6
Hz, He-a), 4.22 (lH, br s, HC-8a), 3.39 (lH, dd, J = 13, 13.5 Hz), 3.33-3.05 (13H, m),
2.96 (lH, br dd, J = 5.5, 13 Hz, HC-7"), 2.78-2.52 (4H, m), 2.23-2.31 (4H, m), 2.01
(lH, ddd, J= 4,5.5,9.5 Hz, HC-6"), 1.71 (lH, ddd, J= 3,5, 13.5 Hz), 1.62-1.54 (lH,
m), 1.50-1.36 (2H, m), 1.48 (3H, s), 1.40 (3H, s).
13C NMR (75 MHz, C6D6) 8 110.6 (s), 109.1 (s), 100.1 (s), 72.1 (d), 70.7 (d), 70.6 (d),
65.1 (t), 64.6 (t), 64.4 (t), 63.9 (t), 46.7 (d), 46.4 (d), 44.5 (d), 41.5 (d), 36.9 (t), 34.5 (t),
30.4 (q), 29.8 (t), 27.3 (t), 27.2 (t), 27.1 (t), 25.2 (t), 23.0 (t), 19.7 (q).
LRMS (EI), m/z (relative intensity): 534 ([M]+, 11), 458 (5), 414 (7), 199 (7), 189 (7),
159 (14), 132 (65), 99 (100).
HRMS m/z calcd for C24H3807S3 534.1780, found 534.1775 (EI).
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Figure At. Isomerization of a mixture of211st:211ac:211at (1 :98:1) with a total
aldol concentration of 0.03 M (4 mg in 0.6 ml) in the presence of imidazole
(0.4 M) in CDC!).
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Figure A2. Isomerization of a mixture of 211st:211ac:211at (94:4:2) with a total
aldol concentration of 0.03 M (4 mg in 0.6 ml) in the presence of imidazole
(0.4 M) in CDC!).
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Figure A3. Isomerization of a mixture of211st:211ac:211sc:211at (2:2: 1:95) with a
total aldol concentration of 0.03 M (4 mg in 0.6 ml) in the presence of
imidazole (0.4 M) in CDC!).
306
1=.~ anti, trans
--anti,cis
--syn,cis
-syn,trans
anti, trans
+ anti,cis
.A syn,cis
• syn,trans
300200100
time (hrs)
o...--------,------,.-------l
o
0.8
c
0 0.6..(.)
eu
...
....
Q)
0.4
"0
E
0.2
Figure A4. Isomerization of a mixture of211st:211ac:211at (1 :98: 1) with a total
aldol concentration of 0.03 M (4 mg in 0.6 ml) in the presence of imidazole
(0.8 M) in CDC!].
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Figure AS. Isomerization of a mixture of211st:211ac:211at (94:4:2) with a total
aldol concentration of 0.03 M (4 mg in 0.6 ml) in the presence of imidazole
(0.8 M) in CDC!].
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Figure A6. Isomerization ofa mixture of211st:211ac:211sc:211at (2:2:1 :95) with a
total aldol concentration of 0.03 M (4 mg in 0.6 ml) in the presence of
imidazole (0.8 M) in CDC!).
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Figure A7. Isomerization of a mixture of 165a (C}):165d (Cs anti) of 99: 1 with a
total aldol concentration of 0.03 M (8 mg in 0.6 ml) in the presence of
imidazole (0.40 M) in CDC!).
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Figure A8. Isomerization of a mixture of 165b (Cs syn):165a (C I ) of95:5 with a
total aldol concentration of 0.03 M (8 mg in 0.6 ml) in the presence of
imidazole (0.40 M) in CDC!).
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Figure A9. Isomerization of a mixture of 165a (C I ):165d (Cs anti) of 3:97 with a
total aldol concentration of 0.03 M (8 mg in 0.6 ml) in the presence of
imidazole (0.40 M) in CDC!).
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Figure AIO. Isomerization of a mixture of 165a (C I ):165d (Cs anti) of 99: 1 with a
total aldol concentration of 0.03 M (8 mg in 0.6 ml) in the presence of
imidazole (0.80 M) in CDC!).
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Figure All. Isomerization of a mixture of 165b (Cs syn):165a (C I ) of95:5 with a
total aldol concentration of 0.03 M ( 8 mg in 0.6 ml) in the presence of
imidazole (0.80 M) in CDC!).
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Figure A12. Isomerization of a mixture of 165a (C 1):165d (Cs anti): of 3:97 with a
total aldol concentration ofO.03M (8mg in 0.6ml)in the presence of
imidazole (0.80M) in CDCb.
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Figure A13. Isomerization of a mixture of212a (Cs syn):212b (C1):212c (Cs anti): of
1:98:1 with a total aldol concentration of 0.01 M (4mg in 0.6 ml) inthe
presence of imidazole (0.40 M) in CDCb.
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Figure A14. Isomerization of a mixture of212a (Cs syn):212b (C1):212c (Cs anti): of
92:5:3 with a total aldol concentration of 0.01 M (4 mg in 0.6 ml) in the
presence of imidazole (0.40 M) in CDC!).
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Figure AIS. Isomerization of a mixture of212b (CI):212c (Cs anti) of 4:96 with a
total aldol concentration of 0.01 M (4 mg in 0.6 ml) in the presence of
imidazole (0.40 M) in CDC!).
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Figure A16. Isomerization ofa pure 213a (>99:1) with a concentration of 0.01 M (4
mg in 0.6 ml) in the presence of imidazole (0.40 M) in CDC!).
1 1
0.8 0.5
s::
0 ~,.
+:i 0.6 0(.)
C'G 0 1500 3000~
.!e 0.4
0
E
0.2
--213a
-213b
0 @----,~213c
0 200 400 600 800 1000 -213d
time (hrs)
Figure A17. Isomerization of a mixure of213b:213d (95:5) with a total aldol
concentration of 0.01 M (4 mg in 0.6 ml) in the presence of imidazole (0.40
M) in CDC!).
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Figure A18. Isomerization ofpure of213c (>99:1) with a concentration of 0.01 M (4
mg in 0.6 ml) in the presence of imidazole (0.40 M) in CDC!).
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Figure A19. Isomerization of a mixure of213a:213b:213d (3:2:95) with a total aldol
concentration of 0.01 M (4 mg in 0.6 ml) in the presence of imidazole (0.40
M)inCDC!).
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